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Calorie restriction (CR) has been established as the only non-genetic 
method of altering longevity and attenuating biological changes associated with 
aging. This nutritional paradigm has been effective in nematodes, flies, rodents, 
dogs and possibly non-human primates. Its long history notwithstanding, little is 
known regarding the exact mechanism(s) of CR action or its potential impact on 
the hypothalamic-pituitary-gonadal (HPG) axis. The objectives of this project 
were to: 1) analyze neuroendocrine changes to the HPG axis that occur with 
aging and 2) evaluate the effects of moderate CR on reproductive function in 
male rhesus macaques. 
Pituitary gene expression profiling, semi-quantitative RT-PCR (sqRT-PCR) 
and immunohistochemistry showed circadian clock mechanism components 
present in three age categories of macaques, demonstrated age differences in 
expression for Per2, indicated differential expression of Per2 and Bmal1 at 
  
opposing time points and revealed daily rhythmic expression of REV-ERBα 
protein. These data indicate the ability of the macaque pituitary to express core-
clock genes, their protein products, and to do so in a 24-hour rhythm. 
Young Adult CON and CR pituitary gene expression profiles detected 
potential differential expression in <150 probesets. A decline in TSHR and CGA 
was detected in CR macaques as measured by sqRT-PCR. Other genes 
investigated showed no diet-induced changes. 
Young Adult CON and CR testicular gene expression profiles detected 
potential differential expression in <300 probesets although mRNA expression 
was not altered based on sqRT-PCR and real-time RT-PCR. Age-related and/or 
diet-induced changes in HSD17β3, INSL3, CSNK1E and CGA were observed in 
a separate experiment with CGA in Old Adult CR subjects returning to youthful 
levels.  
Semen samples were collected from Young Adult CON and CR 
macaques. Normal spermiogram measures, ZP-binding, AR assay and SCSA® 
were conducted and indicated no differences between CON and CR-treated 
animals. Both groups exhibited similar daily testosterone profiles with no 
differences in mean or maximum levels; however, daily minimum testosterone 
levels were lower in CON animals. 
It appears that moderate CR had limited impact on neuroendocrine or 
reproductive function in male rhesus macaques based on our selected endpoints. 
Thus, advantageous CR health benefits can be achieved without obvious 
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The past two decades have seen an upward trend in the average age of 
couples having children (Buwe et al., 2005). The average age of motherhood in 
the United States has increased from 21.4 years in 1971 to an all time high of 
25.1 years. Although some of this demographic shift can be attributed to lower 
teen birth rates, much of it is due to an increase in older women having children. 
Women between the ages of 35-45 years now have children at the highest levels 
in three decades (Thacker, 2004). Paralleling this rise, since 1980 there has 
been a 16-24% increase in the birth rate for U.S. fathers over age 35 years 
(Buwe et al., 2005; Eskenazi et al., 2003; Kidd et al., 2001). The increase in older 
adults having children can be traced to a number of factors.  The two biggest 
contributors, however, are socioeconomic pressures and the implementation of 
assisted reproductive technologies (ART) (Plas et al., 2000). This reality has 
driven a subsequent interest in understanding better the consequences of normal 
reproductive aging in both genders. 
The hypothalamic-pituitary-gonadal axis (HPG) is central to reproductive 
function and retains remarkable similarity across higher order taxa (Everett, 
1994).  After a period of latency early in life, the axis becomes activated at 
puberty. A period of reproductive maturity and activity follows, after which there is 
a period (variable in length) of reproductive senescence and loss of function. 




including fish, mollusks, rodents, rabbits, dogs, whales, elephants, domestic 
livestock and non-human primates. This decline, however, is not uniform and can 
vary depending on species and gender (Austad, 2001; Kirkwood and Austad, 
2000; Packer et al., 1998).  
The male primate HPG axis (Figure 1.1) appears particularly resilient and 
overt reproductive decline is almost negligible, as compared to females who 
undergo menopause. Subtle alterations do occur, however, resulting in 
decreased testosterone (T) levels and increased sperm abnormalities over time. 
Using rhesus macaques as a model, it was our intention to investigate these age-
related changes in order to gain a better understanding of overall decline to the 
system. In addition, we were interested in examining the potential effects of 




 The original search for a unifactorial cause of aging such as a gene or 
decline of a major body system has since been replaced with the view that aging 
is a complex multifactorial process (Weindruch and Walford, 1988; Weinert and 
Timiras, 2003).  The cascade of events that leads to normal aging may interact 
simultaneously at the molecular, cellular and systemic level. When these 
physiological systems go awry, the result is a disruption of functional organization 
that inhibits the organism’s ability to respond to stress. Aging then becomes the 




homeostatic imbalance, pathology and ultimately death (Weindruch and Walford, 
1988).  Put another way, aging is the progressive loss of function (including 
reproductive capacity) accompanied by increasing incidence of disease and 
mortality (Kirkwood and Austad, 2000). 
A few examples of age-related homeostatic imbalance include decreased 
stress response, increased pathology, decline in memory function and 
documented alterations in circadian organization, such as changes in hormonal 
rhythms, core body temperature, sleep/wake cycles, and response to the phase-
shifting effects of light (Asai et al., 2001; Hofman and Swaab, 2006; Oster et al., 
2003). Although the physiological underpinnings remain unclear for many of 
these parameters, studies of circadian function suggest that the amplitude of the 
hypothalamic circadian pacemaker is decreased in older animals (Kolker et al., 
2003) while some findings have shown deterioration of transcription and 
rhythmicity in peripheral tissues, including lung and aortic/cardiac muscle cells 
(Kunieda et al., 2006; Yamazaki et al., 2002). 
 There are a host of theories that attempt to explain normal aging.  They 
can often be categorized into evolutionary, molecular, cellular and systemic 
theories. Several of them will be briefly summarized, including the Disposable 
Soma Theory, Gene Regulation Theory, Free Radical Theory and 
Neuroendocrine Theory. Each may adequately describe some or all of the 
observed aging processes alone or in combination with other theories (Kirkwood 





 Disposable Soma Theory 
 The Disposable Soma Theory proposes that lifespan is dictated by life 
history trade-offs involving optimal allocation of metabolic resources between 
somatic maintenance and reproduction (Kirkwood and Austad, 2000). Selective 
pressures have incredible power to shape life history patterns over evolutionary 
time, especially when imposed during juvenile or early adult development. These 
forces can ultimately lead to large species differences in the age of sexual 
maturation, size and spacing of litters and the age at which fecundity begins to 
fall. Genetic loci responsible for these parameters are likely to be important 
mediators that allow organisms to adapt to situations where changes in intrinsic 
mortality rate permit a decelerated life history schedule. In other words, animals 
may have the innate ability to shift metabolic resources from growth and 
reproduction to improved somatic maintenance and repair when forces of 
extrinsic mortality are lessened (Kirkwood and Austad, 2000; Miller et al., 2002). 
Such a shift would effectively slow aging and prolong disease resistance and 
health. Lifespan thus becomes a species specific function of survivability and 
reproductive strategy in a competitive environment; the balance of resources 
invested in longevity versus reproduction determines lifespan. Organisms that die 
primarily from predation and environmental interactions will evolve a lifespan 
optimal for their own particular niche (Weinert and Timiras, 2003). The 
Disposable Soma Theory explains why an organism lives for a given period of 
time, but it makes no attempt to explain the underlying molecular nature of aging. 




exact their effect through hormonal and other developmental pathways (Miller et 
al., 2002; Weinert and Timiras, 2003).  In this regard, this theory overlaps with 
the second theory, Gene Regulation. 
 
 Gene Regulation Theory 
 The Gene Regulation Theory proposes that senescence results from 
changes in gene expression. Selective pressures would give an organism a 
distinct advantage if it was able to utilize genes that promote longevity (Weinert 
and Timiras, 2003). The recent development of microarray technology has 
allowed for the transcriptional profiles of normal aging in a wide variety of 
species. The resulting data can then be compared to profiles generated by 
interventions intended to slow or accelerate aging. By making such comparisons 
gene expression changes can be identified which may help unlock the key 
genetic components to aging systems. One example of this is the identification of 
an insulin-like signaling pathway or its homolog that can modify lifespan in yeast, 
nematodes, flies and mice (Kenyon, 2001; Weinert and Timiras, 2003). Lifespan 
extension results from the activation of a conserved transcriptional factor 
following insulin-like signaling reduction. This model indicates that gene 
expression can regulate lifespan. Whether this system or an analogous system is 
conserved in longer lived model organisms remains to be determined.  And while 
regulation of gene expression may start the cascade, lifespan extension in this 




particularly to reactive oxygen species (ROS). Both these responses are 
observed in these models (Kenyon, 2001). 
 
 Free Radical Theory 
 The Free Radical Theory proposes that aging is caused by cumulative 
oxidative damage generated by free radical-containing ROS produced during 
normal cellular respiration (Koubova and Guarente, 2003; Weinert and Timiras, 
2003). Free radicals are highly reactive molecules that carry an unpaired electron 
on their surface. They are prone to indiscriminately and destructively oxidize any 
compound they encounter. Because approximately 90% of cellular oxygen is 
consumed in the mitochondria, and 3% of molecular oxygen reduced by 
mitochondria is not reduced to water, mitochondria may be the major intracellular 
contributor to superoxide (O2-.) generation and to oxidative stress in general 
(Huang and Manton, 2004). The Mitochondrial Theory of aging, a variant to the 
Free Radical Theory, suggests that accumulation of damage to mitochondria, 
mitochondrial DNA, and RNA specifically leads to aging in humans and animals 
(Weinert and Timiras, 2003). A growing body of evidence and experimental 
support implicates mitochondrial derived ROS as a major cause of cellular 
decline. A direct relationship between individual age, species longevity and rate 
of mitochondrial ROS production has been documented (Gredilla and Barja, 
2005; Kirkwood and Austad, 2000; Weinert and Timiras, 2003). Production 
results from leakage of the mitochondrial electron transport chain under normal 




eliminate the resulting superoxide anion by converting it into hydrogen peroxide 
(H2O2) via superoxide dismutase (SOD). Catalase then converts H2O2 to 
molecular oxygen and water. This defense, however, is not always completely 
effective. Excessive ROS production may overwhelm the antioxidant capacity of 
cells thereby initiating a pathogenic cascade of events. In addition, age-related 
impairment in respiratory enzymes decreases ATP synthesis and enhances ROS 




The Neuroendocrine Theory proposes that aging is a result of neural and 
endocrine functional changes which are crucial for 1) coordinated communication 
and response of an organism to its environment, 2) programming physiological 
responses to that environment, and 3) maintaining an optimal functional state to 
balance reproduction and survival while responding to environmental needs 
(Weinert and Timiras, 2003). A major component of this theory is the perception 
of the hypothalamus and pituitary gland as critical pacemakers of the system. 
These two organs occupy a unique niche within the neuroendocrine system by 
acting as a connecting point between reproduction (via the HPG axis) and stress 
response (via the hypothalamic-pituitary-adrenal axis; HPA). In this regard the 
neuroendocrine theory is really a more holistic approach which recognizes that 
aging must depend more on interrelations between hormonal and neural signals 




the HPG/HPA axes, in which aging may change responses but where it is difficult 
to decide which comes first, is a good example of the quandary of 
neuroendocrine aging. It illustrates why studies of reproductive senescence, 
which at first may seem of rather secondary interest with respect to ‘true’ 
senescence, remains a fertile field for aging research (Weindruch and Walford, 
1988). 
 
Overview of Reproductive Decline 
 In humans, female fertility can begin to decline in early thirties and 
culminates with complete reproductive quiescence at approximately 50 years of 
age (Buwe et al., 2005; Kidd et al., 2001).  Thus, female aging leads to complete 
elimination of reproductive potential thought to stem from the dramatic loss of 
ovarian follicles. Reproductive aging in men typically follows a more gradual 
course than in females. The age-related demise seen in male reproduction may 
be due to functional deterioration of the system at several sites including 
testosterone synthesis in the Leydig cells, hypothalamic production of 
gonadotropin-releasing hormone (GnRH), pituitary gland release of 
gonadotropins and/or other integrative neuroendocrine components that impact 
the HPG axis as a whole (Harman et al., 2001; Moffat et al., 2002; Ottinger, 
1998). Still, men generally do not undergo an unavoidable and distinct cessation 
of reproductive capacity as spermatogenesis continues well into old age with no 
known critical threshold with respect to sperm production (Buwe et al., 2005; 




reported in a 94-year-old man (Plas et al., 2000). This does not mean, however, 
that there are no physiological changes. 
 One consequence of reproductive decline in men and women can be 
infertility, which has a major impact on public health.  In the United States 
approximately 15% of couples of reproductive age will experience difficulty 
conceiving and approximately 7% of married couples are not able to conceive 
after trying for a year (Eskenazi et al., 2003; Kidd et al., 2001). Depending on the 
figures used, the proportion of infertility that is attributable to male factors ranges 
from 25-50%, making it the single most common cause of infertility in clinical 
cases (Agarwal and Said, 2003; Eskenazi et al., 2003; Kidd et al., 2001; Larson-
Cook et al., 2003). In addition, the risk of spontaneous abortion is almost twice as 
high among men older than 45 years of age than among those aged less than 25 
years, even after adjusting for maternal age (Slama et al., 2005). The question of 
how paternal age influences fertility and reproductive outcome is not easily 
defined nor easily answered since there are no longitudinal studies. Instead, the 
alterations of semen parameters in the aging male are almost always described 
on the basis of cross-sectional sampling (Plas et al., 2000).  Several recent 
studies, however, have shown that many aspects of male fertility are affected by 
aging (Henkel et al., 2005; Kidd et al., 2001; Zubkova and Robaire, 2006). 
 In addition to age, external cues such as nutrition can have a substantial 
impact on the HPG axis of both genders. The recent phenomenon of increased 
average body mass index (BMI) experienced by the Western world has resulted 




typically increases as people get older so that reproductive capacity is not only 
impacted negatively by age but also by the pathologies often associated with 
obesity. In women, excessive amount and distribution of body fat has been 
previously linked to reduced fertility with prolonged time to pregnancy, increased 
risk of irregular menstrual cycles, preterm delivery, spontaneous abortion, 
stillbirths and birth defects (Fejes et al., 2005; Jensen et al., 2004; Kort et al., 
2006). Men with BMI>25 kg/m2 had lower sperm concentration and total sperm 
count compared to men with non-obese BMI (Jensen et al., 2004) while another 
study looked at 520 normal, healthy men, age 26-45 and found an inverse 
relationship between BMI and total number of motile sperm cells and a positive 
relationship between BMI and sperm DNA fragmentation per subject (Kort et al., 
2006). 
 
Male Reproductive Aging 
First and foremost, there is a documented decline in testosterone (T) 
production beginning after 30 years of age and continuing gradually for life 
(Hardy and Schlegel, 2004; Henkel et al., 2005; Ottinger, 1998; Stocco and 
Wang, 2006; Zirkin and Chen, 2000). Observations from the Massachusetts Male 
Aging Study show that total testosterone, often called the male hormone because 
of its ability to masculinize an organism, decreases 0.4-0.8% annually while 
biologically active free T serum levels decrease by 1.2-1.7% per year starting at 
the age of 50 (Henkel et al., 2005; Plas et al., 2000). In men, testosterone is 




system and predominantly drives production of spermatozoa. Consequently there 
is the potential for a cascade effect to the entire reproductive system with its fall. 
Testosterone decline can also result in weakening muscle function, bone density 
and other physiological parameters related to overall aging (Harman et al., 2001; 
Moffat et al., 2002). 
 The decline in circulating testosterone levels would be expected to 
stimulate increased GnRH production by the hypothalamus followed by 
increased production of luteinizing hormone (LH) at the level of the pituitary 
gland. Yet despite the loss of negative feedback, LH levels can reportedly 
respond with slight non-significant increases, unchanged levels, or non-
significant decreases (Hardy and Schlegel, 2004; Ottinger, 1998; Zirkin and 
Chen, 2000).  In contrast, follicle-stimulating hormone (FSH) increases due to 
loss of gonadal inhibin feedback from the Sertoli cells (Ottinger, 1998; Zirkin and 
Chen, 2000). Although T declines it may not be the best measure of general 
male aging since differences between young and old men are not always 
significant due to individual variation (Black and Lane, 2002).  Such variation is 
normal and is often observed in biological parameters of this nature (Henkel et 
al., 2005). 
 Other parameters of reproductive function and fertility of elderly men have 
traditionally focused strictly on semen analysis. Classical spermiograms include 
ejaculate volume, concentration, motility, morphology and count (Plas et al., 




suggests that increased male age is associated with decreased reproductive 
potential. 
The majority of studies suggest that there is a significant inverse 
relationship between semen volume and age (Zubkova and Robaire, 2006). The 
relative decrease reportedly ranges between 3% and 30% when comparing men 
<30 years of age to men 50 years of age or older (Henkel et al., 2005; Kidd et al., 
2001). One small study reported a decrease in semen volume of 0.03 mL per 
year for men between the ages of 22 and 80 (Eskenazi et al., 2003). Conversely, 
the weight of evidence from the literature suggests that sperm concentration 
remains constant or even increases with age (Henkel et al., 2005; Kidd et al., 
2001). These two observations, decreased volume and increased concentration, 
may be due to insufficient functioning of the accessory sex glands, particularly 
the seminal vesicles, in elderly men (Henkel et al., 2005). 
There are very consistent reports of significantly lower sperm motility in 
the range of 3-37% when comparing men >50 years to men <30 years of age 
(Kidd et al., 2001; Zubkova and Robaire, 2006). Overall, motility can decline 0.7-
4.7% per year depending on whether motility, progressive motility, or total 
progressive motility is measured (Eskenazi et al., 2003). The decrease in overall 
motility may be correlated with the observed decline of testosterone in older men. 
The epididymis, which is dependent on testosterone for its function, is intimately 
involved in sperm maturation and induction of sperm motility. Consequently, 
decreased concentrations of bioactive free T will lead to epididymal dysfunction 




Normal sperm morphology also appears to be negatively correlated with 
age (Zubkova and Robaire, 2006). In men >50 years morphologically abnormal 
sperm increased 4-22% compared to men <30 years old (Kidd et al., 2001). In 
another retrospective study of 1655 men between the ages of 17 and 66, normal 
sperm morphology was found to decline 0.47% annually (Henkel et al., 2005). 
Sperm count, which is a standard measure in most spermiograms, is 
generally not considered as good a measure of age as concentration or motility 
since sperm production is almost always in excess of that needed to realize 
fertility potential. Subfecund sperm counts are usually the result of some 
pathological condition. Additionally, there are high intra-individual variations in 
spermiogram measures obtained on different occasions, consequently cross-
sectional studies on single semen parameter determinations must be interpreted 
with caution (Plas et al., 2000). In general, however, most measures of male 
reproductive health exhibit no evidence of an age ‘threshold’ but rather display 
gradual changes over time (Eskenazi et al., 2003). 
More recently a new measure of male fertility that deals with DNA integrity 
has been investigated. This new assay sets quantifiable levels for reproductive 
success that are highly correlated with age. The assay takes advantage of the 
difference between male and female gamete meiotic potential to measure DNA 
integrity, an essential component for the accurate transmission of genetic 
information to the offspring. Since spermiogenesis is a continuous process 
starting during puberty, spermatagonia undergo high numbers of replications and 




linear increase of ~23 divisions per year thereafter. Thus, spermatogonia of a 28-
year-old father may have already undergone ~380 mitoses and DNA replications, 
which increases to 540 in a 35-year-old male. In contrast, complete oogenesis in 
female primates occurs prior to birth with relatively constant 22 cell divisions. Due 
to these high numbers, the risk of transcriptional DNA errors during sperm 
production increases (Buwe et al., 2005; Plas et al., 2000; Zubkova and Robaire, 
2006). The sperm chromatin structure assay (SCSA®) is a flow cytometric 
technique that uses semen to determine the susceptibility of sperm nuclear DNA 
to acid-induced DNA denaturation in situ. The resulting ratio of denatured single-
stranded DNA to total DNA gives a DNA fragmentation index (DFI) expressed as 
a percentage (Agarwal and Said, 2003; Evenson and Wixon, 2006). In multiple 
studies DFI levels >30% have proven incompatible with in vivo fertility and in vitro 
ART procedures (Bungum et al., 2004; Larson-Cook et al., 2003). Sperm 
susceptibility to DNA fragmentation increases with age so the importance of this 
assay cannot be understated. Overall, about one of 200 human livebirths 
possess a numerical or structural aberration which may severely affect the 
mental and physical integrity of a child (Buwe et al., 2005). Paternal (and 
maternal) age only increases the incidence of these disorders. There are 
approximately 20 different known genetic disorders correlated with paternal age 
(Thacker, 2004; Zubkova and Robaire, 2006), while children born to men 50 
years or older are three times more likely to develop schizophrenia than children 





Models of Reproductive Aging in Males 
The study of aging systems in humans can be very prohibitive due to cost, 
complex variables in lifestyle and time requirement. Therefore, there is a great 
need to find appropriate, alternative animal models. The ideal model of male 
reproductive aging would have similar endocrine and neuroendocrine aspects to 
human testicular biology. Additionally, if possible, the model should have 
reproductive traits which can be manipulated in the laboratory, i.e. transgene or 
natural mutations resulting in accelerated or delayed examples of testicular 
aging. It is important to be able to compare normal aging to accelerated and/or 
delayed models as a way of elucidating the aging process as well as the 
underlying mechanisms contributing to it. Two model systems, each with their 
own benefits and deficits, have made up the majority of studies. 
 
Rodent Models 
 The reasons for using rodent models in reproductive aging research are 
numerous. They are relatively short-lived, inexpensive to maintain and the 
availability of homogenous laboratory strains permit controlled research 
experiments. Overall life history, including health and reproductive parameters in 
rodents, are well characterized. Furthermore, genetic manipulation of specific 
genes has made it possible to study aspects of reproductive decline in transgenic 
models. Rodents also parallel many of the normal reproductive deficits observed 




 In the Brown Norway (BN) rat, decreased serum and intratesticular 
testosterone levels as a result of impaired Leydig cell steroidogenesis have been 
reported (Chen et al., 2002; Syntin et al., 2001; Zirkin and Chen, 2000). Decline 
in steroidogenic pathway production within these cells appears to be due to 
malfunction of the pathway itself rather than a loss of Leydig cell numbers (Chen 
et al., 1996; Chen and Zirkin, 1999; Zirkin, 2006). Serum LH levels do not decline 
as a result of steroid loss, but there are measurable changes in LH pulse and 
interval (Chen et al., 2002). In both humans and rodents, age-related loss in the 
numbers of spermatogenic cells within the seminiferous tubules begins focally 
with atrophic tubules often adjacent to tubules exhibiting normal 
spermatogenesis. Eventually the loss of germ cells will spread throughout the 
testis causing a progressive loss of testis weight in the rat (Syntin et al., 2001). 
With increasing age rodent epididymal epithelium acquires morphological 
hallmarks of decay (Jervis and Robaire, 2003) including significantly greater 
levels of reactive oxygen species produced by Leydig cell mitochondria when 
compared to younger males (Chen et al., 2001; Chen et al., 2004). Finally, 
spermatozoa from older rats have altered chromatin packaging and integrity 
(Zubkova and Robaire, 2006). 
Also of importance is the neurological impact of reproductive decline, 
specifically of testosterone loss. Recently it has been understood that the brain is 
androgen-responsive and exhibits age-related T depletion, thus making it 
vulnerable to senescent effects of androgen loss. Studies show that men with 




AD. Importantly, testosterone depletion appears to occur well before clinical and 
pathological diagnosis of AD, suggesting that low T contributes to AD 
pathogenesis rather than results from it. This has been verified in 3xTg-AD mice 
(a triple transgenic mouse model of AD) in which androgen depletion accelerated 
the development of AD-like neuropathology, both in deposition of β-amyloid 
plaques and behavioral impairment. These effects were prevented with androgen 
treatment (Rosario et al., 2006).   
There are two reasons, however, why rodents may not be appropriate for 
the analysis of aging in mammals. Laboratory-adapted stocks of rodents 
experience selected pressures for rapid maturation and large body size. Along 
with genetic homogeneity, as a result of decades of structured breeding, the 
resulting stocks may have lost natural alleles that slow the aging process. As a 
result, the genetic and physiological mechanisms against late-life diseases and 
which time mammalian aging may have disappeared (Miller et al., 2002). 
Secondly, given the complexity of human physiology, it may be more 
advantageous to study organisms more phylogenetically similar. The best 
alternative for aging research applicable to human health may then be the use of 
non-human primates (NHP). 
 
Non-Human Primate Models 
The ideal model for investigating reproductive senescence would be 
actual human subjects since it would permit the most direct application of 




assisted reproductive technology has indeed supported the rapid advancement 
of research in human reproduction. Unfortunately, much of the demand is the 
result of postponement of childbearing and the increased incidence of infertility 
with age. Consequently, much of the information gained is collected at later life 
stages when reproductive senescence is more advanced. To understand the 
normal progression of reproductive decline, studies must be undertaken that can 
follow the entire aging process. In this regard non-human primates, in particular 
the rhesus macaque (Macaca mulatta), make very good models. 
Rhesus macaques adapt well to laboratory settings and have been used 
for the better part of a century in a number of research endeavors. A great deal is 
known about their general husbandry, nutritional requirements, breeding 
practices and veterinary care. As normal, healthy rhesus macaques get older, 
values for routine hematological and blood chemistry variables exhibit notable 
and likely biologically relevant variations. These age effects most likely reflect 
normal patterns of change associated with the aging process (Smucny et al., 
2001). Most importantly, the rhesus macaque shares 97.5% genetic homology to 
humans (Gibbs et al., 2007). This close genetic relationship produces a highly 
similar aging phenotype to humans and has been extensively reviewed 
elsewhere by Roth et al. (2004). Important parallels exist with regards to 
metabolism, body composition, cardiopulmonary system, reproduction and 
behavior. Disadvantages to rhesus macaques as research models include limited 
availability, cost of procurement and maintenance, risk of disease transmission 




sub-species designation as there are Chinese-origin and Indian-origin rhesus 
macaques. And with a maximum lifespan of 40 years, or roughly three times the 
rate of aging for humans, large investments of time, money and effort are still 
required for longitudinal studies with this species (Ingram et al., 1990; Roth et al., 
2004). 
Many fields of human health have indeed benefited from the use of rhesus 
macaques in research, including the study of female reproductive aging. There 
is, however, surprisingly little known about the effect of senescence on the male 
rhesus macaque system. Longitudinal studies are very few and when performed 
have focused on other systems of interest such as metabolism, immune function 
or cognitive and neural aging. Some of this can be attributed to the long held 
misperception that human males do not experience reproductive decline of any 
consequence. 
While there are several reports of semen collection in a number of NHP 
species (Ji et al., 2001; Morrell, 1997; Platz et al., 1980; Ramesh et al., 1998; 
Schaffer et al., 1992; Tollner et al., 1990; VandeVoort et al., 1993; Yeoman et al., 
1997), these studies are usually cross-sectional in nature. Often they are the 
result of single or short time-point measures with small sample sizes. Very often 
such reports come from zoos or research facilities maintaining breeding colonies 
of animals for ART development. Normally the goal in these settings is 
successful pregnancy and birth with female gametes receiving higher priority. 
When there is a problem on the male side, whether due to mate incompatibility, 




through the use of cryopreservation. While this may be the most effective way to 
manage time and resources in these circumstances, it does little to illuminate the 
problems and mechanisms behind male reproductive decline. 
There have been sporadic studies of testosterone measurement in rhesus 
macaques, but even these are contradictory. Some reports claim non-significant 
declines in testicular mass, serum T levels and pulsatile T release in aged 
animals (Black and Lane, 2002; Roth et al., 2004), while others show no 
evidence of different T levels with age (Mattison et al., 2003; Mattison et al., 
2001). This can perhaps be attributed to poor sampling and/or the fact that T 
levels vary widely amongst individuals, throughout the day and even from day-to-
day. It seems, however, that despite the value of rhesus macaques in 
investigating human systems of health, the area of male reproductive 
senescence remains wide open for study. 
 
Evaluating Reproductive Aging in Males 
When it comes to evaluating male reproductive potential there is no single 
measure which correlates perfectly with age. Although some, such as the sperm 
chromatin structure assay, can be highly predictive it is not necessarily an age 
specific test. And others, such as testosterone measures, take an enormous 
amount of effort to monitor long term as needed to draw any conclusions. What 
we are left with is the need for a comprehensive battery of tests which, when 
taken as a whole, can provide a general idea of reproductive health and ability. 




mentioned in the section on male reproductive aging or in Table 1.1 on page 40. 
They include count, concentration, weight, volume, pH, motility and morphology. 
These are typical spermiogram measures of semen production that are part of 
any standard fertility clinic or research protocol. There are also dozens of other 
more extensive tests which are not usually performed unless absolutely 
necessary due to cost and time constraints. For a review of these techniques see 
Jeyendran (2003). Four that are worth mentioning specifically, however, include 
the hypo-osmotic swelling (HOS) assay, sperm chromatin structure assay 
(SCSA®), zona pellucida binding and acrosome reaction assay (ZP binding and 
AR), and seminal plasma constituent analysis. 
 
Hypo-osmotic Swelling Assay 
One property of any cell membrane is to selectively regulate the 
movement of molecules across its surface. When exposed to hypo-osmotic 
conditions the cell will allow water to enter the cytoplasm in an attempt to reach 
osmotic equilibrium. Spermatozoa display this same ability. It can be assumed 
that the capacity of sperm to swell in the presence of a hypo-osmotic solution is a 
sign that membrane integrity and normal functional activity are intact. Membrane 
integrity is not only important for sperm metabolism, but critically timed changes 
in membrane properties are required for successful sperm activation, acrosome 
reaction and binding to the oocyte. Whereas histological techniques and ‘live-
dead’ morphology stains only measure whether the membrane is morphologically 




(Jeyendran et al., 1984). This assay is simple to run and demonstrates a high 
correlation between the percentage of sperm in an ejaculate that are capable of 
swelling and their ability to undergo activation and/or oocyte binding. As a result, 
the assay has been applied clinically in human fertility clinics as well as research 
settings with non-human primates (Jeyendran, 2003; Kholkute et al., 2000; 
Rutllant et al., 2003). 
 
Sperm Chromatin Structure Assay 
The sperm chromatin structure assay (SCSA®) mentioned earlier is the 
most statistically robust tool used to measure sperm nuclear DNA fragmentation 
and has proven highly effective in predicting fertility outcome both in vivo and in 
vitro (Larson-Cook et al., 2003). Sperm chromatin is normally a highly organized 
and compact structure. Consisting of DNA and heterogeneous nucleoproteins, it 
is condensed and insoluble to protect genetic integrity and allow for transport 
through the male and female reproductive tracts. Accumulating data suggest that 
alterations in genomic organization of the sperm nuclei are negatively correlated 
with the fertility potential of sperm. Recent reports by Evenson et al. (2006) have 
indicated that natural pregnancy is not possible when >30% of sperm DNA is 
damaged. It has also been suggested that sperm DNA integrity may be a more 
objective measure of sperm function compared to standard semen analysis, 
which can be very subjective and prone to intra- and inter-observer variability 
(Agarwal and Said, 2003). This is the case with in vitro fertilization (IVF) and 




sufficient to evaluate with precision sperm performance and may result in failure 
to form viable embryos even though sperm could fertilize the oocyte and trigger 
early preimplantation development. Findings such as these suggest that 
pathologically increased sperm DNA fragmentation is one of the main paternally 
derived causes of repeated assisted reproductive failures with ICSI (Tesarik et 
al., 2006). 
Of particular interest is the ability for SCSA® to distinguish between normal 
DNA degradation and that caused by exposure to ROS. Programmed cell death 
(apoptosis) is a physiological process in the seminiferous tubules and appears 
necessary for normal spermatogenesis, probably because it maintains an optimal 
cell number ratio between individual germ cell stages and Sertoli cells. In one 
study of 36 normal men between the ages of 53 and 88, accelerated apoptosis of 
primary spermatocytes was determined to be one of the causes of germ cell loss 
with aging (Kimura et al., 2003). Unlike apoptotic activity found in aging, the 
mechanisms of DNA damage detected in ejaculated sperm is related to oxidative 
damage brought about by ROS present in the fluid filling the male genital tract. 
Antioxidant treatment orally has been shown to reduce the percentage of DNA 
fragmented sperm markedly (Tesarik et al., 2006). 
 
Zona Pellucida Binding and Acrosome Reaction Assay 
  Eutherian spermatozoa cannot penetrate the zona pellucida (ZP), or 
glycoprotein membrane surrounding the oocyte, immediately after ejaculation. 




the ability to undergo the acrosome reaction, is required (Mortimer, 1994; 
Yanagimachi, 1994). Capacitation regulates the induction of the acrosome 
reaction and is marked by hyperactivation in motility of the sperm. The sequence 
of events leading to in vivo fertilization can thus be expressed as: ejaculation → 
capacitation → ZP binding → acrosome reaction → 
oocyte penetration → fertilization. An in vitro assay has been developed which 
quantifies the ability of collected sperm to complete this sequence (Jeyendran, 
2003; VandeVoort et al., 1992). 
In vivo capacitation normally occurs within the female reproductive tract, 
and while human sperm will spontaneously activate in vitro, rhesus macaque 
spermatozoa will not. Capacitation of rhesus macaque sperm in vitro is facilitated 
by exposure to two activators: caffeine and dbcAMP (VandeVoort et al., 1994). 
When capacitated sperm are exposed to whole oocytes or zona pellucida 
membranes in vitro, ZP binding will occur. This binding acts as a signal to induce 
the sperm acrosome reaction. 
The acrosome is a membrane bound, hydrolytic enzyme-containing 
organelle that overlies the anterior end of the sperm head. Following ZP binding 
but prior to actual fertilization, the outer acrosomal membrane fuses with the 
surrounding sperm plasma membrane resulting in formation of vesicles. The 
hydrolytic contents of the acrosome are then released through holes between the 
fused membranes and allow the underlying plasma membrane to fuse with the 
inner vitelline membrane of the oocyte. This fusion allows the sperm to eventually 




Almost all rhesus macaque sperm are intact upon ZP binding and 
although they will bind when exposed to heterologous or homologous ZP 
proteins in vitro, they will only acrosome react when exposed to a homologous 
sperm-ZP interaction (VandeVoort et al., 1992; VandeVoort et al., 1994). The ZP-
induced acrosome reaction occurs rapidly (VandeVoort et al., 1994), and unlike 
humans where acrosome-reacted sperm can still bind, if rhesus macaque sperm 
acrosome react prior to interaction with the oocyte, their binding capacity is 
significantly reduced (VandeVoort et al., 1997). Because zona pellucida binding 
and the acrosomal reaction occur on the external surface of the oocyte and 
activated sperm head, respectively, these processes can be microscopically 
observed and quantified using dual fluorescent staining. 
 
Seminal Plasma Constituent Analysis 
Much effort has focused on measures of sperm integrity and yet sperm 
only make up 1% to 5% of the total volume of an ejaculate (Owen and Katz, 
2005). The remaining volume consists of a large number of varied constituents 
secreted by the accessory sex glands; mainly the bulbourethal gland, seminal 
vesicles and prostate. These constituents include potassium, semenogelin, 
bicarbonate, fructose, magnesium, prostaglandins, ascorbic acid and proteins 
from the seminal vesicles and calcium, zinc, citric acid, prostate-specific antigen 
and albumin from the prostate (Jeyendran, 2003; Mortimer, 1994). In the primate 




believed to aid in the lubrication of the urethra in the first stage of ejaculation 
(Harrison and Lewis, 1986). 
 Since the seminal vesicles and prostate contribute approximately 60% and 
25% of the seminal plasma volume, respectively, it is of great interest to 
determine if these glands are functioning properly (Gonzales, 2001; Owen and 
Katz, 2005). Seminal vesicle secretion is important for sperm metabolism, semen 
coagulation, sperm motility, stability of chromatin and suppression of immune 
activity in the female reproductive tract (Gonzales, 2001; Lewis-Jones et al., 
1996). Specifically fructose, the major carbohydrate in human semen, has been 
reported to be a source of energy for the motile sperm (Elzanaty et al., 2002; 
Lewis-Jones et al., 1996). As a result, the measurement of seminal fructose has 
been used in most fertility labs worldwide and by the World Health Organization 
as a marker of seminal vesicle function (Gonzales, 2001; Harrison and Lewis, 
1986). 
 In the rhesus macaque, secretion from the cranial lobe of the prostate 
mixes with fluid from the seminal vesicles to bring about coagulation of the 
seminal plasma following ejaculation (Harrison and Lewis, 1986). Prostate 
derived citrate is one of the most important anions present in human semen and 
is probably responsible for regulating ionized calcium levels in the seminal 
plasma. It may also be responsible for the high buffering capacity of semen 
which allows sperm to survive in the acidic vaginal environment until it can enter 




and citric acid concentration is, therefore, one of the major methods for 
evaluating human seminal vesicle and prostatic function. 
 
 Finally, reference should be made to gene microarray technology. For 
many years the theoretical application of microarray technique held great 
promise, but only in the last few years has its practical application expanded as 
genetic sequencing of whole species genomes has been achieved. It has been 
less than two years since the rhesus macaque microarray chip became available 
to investigators. While not specifically a method for evaluating reproductive 
measures, it is nonetheless a very powerful tool for determining changes to gene 
expression profiles. Using high-density oligonucleotide expression arrays, 
researchers can quickly screen thousands of transcripts to determine genes of 
interest. This technology has been used to investigate gene expression in 
components of the HPG axis including the anterior pituitary gland, epididymis, 
Leydig cells and spermatogenic cells (Chen, 2004; Chen et al., 2004; He et al., 
2006; Jervis and Robaire, 2003; Syntin et al., 2001; Wrobel and Primig, 2005). 
Biologically relevant variations can then be further verified using semi-
quantitative reverse transcriptase polymerase chain reaction (sqRT-PCR), 
quantitative real-time RT-PCR (qRT-PCR), in situ hybridization, 
immunohistochemistry (IHC), or various other techniques. In the case of the HPG 
axis tissues can be evaluated for the effect of age, chemical exposure, disease 






Calorie restriction (CR) can be defined as undernutrition without 
malnutrition (Black et al., 2001; Dhahbi et al., 2004; Hursting et al., 2003; 
Koubova and Guarente, 2003; Lane et al., 1999b). In this paradigm essential 
nutrients and vitamins are provided to an organism while limiting total energy 
(calorie) intake. Often various other terms are used interchangeably, and 
incorrectly, when referring to similar manipulation of energy intake in the context 
of diet.  Other methodologies, in addition to calorie or caloric restriction, include 
energy restriction, diet restriction, dietary energy restriction, total dietary 
restriction, food or feed restriction, fasting, underfeeding and starvation. The 
fundamental distinction between these paradigms is whether restriction is 
achieved by feeding a reduced amount of food without any adjustment in nutrient 
density, or if formulation of dietary nutrient density is adjusted upwards to 
compensate. Without adjustments the investigator cannot know if the results are 
due to energy restriction only or are the result of nutrient insufficiency. Adjusting 
nutrient density allows for investigation of energy restriction effects without the 
confounding effect of variation in the amount of nutrients or other dietary factors 
ingested (Thompson et al., 2002). In this regard, CR falls into the former category 
and results in lower energy input without sacrificing nutritional competence. 
In their pioneering experiments, McCay et al. (1935) reduced caloric input 
to white rats and successfully demonstrated the effect of retarding growth upon 
the total length of life. Individuals of both sexes attained extreme ages beyond 




studies also demonstrated lower incidences of tumors and certain other 
diseases. The fact that a number of disease incidences can be substantially 
altered by variation in both type and quantity of certain dietary components 
independent of calorie effect, without influencing lifespan, serves to underscore 
that disease is distinct from aging (Weindruch and Walford, 1988). 
Since McCay’s initial studies in rats, moderate calorie restriction has been 
established as the only non-genetic method of altering longevity and attenuating 
biological processes associated with aging. Successful CR does not lead to 
malnutrition, but instead provides the essential nutrients in adequate amounts 
while restricting calorie intake to a range 30-70% below the ad libitum level. The 
lifespan extending effects seem to depend very specifically on energy (calorie) 
restriction since restriction of fat, protein, or carbohydrate without energy 
restriction does not increase the maximum lifespan of rodents. It is also not 
increased by general vitamin supplementation, supplementation with vitamin E or 
other antioxidants, or alteration of the type of fat, protein, or carbohydrate in the 
diet (Lane et al., 1995; Roth et al., 2000; Weindruch and Sohal, 1997; Weindruch 
and Walford, 1988). 
 
Aging and Calorie Restriction 
Moderate calorie restriction extends lifespan by slowing the rate of 
physiological decline and retarding age-related chronic diseases in a variety of 
species. To date this nutritional paradigm has been found to be effective in 




rats, dogs and possibly non-human primates such as squirrel monkeys and 
cynomolgus and rhesus macaques (Ingram et al., 1990; Lane et al., 1999b; Roth 
et al., 1999; Weindruch and Walford, 1988). Calorie restriction is not only 
effective for extending lifespan but exhibits great consistency across species and 
demonstrates widespread, beneficial health effects on almost every physiological 
system within the organism. Researchers have shown that CR can reduce body 
mass and adiposity, lower body temperature and initially reduce metabolic rate, 
lower blood pressure, and significantly slow growth and skeletal maturation. It 
has been successful in reducing glucose and fasting plasma insulin levels while 
increasing insulin sensitivity and levels of high density lipoproteins. In addition, 
CR alters neuorendocrine and sympathetic nervous system function by lowering 
levels of growth hormone (GH), thyroid-stimulating hormone (TSH) and thyroid 
hormones, insulin-like growth factor 1 (IGF-I), and gonadotropins while 
increasing glucocorticoid and catecholamine levels. It has also been shown to 
reduce oxidative stress and alter gene expression profiles (Gredilla and Barja, 
2005; Gresl et al., 2001; Heilbronn and Ravussin, 2003; Koubova and Guarente, 
2003; Lane et al., 1997). 
The longer the duration and the greater the degree of calorie restriction 
(within the limits tolerated by the species) following the post-weaning period of 
life the greater the effect on survival and the rate of aging (Merry, 2002). 
Although the exact mechanism(s) of action explaining how this occurs is still 
largely unknown, it is believed to be evolutionarily conserved and acts by altering 




al., 2003). This is evidenced by the wide range of biological parameters, 
mentioned above, that are simultaneously affected in species put under this 
paradigm. 
While data on life extension in a wide range of species strongly suggests 
that CR mechanisms are universal across species, the paradigm had not been 
studied in an animal model living longer than four years until the late 1980’s. In 
1987, to address the relevance of this nutritional intervention to human health, 
the National Institute on Aging (NIA) began the first study of CR and aging in 
non-human primates (NHP) using rhesus macaques to determine its potential 
application in humans (Ingram et al., 1990). Definitive evidence showing that CR 
extends life span in these animals is not yet available because of a maximal life 
expectancy of 40 years; however, the emerging data from the study as well as 
ongoing studies of rhesus and cynomolgus macaques at the University of 
Wisconsin-Madison, University of Maryland, and Wake Forest University School 
of Medicine strengthens the possibility that the diverse beneficial effects of CR 
seen in other lower species will also apply to NHP and ultimately humans. 
 Animals in the NIA study were gradually restricted until a 30% calorie 
restricted diet had been reached. By definition, the diet was supplemented with 
additional vitamins and minerals to guard against malnutrition (Ingram et al., 
1990; Mattison et al., 2005). Several endpoints have since been investigated in 
studying the long-term effects of CR on aging in these animals. Results parallel 
those listed above and show CR-induced attenuation of age changes in plasma 




Treatment animals weigh less, have less body fat, and lower body temperatures 
than their matching control counterparts. These data provided early evidence of 
the potential benefit of CR for the risk for diabetes and cardiovascular disease 
(Lane et al., 1999a; Mattison et al., 2003). Additionally, tumor incidence is lower 
and mortality in the calorie restricted animals is about half that observed in 
controls (Mattison et al., 2003; Roth et al., 2002). For the most part, the 
Wisconsin Regional Primate Research Center study confirms these findings in 
their own calorie restricted animals despite a slightly different experimental 
implementation of the CR treatment (Gresl et al., 2001). 
 
Potential Impact of Moderate CR on Reproduction in Females and Males 
The effects of moderate calorie restriction on the HPG axis are mixed and 
adjustments must be made for level of calorie restriction and the species utilized. 
Data from rats and mice are inconsistent with regard to CR effect on female 
reproduction. In mice, restriction disrupts normal cycling; however, when returned 
to an ad libitum diet, CR mice will resume normal reproductive function and can 
cycle longer than continuously ad libitum fed mice (Weindruch and Walford, 
1988). Rats maintained at 50% body weight (as compared to control littermates) 
still achieved sexual maturation, albeit delayed, with onset of puberty observed 
once the animals reached body weights similar to pubertal controls (Gredilla and 
Barja, 2005; Holehan and Merry, 1985). Calorie restriction has also been proven 
to significantly increase reproductive longevity without disrupting normal cycling 




senescence in rodents either by delaying puberty or initiating a period of ovarian 
‘rest’. 
More recent data suggest that calorie restriction affects reproductive 
longevity at the level of the hypothalamus and/or pituitary gland. Investigators 
have found that female rats restricted to 60% of ad libitum food after the onset of 
puberty did not experience any interruption of normal cycling, but delayed 
cessation of estrous cycles was still observed (McShane and Wise, 1996). 
Therefore, they concluded that calorie restriction affected the HPG axis in rats by 
a mechanism other than simply delaying puberty or disrupting normal cycling. 
They hypothesized that calorie restriction may actually preserve the reproductive 
neuroendocrine axis, allowing for prolonged reproductive ability in these animals. 
Preliminary data in female rhesus macaques aged 7-27 years suggests no 
adverse effects of long-term CR with regard to reproductive hormones (Black et 
al., 2001; Mattison et al., 2003). Researchers have also documented no 
interruption of normal ovarian cyclicity in young and menopausal restricted 
subjects, suggesting that long-term energy restriction does not negatively affect 
the animals (Lane et al., 2001; Mattison et al., 2003). More recently it has been 
demonstrated that young female rhesus macaques continue to cycle normally 
under short-term, moderate calorie restriction (Wu, 2006). 
Initiation of short-term, moderate CR in old females, however, has had 
mixed results. Embryonic development was improved in vitro using oocytes 
collected from older macaques maintained on a calorie restricted diet compared 




beyond the blastocyst stage and no old control embryos were observed at 
expanded blastocyst or hatched blastocyst stages (Wu, 2006). In the first 1-2 
years under the dietary regiment however, even though no adverse effects were 
observed, there was a trend to advance cycle irregularity after three years on the 
treatment. Parallel work in long-term old CR macaques has not been completed 
so it remains to be seen if they will continue to function similarly to the old control 
animals, or if they will also begin to show advanced signs of menstrual cycle 
irregularity (Wu, 2006). Despite these investigations effects of CR on normal 
female reproductive parameters in the rhesus macaque are still poorly 
understood. 
 In the male reproductive axis, early onset CR in rats results in delayed 
pubertal peak of serum testosterone and a 30% reduction in peak height once 
puberty is reached. Later in life, however, T levels are similar and remain 
elevated longer in CR males while LH levels are consistently higher throughout 
life when compared to control animals. Although capable of successful breeding, 
young calorie restricted male rats experience slightly reduced fertility which 
recovers later in life (Weindruch and Walford, 1988). Generally speaking, 
evidence for male reproductive senescence in rodents is unconvincing so most 
work has been done in females where precipitous reproductive decline is a 
hallmark of aging. Overall, male rats appear less sensitive than females, 





In male rhesus macaques, as with rats, moderate calorie restriction 
implemented prior to puberty can delay the maturational increase in circulating 
testosterone concentrations, indicative of reproductive activation, by 
approximately one year (Lane et al., 1997; Roth et al., 2000). Concomitantly, 
skeletal growth was also limited in these animals (Mattison et al., 2003; Roth et 
al., 2000). In total, however, there have been very few investigations into the 
effects of calorie restriction on male rhesus macaque reproduction and no reports 
of its impact on semen analysis or sperm function parameters. With only four 
known studies underway using approximately 160 males, only 75 of them calorie 
restricted, there has been little opportunity to pursue such investigations until 
now. 
As part of the ongoing study being undertaken by the NIA, a detailed 
panel of measurements was added in order to ascertain the impact of calorie 
restriction on male rhesus macaque reproductive fitness. Sixty animals are 
designated as part of the longevity aspect of the study so measurements and 
procedures are extremely limited in these males; general health measures have 
been previously summarized by Roth et al. (2004). Fortunately, 23 young adult 
and old adult males (CON=11, CR=12) were designated as part of the short-term 









The average lifespan of humans can be prolonged and has in fact been 
markedly increased by improving environmental conditions, as demonstrated by 
advancements in health care technology. In contrast, maximal lifespan is thought 
to be increased by actually decreasing the rate of aging and has remained 
largely unchanged in modern times (Weindruch and Sohal, 1997). Calorie 
restriction in short-lived species has demonstrated that CR regimens extend 
lifespan, retard age-related disease, and maintain the vitality of a wide range of 
organisms. Numerous laboratories worldwide have repeated, in various forms, 
this work first reported by McCay et al. (1935). What this nutritional paradigm 
does to the reproductive axis in these organisms, however, is still unclear. 
In the preceeding sections I have attempted to establish a framework from 
which the interaction between aging and calorie restriction can be understood.  I 
have also established the need for detailed investigations into the impact of this 
nutritional paradigm on the HPG axis, particularly in higher order species.  It is 
my goal then to pursue these investigations through analysis of rhesus macaque 
aging with particular focus on the neuroendocrine component since these 
neuroendocrine changes may coordinate the life prolonging response of animals 
to CR. The nervous system likely plays an important role in the initial response to 
altered caloric intake by sensing the change. This sensation of reduced food 
most likely occurs within the GI tract or CNS. Although all cells within the 
organism could respond directly and independently to reduced calories via 




achieved without the systemic control mediated by neural and endocrine factors. 
These CR effects presumably involve the same neural and endocrine driven 
mechanisms that coordinate metabolic adaptation to such environmental 
perturbations as starvation, thermal stress, and exercise.  An example is the 
reduction in gonadotropin levels and gonadal function in response to reduced 
leptin levels caused by less food (Heilbronn and Ravussin, 2003; Koubova and 
Guarente, 2003). 
The collaborative effort between the National Institute on Aging, the 
Oregon Health and Science University-Oregon National Primate Research 
Center (OHSU-ONPRC) and the University of Maryland has made possible a 
comprehensive analysis of the effects of moderate calorie restriction on 
reproductive function in young and old male rhesus macaques. Therefore, the 
objectives of this project were to: 1) analyze general neuroendocrine changes to 
the HPG axis that occur with aging and 2) evaluate the effects of moderate (30%) 





Age is an issue of mind over matter. If you don’t mind, it doesn’t matter. 
 





How old would you be if you didn’t know how old you are? 
 





When you stop seeing beauty you start growing old 
The lines on your face are a map to your soul 
When you stop taking chances you'll stay where you sit 
You won't live any longer but it'll feel like it 
 

























Figure 1.1 Hypothalamic-Pituitary-Gonadal Axis Schematic representation of 
the male hypothalamic-pituitary-gonadal axis and the major hormones involved.  
Hypothalamic production of gonadotropin-releasing hormone (GnRH) stimulates 
pituitary gland production of gonadotropins luteinizing hormone (LH) and follicle-
stimulating hormone (FSH). Testicular response to LH stimulates the release of 













Table 1.1 Summary of Semen Measurements 
Measure Rationale 
Ejaculate appearance Indicative of cell (sperm) numbers 
Ejaculate weight Indicative of accessory sex gland production and secretion 
Ejaculate color Abnormal color may indicate accessory sex gland or other clinical pathology 
Ejaculate volume Low volume may indicate retrograde semen flow into the bladder or accessory sex gland pathology 
Osmolarity/osmolality Indicative of ionic composition 
pH Indicative of ratio of alkaline seminal vesicle secretions and acidic prostatic secretions 
Count Indicative of overall spermatogenesis success 
Concentration Indicative of successful spermatogenesis and accessory sex gland production 
Motility Indicative of sperm ability to reach the ova 
Morphology Indicative of cell maturation status 
Activation (capacitation) Indicative of sperm ability to reach the ova and then penetrate the zona pellucida 
Agglutination May indicate possible surface antigen problems 
Zona pellucida (ZP) 
binding 
Sperm binding to the ZP outer surface is a prerequisite for oocyte 
vitelline membrane binding and penetration 
Acrosome reaction Prior to fertilization the outer acrosomal membrane fuses with the surrounding plasma membrane 
Hypo-osmotic swelling 
assay 
Indicative of intact sperm membrane. Membrane integrity can 
influence motility, activation, acrosome reaction and is required for 
successful fusion with the ova 
Seminal plasma 
composition Overall measure of accessory sex gland contribution 
Sperm chromatin 










EFFECTS OF AGE ON CORE-CLOCK GENE EXPRESSION IN THE MALE 
RHESUS MACAQUE (MACACA MULATTA) PITUITARY GLAND 
 
INTRODUCTION 
Biological organisms exhibit a wide range of natural rhythms, including 
endogenous circadian oscillations with a periodicity of approximately 24 hours 
(Takahashi et al., 2001). These intrinsic, elemental rhythms regulate diverse 
physiological processes including metabolism, stress response, 
thermoregulation, and reproduction. The hypothalamic suprachiasmatic nucleus 
(SCN) acts as a master circadian pacemaker to synchronize, coordinate and 
sustain circadian physiology and function in mammals (Refinetti, 2005; 
Takahashi et al., 2001).  Because the intrinsic period of the SCN oscillator is not 
exactly 24 hours, it will drift out of phase with the solar day unless synchronized 
or ‘entrained’ by sensory input (zeitgebers), such as temperature changes, food 
intake or light-dark cycles. Light (photic information) is by far the most important 
external entraining cue in mammals. Visual light is transmitted primarily from the 
eye via the retinohypothalamic tract (RHT) and terminates in the ventral part or 
core of the SCN (Abizaid et al., 2004; Hofman and Swaab, 2006; Reppert and 
Weaver, 2002). The nucleus responds to timing signals received from these 
afferent pathways and drives overt circadian rhythms throughout the body via its 
own efferent connections and neuroendocrine outputs (Lowrey and Takahashi, 




The molecular clock mechanism consists of core circadian clock genes 
and appears to be highly conserved at the intracellular level. Core genes are 
those whose mRNA translates into protein products which are necessary 
components for the generation and regulation of circadian rhythms, that is, 
proteins which form the primary molecular circadian oscillatory mechanism within 
individual cells throughout the organism (Lowrey and Takahashi, 2004). The 
system involves interconnected cyclic transcriptional/translational feedback loops 
that autoregulate the expression of both positive and negative oscillator 
components as well as their respective output proteins (Figures 2.1 and 2.2). 
In mammals the positive components that comprise the transcriptional 
activators are CLOCK and BMAL1. These proteins dimerize and bind 
constitutively to E-box cis-regulatory enhancer sequences in the promoter 
regions of various genes, including the negative components of the feedback 
loop (Figure 2.3). The negative components include the Period proteins (PER1, 
PER2) and Cryptochrome proteins (CRY1, CRY2) which act to disrupt activity of 
the bound CLOCK/BMAL1 transcriptional complex, and subsequently generate a 
circadian rhythm in their own transcription. The positive and negative feedback 
loops are connected by the product of another core-clock gene, REV-ERBα. This 
gene codes for an orphan nuclear receptor, and like the PER and CRY genes, is 
activated by CLOCK/BMAL1 heterodimers binding to E-box enhancers. REV-
ERBα protein inhibits BMAL1 gene transcription by functionally competing with 
retinoic acid-related orphan receptors (ROR) at the retinoic acid-related orphan 




BMAL1 activation of REV-ERBα attenuates its own transcription. Finally, 
significant posttranslational modifications play a critical role in generating 24-hour 
rhythms of mRNA and protein levels. Phosphorylation of PER proteins 
(especially PER2) by casein kinase 1 epsilon (CSNK1E) activates their 
degradation and is the rate limiting step in their accumulation. Only after there is 
adequate PER present in the cytoplasm to overwhelm CSNK1E-mediated 
degradation, does enough PER persist to dimerize with CRY. Casein kinase then 
phosphorylates the dimer to allow for nuclear translocation and disruption of the 
positive CLOCK/BMAL1 complex. These inherent transcription, translation, and 
posttranslational modifications give the clock its own natural rhythmicity 
approximately equal to one terrestrial day (Glossop and Hardin, 2002; 
Guillaumond et al., 2005; Lowrey and Takahashi, 2004; Okamura et al., 2002; 
Reppert and Weaver, 2002). 
Genetic components of this clock mechanism are also expressed in 
various peripheral tissues, raising the possibility that circadian physiology is 
ultimately regulated by a coordinated network of oscillators rather than by the 
single master circadian clock of the suprachiasmatic nucleus (Balsalobre, 2002; 
Balsalobre et al., 1998; Glossop and Hardin, 2002). Revision of the circadian 
paradigm, whereby mammalian circadian rhythms are coordinated by a network 
of subordinate, peripheral oscillators located in multiple tissues throughout the 
body and synchronized by the SCN, allows each of these oscillators to regulate 
circadian expression of a portion of the tissue genome and to coordinate tissue-




immunohistochemistry experiments with a number of species have shown that 
circadian transcriptional mechanisms temporally regulate biochemical pathways 
in various tissues throughout the body including hypothalamus, pineal, liver, 
heart, kidney and adrenal (Balsalobre, 2002; Chappell et al., 2003; Jilg et al., 
2005; Lemos et al., 2006; Morse and Sassone-Corsi, 2002; Stehle et al., 2003; 
von Gall et al., 2002). These constituent clock mechanisms work by driving the 
circadian expression of specific sets of genes. These studies demonstrate that 
many proteins involved in general cellular and tissue-specific pathways can 
accumulate in a circadian manner and appear to be controlled by clock 
mechanisms in many cases. 
Throughout life and during specific life stages the hypothalamic-pituitary-
gonadal axis is responsible for a number of circadian activities in mammals 
including rhythmic release of gonadotropin-releasing hormone (GnRH), 
luteinizing hormone (LH), growth hormone (GH) and adrenocorticotropic 
hormone (ACTH) (Griffin and Ojeda, 2000; Knobil et al., 1994). In fact, the levels 
of most reproductive hormones, such as testosterone (T), are regulated in a 
circadian fashion in mammals (Jilg et al., 2005; Sehgal, 2004). Intuitively this 
makes sense since the pituitary, as the master endocrine gland, is ideally 
situated in the axis to exert direct control over such neuroendocrine functions 
(Everett, 1994). Experimental evidence in the rat pituitary gland has shown that 
at least some components of the circadian mechanism (Per1, Per2, Cry1) are 
present in the adenohypophysis but not the neurohypophysis (Shieh, 2003). It 




pituitary gland works to fine-tune and regulate physiological events within its 
domain. 
In view of the experimental evidence, our goal was to examine whether 
the pituitary gland of the rhesus macaque expresses core-clock genes and their 
protein products; to quantify expression levels of selected genes; to determine if 
expression follows a 24-hour rhythmic pattern; and to reveal any age-related 
alterations in the system. 
 
MATERIALS AND METHODS 
Animals and Diet 
All experiments made use of banked rhesus macaque (Macaca mulatta) 
tissues from previous unrelated studies and were approved for use by the 
Institutional Animal Care and Use Committees at the University of Maryland and 
the Oregon National Primate Research Center. Animals were individually housed 
in a temperature-controlled environment under 12L:12D photoperiod (lights on 7 
h -19 h) and allowed auditory, visual and olfactory interaction with male and 
female conspecifics in the vivarium. Food was provided in two meals at 8 h and 
15 h daily; water was available ad libitum. Diet consisted of primate chow (Purina 
Mills, Inc.; St. Louis, MO) supplemented with fresh fruits and vegetables. Animals 
were sacrificed according to the NIH Guide for the Care and Use of Laboratory 
Animals.  
Experiment 1: Gene Expression Profiling and Age Characterization 




Adult (18 – 26 years) male rhesus macaques were sacrificed between 11 h and 
15 h. Pituitary glands had either been kept whole or sectioned sagittally and 
placed in RNAlater® (Ambion, Inc.; Austin, TX) and then frozen in liquid nitrogen 
or simply flash frozen in liquid nitrogen. 
Experiment 2: Phase Shift Characterization 
Six ovariectomized female rhesus macaques (8 – 11 years) were 
sacrificed at either 1 h or 13 h. Pituitary glands had either been kept whole or 
sectioned sagittally and placed in RNAlater® (Ambion, Inc.; Austin, TX) and then 
frozen in liquid nitrogen or simply flash frozen in liquid nitrogen. 
Experiment 3: 24-hour Gene Expression 
Five additional ovariectomized females (7 – 12 years) were sacrificed in 4-
hour intervals at 3 h, 7 h, 15 h, 19 h, and 23 h; tissue was unavailable for 11 h. 
Pituitary glands had been kept whole and fixed in 4% paraformaldehyde. 
 
RNA Extraction and Gene Microarrays 
Whole pituitary glands or ½ sagittally cut sections were homogenized 
using a PowerGen rotor-stator homogenizer (Fisher Scientific; Pittsburgh, PA). 
Total RNA was isolated using RNeasy columns (QIAGEN; Valencia, CA); 
concentration and integrity were assessed by microcapillary electrophoresis 
using a model 2100 Agilent Bioanalyzer (Santa Clara, CA; see Appendix A for 
more detail). Only male samples from experiment 1 (n=3 for each age group) 
were sent for analysis to the Affymetrix Microarray Core of the OHSU Gene 




Analysis was performed in accordance with the manufacturer’s 
instructions (Affymetrix GeneChip® Analysis Technical Manual; Santa Clara, CA). 
Labeled target cRNA was prepared from total RNA samples and hybridized to 
human arrays (Affymetrix HG_U133A) detecting a total of 18,400 transcripts. 
Image processing and expression analysis were performed using Affymetrix 
GCOS v1.2 software. A number of quality control metrics were utilized as a 
measure of probe quality and included chip background, chip noise, total 
fluorescent intensity, number of genes detected and the 3’/5’ ratio of the 
housekeeping genes β-actin and GAPDH. These metrics are assessed to 
determine the validity of the data obtained from the scanned GeneChip®. Data 
were normalized to an average intensity on each chip which enabled direct 
comparisons between the nine different arrays. 
 
Semi-quantitative RT-PCR 
PrimerExpress® software (Applied Biosystems; Foster City, CA) was used 
for all primer and probe design (Appendix G). Specific primers were designed for 
each transcript using the human sequences and then BLASTed against the 
macaque sequences available at the Human Genome Sequencing Center at 
Baylor College of Medicine (http://www.hgsc.bcm.tmc.edu/projects/rmacaque/) to 
obtain, whenever possible, the macaque sequences. The primers were 





Total RNA (1 µg) was used to synthesize cDNA using the Omniscript kit 
(QIAGEN) and oligo d(T)15 primers (Promega Corp; Madison, WI). The reaction 
was performed following the manufacturer’s instructions in a 20 µl volume at 
37oC for 1 hour. The linear range of amplification was calculated for each pair of 
primers using pooled samples and reactions were performed in duplicate. sqRT-
PCR amplifications were performed using 1 µl of cDNA, 200 µM deoxynucleotide 
triphosphates (Promega), 0.5 µM of each primer, and 2.5 U of HotStarTaq® 
polymerase (QIAGEN) in a 25 µl reaction volume. The reactions were performed 
using the following program: 95oC, 15 min; 94oC, 1 min; specific annealing 
temperature for each primer set (Table 2.1), 1 min and 72oC, 1 min (see 
Appendix H for specific details). 
Aliquots (7 µl) of reaction product were resolved by electrophoresis on 2% 
agarose gels with ethidium bromide and photographed under ultraviolet light. 
Subsequent image analysis was performed using ImageJ software 1.37v (NIH; 
Bethesda, MD; http://rsb.info.nih.gov/ij/). Briefly, a single rectangle was drawn 
horizontally around all bands in a selected gel image and a plot profile of signal 
intensities was generated. Area selections were created under the peak for each 
band using the ‘straight lines selection’ tool. Area under the curves was then 
measured and provided area statistics for analysis. Appendix I discusses 
troubleshooting for primer design, sqRT-PCR and gel imaging. 
 
Taqman® Quantitative Real-Time RT-PCR 




random hexamer primers (Promega), 200 ng of RNA and the Omniscript kit 
(QIAGEN). The RT reaction was then diluted 1:100 for PCR analysis. The PCR 
mixtures contained 5 µl of Taqman® Universal PCR Master Mix (Applied 
Biosystems), 300 nM Rev-Erbα primers (Invitrogen), 50 nM human β-actin 
primers (Applied Biosystems), 250 nM Rev-Erbα probe (Sigma; St. Louis, MO) 
and 2 µl cDNA. Reactions were run in triplicate for higher accuracy. The 
amplification was performed as follows: 2 min at 50oC, 10 min at 95oC, and then 
40 cycles each at 95oC for 15 sec and 60oC for 60 sec in an ABI/Prism 7700 
Sequences Detector System (Applied Biosystems). The β-actin standard curve 
was used to convert the critical threshold values (i.e. above background) into 
relative RNA concentrations for each sample. The Rev-Erbα primers and probe 
were designed using the rhesus macaque sequence available in the GenBank 
database (accession no. BV208705) and are listed in Table 2.1. 
 
Immunohistochemistry 
Fixed pituitary glands were sectioned (25 µM) horizontally from inferior to 
superior orientation using a frozen-stage sliding microtome. Three continuous 
sections from three different areas at approximately ¼, ½ and ¾ of the way 
through the gland were utilized for each animal to give broad sampling. All 
sections were subjected to 20-second microwave antigen retrieval (MAR) in 2X 
Antigen Retrieval Citra (BioGenex; San Ramon, CA) prior to staining; this 
improved considerably the accessibility of antigens in the tissue. Sections were 




antibody against human REV-ERBα (Lifespan Biosciences; Seattle, WA), ABC 
amplification (Vector Laboratories; Burlingame, CA), and DAB chromogen 
(Sigma; St. Louis, MO). As a control, tissue that was not MAR-treated or was not 
exposed to primary antibody during incubation was included. This served as a 
validation of both the primary antibody and the method as well as to rule out any 
false-positive results or altered immunostaining patterns. Sections were mounted 
onto Fisherbrand Superfrost Plus microscope slides (Fisher Scientific) and 
coverslipped with DPX mountant (Fisher Scientific) for imaging. (See Appendix J 
for more detail.) 
 
Statistical Analysis 
 Data are expressed as mean + SEM for each parameter measured in 
each group. Signal intensity and mRNA expression levels were analyzed by 
Student’s t-test or one-way ANOVA. In order to control for experiment-wide false 
positives while still maintaining statistical power, each Student’s t-test was 
treated as an independent test and, therefore, alpha was adjusted to correct for 
multiple comparisons. To accomplish this sequential Bonferroni with Simes-
Hochberg correction was used (Hochberg, 1988). If group differences were 
revealed by ANOVA, differences between individual groups were determined 
with the Tukey-Kramer post-hoc analysis using GraphPad Prism (GraphPad; San 
Diego, CA). Power analysis was performed using Statistical Analysis System 
(SAS Institute; Cary, NC). For all analyses significant differences were 





Experiment 1: Gene Expression Profiling and Age Characterization 
 Mean signal intensity values from the Affymetrix GeneChip® microarray for 
three age categories of rhesus macaques are listed in Table 2.2. All probesets 
for the six core-clock genes investigated are shown as well as Clock which was 
not investigated further. Because we were specifically interested in core-clock 
genes we did not perform a comprehensive screening and filtering of the 
microarray data, as was done for experiments discussed in Chapters 3 and 4. 
Instead we searched the probeset library for the seven genes of interest in order 
to compile Table 2.2. A significant difference was observed between Per2 
expression in Young Adults and the other two age groups. A significant 
difference was also detected between Juvenile Bmal1 expression and Young 
Adult mRNA levels. 
 Figure 2.4 provides validation information for the microarray data which 
was conducted by showing sqRT-PCR amplification of all six core-clock genes in 
the three age groupings of macaques. Amplicons were detected between 26-28 
cycles at 65-66oC (Table 2.1). 
 The sqRT-PCR expression levels for the core-clock genes within the three 
age groups of macaques are shown in Figures 2.5 A-F. Significant differences 
were detected between Juvenile animals and the other two groups for Per2 
expression (Graph A). In both instances a negative fold-change resulted, with a 
37% decline in Young Adult mRNA expression and a 42% decline in Old Adults 




Csnk1ε and Bmal1 expression (Graphs B-C) were not statistically significant but 
did trend in a similar direction as the microarray data. 
 
Experiment 2: Phase Shift Characterization 
 Semi-quantitative RT-PCR expression levels for the rhythmically 
expressed core-clock genes are demonstrated at two opposing time-points (1h 
and 13h) in Figure 2.6. Csnk1ε was not measured because it is constitutively 
expressed throughout the 24-hour cycle. 
 The sqRT-PCR expression levels for the five rhythmically expressed core-
clock genes are depicted in Figures 2.7 A-E. Significant differences were 
identified in Per2 and Bmal1 mRNA expression at the opposing time-points with 
both being expressed more highly at 13h. Per2 exhibited a 1.33 (+0.05) fold-
increase in expression while Bmal1 levels increased 1.82 (+0.34) fold from the 1h 
time point. 
 The results of Taqman® quantitative real-time RT-PCR of Rev-Erbα are 
given in Figure 2.8. Expression levels were not significantly different at these two 
time-points. 
 
Experiment 3: 24-hour Gene Expression 
 A representative section of rhesus macaque pituitary gland is shown in 
Figure 2.9 with immunostaining for REV-ERBα. Staining can clearly be seen in 
the anterior and intermediate pituitary but not the posterior pituitary gland, 




Representative single-label immunohistochemistry staining for REV-ERBα 
in the anterior pituitary gland of the rhesus macaque is depicted in Figure 2.10. 
Temporal changes in staining intensity are clearly observed across the 24-hour 
cycle providing evidence of rhythmic expression of a core-clock gene. 
 
Discussion 
Biological organisms exhibit endogenous circadian rhythms which regulate 
a diverse array of physiological processes, such as temperature regulation, 
energy metabolism, blood pressure and sleep/wake cycle (Takahashi et al., 
2001). The hypothalamic suprachiasmatic nucleus (SCN) acts as the master 
circadian pacemaker to synchronize, coordinate and sustain circadian activity 
(Refinetti, 2005; Takahashi et al., 2001). Sensory input (zeitgebers) to the SCN 
from afferent pathways drives circadian rhythms throughout the body via efferent 
connections and humoral outputs (Lowrey and Takahashi, 2004; Morse and 
Sassone-Corsi, 2002; Stehle et al., 2003). The molecular clock mechanism 
consists of highly conserved core circadian clock genes and, in mammals, 
includes Per1, Per2, Cry1, Bmal1, Clock, Rev-Erbα and Csnk1ε. Together these 
genes form an interconnected cyclic transcriptional/translational feedback loop 
that autoregulates the expression of oscillator components and their respective 
output genes (Reppert and Weaver, 2002). 
Genetic components of this clock mechanism are also expressed in 
various peripheral tissues including pineal, liver, heart, kidney, adrenal and 




et al., 2006; Morse and Sassone-Corsi, 2002; Stehle et al., 2003; von Gall et al., 
2002). It is known that immortalized GT1-7 mouse hypothalamic GnRH neurons 
contain a functional circadian clock mechanism and that they exhibit pulsatile 
GnRH secretion in vitro. These cells exhibit significant rhythmic gene expression 
of Bmal1, Per1, and Per2 (Gillespie et al., 2003). Experimental findings have also 
established a direct connection of primary visual afferents to GnRH and 
dopamine-producing neuroendocrine cells of the vervet monkey hypothalamus 
(Abizaid et al., 2004). This retinal connection is outside of the predominant 
retinohypothalamic tract to the SCN. These hormone producing neurons are 
regulators of pituitary gland gonadotrophs and lactotrophs and reveal for the first 
time in primates that light stimuli can reach the HPG axis, providing a direct and 
independent pathway from the SCN master circadian clock for the photic 
modulation of hormone release. Throughout life and during specific life stages 
the hypothalamic-pituitary-gonadal axis is responsible for a number of circadian 
activities in mammals. All of this leads to the distinct possibility that the pituitary 
gland may also contain its own circadian clock mechanism.  
At least some of the molecular clock components have been shown to 
exist in the rat pituitary gland. In situ hybridization experiments mapped Per1, 
Per2 and Cry1 mRNA to areas of the anterior pituitary, pars tuberalis/median 
eminence and intermediate pituitary gland. No signals for mRNA expression 
were detected in the posterior pituitary gland (Shieh, 2003). Early work 
investigated the possibility that the pituitary gland functions as an autonomous 




hypothalamic control (Lewy et al., 1996). The results, in mice, indicated that 
pituitary gland gonadotrophs are capable of producing rhythms of LH release for 
a long duration in vitro. More recently data demonstrated in vitro release patterns 
of prolactin, which are affected by photoperiod and age in vivo. They 
demonstrated in the rat model that both mean levels and rhythmic prolactin 
release are determined by the age of the animal, the circadian time of pituitary 
gland isolation, and the photoperiodic conditions in which the animal was housed 
(Lewy et al., 2005).  
Our experimental data build on the published literature and demonstrate 
that mRNA and protein core-clock components are indeed expressed in the 
rhesus macaque pituitary gland at measurable levels; that mRNA levels are 
significantly different at two specific, opposing time points; that protein synthesis 
and turnover of at least one component oscillated with a 24-hour rhythmic 
pattern; and that at least one mRNA component of the clock mechanism was 
affected by age. 
 
Experiment 1: Gene Expression Profiling and Age Characterization 
GeneChip® microarrays were used to identify expression of seven core-
clock genes in the rhesus macaque pituitary gland: Per1, Per2, Bmal1, Cry1, 
Clock, Rev-Erbα and Csnk1ε. Microarray results showed small but significant 
changes in mRNA expression across the three age categories of interest. 
Specifically, Per2 expression in Young Adults was significantly less than the 




Adults compared to Juvenile animals (P<0.05). At the time of the experiments the 
rhesus macaque GeneChip® was unavailable so the human chip (Affymetrix 
HG_U133A) was utilized. Given the high similarity between non-human primate 
(NHP) and human genomes [e.g. 98.77% similarity between chimpanzee and 
human, (Dillman and Phillips, 2005); 97.5% between rhesus macaque and 
human (Gibbs et al., 2007)], it was reasonable to expect that the human 
GeneChip® could successfully hybridize with NHP samples. This has in fact been 
determined in multiple studies (Dillman and Phillips, 2005; Wang et al., 2004).  
Overall, few age-related changes in pituitary gland gene expression were 
detected utilizing the 18,400 transcripts on the Affymetrix HG_U133A human 
array. This finding correlates well with other reports that the pituitary gland 
exhibits a high consistency of mRNA expression with aging, indicating that this 
may be a fundamental characteristic of the gland. Previous microarray 
experiments have revealed few hypothalamic and pituitary gland changes in 
gene expression in 3, 15, and 24 month old Sprague-Dawley male rats (Kappeler 
et al., 2003). Out of a total of 1183 genes on the microarray, only 454 were 
detected in the hypothalamus and 115 in the pituitary gland, representing 38% 
and 10% of the detectable RNAs, respectively. More importantly, in the pituitary 
gland, only six genes were differentially expressed in an age dependent manner 
[GABAA β1, cocaine- and amphetamine-regulated transcript (CART), 
heterogeneous nuclear ribonucleoprotein K (hnRNP-K), GH, 
phosphofructokinase (PFK) and cyclin D2 (CCND2)]. Kappeler et al. concluded 




expression appeared to be restricted to rather modest number of genes.  Finally, 
it should be noted that there were only one or two probesets for each circadian 
gene as compared to most other genes which may have as many as 11-16 
probesets. Fundamentally and most important, however, our array data did 
indicate that the clock mechanism was present in the rhesus macaque pituitary 
gland. 
Microarray data were validated using sqRT-PCR. Experimental findings 
showed that all six of the investigated genes (Clock was not analyzed) were 
present. Per2 expression again showed a significant difference (P<0.05) between 
age categories, with expression 60% higher in Juvenile animals as compared to 
Young Adult but also Old Adult animals, which was not detected by the 
microarray data alone. This further emphasizes the need for additional 
experiments to support microarray data of any kind.  
Of the other non-significant transcripts, Csnk1ε and Bmal1 were close to 
statistical significance, possibly due to large variation within some groups. Based 
on our experimental means and standard deviations, power analysis indicated 
we would have needed to double our sample size to nine animals per group in 
order to have had a 90% chance of detecting a difference in Csnk1ε expression. 
The trend for Bmal1 was not as strong, as even this larger sample size would 
have only achieved a 60% chance of detecting significant differences. Both of 
these transcripts, however, did trend in the direction of the microarray data with 




While the changes may have been subtle this line of investigation is still 
very important since age changes have the potential to cause temporal 
dysregulation of gene expression, a principal factor in cellular malfunction and 
disease. It’s worth noting, too, that the pituitary gland is also a very 
heterogeneous tissue consisting of multiple cell types (gonadotrophs, 
lactotrophs, somatotrophs) and each may have its own inherent circadian timing 
mechanism. The pars tuberalis, for example, expresses clock genes which are 
entrained by melatonin (Stehle et al., 2003). Melatonin activation results in 
modulation of prolactin levels (Jilg et al., 2005; von Gall et al., 2002) and would 
be activated at a very different time than gonadotropin-releasing cells. Such 
cellular variation may have inhibited our ability to detect gland-wide mRNA 
expression changes. 
 
Experiment 2: Phase Shift Characterization 
Pituitary gland samples from ovariectomized females obtained at 1h and 
13h provided opposing times in the circadian cycle and therefore were useful in 
verifying circadian changes. Additionally, since hormone variation can influence 
gene expression, this tissue allowed demonstration of universal circadian 
changes across gender by eliminating the fluctuating hormone environment. Five 
rhythmically expressed core-clock genes were measured using sqRT-PCR. 
Expression of Per2 and Bmal1 levels were significantly different (P<0.05), with 
Per2 displaying a fold-change of 1.33 (+0.05) from 1h to 13h and Bmal1 showing 




observed for Rev-Erbα mRNA levels at 1h vs 13h using Taqman® quantitative 
real-time PCR. 
The fact that Per2 and Bmal1 both increased at 13h compared to 1h was 
somewhat surprising. In the SCN these two transcripts would be in antiphase to 
one another at these sampling times (Figure 2.11). While Per2 should be high 
during circadian day (13h) and low at circadian night (1h), Bmal1 would be the 
exact opposite. Our findings in the pituitary gland are most likely attributed to the 
nature of this peripheral tissue. There are reports that peripheral tissues exhibit a 
3-9 hour phase shift in mRNA core-clock oscillation compared to the SCN, 
suggesting that peripheral tissues might be receiving timing cues from the master 
oscillator in a delayed fashion (Morse and Sassone-Corsi, 2002). If such a phase 
shift is occurring in the pituitary gland, our sampling times would be capturing the 
circadian rhythms at very different expression points. In this case, it appears that 
the pituitary gland was shifted by 8-9 hours in production of mRNA.  
These data lead to the interesting question of rhythms in gene expression 
for organs that are in communication via hormonal signals. For example, Lemos 
et al. (2006) found core-clock gene expression in the rhesus macaque adrenal 
using real-time PCR of Rev-Erbα to investigate phase shift. Their adrenal 
samples came from the same animals and time-points as our pituitary glands and 
the probes and primers were the same as in our analysis. Their results revealed 
Rev-Erbα expression was significantly lower (P<0.05) at 13h than 1h. These 




signals from the SCN, may regulate its own circadian expression of genes within 
the limits of its physiological constraints and demands. 
 
Experiment 3: 24-hour Gene Expression 
Pituitary gland tissue from ovariectomized females collected at 4-hour 
intervals across the day was analyzed to determine if core-clock protein 
expression followed a 24-hour rhythmic pattern. REV-ERBα was targeted using 
immunohistochemical staining as it is localized to the nucleus and because it 
links the positive and negative feedback loops of the molecular clock mechanism. 
Staining for REV-ERBα protein revealed a temporal change in expression within 
the anterior and intermediate pituitary gland of the rhesus macaque. As with 
mRNA expression, there may be a noticeable phase shift in protein expression 
levels compared to the SCN as the peripheral tissues receive timing cues from 
the master oscillator in a delayed fashion (Figure 2.12). 
Our staining technique proved very successful in detecting the circadian 
protein. Future work involving double-staining of the pituitary gland for REV-
ERBα and FSH/LH is particularly appealing. DAB immunohistochemistry 
identified the nuclear REV-ERBα and combined with NiCl staining for cytoplasmic 
FSH/LH could potentially demonstrate colocalization of the proteins. This would 
give added weight to the theory that core-clock gene expression is of 
physiological relevance in the pituitary gland, particularly with regard to daily 




Taken together, the data from these experiments supports the presence of 
an intrinsic clock mechanism which may contribute to the rhythmic physiology of 
the pituitary gland and that expression of selected genes may become altered 
during aging. There are well documented alterations in circadian organization 
during aging, including changes in hormonal rhythms, core body temperature, 
sleep/wake cycles, activity and locomotor patterns, behavioral responses, and 
response to the phase-shifting effects of light (Asai et al., 2001; Hofman and 
Swaab, 2006; Oster et al., 2003).  Despite these overt signs, however, the 
physiological underpinnings for the circadian dysregulation remain unclear. 
Studies suggest that the amplitude of the central circadian pacemaker is 
decreased in older animals. It has recently been reported that Clock and Bmal1 
expression in the SCN decreased with age in hamsters, but that there was no 
difference between young and old hamsters in the expression of either Per1 or 
Per2 (Kolker et al., 2003). The change in Clock/Bmal1 expression was not 
enough to disrupt the overall cycle as the circadian mechanism continued to 
exhibit a normal phase profile (Hofman and Swaab, 2006; Kolker et al., 2004). 
Similar results were found in rats where Per and Cry expression levels in the 
SCN were not dampened or disrupted by aging (Asai et al., 2001; Hofman and 
Swaab, 2006; Yamazaki et al., 2002). It appears then that the daily rhythm of 
expression of core-clock genes is similar in the SCN of young and old rodents 
and that oscillation of the master pacemaker remains remarkably stable. 
Within peripheral tissues there appears to be more variation in aging 




shown deterioration of transcription and rhythmicity in peripheral tissues, 
including lung and aortic/cardiac muscle cells (Kunieda et al., 2006; Yamazaki et 
al., 2002), other research has found no age-related decline in liver, pineal, kidney 
or pituitary gland rhythmicity (Hofman and Swaab, 2006; Yamazaki et al., 2002). 
It may be that some peripheral tissues, like the pituitary gland, are more resilient 
with regard to circadian changes brought about by cellular senescence. In this 
way they may mirror the stability seen in the suprachiasmatic nucleus. 
Finally, there may be a biological significance to the trend observed in the 
decline of Csnk1ε in the pituitary gland with age. Hamsters harboring the 
naturally occurring tau mutation possess a mutated Csnk1ε that is unable to fully 
phosphorylate its physiologically relevant substrate, Per2 (Eide and Virshup, 
2001). Because limited phosphorylation leads to less Per2 degradation it is able 
to build up quicker in the cytoplasm. With higher Per2 content the Per/Cry dimer 
forms faster causing the negative loop of the cycle to progress more rapidly. That 
is to say, a shorter circadian cycle persists which is closer to 20-22 hours in the 
tau mutant (Eide and Virshup, 2001; Morse and Sassone-Corsi, 2002). In 
addition, the tau hamster exhibits accelerated LH pulse frequencies suggesting 
that the underlying GnRH pulsatility may be fundamentally altered by this 
circadian mutation (Chappell et al., 2003). 
We have observed parallel findings in the testes of aging rhesus 
macaques with significant decreases in Csnk1ε expression as measured by 
sqRT-PCR (Chapter 4). How this deficiency in a core-clock gene component 




mutations have no effect on Per mRNA expression or the nuclear accumulation 
of PER proteins in the SCN. The mutation does, however, have unanticipated 
consequences for circadian timing in the periphery, including tissue-specific 
phase advances and/or reduced amplitude of circadian gene expression. The 
reprogrammed output from the clock is associated with peripheral desynchrony, 
which in turn could account for the physiological manifestations of the mutation 
(Dey et al., 2005). These actions of Csnk1ε may partially explain the altered 
expression levels in other core-clock genes such as Per2 and Bmal1 within the 
tissue. Each tissue type may be very different and it would take more 
experimental evidence before the mysteries of circadian mechanisms in each will 
be unlocked. A central unresolved issue is to what extent age-related changes in 
circadian behavior are the result of effects on the central SCN pacemaker, on 




Genome-wide expression profiling of rhesus macaque pituitary gland was 
performed and showed that several of the genetic components of the circadian 
clock mechanism (Per1, Per2, Cry1, Bmal1, Clock, Rev-Erbα and Csnk1ε) were 
clearly present in all pituitary glands, regardless of age. Semi-quantitative RT-
PCR (sqRT-PCR) confirmed the presence of these core-clock genes and also 
indicated significant age differences in expression for at least one component 




by showing differential expression of core-clock genes at two opposite time-
points. Specifically, we found that expression of Per2 and Bmal1 were 
significantly higher (P<0.05) at 1300 h as compared to 0100 h. Expression levels 
of Rev-erbα as measured with qRT-PRC were not found to be significantly 
different at these two time-points. In a final experiment, however, 
immunohistochemistry performed on pituitary gland tissue collected across a 24-
hour period demonstrated rhythmic expression of REV-ERBα protein in the 
anterior pituitary gland of ovariectomized females. Taken together these data 
indicate the ability of the rhesus macaque pituitary gland to express core-clock 
genes, their protein products, and to do so in a 24-hour rhythmic pattern. To our 
knowledge, these findings are the first demonstration of a potential molecular 
clock mechanism in a primate pituitary gland. It remains to be elucidated whether 
this mechanism is expressed in all pituitary gland cells or only in specific cell 
types, and whether they play a physiological role in circadian endocrine function. 
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Figure 2.1 Mammalian Circadian Clock Model (mRNA Expression) 
Schematic presentation of core-clock mRNA expression within the 
suprachiasmatic nucleus (SCN). Circadian time represents the endogenous 
phases of the intracellular clock mechanism which in this example is entrained 
and reset by the daily light cycle (zeitgeber). With a 12L:12D photoperiod relative 
mRNA expression levels would follow this pattern. Bmal1 transcript peaks in the 
middle of circadian night and is the driving force behind the clock mechanism. 
Per and Rev-Erbα (and to a lesser extent Cry) transcript levels peak during the 
mid to late circadian day antiphase to the Bmal1 peak. Csnk1ε and Clock (not 
shown) are both constitutively expressed throughout the day. Data used to create 
this graph was compiled from Glossop and Hardin, 2002, and Lowrey and 



















































Figure 2.2 Mammalian Circadian Clock Model (Protein Expression) 
Schematic presentation of core-clock protein expression within the 
suprachiasmatic nucleus (SCN). Circadian time represents the endogenous 
phases of the intracellular clock mechanism which in this example is entrained 
and reset by the daily light cycle (zeitgeber). With a 12L:12D photoperiod relative 
protein expression levels would follow this pattern. Observe the variable shift in 
peak translation levels for each gene compared to its mRNA expression in Figure 
2.1. Data used to create this graph was compiled from Glossop and Hardin, 





Modified from: Reppert, S. M. and Weaver, D. R. (2002). Coordination of circadian timing in 
mammals. Nature. 418, 935-941. 
 
Figure 2.3 Mammalian Circadian Clock Model The clock mechanism consists of positive 
(green, or light grey) and negative (red, or dark grey) feedback loops. CLOCK (C, oval) and 
BMAL1 (B, oval) form heterodimers and constitutively activate transcription of the Per, Cry, and 
Rev-Erbα genes through E-box enhancers in their promoter regions. As the levels of PER (P, 
circle) and CRY (C, diamond) proteins increase they form complexes that are phosphorylated by 
casein kinase 1 epsilon (CKIε or CSNK1E) and translocate into the nucleus. Once in the nucleus 
these complexes associate with the CLOCK-BMAL1 heterodimers to shut down transcription 
while the heterodimer remains bound to DNA, forming the negative feedback loop. For the 
positive feedback loop, increasing REV-ERBα levels (R, circle) functionally compete with retinoic 
acid-related orphan receptors (ROR) at the retinoic acid-related orphan receptor response 
elements (RORE) in the Bmal1 promoter to repress transcription. PER-CRY mediated inhibition 





sqRT-PCR primers Forward sequence Reverse sequence Amplicon Cycles Temp 
Per1 GCCAGCATCACTCGCAGCAGC GTGGGTCATCAGGGTGACCAGG ~400 bp 27 65oC 
Per2 CATCCACTGGTGGACCTCGCG GGCTCACTGGGCTGCGACGC ~325 bp 27 65oC 
Cry1 GCCTGTCCTAAGAGGCTTCCCTG ACTGAGACCAGTGCCCATGGAGC ~375 bp 28 65oC 
Bmal1 CACAGCATGGACAGCATGCTGC GCCACCCAGTCCAGCATCTGC ~450 bp 26 65oC 
Rev-Erbα TGGCGCTTACCGAGGAGGAGC TCCACCCGGAAGGACAGCAGC 225 bp 26 66oC 
Csnk1ε AAGTATGAGCGGATCAGCGAGA CCGAATTTCAGCATGTTCCAGT 218 bp 28 65oC 
β-actin CATTGCTCCTCCTGAGCGCAAG GGGCCGGACTCGTCATACTCC ~300 bp 22 65oC 
 
Taqman® qRT-PCR 
β-actin primers N/A 40 60oC 
Taqman® qRT-PCR 
β-actin probe 
Human ACTB (beta actin) Endogenous Control 
(Applied Biosystems; Foster City, CA) 
N/A 40 60oC 
Taqman® qRT-PCR 
Rev-Erbα primers ACCCTGAACAACATGCATTCC GGAGAGAGAAGTGCAGAGTTCGA ~100 40 60oC 
Taqman® qRT-PCR 
Rev-Erbα probe 5’-6FAM-CTGCCGCTGCCCCCTTGTACA-TAMRA-3’ N/A 40 60oC 
 
Table 2.1 Core-Clock Gene Primers and Probes Forward and reverse primer sequences (5’ to 3’) used for sqRT-PCR 
and qRT-PCR are shown along with the expected amplicon sizes, annealing temperatures and number of cycles run for 
each reaction. Primers and qRT-PCR probes were designed using human or rhesus macaque gene sequences and 





probeset gene Juvenile Young Adult Old Adult 
202861_at Per1 765 + 185 553 + 44 735 + 103 
36829_at Per1 1301 + 254 1037 + 115 1038 + 46 
205251_at Per2 1881 + 57 1283 + 327 1460 + 101 
208518_s_at Per2 311 + 27a 186 + 15b 317 + 25a 
209674_at Cry1 314 + 62 309 + 63 360 + 124 
209824_s_at Bmal1 500 + 30a 792 + 71b 630 + 69a,b 
210971_s_at Bmal1 298 + 31 355 + 80 444 + 123 
31637_s_at Rev-Erbα 1989 + 232 2617 + 203 2188 + 282 
202332_at Csnk1ε 207 + 13 184 + 16 148 + 18 
204980_at Clock 280 + 16 365 + 38 357 + 41 
217563_at Clock 142 + 25 172 + 18 142 + 15 
 
Table 2.2 Gene Expression Profiles of Core-Clock Genes in the Rhesus Macaque Pituitary Gland Mean signal 
intensity values (+SEM) of core-clock gene expression across three age categories (n=3) of rhesus macaques (Juvenile = 
1 - 2 years, Young Adult = 7 - 12 years, and Old Adult = 18 - 26 years) as measured by GeneChip® microarray 
(Affymetrix). Significant differences were observed in Per2 and Bmal1 expression using one-way ANOVA and Tukey-
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Figure 2.4 Age Distribution of Core-Clock Genes in the Rhesus Macaque 
Pituitary Gland Representative sqRT-PCR results validating the microarray data 
and demonstrating expression of clock genes across three age categories (n=4) 
of rhesus macaques (Juvenile = 1 - 2 years, Young Adult = 7 - 12 years, and Old 
Adult = 18 - 26 years). The housekeeping gene β-actin was used as a positive 







Figures 2.5 A-F sqRT-PCR Expression Levels of Core-Clock Genes Across 
Age Categories in the Rhesus Macaque Pituitary Gland Each bar, along with 
SEM, represents mean, normalized fluorescence data from four animals. 
Statistical comparisons were made using one-way ANOVA and Tukey-Kramer 
post-hoc analysis (P<0.05). Significant differences were observed in Per2 
expression (Graph A) between Juvenile animals and the other two groups, 
resulting in a negative fold-change of 0.63 (+0.05) and 0.58 (+0.06), respectively. 
Csnk1ε and Bmal1 expression (Graphs B-C) did not reach significant levels due 
to large variation within some groups, but trends were observed that correlated 









































































































































































































































































































Figure 2.6 Phase Shift Expression of Core-Clock Genes in the Rhesus 
Macaque Pituitary Gland Representative sqRT-PCR results demonstrating 
expression of core-clock genes at 1 h (lanes 1-3) and 13 h (lanes 4-6). The 
housekeeping gene β-actin was used as a positive control and for normalizing 
images for analysis. Csnk1ε was not measured because it is constitutively 











Figures 2.7 A-E sqRT-PCR Expression Levels of Core-Clock Genes at    
0100 h and 1300 h in the Rhesus Macaque Pituitary Gland Each bar, along 
with SEM, represents mean, normalized fluorescence data from three animals. 
Statistical comparisons were made using Student’s t-test (*, P<0.05). Significant 
differences were observed in expression levels between time points and resulted 



















































































































































































































































































































































Figure 2.8 Taqman® Quantitative Real-Time PCR of Rev-Erbα in the Rhesus 
Macaque Pituitary Gland Each bar, along with SEM, represents mean, 
normalized fluorescence data from three animals. Statistical comparisons were 











Figure 2.9 Immunohistochemistry of REV-ERBα Distribution Within the Rhesus Macaque Pituitary Gland REV-
ERBα nuclear immunostaining in the pituitary gland demonstrating regional variation in protein expression. A) very low 
power magnification of entire pituitary gland (anterior pituitary=AP, posterior pituitary=PP, intermediate pituitary=IP). B) all 


















Figure 2.10 Immunohistochemistry of Circadian Expression of REV-ERBα in the Rhesus Macaque Pituitary Gland 
REV-ERBα nuclear immunostaining (black arrows) in the anterior pituitary gland showing temporal changes in intensity 
across a 24-hour cycle (400X bright-field). The horizontal white and black bar represent day and nighttime. 
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Figure 2.11 Mammalian Circadian Clock Model (mRNA Expression) with 
Experimental Sampling Time Points Schematic presentation of core-clock 
mRNA expression within the suprachiasmatic nucleus (SCN). Vertical black 
boxes represent the sampling time points for pituitary glands in Experiment 2: 
Phase shift expression of core-clock genes. Peripheral tissue presumably 
exhibits a similar pattern of expression but in which the mRNA peaks are phase 































































Figure 2.12 Mammalian Circadian Clock Model (Protein Expression) with 
Experimental Sampling Time Points Schematic presentation of core-clock 
protein expression within the suprachiasmatic nucleus (SCN). Vertical black 
boxes represent the sampling time points for pituitary glands in Experiment 3: 24-
hour gene expression changes of core-clock genes. Peripheral tissue 
presumably exhibits a similar pattern of expression but in which the protein peaks 










EFFECTS OF MODERATE CALORIE RESTRICTION ON PITUITARY GLAND 




Calorie restriction (CR), defined as undernutrition without malnutrition, has 
been established as the only non-genetic method of altering longevity and 
attenuating the biological changes associated with aging (Koubova and 
Guarente, 2003; Lane et al., 1999b; McCay et al., 1935). Calorie restricted 
animals receive essential nutrients and vitamins while total calorie intake is 
decreased to a range 30-70% below ad libitum levels. The result is lower energy 
input without sacrificing nutritional competence (Weindruch and Walford, 1988). 
Some characteristic markers of CR include reduced body mass and adiposity, 
lower body temperature, slowed growth, delayed skeletal maturation, and 
decreased glucose and fasting plasma insulin levels. In addition, CR has been 
shown to alter gene expression profiles and modify neuorendocrine function by 
lowering levels of growth hormone (GH), thyroid stimulating hormone (TSH) and 
thyroid hormones (Gredilla and Barja, 2005; Gresl et al., 2001; Heilbronn and 
Ravussin, 2003; Koubova and Guarente, 2003; Lane et al., 1997). Although the 
exact mechanisms of action explaining CR’s benefits are still elusive, this 
experimental paradigm has been found to be effective in a diversity of species 




human primates (Ingram et al., 1990; Lane et al., 1999b; Roth et al., 1999; 
Weindruch and Walford, 1988). 
Moderate calorie restriction is believed to successfully intervene in the 
cascade of events which lead to normal aging, thus accounting for its 
advantageous health benefits. These aging events occur simultaneously at 
molecular, cellular and systemic levels, resulting in disruption of homeostatic 
mechanisms and progressive loss of function (including reproductive capacity). A 
few examples of age-related homeostatic imbalance include decreased stress 
response, increased pathology, decline in memory function and documented 
alterations in circadian organization, such as changes in hormonal rhythms, core 
body temperature and sleep/wake cycles (Asai et al., 2001; Hofman and Swaab, 
2006; Oster et al., 2003). In males, the age-related reproductive demise occurs 
with functional deterioration of the system at several sites including reduced 
testosterone (T) production, decreased hypothalamic gonadotropin-releasing 
hormone (GnRH) and altered pituitary gland release of gonadotropins (Harman 
et al., 2001; Moffat et al., 2002; Ottinger, 1998). 
While data on life extension in a wide range of species strongly suggests 
that CR mechanisms are universal across species, few studies were conducted 
in an animal model living longer than four years until the late 1980’s. In 1987, to 
address the relevance of this nutritional intervention to human health, the 
National Institute on Aging began the first study of CR and aging in non-human 
primates using rhesus macaques (Macaca mulatta) to determine its potential 




investigated in studying the long-term effects of CR on aging in these animals. 
Results parallel findings in other species and verified the CR-induced attenuation 
of age-related changes in plasma triglycerides, oxidative damage, and glucose 
regulation (Mattison et al., 2003; Roth et al., 2002). Treatment animals weighed 
less, with reduced body fat and lower body temperatures than their matching 
control counterparts, providing early evidence of the potential benefit of CR for 
individuals at risk for diabetes and cardiovascular disease (Lane et al., 1999a; 
Mattison et al., 2003). 
As with rats, moderate calorie restriction implemented prior to sexual 
maturity delayed the maturation-related increase in circulating testosterone 
concentrations and postponed skeletal growth by approximately one year in male 
rhesus macaques (Lane et al., 1997; Mattison et al., 2003; Roth et al., 2000). 
Less is known, however, about the impact of CR on the hypothalamic-pituitary-
gonadal (HPG) axis when the dietary intervention is applied post-pubertally. In 
light of the essential functions of the neuroendocrine system and the pituitary 
gland in the HPG axis, it is important to examine pituitary gland function as a 
critical site for CR-associated effects. 
The aim of the present study was to investigate the impact of CR on 
pituitary gland gene expression and to quantify expression levels in adult rhesus 
macaques (Macaca mulatta). We were particularly interested in genes 






MATERIALS AND METHODS 
Animals and Diet 
All experiments were approved for use by the Institutional Animal Care 
and Use Committees at the University of Maryland and the Oregon National 
Primate Research Center. The study consisted of 10 Young Adult (12 years) 
male rhesus macaques (Macaca mulatta) fed a control diet (CON; n=5) or calorie 
restricted at 30% CON (CR; n=5) for eight years, beginning post-pubertally. 
Animals were individually housed in a temperature-controlled environment under 
12L:12D photoperiod (lights on 7 h -19 h) and allowed auditory, visual and 
olfactory interaction with male and female conspecifics in the vivarium. Food was 
provided in two meals at 8 h and 15 h daily; water was available ad libitum.  
The diet consisted of individual biscuits that had been specially formulated 
for this study (Ingram et al., 1990) supplemented with a daily low calorie treat. 
The composition of the diet was 15% protein, 5% fat and 5% fiber with a caloric 
content of approximately 3.7 kcal/g. Biscuits included a vitamin/mineral mix that 
was 40% higher than the recommended allowance for rhesus macaques by a 
National Research Council report (NRC, 1978), but were otherwise similar to 
those used in many laboratory studies of rhesus macaques. This vitamin/mineral 
supplementation was designed to ensure sufficient availability of essential 
nutrients in both the CON and CR diets. Thus, it should be clear that the CON 
and CR groups were receiving exactly the same diet. Biochemical assays were 
performed periodically and with every new shipment to ensure diet content and 




The amount of food provided to CON animals was provided at an ad 
libitum level, originally determined with the individual leaving a few uneaten 
biscuits each day during regular measurements of food consumption. CR 
macaques were given 30% less than age- and body-weight matched controls. 
Food allotments were held constant other than as needed on a case-by-case 
basis when warranted by greater than acceptable changes in body weight (Lane 
et al., 1999b; Mattison et al., 2005). 
Animals were sacrificed according to the NIH Guide for the Care and Use 
of Laboratory Animals. Pituitary glands were collected and sectioned sagittally. 
One half of each pituitary gland was flash frozen in liquid nitrogen and the other 
half was fixed in 4% paraformaldehyde. 
 
RNA Extraction and Gene Microarrays 
Sagittally cut, flash frozen pituitary gland sections were homogenized 
using a PowerGen rotor-stator homogenizer (Fisher Scientific; Pittsburgh, PA). 
Total RNA was isolated using RNeasy columns (QIAGEN; Valencia, CA); 
concentration and integrity were assessed by microcapillary electrophoresis 
using a model 2100 Agilent Bioanalyzer (Santa Clara, CA; see Appendix A for 
more detail). Three samples from both treatment groups were sent for microarray 
analysis at the Affymetrix Microarray Core of the OHSU Gene Microarray Shared 
Resource. 
Analysis was performed in accordance with the manufacturer’s 




Labeled target cRNA was prepared from total RNA samples and hybridized to 
GeneChip® Rhesus Macaque Genome Arrays detecting over 47,000 transcripts. 
Image processing and expression analysis were performed using Affymetrix 
GCOS v1.2 software. A number of quality control metrics were utilized as a 
measure of probe quality and included chip background, chip noise, total 
fluorescent intensity, number of genes detected and the 3’/5’ ratio of the 
housekeeping genes β-actin and GAPDH. These metrics are assessed to 
determine the validity of the data obtained from the scanned GeneChip®. Data 
were normalized to an average intensity on each chip which enabled direct 
comparisons between the six different arrays. 
 
Gene Microarray Filtering 
Microarray data filtering was performed using Genesifter® software 
(vizXlabs; Seattle, WA) followed by hand analysis and determination of genes of 
interest (see Appendices B and C). Briefly, unscaled array data was normalized 
and log2 transformed using robust multi-array average (RMA) analysis. Student t-
test (P<0.05) comparisons with Benjamini-Hochberg post-hoc corrections were 
performed. Signal quality and fold-change parameters were not set in order to 
allow for qualitative and quantitative hand filtering later. Probesets showing a 
significant change between treatments were then imported into Excel (Microsoft; 
Redmond, WA) and filtered for a minimum 1.5 fold-change in expression. Based 
on this gene discovery method, probesets meeting these criteria for significance 




52,000+ probesets was performed to identify non-significantly changed probesets 
of interest. These included genes that were highly expressed and/or fell into the 
categories of reproduction, metabolism and oxidative stress. Table 3.1 lists the 




PrimerExpress® software (Applied Biosystems; Foster City, CA) was used 
for all primer and probe design (Appendix G). Specific primers were designed for 
each transcript using the predicted rhesus macaque mRNA sequences posted at 
the National Center for Biotechnology Information (NCBI) Entrez Nucleotide 
database. The primers were purchased from Invitrogen (Carlsbad, CA) and the 
sequences are given in Table 3.2. 
Total RNA (1 µg) was used to synthesize cDNA using the Omniscript kit 
(QIAGEN) and oligo d(T)15 primers (Promega Corp; Madison, WI). The reaction 
was performed following the manufacturer’s instructions in a 20 µl volume at 
37oC for 1 hour. The linear range of amplification was calculated for each pair of 
primers using pooled samples and reactions were performed in duplicate. sqRT-
PCR amplifications were performed using 1 µl of cDNA, 200 µM deoxynucleotide 
triphosphates (Promega), 0.5 µM of each primer, and 2.5 U of HotStarTaq® 
polymerase (QIAGEN) in a 25 µl reaction volume. The reactions were performed 




temperature for each primer set (Table 3.2), 1 min and 72oC, 1 min (see 
Appendix H for specific details). 
Aliquots (7 µl) of reaction product were resolved by electrophoresis on 2% 
agarose gels with ethidium bromide and photographed under ultraviolet light. 
Subsequent image analysis was performed using ImageJ software 1.37v (NIH; 
Bethesda, MD). Briefly, a single rectangle was drawn horizontally around all 
bands in a selected gel image and a plot profile of signal intensities was 
generated. Area selections were created under the peak for each band using the 
‘straight lines selection’ tool. Area under the curves was then measured and 
provided area statistics for analysis. Appendix I discusses troubleshooting for 
primer design, sqRT-PCR and gel imaging. 
 
Taqman® Quantitative Real-Time RT-PCR 
cDNA was prepared by random-primed reverse transcription using 
random hexamer primers (Promega), 200 ng of RNA and the Omniscript kit 
(QIAGEN). The RT reaction was then diluted 1:100 for PCR analysis. The PCR 
mixtures contained 5 µl of Taqman® Universal PCR Master Mix (Applied 
Biosystems), 300 nM CGA primers (Invitrogen), 50 nM human β-actin primers 
(Applied Biosystems), 250 nM CGA probe (IDT; Coralville, IA) and 2 µl cDNA. 
Reactions were run in triplicate for higher accuracy. The amplification was 
performed as follows: 2 min at 50oC, 10 min at 95oC, and then 40 cycles each at 
95oC for 15 sec and 60oC for 60 sec in an ABI/Prism 7700 Sequences Detector 




the critical threshold values (i.e. above background) into relative RNA 
concentrations for each sample. The CGA primers and probe were designed 
using the predicted rhesus macaque sequence available in the NCBI Entrez 
Nucleotide database and are listed in Table 3.2. 
 
Amplicon Sequencing 
Following amplification the PCR samples contain a complex mixture of 
specific PCR product and residual reaction components such as primers, 
unincorporated nucleotides, enzyme(s), salts and non-specific amplification 
products. The PCR products were purified using a QIAquick Gel Extraction Kit 
(Qiagen). Purified samples were then submitted to the Molecular and Cell 
Biology Core of the Oregon National Primate Research Center. DNA sequencing 
was performed on an ABI 3130XL Genetic Analyzer using Dye Terminator 
sequencing chemistry. The resulting sequences were then BLASTed at the NCBI 




 Data are expressed as mean + SEM for each gene measured in each 
group. Signal intensity and mRNA expression levels were analyzed by Student’s 
t-test. In order to control for experiment-wide false positives while still maintaining 
statistical power, each Student’s t-test was treated as an independent test and, 




this sequential Bonferroni with Simes-Hochberg correction was used (Hochberg, 
1988). For all analyses significant differences were established at P<0.05 unless 
otherwise adjusted by Bonferroni correction. 
 
RESULTS: 
Gene Microarray and Filtering 
Initial Genesifter® sorting indicated ~26,000 probesets were upregulated in 
CR animals compared to CON while ~26,700 probesets were downregulated. 
Based on filter criteria (t-test; P<0.05) 1018 of these probesets were significantly 
different between the two treatments. When a 1.5 fold-change requirement was 
applied we then detected only 145 probesets with the potential to be differentially 
expressed. (For a complete list of these probesets see Appendix D). 
Two potentially significant genes were chosen from this set to investigate 
further, including the TSH receptor (TSHR) and 1-acylglycerol-3-phosphate O-
acyltransferase 3 (AGPAT3), a component of the triacylglycerol synthetic 
pathway. In addition, five other genes not meeting our filter conditions were 
investigated which were highly expressed and/or fell into the categories of 
reproduction, circadian mechanisms and oxidative stress (Table 3.1). These 
included sperm-specific antigen 2 (SSFA2), a surface antigen responsible for 
zona pellucida binding; glycoprotein hormone common alpha subunit (CGA); 
uncoupling protein 2 (UCP2); casein kinase 1 epsilon (CSNK1E), a core-clock 





sqRT-PCR and qRT-PCR 
Semi-quantitative RT-PCR amplification of all six genes investigated in the 
two treatment groups (n=5) are demonstrated in Figure 3.1. Amplicons were 
detected between 22-29 cycles at 62-65.5oC (Table 3.2). Consistent with the 
microarray data, COX2 mRNA expression was undetectable in any of the 
samples. 
 The sqRT-PCR expression levels for the genes within the two treatment 
groups are shown in Figures 3.2 A-F. In agreement with the microarray data, 
results showed a significant decline of 25% in glycoprotein hormone alpha 
subunit (CGA) mRNA expression in CR animals compared to CON. A significant 
decrease of 45% in expression of the TSH receptor was also observed in CR 
animals. Other genes associated with oxidative stress, circadian mechanisms 
and reproduction showed no significant diet-induced changes. These included 
AGPAT3, UCP2, CSNK1E and SSFA2. 
The results of Taqman® quantitative real-time RT-PCR of CGA are 
represented in Figure 3.3. Expression levels were significantly different between 




The complete sequences for experimentally derived PCR products are 
listed in Table 3.3, as determined by DNA sequencing. The resulting sequences 




almost every instance, the experimentally derived sequence returned a best fit 
for the predicted rhesus macaque mRNA sequence which had been used for 
primer design.  
 
DISCUSSION 
Biological aging is associated with functional decline at the cellular, organ 
and system levels. Conversely, gene and protein expression changes triggered 
by calorie restriction (CR) are also thought to alter biological response, resulting 
in an attenuation of the aging process (Weindruch and Walford, 1988). Given the 
essential functions of the neuroendocrine system, it is not surprising that more 
interest is being directed to this system and its role in aging. The pituitary gland, 
as the central organ in the HPG axis, is a key component of the neuroendocrine 
system. From here neurological and endocrine signals are integrated and 
processed before bioactive peptides/hormones are released into the body. These 
pituitary gland messengers play a critical role in maintaining homeostatic function 
and their modification has been suggested to play a part in an organism’s ability 
to respond to the biological disruptions caused by age (Chen, 2004). 
 In the present study we investigated the impact of moderate CR on 
pituitary gland gene expression and quantified expression levels in adult male 
rhesus macaques (Macaca mulatta) subjected to eight years of post-pubertally 
implemented restriction. We were particularly interested in genes associated with 
reproduction, circadian mechanisms, metabolism and oxidative stress. Health 




overall impact on the HPG axis is difficult to assess. It would be valuable to know 
if calorie restriction had conferred beneficial health effects without negatively 
impacting the neuroendocrine capability of the pituitary gland. 
Previous evidence demonstrated that depending on age, gender and 
species, the effects of calorie restriction on the HPG axis are mixed. Female rats 
restricted to 60% of ad libitum food after the onset of puberty did not experience 
any interruption of normal cycling and delayed cessation of estrous cycles was 
observed (McShane and Wise, 1996). Preliminary data in female rhesus 
macaques aged 7-27 years suggests no adverse effects of long-term CR with 
regard to reproductive hormones (Black et al., 2001; Mattison et al., 2003). No 
interruption of normal ovarian cyclicity was observed in young and menopausal 
calorie restricted animals, suggesting that long-term energy restriction does not 
negatively affect the animals (Lane et al., 2001; Mattison et al., 2003). More 
recently it has been demonstrated that young female rhesus macaques continue 
to cycle normally under short-term, moderate calorie restriction (Wu, 2006). In 
the male reproductive axis, young calorie restricted male rats experienced 
slightly reduced fertility which returned to normal levels in adults (Weindruch and 
Walford, 1988). Overall, male rats appear less sensitive than females with 
regards to reproductive development and the impact of calorie restriction.  
Our investigation of the effects of CR on the HPG axis began with 
microarray analysis of total RNA expression in the rhesus macaque pituitary 
gland. To ascertain biologically relevant changes, robust multi-array average 




probeset significance (Irizarry et al., 2003). Based on RMA and filter criteria (t-
test; P<0.05), 1018 probesets out of 52,000+ were significantly different between 
the two treatments. When a 1.5 fold-change requirement was applied, only 145 
probesets were detected with the potential to be differentially expressed. Based 
on previous experiences in our laboratory we typically dropped from 
consideration any probesets which displayed detection levels below 100 on the 
array. In those instances, however, we were utilizing rhesus macaque tissue with 
human arrays (Affymetrix HG_U133A) and were primarily concerned with cross-
hybridization and false-positives. When we attempted to remove probesets 
containing signals below 100 in the present study it brought the total probesets to 
30. Because this would have severely limited our analysis, and because we were 
less concerned with cross-hybridization with the newly available GeneChip® 
Rhesus Macaque Genome Arrays, we decided to work with the 145 probesets. 
The fact that we had only 30 probesets (and potentially fewer genes) 
identified following more stringent screening is not unexpected. Using similar 
screening techniques, researchers found 145 significantly altered probesets in 
the hypothalamus of 4-month-old mice exposed to short-term 30% CR (Selman 
et al., 2006). This was, however, without a fold-change requirement and, 
because they were not doing follow-up work with the RNA, they did not remove 
weak array signals. In a separate study of rat anterior pituitary gland gene 
expression (Chen, 2004), only 19 out of 542 detectable genes were identified as 




rats that were restricted for 21 months they found only 18 genes that were 
significantly changed between treatment groups. 
In addition to the 145 potentially different probesets, we also performed a 
keyword search of the entire microarray dataset and identified non-significantly 
changed probesets of interest, including genes that were highly expressed and/or 
fell into the categories of reproduction, circadian mechanisms, metabolism and 
oxidative stress. Finally, we compiled a list of probesets/genes to initially 
investigate (Appendix F) and designed primers for them. A complete analysis 
was performed on a selected subset of these genes (see Appendix I for details). 
Final selection for analysis of pituitary gland genes for verification of expression 
included: thyroid-stimulating hormone receptor (TSHR); 1-acylglycerol-3-
phosphate O-acyltransferase 3 (AGPAT3), a component of the triacylglycerol 
biosynthesis pathway; glycoprotein hormone common alpha subunit (CGA); 
uncoupling protein 2 (UCP2); casein kinase 1 epsilon (CSNK1E), a core-clock 
gene; and sperm-specific antigen 2 (SSFA2), a surface antigen responsible for 
zona pellucida binding (Figure 3.1). We were not sure why SSFA2 would have 
been present in pituitary gland tissue, but the microarray data showed high 
expression levels in our samples. Cyclooxygenase 2 (COX2), which showed no 
expression on the microarray data, was also included as a negative control 
measure of cellular stress in the animals. 
As expected, most of the pituitary gland hormones or their components 
were highly expressed according to the microarray data. Many of them, however, 




such as growth hormone (GH) and proopiomelanocortin (POMC) were not 
investigated beyond the microarray output, but may be of potential interest to 
others. Five genes that were of great interest for metabolic and reproductive 
function included the specific beta subunits for each of the glycoprotein 
hormones, LH, FSH, CG and TSH, along with the shared alpha subunit chain, 
CGA. Preliminary attempts were made to identify their expression utilizing sqRT-
PCR with mixed results. In the case of the alpha subunit, the cDNA amplification 
worked well and single-band amplicons were successfully obtained within the 
linear range of amplification. In other instances, such as TSHβ and LHβ, 
difficulties were encountered. We were originally concerned with LHβ because 
there was no probeset on the microarray and no sequence available in the NCBI 
databases. The closest comparable sequence was for cynomolgus macaque 
(Macaca fascicularis) mRNA. Although it might be assumed there is high 
homology between these two species, after designing primers to the cynomolgus 
sequence we were not able to achieve positive results with our samples. Equally 
frustrating was our inability to remove double-banding of TSHβ amplicons on the 
gels (Appendix I). Because of these difficulties it was decided not to spend time 
pursuing FSHβ if LH and TSH beta subunits were not going to be possible. 
Additionally, unlike the substantial fold-change demonstrated by CGA, the beta 
glycoprotein subunits gave less indication of differential expression based on the 
microarray dataset. We decided instead to focus on the genes that showed the 
most potential for exhibiting real expression changes and for which we were able 




Significant differences were detected between treatment groups in CGA 
and TSH receptor mRNA expression. Microarray data had originally shown CGA 
to be highly expressed with an incredibly large fold-change difference (Table 
3.1). It was determined to be non-significant, however, due to large variation 
within the calorie restricted animals. As shown in Figures 3.2A and 3.3, PCR 
detection conducted with a sample size of five in each treatment group, including 
the three animals used for microarray analysis, was able to reveal significant 
differences between groups. Results of sqRT-PCR measurement showed a 25% 
lower level of CGA expression in CR-treated animals compared to CON subjects 
while qRT-PCR results showed an even larger difference in CR animals with 
43% lower level of expression. Quantitative PCR calculations were based on a 
sample size of four in both treatments as compared to five animals for sqRT-
PCR. During analysis one animal from each category was removed as an outlier 
because their average detection signal was more than two standard deviations 
away from the group mean. PCR analysis was completed by sequencing the 
experimentally derived amplicons. Table 3.3 shows the sequences along with the 
results of the NCBI database search. For both the forward and reverse 
sequence, the best fit result was the same predicted rhesus macaque sequence 
that had been used for designing the primer pair. 
The other significant finding of our study was in regard to TSH receptor 
expression. Here again the CR treatment group showed lower expression levels 
compared to the CON animals with a 45% decline based on sqRT-PCR data 




which also indicated a large decline in expression among the CR-treated 
animals. As with all other PCR products, we are confident that we successfully 
detected TSHR cDNA based on our sequencing results (Table 3.3). 
The question remains as to the biological relevance of these changes. The 
observed alterations in CGA expression are more difficult to interpret due to the 
lack of β-subunit information. It would have been advantageous to check all the 
β-subunits, but because of the problems mentioned earlier (i.e. no LHβ rhesus 
macaque sequence, multiple gel bands), we were not able to get a complete 
picture of glycoprotein hormone subunit production. To have a complete 
understanding would have required more time than we had available and 
practically we felt it more efficient and feasible to determine expression levels for 
the common alpha subunit first. Unfortunately, without further analysis of the 
unique beta subunits it is impossible to determine if the change in CGA is related 
to FSH/LH levels in the reproductive axis or, alternatively, to TSH levels in the 
metabolic pathway. 
Because calorie restriction is a nutritional paradigm, impact on an animal’s 
metabolism is a likely mode of action. In fact, several hypotheses related to the 
mechanisms of CR’s biological effects are linked to reduced (or more efficient) 
processing of energy (Heilbronn and Ravussin, 2003; Mattison et al., 2003; 
Weinert and Timiras, 2003). Two manifestations of CR-induced metabolic 
adjustments that have been well documented in rodents, non-human primates 
and humans, are lower core-body temperature (Heilbronn et al., 2006; Lane et 




and suppression of the thyroid axis as measured by lower TSH and thyroid 
hormone levels (Gredilla and Barja, 2005; Heilbronn and Ravussin, 2003; 
Koubova and Guarente, 2003; Mattison et al., 2001). These two phenomena may 
be linked since a depression in body temperature often indicates a reduction in 
the rate of oxygen consumption. The hypometabolic state imposed by CR is 
reflected by the approximately 50% reduction in serum triiodothyronine (T3) 
hormone concentrations (Weindruch and Sohal, 1997). The changes in CGA and 
TSHR mRNA expression in our CR animals seems to indicate a modification of 
the metabolic pathway and could potentially correlate with these kinds of 
physiological responses. 
 In adults the thyroid gland and its hormones maintain metabolic stability by 
regulating oxygen requirements, body weight and basal metabolic rate (Griffin 
and Ojeda, 2000). In addition to lower circulating thyroid hormone levels, the 
metabolic rate of both restricted rodents and primates expressed as a function of 
lean body mass is initially reduced during adaptation to CR. This reduction, 
however, is not maintained after the loss of metabolic (lean) body mass (Lane et 
al., 1997; Roth et al., 2000). That is to say, weight loss and reduction in lean 
body mass experienced by the CR animals eventually ‘catch up’ to the slower 
metabolism. Consequently, energy expenditure per lean mass unit is not different 
between diet groups. It would appear then that the mechanism of CR that 
extends lifespan and slows aging is not strictly dependent on a reduction in 





An ongoing human study, however, found a metabolic adaptation 
(decrease in energy expenditure larger than expected on the basis of loss of 
metabolic mass) associated with lower thyroid hormone concentrations 
(Heilbronn et al., 2006). They concluded that metabolic adaptations are closely 
paralleled by a drop in thyroid hormone plasma concentrations, confirming the 
importance of the thyroid pathway as a determinant of energy metabolism. TSHR 
may even be involved at the pituitary gland level, at least in humans, where the 
receptors are found on folliculo-stellate cells which are known to influence 
neighboring endocrine cells. Here an ultra-short-loop pituitary gland feedback 
system may be involved in the pulsatile generation of pituitary gland hormone 
secretion and fine-tuning of their release by attenuating the oscillation in their 
serum levels (Prummel et al., 2004). The changes in CGA and TSHR expression 
measured in our present study may be a result of such feedback regulation. 
 One of the ways that moderate CR is hypothesized to improve health and 
extend lifespan is through a shift of metabolic strategy from growth and 
reproduction to life maintenance (Heilbronn and Ravussin, 2003; Roth et al., 
2000). While the small, but significant decrease in core-body temperature 
exhibited by CR animals may not be sufficient to account for the possible 
increase in efficiency of energy utilization that appears to underlie the slower 
aging rate, it may be a symptomatic marker of more fundamental biological 
alterations. Although there is no direct evidence that reduced body temperature 
slows aging, it is consistent with indirect findings in hibernating animals (Lane et 




been promoted as a potential biomarker of aging (Roth et al., 2002). In the long 
running Baltimore Longitudinal Study of Aging, men with lower core-body 
temperature have been shown to experience greater survival than their 
respective counterparts (Roth et al., 2002). 
 Beneficial effects of CR, whereby resources shift from reproduction to life 
maintenance, would also minimize free radical production by decreasing the 
number of oxygen molecules interacting with the mitochondrial electron transport 
chain. A growing body of evidence and experimental support implicates 
mitochondrial derived reactive oxygen species (ROS) as a major cause of 
cellular decline. A direct relationship between individual age, species longevity 
and rate of mitochondrial ROS production has been documented (Gredilla and 
Barja, 2005; Kirkwood and Austad, 2000; Weinert and Timiras, 2003), and we 
know that CR reduces oxidative stress damage, most likely through a reduction 
of ROS (Heilbronn and Ravussin, 2003; Koubova and Guarente, 2003; Merry, 
2004). Usually uncoupling proteins (such as UCP2) regulate the efficicacy of 
oxidation and as a result suppress the generation of ROS. This mechanism could 
play a critical role in protecting cells against degeneration that can occur naturally 
during aging or during pathological conditions. The existence of robust UCP2 
expression has been documented in all regions of the primate pituitary gland 
where its expression is higher than any other part of the central nervous system 
(Diano et al., 2000).  
 In our study we observed no significant differences between our treatment 




presentation which is not unexpected in young animals as it is assumed that their 
ROS protective mechanisms would be functioning at a robust level. At the same 
time COX2, an indicator of inflammation and cellular damage, was undetectable 
on the microarrays and by sqRT-PCR analysis. Whether or not CR would 
attenuate the expected age-related changes in expression of these two genes by 
maintaining a more metabolically efficient use of oxygen would be very 
interesting to determine. 
 Other genes that showed no expression changes based on sqRT-PCR 
results included 1-acylglycerol-3-phosphate O-acyltransferase 3, sperm-specific 
antigen 2, and casein kinase 1 epsilon (Figure 3.2C,E,F). We included AGPAT3 
in our studies for two reasons. First, it is a key enzyme in the triacylglycerol 
(triglyceride) pathway and CR has been shown  to lower triglyceride levels (Roth 
et al., 2002). Secondly, the GeneChip® Rhesus Macaque Genome Array 
contained seven probesets for AGPAT3 and at least one probeset had been 
labeled as significantly changing in both the pituitary gland and testis (Chapter 4) 
based on our filtering parameters. There were conflicting expression changes in 
these probesets, however, with five of them showing decreased expression in 
CR animals while two others showed increased mRNA expression. Because our 
sqRT-PCR was unable to detect significant differences between groups it is 
difficult to say with any certainty what is occurring with regards to AGPAT3 
mRNA expression. 
With regards to SSFA2, we had not expected to investigate this gene in 




even higher than that seen in the testis (Chapter 4, Table 4.1). Since we had the 
primers available we decided to investigate. It is obvious, based on microarray, 
sqRT-PCR and DNA sequencing results, that SSFA2 was indeed present in the 
sample tissues at relatively high levels. We do not know the significance of this, 
however, since SSFA2 is supposed to be a surface antigen that affects sperm 
binding to the zona pellucida of the oocyte. 
 Although expression levels may not change between treatment groups, 
without further analysis it is unknown whether or not morphological changes may 
be occurring in the pituitary gland. Even though the gland may appear to be 
functioning normally under calorie restricted conditions, there may be changes 
occurring in cell location, number, size, etc. Other quantifiable techniques, such 
as immunohistochemistry or in situ hybridization would have to be employed in 
order to make such a determination. 
 Finally, even though our microarray data revealed very few CR-induced 
gene expression changes in the rhesus macaque pituitary gland, there are some 
caveats. The pituitary gland is composed of multiple regions which lie in very 
close apposition, often invaginating or migrating into one another. Therefore, 
gross dissection of the gland and region-specific gene expression analysis may 
result in erroneous conclusions. Consequently, we chose to use all regions of the 
pituitary gland for our microarray analysis, even though this may have led to 
some loss of sensitivity due to normalization of each probeset’s intensity to an 
average chip intensity value. Also, it is possible that some genes oscillate in one 




expression in different cell types of the gland, resulting in a net cancellation of 
gene expression detection. As a consequence, it is possible that in our analysis 
some genes fell below the detection threshold for expression. It must also be 
emphasized that our microarray measurements all took place in a small window 
of time, as the animals were sacrificed between 11 h and 14 h. Since we know 
that gene expression can be rhythmic in nature (Chappell et al., 2003; Lemos et 
al., 2006; von Gall et al., 2002), it is possible that we measured expression 
during a particular peak or nadir so we cannot exclude the possibility that other 
timepoints would show significant differences in gene expression between 
treatment groups. 
Based on our studies, pituitary gland gene expression appears resistant to 
CR-induced changes. Such stability is not necessarily unexpected as it would be 
disconcerting for components of a primary axis, such as the HPG, to be 
fluctuating too broadly under anything less than pathological conditions. With CR, 
however, there may be a few key components that are carefully modified in such 
a way as to affect multiple physiological responses simultaneously. Because 
thyroid hormones help regulate energy metabolism and body temperature, any 
modification of upstream components of their signaling pathway could influence 
their actions. The documented changes in glycoprotein hormone alpha subunit 
and TSH receptor gene expression in our experimental animals could be just 
such modifications. 
Our studies are among the first to address the potential impact of 




of limited mRNA expression changes, coupled with other measures of CR-
induced attenuation of age-related changes and improved health parameters 
(Mattison et al., 2003; Roth et al., 2002), suggest that advantageous health 
benefits of calorie restriction can be achieved without negative consequences. It 
remains to be elucidated how the changes observed in TSHR and CGA 




In the present study we investigated the impact of moderate calorie 
restriction on pituitary gland gene expression and quantified expression levels in 
adult male rhesus macaques (Macaca mulatta). Total RNA was isolated from the 
pituitary glands of Young Adult (12 years) rhesus macaques fed a control diet 
(CON; n=5) or calorie restricted at 30% CON (CR; n=5) for eight years, beginning 
post-pubertally. Gene expression profiles were obtained from 3 animals in each 
treatment using GeneChip® Rhesus Macaque Genome Arrays (Affymetrix). 
Filtering with Genesifter® (vizXlabs) and a 1.5 fold-change threshold provided 
fewer than 150 probesets out of 52,000+ that were different between groups. We 
chose two genes from this set to investigate further, including the TSH receptor 
(TSHR) and a component of the triacylglycerol synthetic pathway, along with five 
other genes not meeting our filter conditions. In agreement with the microarray 
data, results of semi-quantitative PCR (sqRT-PCR) analysis showed a significant 




also observed a significant decrease in expression of the glycoprotein hormone 
alpha subunit (CGA) in CR animals using sqRT and real-time PCR. Without 
further analysis of the unique beta subunits it is impossible to determine if this 
polypeptide is related to FSH/LH levels in the reproductive axis or, alternatively, 
to TSH levels in the metabolic pathway; changes in TSHR expression seem to 
indicate the latter. Other genes associated with reproduction, circadian 
mechanisms and oxidative stress showed no significant diet-induced changes. 
Our studies are among the first to address the potential impact of CR on pituitary 
gland gene expression in rhesus macaques and findings suggest that 
advantageous health benefits of calorie restriction can be achieved without 
negative consequences. It remains to be elucidated how the changes observed 
in TSHR and CGA expression levels may correlate to the physiological 
manifestations of this nutritional paradigm. 
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Pituitary
Other ID / Probeset CON 1 Call CON 2 Call CON 3 Call Gene ID CR 1 Call CR 2 Call CR 3 Call
MmugDNA.14589.1.S1_at 28.7 P 34.8 P 17.2 P AGPAT 15.5 P 13.2 A 21.8 M
MmugDNA.1459.1.S1_s_at 551 P 375.6 P 402.9 P 341.3 P 458.2 P 437.8 P
MmugDNA.16471.1.S1_at 125 P 96.1 P 90.2 P 104.4 P 71.9 P 61.7 P
MmugDNA.24842.1.S1_at 230.2 P 274.9 P 283.5 P 248.8 P 176.7 P 159.2 P
MmugDNA.24844.1.S1_at 452 P 518 P 394.4 P 639.9 P 520.2 P 517.8 P
MmugDNA.39097.1.S1_at 664 P 569.6 P 555 P 461.2 P 385.9 P 503.7 P
MmugDNA.6884.1.S1_at 312 P 357.7 P 308.2 P 398.2 P 307.1 P 350.4 P
MmugDNA.13477.1.S1_at 23.2 P 17.6 A 1.8 A TSHR 10.3 A 11.2 A 15.4 A
MmugDNA.32655.1.S1_at 57.2 P 33.7 P 35.9 P 20.2 P 22 A 13 A
MmugDNA.796.1.S1_at 14.2 A 9.5 A 18.7 A 3.9 A 24.3 A 5.2 A
MmugDNA.19270.1.S1_at 22.2 A 21.5 A 23.2 A SSFA2 11.7 A 28.5 A 32.1 A
MmugDNA.26522.1.S1_at 340.2 P 363.2 P 308.1 P 378.4 P 124 P 133.1 P
MmugDNA.14233.1.S1_at 942.2 P 911.6 P 1051.8 P 1057 P 1126.6 P 962.9 P
MmugDNA.4648.1.S1_at 946.3 P 499.7 P 470.9 P CGA 245.9 P 4.5 A 212.7 P
MmugDNA.29263.1.S1_at 13438.2 P 14371.6 P 13887.8 P 11745 P 15716.4 P 14219.6 P
MmugDNA.16174.1.S1_at 677.6 P 434.6 P 546.7 P UCP 498.4 P 631.5 P 575.5 P
MmugDNA.1485.1.S1_at 571.1 P 347.6 P 364.4 P 371.7 P 491.3 P 445.8 P
MmugDNA.4494.1.S1_at 27.3 A 21.2 A 3.7 A COX2 21.2 A 21.5 A 18.4 A
MmugDNA.17389.1.S1_at 16.4 A 17.6 A 29 A CSNK1E 21 P 25.2 A 24.7 A
MmugDNA.29650.1.S1_at 39.6 A 42.4 A 25.4 A 69.4 A 11.5 A 58 A
MmugDNA.34870.1.S1_at 293.3 P 315.4 P 214.4 P 312.9 P 189.3 P 242.5 P
MmugDNA.4033.1.S1_at 68.6 P 52.3 P 76.2 P 68.9 P 58.7 P 48.5 P
MmuSTS.1889.1.S1_at 268.6 P 219.3 P 238.8 P 255.9 P 239.1 P 207.6 P  
 
Table 3.1 Microarray Probeset Data for Pituitary Gland Genes Subjected to Experimental Analysis Compiled list of 
pituitary gland genes (and their probesets) investigated experimentally with sqRT-PCR and qRT-PCR (Young Adult CON, 







Probeset Gene ID CON CR
MmugDNA.14589.1.S1_at AGPAT 27 + 5 17 + 3
MmugDNA.1459.1.S1_s_at 443 + 54 412 + 36
MmugDNA.16471.1.S1_at 104 + 11 79 + 13
MmugDNA.24842.1.S1_at 263 + 17 195 + 27
MmugDNA.24844.1.S1_at 455 + 36 559 + 40
MmugDNA.39097.1.S1_at 596 + 34 450 + 34
MmugDNA.6884.1.S1_at 326 + 16 352 + 26
MmugDNA.13477.1.S1_at TSHR 14 + 6 12 + 2
MmugDNA.32655.1.S1_at 42 + 7 18 + 3
MmugDNA.796.1.S1_at 14 + 3 11 + 7
MmugDNA.19270.1.S1_at SSFA2 22 + 1 24 + 6
MmugDNA.26522.1.S1_at 337 + 16 212 + 83
MmugDNA.14233.1.S1_at 969 + 43 1049 + 47
MmugDNA.4648.1.S1_at CGA 639 + 154 154 + 76
MmugDNA.29263.1.S1_at 13899 + 270 13894 + 1158
MmugDNA.16174.1.S1_at UCP 553 + 70 568 + 39
MmugDNA.1485.1.S1_at 428 + 72 436 + 35
MmugDNA.4494.1.S1_at COX2 17 + 7 20 + 1
MmugDNA.17389.1.S1_at CSNK1E 21 + 4 24 + 1
MmugDNA.29650.1.S1_at 36 + 5 46 + 18
MmugDNA.34870.1.S1_at 274 + 31 248 + 36
MmugDNA.4033.1.S1_at 66 + 7 59 + 6





Table 3.2 Gene Expression Profiles in the Rhesus Macaque Pituitary Gland 
Mean signal intensity values (+SEM) of pituitary gland gene expression (Young 
Adult CON, n=3; Young Adult CR, n=3). These genes showed a significant 
(AGPAT, TSHR) or non-significant change (SSFA2, CGA, UCP2, COX2, 
CSNK1E) in gene expression based on GeneChip® Rhesus Macaque Genome 
Array detection (Affymetrix) and our Genesifter® (vixXlabs) filtering parameters 






sqRT-PCR primers Forward sequence Reverse sequence Amplicon Cycles Temp 
CGA GGAGAGTTTACAATGCAGGATTGC GTCATCAAAACAGCACTTGGCA 310 bp 22 62oC 
TSHR CTTCTTTTCTGAAACTGCCAGCTC GAGATTCCAGGTGAGTCCAGCA 302 bp 29 62oC 
AGPAT GCTGACTGTTGGCCAGTTTCA CCTGCAGCATTTCACCAGTACA 316 bp 27 62oC 
UCP2 TGCAAAGCCCTGCTGTTCA AGATAGAGGAACTCTGCCGGAATC 301 bp 26 63oC 
SSFA2 GGAAGAAAGTATTCCGAGCATCGG ACACCTCCACCAGTGCATATCATTG 307 bp 26 65.5oC 
CSNK1E AAGTATGAGCGGATCAGCGAGA CCGAATTTCAGCATGTTCCAGT 218 bp 28 65oC 
COX2 AGAGGCTAGTGCCTCAGAGAG GCTAGCACACAGGCCTATCC 437 bp N/A N/A 
β-actin CATTGCTCCTCCTGAGCGCAAG GGGCCGGACTCGTCATACTCC ~300 bp 23 65oC 
      
Taqman® qRT-PCR 
β-actin primers 
N/A 40 60oC 
Taqman® qRT-PCR 
β-actin probe 
Human ACTB (beta actin) Endogenous Control 
(Applied Biosystems; Foster City, CA) N/A 40 60oC 
Taqman® qRT-PCR 
CGA primers 
TGGAGAGTTTACAATGCAGGATTG AGCAGCAGCCCATACACTGA 101 bp 40 60oC 
Taqman® qRT-PCR 
CGA probe 
5’-6FAM-AATTCTTCTCCAAGCCGGGTGCCC-TAMRA-3’ N/A 40 60oC 
 
Table 3.3 Pituitary Gland Gene Primers and Probes Forward and reverse primer sequences (5’ to 3’) used for sqRT-
PCR and qRT-PCR are shown along with the expected amplicon size, annealing temperatures and number of cycles run 
for each reaction. Primers and qRT-PCR probes were designed using human or rhesus macaque gene sequences and 
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Figure 3.1 Genes in the Rhesus Macaque Pituitary Gland Representative 
sqRT-PCR results validating the microarray data and demonstrating expression 
of pituitary gland genes across the treatment groups of Young Adult rhesus 
macaques (12 years; CON and CR, n=5). The housekeeping gene β-actin was 






Figures 3.2 A-F sqRT-PCR Expression Levels of Genes in the Rhesus 
Macaque Pituitary Gland Each bar, along with SEM, represents mean, 
normalized fluorescence data from five animals. Statistical comparisons were 
made using Student’s t-test (P<0.05). Significant differences were observed in 
CGA expression (Graph A) and TSHR expression (Graph B) between treatment 
groups. In both instances, CR animals demonstrated a negative fold-change in 
mRNA expression of 0.75 (+0.06) and 0.55 (+0.04), respectively. The other 













































































































































































































































































































































Figure 3.3 Taqman® Quantitative Real-Time PCR of CGA in the Rhesus 
Macaque Pituitary Gland Each bar, along with SEM, represents mean, 
normalized fluorescence data for four animals. Statistical comparisons were 
made using Student’s t-test (P<0.05). Results corroborated our sqRT-PCR 
results and demonstrated a significant negative fold-change of 0.57 (+0.10) in 





Table 3.4 Pituitary Gland Gene sqRT-PCR Amplicon Sequences Experimentally derived PCR amplicon sequences as 
determined by DNA sequencing are listed under each of the genes. Following each are the results of a BLAST search in 
the NCBI database to determine a best fit sequence. 
 






Best fit (Same as that used for primer design): gi|109071971|ref|XM_001090917.1| PREDICTED: Macaca mulatta similar to Glycoprotein 
hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common alpha subunit) (Follitropin alpha chain) (Follicle-stimulating 







Best fit (Same as that used for primer design): gi|109071971|ref|XM_001090917.1| PREDICTED: Macaca mulatta similar to Glycoprotein 
hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common alpha subunit) (Follitropin alpha chain) (Follicle-stimulating 
hormone alpha chain) (FSH-alpha) (Lutropin alpha chain) (Luteinizing hormone alpha chain) (LH-alpha), mRNA 
 








Best fit (Same as that used for primer design): gi|109100269|ref|XM_001101290.1| PREDICTED: Macaca mulatta similar to sperm specific 












Best fit (Same as that used for primer design): gi|109100269|ref|XM_001101290.1| PREDICTED: Macaca mulatta similar to sperm specific 
antigen 2, mRNA 
 
C) Uncoupling protein 2 (UCP2) 
pUCP2-Forward primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 








Best fit (Same as that used for primer design): gi|109107894|ref|XM_001115559.1| PREDICTED: Macaca mulatta uncoupling protein 2 (UCP2), 
mRNA 
 






Best fit (Same as that used for primer design): gi|109084461|ref|XM_001104839.1| PREDICTED: Macaca mulatta thyroid stimulating hormone 
receptor, transcript variant 2 (TSHR), mRNA 
 
pTSHR-Reverse primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 




















Best fit (Same as that used for primer design): gi|109065161|ref|XM_001104367.1| PREDICTED: Macaca mulatta 1-acylglycerol-3-phosphate 
O-acyltransferase 3 (AGPAT3), mRNA 
 





















EFFECTS OF MODERATE CALORIE RESTRICTION AND AGE ON 




First reported in the mid-1930’s (McCay et al., 1935), calorie restriction 
(CR) remains the only proven non-genetic paradigm for extending lifespan and 
does so by slowing the rate of physiological decline and retarding age-related 
chronic diseases. Moderate CR also has consistent effects across vertebrate 
classes with beneficial health effects on many physiological systems. To date, 
CR has been found to be effective in a variety of species including nematodes, 
spiders, flies, mollusks, rodents, dogs and possibly non-human primates (Ingram 
et al., 1990; Lane et al., 1999b; Roth et al., 1999; Weindruch and Walford, 1988). 
Researchers have shown that CR can reduce body mass and adiposity, lower 
body temperature and initially reduce metabolic rate, lower blood pressure, and 
significantly slow growth and skeletal maturation. It has been successful in 
reducing glucose and fasting plasma insulin levels while increasing insulin 
sensitivity and levels of high density lipoproteins (Gredilla and Barja, 2005; Gresl 
et al., 2001; Heilbronn and Ravussin, 2003; Koubova and Guarente, 2003; Lane 
et al., 1997). Its long history notwithstanding, however, very little is known with 




For all of its apparent health benefits, the potential impact of CR on the 
hypothalamic-pituitary-gonadal (HPG) axis is also not very well understood. 
Could moderate CR possibly improve reproductive health parameters as it does 
with other systems within the body? Alternatively, could it have no impact or even 
a negative effect on reproductive outcome? Preliminary data in female rhesus 
macaques (Macaca mulatta) aged 7-27 years suggests no adverse effects of 
long-term CR with regard to reproductive hormones (Black et al., 2001; Mattison 
et al., 2003). Researchers have also documented no interruption of normal 
ovarian cyclicity in young and menopausal restricted subjects, suggesting that 
long-term energy restriction does not negatively affect the animals (Lane et al., 
2001; Mattison et al., 2003). More recently it has been demonstrated that young 
female rhesus macaques continued to cycle normally under short-term, moderate 
calorie restriction (Wu, 2006). When implemented prior to sexual maturity, CR 
delays the maturation-related increase in circulating testosterone concentrations 
and postpones skeletal growth by approximately one year in male rhesus 
macaques (Lane et al., 1997; Roth et al., 2000). Generally, less is known about 
post-pubertal implementation of the paradigm on the male HPG system. 
Reproductive aging in men typically follows a more gradual course than in 
females. The age-related demise seen in male reproduction appears to involve 
declining function at several sites including testosterone (T) synthesis in the 
Leydig cells, hypothalamic production of gonadotropin-releasing hormone 
(GnRH), pituitary gland release of gonadotropins and/or other integrative 




2001; Moffat et al., 2002; Ottinger, 1998). This makes determining reproductive 
senescence difficult because spermatogenesis continues well into old age. This 
does not mean, however, that there are no physiological ramifications of aging, 
especially in humans where decreasing testosterone levels, metabolic and 
circadian changes, and increasing body weight are generally associated with 
aging. 
The recent phenomenon of increased average body mass index (BMI) 
experienced by the Western world has resulted in an increased incidence of 
obesity (BMI>25 kg/m2) (Hursting et al., 2003). In women, excessive amount and 
distribution of body fat have been linked to reduced fertility with prolonged time to 
pregnancy, increased risk of irregular menstrual cycles, preterm delivery, 
spontaneous abortion, stillbirths and birth defects (Fejes et al., 2005; Jensen et 
al., 2004; Kort et al., 2006). Men with BMI>25 kg/m2 had lower sperm 
concentration and total sperm count compared to men with lower, non-obese 
BMI levels (Jensen et al., 2004). In another study, BMI and total number of motile 
sperm cells in 520 normal, healthy men, age 26-45 was inversely related and a 
positive relationship was seen between BMI and DNA fragmentation in each 
subject (Kort et al., 2006). Thus, BMI typically increases during aging so 
reproductive capacity is not only impacted negatively by age, but also by the 
pathologies associated with obesity. 
 Since CR is capable of reducing body mass and adiposity and improving 
general health parameters, it would be of great benefit to know if CR could also 




Institute on Aging is currently conducting a study of CR and aging in rhesus 
macaques to determine its potential application in humans (Ingram et al., 1990). 
Results have shown parallel effects to those observed in other species, including 
attenuation of age changes in plasma triglycerides, oxidative damage, and 
glucose regulation (Mattison et al., 2003; Roth et al., 2002). Treatment animals 
weigh less, have reduced body fat and lower body temperatures than their 
matching control counterparts, providing early evidence of the potential benefit of 
CR for individuals at risk for diabetes and cardiovascular disease (Lane et al., 
1999a; Mattison et al., 2003). 
The aim of the present study was to investigate the potential impact of 
moderate CR on testicular gene expression and to quantify expression levels in 
young adult rhesus macaques. We were particularly interested in categories of 
reproductive, circadian, metabolic and oxidative stress genes. Using banked 
testis tissue and a subset of the previously investigated genes, we also 
performed a second experiment to investigate the potential impact and 
interaction of age and CR on expression levels. 
 
MATERIALS AND METHODS 
Animals and Diet 
All experiments were approved for use by the Institutional Animal Care 
and Use Committees at the University of Maryland and the Oregon National 
Primate Research Center. The study consisted of two separate experiments. 




mulatta) fed a control diet (YACON; n=5) or calorie restricted at 30% CON 
(YACR; n=5) for eight years, beginning post-pubertally. Experiment 2 utilized 
banked tissues from previous unrelated studies and included three Juvenile (J; 1-
2 years), three Young Adult (YA; 5-7 years), three Old Adult (OA; 24-30 years) 
and three calorie restricted Old Adult (OACR; 25-27 years) animals. OACR 
males had been on CR for the previous five years prior to sacrifice. 
Males were individually housed in a temperature-controlled environment 
under 12L:12D photoperiod (lights on 7 h -19 h) and allowed auditory, visual and 
olfactory interaction with male and female conspecifics in the vivarium. Food was 
provided in two meals at 8 h and 15 h daily; water was available ad libitum. Diet 
for the J and YA males consisted of primate chow (Purina Mills, Inc.; St. Louis, 
MO) supplemented with limited amounts of fresh fruits and vegetables. 
Diet for the YACON and YACR males and for both OA groups consisted of 
individual biscuits that had been specially formulated to include 15% protein, 5% 
fat and 5% fiber with a caloric content of approximately 3.7 kcal/g; the diet was 
supplemented with a daily low calorie treat (Ingram et al., 1990). Biscuits 
included a vitamin/mineral mix sufficient to provide 40% higher levels than the 
recommended allowance for rhesus macaques by a National Research Council 
report (NRC, 1978). Thus, the CON and CR groups were receiving exactly the 
same diet. Biochemical assays were performed periodically and with every new 





The amount of food provided to CON animals was provided at an ad 
libitum level, originally determined with the individual leaving a few uneaten 
biscuits each day during regular measurements of food consumption. CR 
macaques were given 30% less than age- and body-weight matched CON. Food 
allotments were held constant other than as needed on a case-by-case basis 
(Lane et al., 1999b; Mattison et al., 2005). 
Animals were sacrificed according to the NIH Guide for the Care and Use 
of Laboratory Animals. A single testis was collected and sectioned, with one half 
flash frozen in liquid nitrogen and the other half fixed in 4% paraformaldehyde. 
 
RNA Extraction and Gene Microarrays 
Flash frozen testis sections were homogenized using a PowerGen rotor-
stator homogenizer (Fisher Scientific; Pittsburgh, PA). Total RNA was isolated 
using RNeasy columns (QIAGEN; Valencia, CA); concentration and integrity 
were assessed by microcapillary electrophoresis using a model 2100 Agilent 
Bioanalyzer (Santa Clara, CA; see Appendix A for more detail). Testicular tissue 
from three individuals per treatment group in experiment 1 were sent for analysis 
to the Affymetrix Microarray Core of the OHSU Gene Microarray Shared 
Resource. All RNA extracts were used for subsequent PCR analysis. 
Microarray analysis was performed in accordance with the manufacturer’s 
instructions (Affymetrix GeneChip® Analysis Technical Manual; Santa Clara, CA). 
Labeled target cRNA was prepared from total RNA samples and hybridized to 




Image processing and expression analysis were performed using Affymetrix 
GCOS v1.2 software. A number of quality control metrics were utilized as a 
measure of probe quality and included chip background, chip noise, total 
fluorescent intensity, number of genes detected and the 3’/5’ ratio of the 
housekeeping genes β-actin and GAPDH. These metrics are assessed to 
determine the validity of the data obtained from the scanned GeneChip®. Data 
were normalized to an average intensity on each chip which enabled direct 
comparisons between the six different arrays. 
 
Gene Microarray Filtering 
Microarray data filtering was performed using Genesifter® software 
(vizXlabs; Seattle, WA) followed by hand analysis and determination of genes of 
interest (see Appendices B and C). Briefly, unscaled array data was normalized 
and log2 transformed using robust multi-array average (RMA) analysis. Student t-
test (P<0.05) comparisons with Benjamini-Hochberg post-hoc corrections were 
performed. Signal quality and fold-change parameters were not set in order to 
allow for qualitative and quantitative hand filtering later. Probesets showing a 
significant change between treatments were then imported into Excel (Microsoft; 
Redmond, WA) and filtered for a minimum 1.5 fold-change in expression. Based 
on this gene discovery method, probesets meeting these criteria for significance 
were then considered for investigation. In addition, a keyword search of the entire 
52,000+ probesets was performed to identify non-significantly changed probesets 




categories of reproduction, circadian mechanisms, metabolism and oxidative 
stress. Table 4.1 shows the list of testicular genes (and their probesets) that were 
investigated experimentally with sqRT-PCR and qRT-PCR. 
 
Semi-quantitative RT-PCR 
PrimerExpress® software (Applied Biosystems; Foster City, CA) was used 
for all primer and probe design (Appendix G). Specific primers were designed for 
each transcript using the human or predicted rhesus macaque mRNA sequences 
posted at the National Center for Biotechnology Information (NCBI) Entrez 
Nucleotide database. The primers were purchased from Invitrogen (Carlsbad, 
CA) and the sequences are given in Table 4.2. 
Total RNA (1 µg) was used to synthesize cDNA using the Omniscript kit 
(QIAGEN) and oligo d(T)15 primers (Promega Corp; Madison, WI). The reaction 
was performed following the manufacturer’s instructions in a 20 µl volume at 
37oC for 1 hour. The linear range of amplification was calculated for each pair of 
primers using pooled samples and reactions were performed in duplicate. sqRT-
PCR amplifications were performed using 1 µl of cDNA, 200 µM deoxynucleotide 
triphosphates (Promega), 0.5 µM of each primer, and 2.5 U of HotStarTaq® 
polymerase (QIAGEN) in a 25 µl reaction volume. The reactions were performed 
using the following program: 95oC, 15 min; 94oC, 1 min; specific annealing 
temperature for each primer set (Table 4.2), 1 min and 72oC, 1 min (see 




Aliquots (7 µl) of reaction product were resolved by electrophoresis on 2% 
agarose gels with ethidium bromide and photographed under ultraviolet light. 
Subsequent image analysis was performed using ImageJ software 1.37v (NIH; 
Bethesda, MD). Briefly, a single rectangle was drawn horizontally around all 
bands in a selected gel image and a plot profile of signal intensities was 
generated. Area selections were created under the peak for each band using the 
‘straight lines selection’ tool. Area under the curves was then measured and 
provided area statistics for analysis. Appendix I discusses troubleshooting for 
primer design, sqRT-PCR and gel imaging. 
 
Taqman® Quantitative Real-Time RT-PCR 
cDNA was prepared by random-primed reverse transcription using 
random hexamer primers (Promega), 200 ng of RNA and the Omniscript kit 
(QIAGEN). The RT reaction was then diluted 1:100 for PCR analysis. The PCR 
mixtures contained 5 µl of Taqman® Universal PCR Master Mix (Applied 
Biosystems), 300 nM of each primer (Invitrogen), 50 nM human β-actin primers 
(Applied Biosystems), 250 nM of each probe (IDT; Coralville, IA) and 2 µl cDNA. 
Reactions were run in triplicate for higher accuracy. The amplification was 
performed as follows: 2 min at 50oC, 10 min at 95oC, and then 40 cycles each at 
95oC for 15 sec and 60oC for 60 sec in an ABI/Prism 7700 Sequences Detector 
System (Applied Biosystems). The β-actin standard curve was used to convert 
the critical threshold values (i.e. above background) into relative RNA 




receptor (LHCGR) and glycoprotein hormone common alpha subunit (CGA) 
primers and probes were designed using the predicted rhesus macaque 
sequence available in the NCBI Entrez Nucleotide database and are listed in 
Table 4.3. Steroidogenic acute regulatory protein (StAR) primers and probe 
sequences (Table 4.3) were graciously supplied by Dr. Jon Hennebold (ONPRC) 
and had been previously validated in his lab (Smith et al., 2002). 
 
Amplicon Sequencing 
Following amplification the PCR samples contain a complex mixture of 
specific PCR product and residual reaction components such as primers, 
unincorporated nucleotides, enzyme(s), salts and non-specific amplification 
products. The PCR products were purified using a QIAquick Gel Extraction Kit 
(Qiagen). Purified samples were then submitted to the Molecular and Cell 
Biology Core of the Oregon National Primate Research Center. DNA sequencing 
was performed on an ABI 3130XL Genetic Analyzer using Dye Terminator 
sequencing chemistry. The resulting sequences were then BLASTed at the NCBI 




 Data are expressed as mean + SEM for each gene measured in each 
group. Signal intensity and mRNA expression levels were analyzed by Student’s 




differences between individual groups were determined with the Tukey-Kramer 
post-hoc analysis using GraphPad Prism (GraphPad; San Diego, CA). For all 
analyses significant differences were established at P<0.05. 
 
RESULTS 
Gene Microarray and Filtering: Experiment 1 
Initial Genesifter® sorting indicated ~21,400 probesets were upregulated in 
YACR animals compared to YACON while ~31,400 probesets were 
downregulated. Based on filter criteria (t-test; P<0.05) 1452 of these probesets 
were significantly different between the two treatments. When a 1.5 fold-change 
requirement was applied only 260 probesets with the potential to be differentially 
expressed were detected. For a complete list of these probesets see Appendix E. 
Three genes from this set were further investigated, including a 
component of the triacylglycerol synthetic pathway (AGPAT3), a sperm-specific 
surface antigen (SSFA2), and the LHCG receptor (LHCGR). In addition, eleven 
other genes not meeting our filter conditions were investigated which were highly 
expressed and/or fell into the categories of steroid synthesis, oxidative stress and 
Leydig cell maintenance (Table 4.1).  
 
sqRT-PCR and qRT-PCR: Experiment 1 
Semi-quantitative RT-PCR amplification of all 12 genes successfully 
investigated in the two treatment groups (n=5) for experiment 1 are shown in 




4.2). Consistent with the microarray data COX2 mRNA expression was 
undetectable in any of the samples. Primer difficulties with CYP11A1 interfered 
with obtaining quantifiable results on the agarose gels. 
 The sqRT-PCR expression levels for the genes within the two treatment 
groups of experiment 1 are given in Figures 4.2 A-L. No significant diet-induced 
changes were detected in any of the selected genes. This is in contrast to the 
filtered microarray data which detected a significant difference in AGPAT3, 
SSFA2 and LHCGR mRNA expression between CON and CR groups.  
The results of Taqman® quantitative real-time RT-PCR of CGA, LHCGR 
and StAR are represented in Figures 4.3 A-C. In agreement with sqRT-PCR 
results, no significant diet-induced changes were detected in the three transcripts 
even though LHCGR had been identified as significantly different on the 
microarray data. 
 
sqRT-PCR and qRT-PCR: Experiment 2 
Semi-quantitative RT-PCR amplification of all seven genes investigated in 
the four experimental groups (n=3) for experiment 2 are displayed in Figure 4.4. 
Amplicons were detected between 20-29 cycles at 63-68oC (Table 4.2). 
 The sqRT-PCR expression levels are shown in Figures 4.5 A-G for the 
genes within the four treatment groups of experiment 2. Significant differences 




1) hydroxysteroid 17-beta dehydrogenase (HSD17β3, Figure 4.5E): 
expression was 3.13 (+0.39) fold greater in Young Adult animals 
compared to Juvenile subjects.  
2) insulin-like factor 3 (INSL3, Figure 4.5F): expression in Young Adult 
animals was greater than Juvenile and Old Adult CR subjects, with fold-
changes of 2.15 (+0.34) and 3.84 (+0.62), respectively. 
3) casein kinase 1 epsilon (CSNK1E, Figure 4.5G): expression in Juvenile 
animals was greater than all other groups with a 2.85 (+0.63) fold-increase 
over Young Adults, a 2.93 (+0.65) fold-increase over Old Adults and a 
3.86 (+0.86) fold-increase over Old Adult CR. 
In addition, LHCGR and StAR expression may have shown significant 
differences in the Juvenile group had it not been for the large variation in the 
three animals. HSD3β2 and CYP17A1 were not differentially expressed between 
any of the groups.  
The results of Taqman® quantitative real-time RT-PCR of CGA, LHCGR 
and StAR are shown in Figures 4.6 A-C. While no significant changes were 
detected in LHCGR and StAR expression across our treatment groups, CGA was 
differentially expressed in the Old Adult group compared to Juvenile and Old 
Adult CR animals. Expression levels in the Old Adult group were 35.11 (+10.45) 
fold higher than the younger animals and 4.54 (+1.66) fold higher than their age-






DNA Sequencing: Experiment 1 and 2 
Complete sequences for experimentally derived PCR products are listed 
in Table 4.4, as determined by DNA sequencing. The resulting sequences were 
BLASTed in the NCBI database to determine the sequence of best fit. In almost 
every instance, the experimentally derived sequence returned a best fit for the 




Calorie restriction (CR) has been associated with life extension for over 75 
years and remains the only proven non-genetic paradigm for extending lifespan 
and attenuating the biological processes and chronic diseases associated with 
aging (Heilbronn and Ravussin, 2003; McCay et al., 1935). Moderate CR also 
exhibits great consistency across taxa and demonstrates generalized, beneficial 
health effects; the potential impact of this nutritional paradigm on the 
hypothalamic-pituitary-gonadal axis is less clear. Could moderate CR possibly 
improve reproductive health parameters as it does with other systems within the 
body? Alternatively, could it have no impact or even a negative effect on 
reproductive outcome? Previous evidence suggests that depending on age, 
gender and species, the effects of calorie restriction on the HPG axis are mixed. 
Reproductive senescence in men typically follows a more gradual course 
than in females. This does not mean, however, that there are no physiological 




levels, metabolic and circadian changes, and increasing body weight are 
generally associated with aging. The recent phenomenon of increased average 
body mass index (BMI) experienced by the Western world has resulted in an 
increased incidence of obesity (BMI>25 kg/m2) (Hursting et al., 2003). Men with 
BMI>25 kg/m2 have lower sperm concentration and total sperm count compared 
to men with lower, non-obese BMI levels (Jensen et al., 2004) while BMI and 
total number of motile sperm cells have been shown to be inversely related (Kort 
et al., 2006). Thus, BMI typically increases during aging so reproductive capacity 
is not only impacted negatively by age, but also by the pathologies associated 
with obesity. 
 Since CR reduces body mass and adiposity and improves general health 
parameters, it would be of great benefit to know if CR could also maintain 
reproductive fitness and/or attenuate age changes in the system (Heilbronn and 
Ravussin, 2003; Koubova and Guarente, 2003; Lane et al., 1997). In this study 
we investigated the potential impact of age and moderate CR on testicular gene 
expression and quantified expression levels in rhesus macaques (Macaca 
mulatta). We were particularly interested in genes associated with reproduction, 
circadian mechanisms, metabolism and oxidative stress. 
 
Experiment 1 
Microarrays and Gene Determination 
To ascertain the biologically relevant changes detected by microarray, 




logarithmic methods for detecting probeset significance (Irizarry et al., 2003). 
Based on RMA and filter criteria (t-test; P<0.05), 1452 probesets out of 52,000+ 
were significantly different between the two treatments. When a 1.5 fold-change 
requirement was applied, 260 probesets were detected with the potential to be 
differentially expressed. Based on previous experiences in our laboratory we 
typically dropped from consideration any probesets which displayed detection 
levels below 100 on the array. In those instances, however, we were utilizing 
rhesus macaque tissue with human arrays (Affymetrix HG_U133A) and were 
primarily concerned with cross-hybridization and false-positives. Because this 
would have severely limited our analysis, and because we were less concerned 
with cross- hybridization with the newly available GeneChip® Rhesus Macaque 
Genome Arrays, we decided to work with the 260 probesets. 
In addition to the 260 potentially different probesets, we also performed a 
keyword search of the entire microarray dataset and identified non-significantly 
changed probesets of interest, including genes that were highly expressed and/or 
fell into the categories of reproduction, circadian mechanisms, metabolism and 
oxidative stress. Finally, we compiled a list of probesets/genes to initially 
investigate (Appendix F) and designed primers for them. A complete analysis 
was performed on a selected subset of these genes (see Appendix I for details). 
Final analysis of testicular gene expression in YACON and YACR animals 
included 14 genes for which we were able to design successful primer pairs and 
which showed the most potential for exhibiting real expression changes (Figure 




a component of the triacylglycerol biosynthesis pathway; sperm-specific antigen 
2 (SSFA2), a surface antigen responsible for zona pellucida binding; glycoprotein 
hormone common alpha subunit (CGA); thyroid-stimulating hormone receptor 
(TSHR); uncoupling protein 2 (UCP2); casein kinase 1 epsilon (CSNK1E), a 
core-clock gene;  and insulin-like factor 3 (INSL3), an indicator of Leydig cell 
health. We also measured expression levels for all components of the 
testosterone biosynthetic pathway: LHCGR; StAR; cytochrome P450, family 11, 
subfamily A, polypeptide 1 (CYP11A1 or side-chain cleavage or P450scc); 
cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1 or P450c17); 
hydroxysteroid (17-beta) dehydrogenase 3 (HSD17β3); and hydroxysteroid (3-
beta) dehydrogenase 2 (HSD3β2) (Figure 4.1). Also included was 
cyclooxygenase 2 (COX2), which showed no expression on the microarray data, 
but was used as a negative control measure of cellular stress in the animals. 
  
 Microarray vs. PCR – AGPAT3, SSFA2 and LHCGR 
No significant differences in mRNA expression were detected between 
treatment groups in any of the genes investigated using sqRT-PCR (Figures 4.2 
A-L) or qRT-PCR (Figures 4.3 A-C). This was in contrast to the microarray data 
which had originally shown three of the genes (AGPAT3, SSFA2 and LHCGR) to 
be differentially expressed based on filter criteria. As with data from some of our 
previous experiments, this only further emphasized to us the need for additional 




We were surprised to find no CR-induced changes in AGPAT3 expression 
for two reasons. First, it is a key enzyme in the triacylglycerol (triglyceride) 
pathway, and CR has been shown to lower triglyceride levels (Roth et al., 2002). 
Secondly, the GeneChip® Rhesus Macaque Genome Array contained seven 
probesets for AGPAT3, and at least one probeset had been labeled as 
significantly changing in both the pituitary gland and testis (Chapter 3) based on 
filtering parameters. As with the results from our pituitary gland experiments, 
however, there were conflicting expression changes in these probesets with five 
of them showing decreased expression in CR animals while two others showed 
increased mRNA expression. And, as with the pituitary gland sqRT-PCR findings, 
no significant differences were detected between groups. Because of these 
conflicting results it is difficult to say with any certainty what is occurring with 
regards to AGPAT3 mRNA expression. 
Sperm-specific fertilization antigen 1 and 2 (SSFA1 and SSFA2) are 
sperm surface antigens that appear to affect sperm binding to the zona pellucida 
of the oocyte. More is known about SSFA1 than SSFA2, but both may also have 
a role in sperm cell capacitation and/or acrosome reaction (Naz, 1999; Naz and 
Wolf, 1994). With regards to SSFA2 microarray data, all three probesets showed 
a decrease in expression for CR animals and displayed the largest fold-change 
between groups of any of the testicular genes investigated. For this reason it was 
somewhat unusual not to detect any differences with sqRT-PCR analysis. 
 LHCGR is a member of the subfamily of glycoprotein hormone receptors 




transmembrane domain receptors. In the testis the receptor was originally 
thought to be restricted to Leydig cells but is now known to be present in sperm 
and accessory sex glands (seminal vesicles and prostate) (Ascoli et al., 2002). In 
the testis, luteinizing hormone acts through LHCG receptors on the Leydig cells 
to maintain general metabolic processes and steroidogenic enzymes and to 
regulate the production and secretion of androgens. Androgen production in the 
testis is increased solely by LH binding to its receptor via cAMP activation and is 
the first step in testosterone biosynthesis (Dufau, 1998). 
Initial microarray data contained only two probesets for LHCGR with one 
showing significantly increased expression levels and the other at such low 
expression levels as to be designated ‘absent’ by the filter. In fact, LHCGR 
expression was surprisingly low relative to other gene transcripts considering its 
integral function in the male reproductive system. Originally we had hypothesized 
that the CR-treated animals may have been responding to lower LH levels with 
an increase in LHCG receptor numbers, since it has been demonstrated that CR 
alters neuorendocrine function by lowering gonadotropin levels (Koubova and 
Guarente, 2003). It appears, based on our data, that LHCGR expression is not 
impacted by CR in our young adult rhesus macaques. 
 There are several possible reasons for the discrepancies between our 
microarray data and our PCR results. First, it could be related to the sample 
sizes in each technique. Array data was based on a sample size of three for both 
treatments while sqRT-PCR data utilized five animals in each group. Our qRT-




control animal was removed as an outlier during analysis (average detection 
signal being more than two standard deviations away from the group mean). This 
was one of the YACON animals for which array hybridization had been 
conducted and sqRT-PCR results were within normal range.  
Secondly, the heterogeneous nature of the tissue must be considered. 
The testis is composed of various cell types (Leydig, Sertoli, spermatagonia, 
spermatozoa, etc), each of which may be regulated differentially such that 
transcript expression may go up for a gene in one cell type while decreasing or 
staying the same in another. While every attempt was made to guarantee 
uniformity of the biopsies from the harvested testis, it may be that we simply 
sampled from different areas within the organ itself. Such error may have caused 
variation between techniques when using different animal sample sizes. 
Finally, under the strictest filter requirements, there may have been as few 
as 76 probesets out of 52,000+ changing according to microarray analysis on the 
GeneChip® Rhesus Macaque Genome Array. By choosing to work with 260 
probesets based on our more liberal filtering criteria we simply may have cast too 
wide a net in our investigation. Other researchers have also questioned the use 
of fold-change differences alone in concluding that a given gene has changed 
(Chen et al., 2004) and believe that further analytical measures are required.  
Taken together, it appears that calorie restriction had limited impact on 
testicular gene expression in Young Adult rhesus macaques. While only 260 
probesets (and potentially fewer genes) showed differential expression on the 




quantitative and real-time PCR data for the fourteen genes investigated. These 
findings suggest that CR can elicit beneficial health effects without negative 
consequences on the gonadal portion of the HPG axis. To be completely certain, 
however, further analysis could be performed on the other potentially changing 
genes. In addition, even though expression levels may not change between 
treatment groups, morphological changes could be taking place. While they may 
appear to be functioning normally under calorie restricted conditions, changes in 
cell location, number or size may be occurring. Other quantifiable techniques, 
such as immunohistochemistry or in situ hybridization would have to be 
employed in order to make such a determination.  
  
Experiment 2 
Testosterone is a critical feedback component of the HPG axis and 
essential for production of spermatozoa. Although the impact of its decline on 
reproductive senescence is not completely understood, we know that aging 
brings with it a host of subtle changes to testosterone production. The Brown 
Norway (BN) rat, for example, experiences a significant age-related decline in T 
production as a result of Leydig cell dysfunction rather than a reduction in cell 
numbers (Chen and Zirkin, 1999; Zirkin and Chen, 2000). Overall LHCG receptor 
numbers and their affinity for LH also declines as a function of age in rats (Chen 
et al., 2002; Zirkin and Chen, 2000). In humans there is a documented decline in 
testosterone production beginning after 30 years of age and continuing gradually 




Consequently there is the potential for a cascade effect to the entire reproductive 
system with its fall. Testosterone loss can result in weakening muscle function, 
bone density and other physiological parameters related to overall aging 
(Harman et al., 2001; Moffat et al., 2002). Also of importance is the neurological 
impact of testosterone loss. Men with Alzheimer’s disease (AD) have significantly 
lower T levels than aged men without AD. Importantly, testosterone depletion 
appears to occur well before clinical and pathological diagnosis of AD, 
suggesting that low T contributes to AD pathogenesis rather than results from it 
(Rosario et al., 2006). 
The possible effects of CR on testicular gene expression were then 
invstigated in an aging series of rhesus macaques. Even though limited CR-
related differences in mRNA expression had been observed in the young males, 
could more significant age-related differences in expression be detected, and if 
so would they be attenuated by CR treatment? Analysis was performed on 
banked tissue samples available from the ONPRC using a subset of the genes 
previously investigated in the Young Adult males. The seven genes were 
separated into two categories; those for steroidogenesis and those for Leydig cell 
health and cell cycling. 
 
 Steroidogenesis - LHCGR, StAR, CYP17A1, HSD3β2, HSD17β3 
The initial step in Leydig cell testosterone biosynthesis is the binding of LH 
to its receptor on the cell plasma membrane. This action begins a cascade of 




intracellular cAMP formation, translocation of cholesterol into the mitochondria 
via StAR, association of cholesterol with the cytochrome P450 side-chain 
cleavage enzyme (CYP11A1), production of pregnenolone from cholesterol, 
translocation of pregnenolone from the mitrochondria to the smooth endoplasmic 
reticulum (SER) and conversion of pregnenolone to testosterone via a series of 
enzymatic reactions in the SER (Figure 4.7). 
The entire steroidogenic pathway was analyzed from receptor activation to 
testosterone formation except for one component; due to primer difficulties 
CYP11A1 (P450scc) was unable to be measured (Figure 4.4). No significant 
changes were found in LHCGR, StAR, CYP17A1, or HSD3β2 in the four age 
categories with respect to mRNA expression as measured by sqRT-PCR 
(Figures 4.5 A-D). The only significant difference detected in this pathway was in 
HSD17β3 expression between J animals and YA which displayed a 3.13 (+0.39) 
fold-change increase over the pre-pubertal group (Figure 4.5E). These findings 
are not very surprising since enzymatic activity for androgen production would be 
more prevalent following sexual maturation at puberty.  
It was somewhat surprising, however, that no age-related differences were 
detected in the other genes since StAR protein and mRNA are reduced in older 
rat Leydig cells, as are P450scc activity, protein and mRNA expression (Luo et 
al., 2001). There has also been a demonstrated reduction in activity of each of 
the steroidogenic enzymes responsible for converting cholesterol to testosterone 
in the rat, including P450scc, HSD3β, P450c17 and HSD17β (Luo et al., 1996; 




necessarily reflect mRNA or protein levels. These data were also all derived from 
rat Leydig cell studies as compared to whole tissue testis biopsies which may 
account for the discrepancies or it may be a species-specific aging response.  
 
Leydig cell health and cell cycling - INSL3 and CSNK1E 
The peptide hormone, insulin-like factor 3 (INSL3), is a major secretory 
product of the testicular Leydig cells. It appears to be constitutively expressed 
due to LH stimulation and is a good serum marker for fully differentiated adult 
Leydig cells; its concentration reflecting the functional status of Leydig cells. It 
may, in fact, be a more sensitive marker of Leydig cell function than testosterone 
(Foresta et al., 2004; Ivell and Bathgate, 2002). INSL3 serves an important 
paracrine function by binding to its receptor in seminiferous tubules and germ 
cells to suppress apoptosis. The receptor is not localized to the testis only, but is 
also localized in the pituitary gland. A functional feedback loop with LH (Foresta 
et al., 2004) may be involved in behavioral function (Ivell et al., 2005). Transcripts 
of the INSL3 gene itself represent one of the most abundant mRNAs in the 
Leydig cell. This was observed with the microarray data as INSL3 was the 
highest expressing probeset in the selected genes of study on the testicular 
arrays. 
 When steroidogenic function of the Leydig cells deteriorates there is a 
marked reduction in INSL3 mRNA expression (Ivell and Bathgate, 2002; Ivell et 
al., 2005). For this reason we felt it would make a good age-related marker of 




differences were detected (in relative units) between YA animals (2.35+0.38) and 
J subjects (1.10+0.14) as well as YA and the OACR group (0.61+0.19). 
Expression levels for OA animals (1.40+0.32) fell between their age-matched 
CR-treated counterparts and the YA group, but were not significantly different 
from any of the other three groups (Figure 4.5F). These data show the expected 
age-related decline in INSL3 expression with no apparent effect of CR. 
 Previous studies have found the core circadian clock components PER1, 
CRY1, BMAL1, and CLOCK to be present in mouse testis (Alvarez et al., 2003). 
None of these core-clock genes cycle in the testis as they do in other peripheral 
tissues, but they are expressed at very specific stages of sperm development. 
(i.e. CLOCK in round spermatids and PER1 in spermatogonia subpopulations 
and condensing spermatids) (Morse et al., 2003). Casein kinase 1 epsilon 
(CSNK1E) is another core-clock gene whose product is responsible for 
phosphorylation of other proteins and dimers in the circadian clock molecular 
mechanism. It may not be strictly related to Leydig cells but perhaps to multiple 
cell types in the testis, including Leydig cells, Sertoli cells, and spermatogonia. 
The lack of detectable cycling of circadian genes in the testis raises the 
question as to their function or necessity. Although circadian knockout animals 
are fertile (Alvarez et al., 2003), there may still be an effect on spermatogenesis. 
Possibly subtle affects have not been detected since a careful study of fertility 
and spermatogenesis has not been performed on any of the knockout mouse 
strains. It could also be that timing of the various spermatogenic stages are 




from one stage to the next is disrupted causing modifications of seminiferous 
tubule histology. The cumulative effect could have a negative impact on sperm 
quantity and/or quality. 
We found a significant decline in CSNK1E mRNA expression (relative 
units) between J animals (2.59+0.57) and the other three age categories (YA, 
0.91+0.14; OA, 0.88+0.21; OACR, 0.67+0.12) (Figure 4.5G). In a previous study 
we also investigated the effect of age on CSNK1E expression in the pituitary 
gland. In that tissue a more gradual age-related decline was observed; the data 
did not reach the same level of significance observed here in the testis. The 
biological significance of this possible age-related decline in either tissue is still 
unknown.  
 In experiment 2, several significant age-related changes were detected in 
mRNA expression of seven genes based on sqRT-PCR findings. There were, 
however, no observable differences in expression levels between OA animals 
and their age-matched CR-treated counterparts. These results seem to indicate 
that CR was neither beneficial nor detrimental to testicular function based on the 
selected endpoints. One difference between Old Adults and Old Adult CR 
animals was observed after completing qRT-PCR analysis on an eighth gene. 
 
Glycoprotein hormone common alpha subunit (CGA) 
Quantitative real-time RT-PCR analysis was carried out for three genes: 
LHCGR, StAR, and CGA (Figures 4.6 A-C). As with sqRT-PCR findings, no 




expression. When CGA was measured, however, a significant difference was 
found between treatments with OA subjects showing a 35.11 (+10.45) fold-
change increase over J and a 4.54 (+1.66) fold-change increase over OACR 
animals. While investigating pituitary gland gene expression in a previous 
experiment, we measured CGA levels between Young Adult males and their age-
matched restricted counterparts. In that tissue significantly different levels were 
observed between treatment groups with CR animals exhibiting a negative fold-
change of 0.57 (+0.10). In both instances the CR-treated group exhibited 
significantly lower levels of CGA expression, and in the case of the OACR 
subjects, CGA levels were actually restored to the level of Juvenile and Young 
Adult expression. 
Glycoprotein hormone alpha subunit levels were low in the testes 
compared to LHCGR and StAR measured in our experiments. Nonetheless, 
there may be a biological relevance to their mRNA expression in this tissue. 
Endogenous CGA has been shown to be expressed in rat ovary (Markkula et al., 
1996) and testes (Zhang et al., 1995) where it is believed to perhaps play a role 
as a paracrine factor of gonadal function. It may be that CGA serves a similar 
function in the rhesus macaque testes. 
 Based on mRNA expression and semi-quantitative and real-time PCR 
data, we found limited impact of CR on testicular gene expression in young adult 
and old adult rhesus macaques based on the genes investigated. In the case of 
CGA expression in old adults, however, the nutritional paradigm returned 




CR can elicit general beneficial health effects without negative consequences on 
the gonadal portion of the HPG axis. Our data are also in line with findings from 
Chen et al. (2004) showing only 45 genes to be significantly changing in rat 
Leydig cells with age. In contrast to the effects seen in many other cell types and 
systems, the vast majority (44/45) of the Leydig cell genes that changed with age 
were not ‘rescued’ by CR intervention. The only gene that returned to younger 
expression levels was tubulinα1.  
While it appears there was no protective effect of CR in our studies, with 
the possible exceptioin of CGA, there are alternative analyses that could be 
explored before this is determined. One potential route for further investigation 
would be to extend previous work in the Brown Norway rat to non-human primate 
models. A great deal of information has been gained from studies of BN rat 
Leydig cells, especially with regards to LH signal transduction in the testosterone 
biosynthetic pathway. It has been shown that exogenous LH stimulation of 
LHCGR alone cannot restore testosterone levels in aged Leydig cells. G protein-
coupled adenylate cyclase can be stimulated with forksolin directly, however, to 
restore testosterone levels in the same cells. This seems to indicate that lower 
androgen levels are a result of inefficient signal transduction most likely due to 
problems in the quality of LHCGR, in the G proteins, and/or in their coupling 
(Zirkin and Chen, 2000). Thus, it may be that the aging effect on Leydig cell 
steroidogenesis is not caused by reduced mRNA or proteins involved in LH 
signaling, but rather by diminished functional activity of the proteins. This 




2002; Chen et al., 2004). Reactive oxygen species (ROS) have been shown to 
damage critical components of the steroid synthetic pathway and ROS have 
been shown to be produced during steroidogenesis itself (Chen and Zirkin, 
1999). Chronic suppression of testosterone production by Leydig cells appears to 
prevent aging, possibly by reducing ROS formation (Zirkin and Chen, 2000) while 
temporary chemical destruction of old Leydig cells will allow new cells to grow 
which have the androgen producing ability of cells in young animals, again, 
possibly because they have not been ROS damaged (Chen et al., 1996; Zirkin 
and Chen, 2000). 
 It may be worth our time in future experiments to investigate the impact of 
CR on this much more specific route of reproductive decline. We may have even 
been on the right path as we had initially included glutathione and catalase in our 
studies and dropped them only after experiencing time constraints and primer 
difficulties. These two genes and their products protect against ROS and have 
been shown to have lower mRNA and protein expression as well as lower activity 
levels in aged Leydig cells (Zirkin, 2006). 
 
Summary 
In the present study we investigated the potential impact of age and CR 
on testicular gene expression and quantified expression levels in adult rhesus 
macaques (Macaca mulatta). Experiment 1 consisted of 10 Young Adult (12 
years) rhesus macaques fed a control diet (YACON; n=5) or calorie restricted at 




2 utilized banked tissues from previous unrelated studies and included three 
Juvenile (J; 1-2 years), three Young Adult (YA; 5-7 years), three Old Adult (OA; 
24-30 years) and three calorie restricted Old Adult (OACR; 25-27 years) animals. 
Old Adult CR subjects in experiment 2 were on the nutritional paradigm for the 
previous five years prior to sacrifice. Total RNA was isolated from the testis of all 
animals and gene expression profiles were obtained from three animals in each 
treatment of Experiment 1 using Affymetrix GeneChip® arrays. Out of a potential 
52,000+ probesets, we detected fewer than 300 that were different between 
Young Adult CON and CR animals after filtering with Genesifter® (vizXlabs) and 
a 1.5 fold-change threshold requirement. We chose three genes from this set to 
investigate further including a component of the triacylglycerol synthetic pathway, 
a sperm surface antigen, and the LHCG receptor. We also examined eleven 
other genes covering the steroidogenic pathway, oxidative stress and Leydig cell 
maintenance. Expression was not altered by CR in our genes of interest based 
on semi-quantitative and real-time PCR data. In Experiment 2 we observed age-
related changes in HSD17β3, INSL3 and CSNK1E mRNA expression as 
measured by sqRT-PCR, but detected no significant differences in CR-treated 
Old Adults as compared to there age-matched controls. We did, however, detect 
age and CR-related changes in glycoprotein hormone common alpha subunit 
mRNA expression based on qRT-PCR findings, with expression levels in Old 
Adult CR subjects returning to youthful levels. The biological significance of this 
is undetermined. Our studies are among the first to address the potential impact 




macaque. These findings suggest that CR can elicit beneficial health effects 
without negative consequences on the gonadal portion of the HPG axis and 
perhaps even return some mRNA parameters to more youthful levels. It remains 
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Other ID / Probeset CON 1 Call CON 2 Call CON 3 Call Gene ID CR 1 Call CR 2 Call CR 3 Call
MmugDNA.14589.1.S1_at 332.3 P 287 P 324.8 P AGPAT 315.4 P 293.8 P 349.1 P
MmugDNA.1459.1.S1_s_at 222 P 239.6 P 153.9 P 159 P 164.1 P 222.8 P
MmugDNA.16471.1.S1_at 440.8 P 536.6 P 547.8 P 597.1 P 590.9 P 687.2 P
MmugDNA.24842.1.S1_at 200.2 P 218.3 P 156.4 P 124.7 P 91.8 P 63.4 A
MmugDNA.24844.1.S1_at 207.2 P 293.6 P 142.4 P 212 P 182.6 P 171.1 P
MmugDNA.39097.1.S1_at 380.8 P 532.5 P 402.7 P 321.8 P 238.6 P 295.4 P
MmugDNA.6884.1.S1_at 264.1 P 343.7 P 216 P 290.5 P 235.9 P 231.8 P
MmugDNA.13477.1.S1_at 8.5 P 21.4 A 14.6 A TSHR 8.2 A 15 A 13.7 A
MmugDNA.32655.1.S1_at 22.2 P 37.3 P 49.5 P 40.8 P 42.4 P 55.6 P
MmugDNA.796.1.S1_at 12.7 A 19.3 A 5.3 A 2.1 A 4.2 A 4.5 A
MmugDNA.17932.1.S1_at 25.1 P 16.6 A 33 A LHCGR 24.1 A 19 P 18.5 A
MmugDNA.21104.1.S1_at 220.6 P 133.5 P 114.4 P 357.2 P 229.4 P 243.1 P
MmugDNA.19270.1.S1_at 5.2 A 16.9 A 4.1 A SSFA2 13.3 A 2.8 A 5.1 A
MmugDNA.26522.1.S1_at 171.3 P 207.3 P 131.9 P 63.5 P 47.9 P 57.8 M
MmugDNA.14233.1.S1_at 561 P 644.9 P 530.6 P 463.6 P 426.3 P 411 P
MmugDNA.4648.1.S1_at 2.1 A 0.8 A 0.9 A CGA 3.9 A 1.3 A 10.9 A
MmugDNA.29263.1.S1_at 588.4 P 590.7 P 622.1 P 634 P 658.4 P 630.1 P
MmugDNA.16174.1.S1_at 280.6 P 188.6 P 260.2 P UCP 393.4 P 319.2 P 307.4 P
MmugDNA.1485.1.S1_at 246.9 P 163.3 P 245.9 P 281.4 P 215.2 P 198.7 P
MmuSTS.4519.1.S1_at 342.2 P 154.6 P 184.7 P StAR 163.2 P 480.3 P 109.9 P
MmugDNA.20457.1.S1_at 1398 P 646 P 1301.2 P HSD17B3 902.3 P 1957.9 P 530.3 P
MmugDNA.29281.1.S1_s_at 3349.4 P 1767.8 P 1759.2 P INSL3 2777.2 P 6862.8 P 2318.2 P
MmugDNA.4494.1.S1_at 9.1 M 7.6 A 15.8 A COX2 2.2 A 12.3 A 36.1 P
MmugDNA.17389.1.S1_at 637.2 P 460.7 P 681.5 P CSNK1E 469.4 P 419.5 P 703.9 P
MmugDNA.29650.1.S1_at 69.5 A 41.4 A 47.8 A 42.9 A 58.6 A 62.5 A
MmugDNA.34870.1.S1_at 84.1 A 119.7 A 91.6 A 79.9 A 126.4 A 102.7 A
MmugDNA.4033.1.S1_at 49.1 P 61.3 P 27.6 A 43.3 P 28.3 M 34.8 A
MmuSTS.1889.1.S1_at 66.5 P 118.9 P 52.8 A 78.4 P 70.5 P 80.1 M
MmugDNA.37726.1.S1_at 5.8 A 11.7 A 6.6 A CYP17A1 8.4 A 8.2 P 6.5 A
MmuSTS.4193.1.S1_at 302 P 154.1 P 143 P 159.3 P 725.7 P 166.8 P
MmugDNA.42334.1.S1_at 15.4 A 16.2 A 30.4 A HSD3B2 20.2 A 21.5 P 52.5 P
MmuSTS.601.1.S1_at 16.4 A 3.5 A 5.4 A 0.9 A 10 A 28.7 A
MmugDNA.19420.1.S1_at 722.8 P 822.6 P 551.6 P 815.4 P 695.4 P 572.5 P
MmuSTS.4192.1.S1_at 114.4 P 47.2 P 65.4 P CYP11A1 44 P 142.2 P 47 P  
 
Table 4.1 Microarray Probeset Data for Testicular Genes Subjected to 
Experimental Analysis Compiled list of testicular genes (and their probesets) 
investigated experimentally with sqRT-PCR and qRT-PCR (Young Adult CON, 
n=3; Young Adult CR, n=3). Data are from our GeneChip® Rhesus Macaque 







Table 4.2 Gene Expression Profiles in the Rhesus Macaque Testis Mean 
signal intensity values (+SEM) of testicular gene expression (Young Adult CON, 
n=3; Young Adult CR, n=3). These genes showed a significant (AGPAT, LHCGR, 
SSFA2) or non-significant change (TSHR, CGA, UCP2, StAR, HSD17β3, INSL3, 
COX2, CSNK1E, CYP17A1, HSD3β2, HSD11A1) in gene expression based on 
GeneChip® Rhesus Macaque Genome Array detection (Affymetrix) and our 
Genesifter® (vixXlabs) filtering parameters (letter notations, P<0.05). A subset of 
these genes was also investigated with PCR techniques for age- and CR-
induced changes in experiment 2 (Juvenile, n=3; Young Adult, n=3; Old Adult, 






Probeset Gene ID CON mean CR mean
MmugDNA.14589.1.S1_at AGPAT 315 + 14 319 + 16
MmugDNA.1459.1.S1_s_at 205 + 26 182 + 21
MmugDNA.16471.1.S1_at 508 + 34 625 + 31
MmugDNA.24842.1.S1_at 192 + 18 93 + 18
MmugDNA.24844.1.S1_at 214 + 44 189 + 12
MmugDNA.39097.1.S1_at 439 + 47 285 + 25
MmugDNA.6884.1.S1_at 275 + 37 253 + 19
MmugDNA.13477.1.S1_at TSHR 15 + 4 12 + 2
MmugDNA.32655.1.S1_at 36 + 8 46 + 5
MmugDNA.796.1.S1_at 12 + 4 4 + 1
MmugDNA.17932.1.S1_at LHCGR 25 + 5 21 + 2
MmugDNA.21104.1.S1_at 156 + 33 277 + 41
MmugDNA.19270.1.S1_at SSFA2 9 + 4 7 + 3
MmugDNA.26522.1.S1_at 170 + 22 56 + 5
MmugDNA.14233.1.S1_at 579 + 34 434 + 16
MmugDNA.4648.1.S1_at CGA 1 + 1 5 + 3
MmugDNA.29263.1.S1_at 600 + 11 641 + 9
MmugDNA.16174.1.S1_at UCP 243 + 28 340 + 27
MmugDNA.1485.1.S1_at 219 + 28 232 + 25
MmuSTS.4519.1.S1_at StAR 227 + 58 251 + 116
MmugDNA.20457.1.S1_at HSD17β3 1115 + 236 1130 + 428
MmugDNA.29281.1.S1_s_at INSL3 2292 + 529 3986 + 1444
MmugDNA.4494.1.S1_at COX2 11 + 3 17 + 10
MmugDNA.17389.1.S1_at CSNK1E 593 + 67 531 + 88
MmugDNA.29650.1.S1_at 53 + 9 55 + 6
MmugDNA.34870.1.S1_at 98 + 11 103 + 13
MmugDNA.4033.1.S1_at 46 + 10 35 + 4
MmuSTS.1889.1.S1_at 79 + 20 76 + 3
MmugDNA.37726.1.S1_at CYP17A1 8 + 2 8 + 1
MmuSTS.4193.1.S1_at 200 + 51 351 + 188
MmugDNA.42334.1.S1_at HSD3β2 21 + 5 31 + 11
MmuSTS.601.1.S1_at 8 + 4 13 + 8
MmugDNA.19420.1.S1_at 699 + 79 694 + 70












sqRT-PCR primers Forward sequence Reverse sequence Amplicon Cycles Temp 
CGA GGAGAGTTTACAATGCAGGATTGC GTCATCAAAACAGCACTTGGCA 310 bp 22 62oC 
TSHR CTTCTTTTCTGAAACTGCCAGCTC GAGATTCCAGGTGAGTCCAGCA 302 bp 29 62oC 
AGPAT GCTGACTGTTGGCCAGTTTCA CCTGCAGCATTTCACCAGTACA 316 bp 27 62oC 
UCP2 TGCAAAGCCCTGCTGTTCA AGATAGAGGAACTCTGCCGGAATC 301 bp 26 63oC 
SSFA2 GGAAGAAAGTATTCCGAGCATCGG ACACCTCCACCAGTGCATATCATTG 307 bp 26 65.5oC 
CSNK1E AAGTATGAGCGGATCAGCGAGA CCGAATTTCAGCATGTTCCAGT 218 bp 28 65oC 
COX2 AGAGGCTAGTGCCTCAGAGAG GCTAGCACACAGGCCTATCC 437 bp N/A N/A 
β-actin CATTGCTCCTCCTGAGCGCAAG GGGCCGGACTCGTCATACTCC ~300 bp 23 65oC 
LHCGR AGTGTAGACCATGACCACTGCC TGAGACAGGGTTCCTACTCACG 610 bp 26 63oC 
StAR AACACCACAGAACAAGCAGCG ATATTGGCCAGGATGGTCTCG 281 bp 29 68oC 
HSD17β3 AGGCCCTGCAAGAGGAATATAGAG CCTGACCTTGGTGTTGAGCTTC 302 bp 25 66oC 
INSL3 CCTCTGTCCCTACTGATTCCTC TGCACATGCAGGGAGCGGAG 313 bp 20 63oC 
HSD3β2 CCACACGGTGACATTGTCAAAT CCCACATGCACATCTCTGTCAT 211 bp 28 65oC 
CYP17A1 GAGTGGCACCAGCCGGATCAG CTCCAGGCCTGGCGCACCTTG 287 bp 25 65oC 
CYP11A1 GCCATCTATGCTCTGGGCCGAG CCATCCTCTCTGATCACTGCTGG 328 bp N/A N/A 
 
Table 4.3 Testicular sqRT-PCR Gene Primers Forward and reverse primer sequences (5’ to 3’) used for sqRT-PCR are 
shown along with the expected amplicon size, annealing temperatures and number of cycles run for each reaction. 
Primers were designed using human or rhesus macaque gene sequences and PrimerExpress® software (Applied 








and probes Forward sequence Reverse sequence Amplicon Cycles Temp 
Taqman® qRT-PCR 
β-actin primers 
N/A 40 60oC 
Taqman® qRT-PCR 
β-actin probe 
Human ACTB (beta actin) Endogenous Control 
(Applied Biosystems; Foster City, CA) N/A 40 60oC 
Taqman® qRT-PCR 
LHCGR primers 
TGCTAAGAAAATGGCAATCCTCAT CTGTGATAAGAGGCGCTTTGAA 101 bp 50 60oC 
Taqman® qRT-PCR 
LHCGR probe 
5’-6FAM-TTCACCGATTTCACCTGCATGGCA-TAMRA-3’ N/A 50 60oC 
Taqman® qRT-PCR 
StAR primers 
ACTTCCAGCCAGTGGGTGAA CTGGCATGGCCACAGACTT 101 bp 40 60oC 
Taqman® qRT-PCR 
StAR probe 
5’-6FAM-CGGAGCACGGTCCCACTTGCAT-TAMRA-3’ N/A 40 60oC 
Taqman® qRT-PCR 
CGA primers 
TGGAGAGTTTACAATGCAGGATTG AGCAGCAGCCCATACACTGA 101 bp 40 60oC 
Taqman® qRT-PCR 
CGA probe 
5’-6FAM-AATTCTTCTCCAAGCCGGGTGCCC-TAMRA-3’ N/A 40 60oC 
 
Table 4.4 Testicular qRT-PCR Gene Primers and Probes Forward and reverse primer sequences (5’ to 3’) used for 
qRT-PCR are shown along with the expected amplicon size, annealing temperatures and number of cycles run for each 
reaction. Primers and probes were designed using rhesus macaque gene sequences and PrimerExpress® software 







Figure 4.1 Genes in the Rhesus Macaque Testis – Dietary Effect 
Representative sqRT-PCR results validating the microarray data and 
demonstrating expression of testicular genes across the treatment groups of 
Young Adult rhesus macaques (12 years; CON and CR, n=5). The housekeeping 
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Figures 4.2 A-L sqRT-PCR Expression Levels of Genes in the Rhesus 
Macaque Testis – Dietary Effect Each bar, along with SEM, represents mean, 
normalized fluorescence data from five animals in experiment 1. Statistical 
comparisons were made using Student’s t-test (P<0.05). None of the transcripts 




















































































































































































































































































































































































































































































































































































Figures 4.3 A-C Taqman® Quantitative Real-Time PCR of Genes in the 
Rhesus Macaque Testis – Dietary Effect Each bar, along with SEM, represents 
mean, normalized fluorescence data for animals in experiment 1 (CON, n=4; CR, 
n=5). Statistical comparisons were made using Student’s t-test (P<0.05). None of 













































































































































































































Figure 4.4 Genes in the Rhesus Macaque Testis – Age and Dietary Effect 
Representative sqRT-PCR results demonstrating expression of testicular genes 
across the treatment groups in experiment 2: Juvenile (1-2 years); Young Adult 
(5-7 years); Old Adult (24-30 years); and Old Adult CR (25-27 years). The 
housekeeping gene β-actin was used as a positive control and for normalizing 









Figures 4.5 A-G sqRT-PCR Expression Levels of Genes in the Rhesus 
Macaque Testis – Age and Dietary Effect Each bar, along with SEM, 
represents mean, normalized fluorescence data from three animals in experiment 
2. Statistical comparisons were made using one-way ANOVA and Tukey-Kramer 
post-hoc corrections (P<0.05).  
 
Significant differences were observed in three of the transcripts: 
1. HSD17β3 (Graph E) – YA expression was 3.13 (+0.39) fold greater than J 
2. INSL3 (Graph F) – YA expression was 2.15 (+0.34) fold greater than J and 
3.84 (+0.62) fold greater than OACR 
3. CSNK1E (Graph G) – J expression was greater than all other groups with 
2.85 (+0.63) fold-increase over YA, 2.93 (+0.65) fold-increase over OA 
and 3.86 (+0.86) fold-increase over OACR 
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Figures 4.6 A-C Taqman® Quantitative Real-Time PCR in the Rhesus 
Macaque Testis – Age and Dietary Effect Each bar, along with SEM, 
represents mean, normalized fluorescence data for three animals in experiment 
2. Statistical comparisons were made using one-way ANOVA and Tukey-Kramer 
post-hoc corrections (P<0.05). 
 
Results demonstrated significant differential expression for tCGA with the OA 
group 35.11 (+10.45) fold higher than J animals and 4.54 (+1.66) fold higher than 
OACR subjects. 
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Table 4.5 Testis Gene sqRT-PCR Amplicon Sequences Experimentally derived PCR amplicon sequences as 
determined by DNA sequencing are listed under each of the genes. Following each are the results of a BLAST search in 
the NCBI database to determine a best fit sequence. 
 





Best fit (Same as that used for primer design): gi|109102901|ref|XM_001114090.1| PREDICTED: Macaca mulatta luteinizing 






Best fit (Same as that used for primer design): gi|109102901|ref|XM_001114090.1| PREDICTED: Macaca mulatta luteinizing 
hormone/choriogonadotropin receptor (LHCGR), mRNA 
 






Best fit (Same as that used for primer design): gi|109086163|ref|XM_001090472.1| PREDICTED: Macaca mulatta similar to steroidogenic acute 







Best fit (Same as that used for primer design): gi|109086163|ref|XM_001090472.1| PREDICTED: Macaca mulatta similar to steroidogenic acute 


















Best fit (Same as that used for primer design): gi|109071971|ref|XM_001090917.1| PREDICTED: Macaca mulatta similar to Glycoprotein 
hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common alpha subunit) (Follitropin alpha chain) (Follicle-stimulating 
hormone alpha chain) (FSH-alpha) (Lutropin alpha chain) (Luteinizing hormone alpha chain) (LH-alpha), mRNA 
 







Did not return any macaque sequences in the list of Best fit, but did return these two: 
gi|114676076|ref|XM_001173682.1| PREDICTED: Pan troglodytes similar to Insulin-like 3 precursor (Leydig insulin-like peptide) (Ley-I-L) 
(Relaxin-like factor), mRNA 






Did not return any macaque sequence in the list of Best fit, but did return these two:  
gi|114676076|ref|XM_001173682.1| PREDICTED: Pan troglodytes similar to Insulin-like 3 precursor (Relaxin-like factor), mRNA 












Best fit (Same as that used for primer design): gi|109112386|ref|XM_001105829.1| PREDICTED: Macaca mulatta estradiol 17 beta-








Best fit (Same as that used for primer design): gi|109112386|ref|XM_001105829.1| PREDICTED: Macaca mulatta estradiol 17 beta-
dehydrogenase 3, transcript variant 2 (HSD17B3), mRNA 
 





Best fit (Same as that used for primer design): gi|109100269|ref|XM_001101290.1| PREDICTED: Macaca mulatta similar to sperm specific 
antigen 2, mRNA 
 
tSSFA2-Reverse primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 
secondary structures due to sticky GC regions. 
 
















Did not return any macaque sequences in the list of 4 Best fit. 
 
Thyroid stimulating hormone receptor (TSHR) 
tTSHR-Forward primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 






Best fit (Same as that used for primer design): gi|109084461|ref|XM_001104839.1| PREDICTED: Macaca mulatta thyroid stimulating hormone 
receptor, transcript variant 2 (TSHR), mRNA 
 






Best fit (Same as that used for primer design): gi|109065161|ref|XM_001104367.1| PREDICTED: Macaca mulatta 1-acylglycerol-3-phosphate 












Best fit (Same as that used for primer design): gi|109065161|ref|XM_001104367.1| PREDICTED: Macaca mulatta 1-acylglycerol-3-phosphate 
O-acyltransferase 3 (AGPAT3), mRNA 
 






Best fit (Same as that used for primer design): ref|XM_001093672.1| PREDICTED: Macaca mulatta casein kinase 1 epsilon (CSNK1E), mRNA 
 
tCSNK1E-Reverse primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 
secondary structures due to sticky GC regions. 
 





Best fit (Same as that used for primer design): ref|XM_001113717.1| PREDICTED: Macaca mulatta hydroxy-delta-5-steroid dehydrogenase, 3 






Best fit (Same as that used for primer design): ref|XM_001113717.1| PREDICTED: Macaca mulatta hydroxy-delta-5-steroid dehydrogenase, 3 
beta- and steroid delta-isomerase 2, transcript variant 1 (HSD3B2), mRNA 
 
Cytochrome P450c17 (CYP17A1) These primers were designed previously in Dr. Urbanski’s lab using the human sequence. They have been 









Best fit: ref|NM_001040232.1| Macaca mulatta cytochrome P450c17 (CYP17A1), mRNA 
 
tCYP17A1-Reverse primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 
secondary structures due to sticky GC regions. 
 
Cytochrome P450scc (CYP11A1) These primers were designed previously in Dr. Urbanski’s lab using the human sequence. They have been 
validated in the rhesus adrenal. As a positive control we amplified adrenal tissue and submitted the PCR samples for sequencing along with our 
testis PCR. We were unable to get successful single PCR bands for CYP11A1 in the testis of all our animals so no sqRT-PCR determinations 
could be made. In trying to determine if the problem was temperature related or due to poor probe design we cut three single bands out of the 
gel and sequenced them along with the adrenal control. The results show that we were successfully targeting the proper cDNA. With more time 







Best fit: ref|XM_001096506.1| PREDICTED: Macaca mulatta cytochrome P450, subfamily XIA, mRNA 
 
aCYP11A1-Reverse primer 
Unknown - primer did not anneal during sequencing. Poor sequencing may have been the result of impure PCR mixture or amplicons forming 


























Modified from: Simard, J. et al. (2005). Molecular biology of the 3 beta-hydroxysteroid 
dehydrogenase/Delta(5)-Delta(4) isomerase gene family. Endocrine Reviews. 26, 525-582. 
 
 
Figure 4.7 Schematic Representation of Testosterone Biosynthesis Red (or 
dark grey) boxes indicate the primary components and enzymes in the Leydig 
cell testosterone biosynthetic pathway that were investigated. P450scc is also 
known as Cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1) or 
cholesterol side-chain cleavage. P450c17 is the same as Cytochrome P450, 





EFFECTS OF MODERATE CALORIE RESTRICTION ON SELECTED 
MEASURES OF REPRODUCTIVE FUNCTION IN THE MALE RHESUS 
MACAQUE (MACACA MULATTA) 
 
INTRODUCTION 
Over the last 75 years calorie restriction (CR) has been established as the 
only proven non-genetic method of altering longevity and attenuating the 
biological changes associated with aging (Koubova and Guarente, 2003; Lane et 
al., 1999b; McCay et al., 1935). Moderate calorie restriction is believed to 
successfully intervene in the cascade of events that underlie normal aging, thus 
accounting for its advantageous health benefits. CR also exhibits great 
consistency across mammalian taxa and demonstrates generalized, beneficial 
health effects on almost every physiological system within the organism. To date 
this nutritional paradigm has been found to be effective in a variety of species 
including nematodes, spiders, flies, mollusks, rodents, dogs and possibly non-
human primates, such as squirrel monkeys and cynomolgus and rhesus 
macaques (Ingram et al., 1990; Lane et al., 1999b; Roth et al., 1999; Weindruch 
and Walford, 1988). Its long history notwithstanding, however, very little is known 
with regard to the exact mechanism(s) of action of CR. Equally unknown is the 
potential impact of this nutritional paradigm on the hypothalamic-pituitary-gonadal 




parameters as it does with other systems within the body? Alternatively, could it 
have no impact or even unfavorable effects on reproductive outcome?  
Previous work in our lab has found limited impact of CR on testicular gene 
expression in young adult or old adult rhesus macaques based on mRNA 
expression and semi-quantitative and real-time PCR data (Chapter 4). These 
findings suggest that CR can elicit general beneficial health effects without 
negative consequences on the gonadal portion of the HPG axis, meaning calorie 
restriction could potentially be implemented without causing problems with 
testicular physiology. This is especially relevant as the past two decades have 
seen an upward trend in the average age of couples having children (Buwe et al., 
2005) with a 16-24% increase in the birth rate for U.S. fathers over age 35 years 
(Buwe et al., 2005; Eskenazi et al., 2003; Kidd et al., 2001). Additionally, external 
cues such as nutrition can have a substantial effect on the HPG axis. The recent 
phenomenon of increased average body mass index (BMI) experienced by the 
Western world has resulted in an increased incidence of obesity (Hursting et al., 
2003). Obese men have lower sperm concentration and total sperm count 
compared to men with a BMI below obese levels (Jensen et al., 2004), while 
another study found an inverse relationship between BMI and total number of 
motile sperm cells and a positive relationship between BMI and DNA 
fragmentation per subject (Kort et al., 2006). The risk for increased BMI typically 
goes up as men get older, so that reproductive capacity is not only impacted 




Since CR is capable of reducing body mass and adiposity and improving 
general health parameters, it would be of great benefit to know if CR could also 
maintain reproductive fitness and/or attenuate age changes in the system. In 
contrast to our previous work which found no negative consequence of CR for 
testicular gene expression, other research has documented a significant effect on 
epididymal gene expression in Brown Norway rats (Jervis and Robaire, 2003).  
Changes in epididymal function could potentially lead to post-production sperm 
alterations.  
The aim of the present study was to investigate the potential impact of 
moderate CR on parameters of normal sperm physiology and function in young 
adult rhesus macaques as measured through the use of semen collection and 
analysis. 
 
MATERIALS AND METHODS 
Animals and Diets 
All experiments were approved for use by the Institutional Animal Care 
and Use Committees at the University of Maryland and the Oregon National 
Primate Research Center. The study consisted of 8 Young Adult (12 years) male 
rhesus macaques (Macaca mulatta) fed a control diet (CON; n=4) or calorie 
restricted at 30% CON (CR; n=4) for the previous 8 years post-pubertally. For 
plasma testosterone analysis another animal was included in each group (CON 
and CR; n=5). Animals were individually housed in a temperature-controlled 




auditory, visual and olfactory interaction with male and female conspecifics in the 
vivarium. Food was provided in two meals at 8 h and 15 h daily; water was 
available ad libitum.  
Diet consisted of individual biscuits that had been specially formulated for 
this study supplemented with a daily low calorie treat (Ingram et al., 1990). The 
general composition of the diet was 15% protein, 5% fat and 5% fiber with a 
caloric content of approximately 3.7 kcal/g. Biscuits included a vitamin/mineral 
mix that was 40% higher than the recommended allowance for rhesus macaques 
by a National Research Council report (NRC, 1978), but were otherwise similar 
to those used in many laboratory studies of rhesus macaques. Supplementation 
was designed to offset any potential malnutrition in CR animals. Thus, it should 
be clear that the CON and CR groups were receiving exactly the same diet. 
Biochemical assays were performed periodically and with every new shipment to 
ensure diet content and quality (Black et al., 2001; Mattison et al., 2005). 
The amount of food provided to CON animals was originally determined to 
be approximately ad libitum because they were observed to leave a few uneaten 
biscuits each day during regular measurements of food consumption. CR 
macaques were given 30% less than age- and body-weight matched controls. 
Food allotments were held constant other than as needed on a case-by-case 
basis when warranted by greater than acceptable changes in body weight (Lane 







Penile electrostimulation (PES) is known to work in unanesthetized, 
manually restrained primates (Gould and Mann, 1988; Kholkute et al., 2000; 
Mastroianni and Manson, 1963). Following methods described previously 
(Sarason et al., 1991), PES was performed on three separate occasions for each 
study animal; one collection in spring (March-April) and two collections in fall 
(September-October). All animals were fitted with a lightweight metal alloy collar 
and acclimated to the collection procedure through a 17-day habituation 
regiment. Training involved familiarizing the animals to collared pole restraint, 
removal from their individual cages, restraint in the collection chair, collection, 
and return to their cages. To facilitate animal handling and alleviate any 
discomfort, animals were given 10 mg diazepam and 80 mg acetaminophen one 
hour prior to training or collection. 
 
Semen Collection and Processing 
Semen samples were collected into sterile collection tubes and allowed to 
liquefy at room temperature (RT) prior to evaluation (see Appendices K-M for 
detail). Ejaculate weight was obtained and exactly 30 minutes post-collection the 
liquid fraction of sample was transferred to a sterile centrifuge tube. Volume was 
recorded and aliquots were removed for osmolarity, pH and morphology 
determination. The remaining liquid fraction was then suspended in 15 mL warm 
TALP-Hepes with bovine serum albumin (BSA) and centrifuged at 130-150G for 




frozen for later seminal plasma analysis. The wash procedure was repeated 
twice. Following centrifugation the sperm pellet was resuspended in 1 mL warm 
TALP-BSA and placed in 5% CO2/95% air at 37oC. Aliquots for viability, count 
and concentration were taken and sperm motility was measured. The remaining 
sample was then used for zona pellucida binding and acrosomal staining assay 
(Appendices N-P), sperm chromatin structure assay, or frozen for future post-
thaw analysis (Appendices Q and R). A summary of semen measurements can 
be found in Table 5.1. 
 
Count, Concentration and Motility Analysis 
 After washing and resuspension, count and concentration were measured 
with phase contrast microscopy using a Neubauer hemocytometer. Percent 
motility was determined for fresh washed and frozen-thawed samples by visual 
observation at 200X magnification with duplicate counts of 100 sperm using a 
phase contrast microscope. Motility was measured as total movement, not just 
forward progress, which was accounted for with status rating (see Appendix K for 
details). 
 
Viability, Osmolarity and pH Analysis 
Sperm viability was determined for fresh semen samples using the hypo-
osmotic swelling (HOS) assay previously described by Jeyendran (2003; for 
detail see Appendix L). Briefly, 5 µL of washed semen was incubated with 100 µL 




sperm were then observed with phase contrast microscopy for swelling. Results 
were recorded as a percent of the total count. 
Osmolarity and pH were determined for freshly collected raw samples 
using a Vapro® Vapor Pressure Osmometer (Wescor; Logan, UT) and EMD 
colorpHast pH Strips (Fisher Scientific; Hampton, NH).  
 
Morphology Analysis 
Sperm morphology was scored for freshly collected raw samples as well 
as frozen-thawed sperm using one-step eosin-nigrosin staining (EN; IMV 
International Corp; Maple Grove, MN; see Appendix M for details). Briefly, 
smears were made by mixing equal volumes of semen and EN stain, air dried, 
coverslipped and examined at 1000X under oil immersion (100X bright-field). 
Two slides and 300 total sperm were examined for each collection. Results were 
recorded as percent Normal or Abnormal with abnormal sperm further subdivided 
into Head, Midpiece or Tail abnormality. 
 
Seminal Plasma Assay 
 Accessory sex gland activity was measured via the seminal vesicle and 
prostate markers, fructose and citric acid, respectively. Enzymatic BioAnalysis 
kits were utilized with analysis performed in accordance with the manufacturer’s 
instructions (Boehringer-Mannheim/R-Biopharm; Marshall, MI). Fructose was 
quantified by reaction with hexokinase and the stoichiometrically produced 




contribution was similarly determined utilizing an enzymatic reaction and the 
reduction of NADH was evaluated with an absorbance change at 340nm. The 
assay sensitivity limit for fructose was 0.25 µg/mL and for citric acid it was 0.2 
µg/mL. 
 
ZP Binding and AR Assay 
 A modified zona pellucida binding and acrosomal staining assay 
(Appendices N-P) was performed with all fresh sperm samples according to 
previously described methods (VandeVoort et al., 1992; VandeVoort et al., 1994; 
VandeVoort et al., 1997). Briefly, washed sperm samples in TALP-BSA (10 x 106 
sperm/mL) were activated by adding dbcAMP and caffeine (Sigma-Aldrich Corp; 
St. Louis, MO). A total of 2-10 zona pellucida were placed in 100 µL drops of the 
capacitated sperm suspension under mineral oil (Sigma-Aldrich Corp) for 1 
minute. Following coincubation, ZP were quickly rinsed in a series of media 
washes to remove any unbound sperm and immediately fixed in cold absolute 
ethanol. After fixation ZP were placed on 10-well Teflon-masked glass slides 
(Tekdon Inc; Myakka City, FL), allowed to air dry and then coverslipped. Binding 
and acrosomal status of sperm was determined by fluorescent microscopy using 
Hoescht chromatin staining and indirect immunofluorescence of a polyclonal 
antisperm antiserum that labels the acrosomal contents of intact sperm. Labeling 
was performed directly on the glass slides to allow rapid processing of ZP while 
minimizing the use of antisera. Acrosomal status of ZP-bound sperm is reported 




for labeling were generously provided by Dr. Cathi VandeVoort of the California 
National Primate Research Center at the University of California-Davis. 
 
SCSA® 
The sperm chromatin structure assay is a flow-cytometric test that 
measures the susceptibility of sperm nuclear DNA to acid-induced DNA 
denaturation in situ. The assay was used to determine the percentage of sperm 
with elevated levels of DNA fragmentation in washed, fresh-frozen semen. 
Frozen, washed sperm samples were submitted to SCSA® Diagnostics 
(Brookings, SD) for analysis per their laboratory specifications. 
 
Testosterone Sampling and Analysis 
 Animals were surgically fitted with an indwelling subclavian vein catheter 
which enabled remote serial blood samples to be collected from an adjacent 
room without disturbing the animals (Downs and Urbanski, 2006). Blood samples 
(1 mL) were collected from each subject every 30 minutes over a 24-hour period. 
Samples were placed in EDTA-coated glass tubes and centrifuged at 4oC; 
plasma was stored at –20oC until assay for testosterone (T). Plasma testosterone 
concentrations were measured by radioimmunoassay (RIA) as previously 








Data for each male were averaged for three collections and then group 
treatment averages were determined. Data are expressed as group mean + SEM  
(CON and CR; n=4) of all semen collections for each parameter measured.  
Group mean testosterone values (CON and CR; n=5) were determined by 
taking the overall mean of the individual hormone values spanning the entire 24-
hour sampling period. Group maximum T values were determined by first 
identifying the maximum value for an individual and then averaging it with two 
adjacent values on each side of the time point. The mean of those individual 
maximum values was then recorded. Similarly, the group minimum values were 
determined by taking the mean of the five adjacent lowest values for each 
individual.  
Statistical comparisons between CON and CR groups were made by 
Student’s t-test using SPSS (SPSS Inc.; Chicago, IL) or Excel (Microsoft; 
Redmond, WA). Tests for heterogeneity of variance for semen parameters were 
determined using Statistical Analysis System (SAS Institute; Cary, NC). For all 
analyses significant differences were accepted at P<0.05. 
 
RESULTS 
Circannual patterns of testicular function have been reported in the rhesus 
macaque with distinct seasonal variations in testicular volume, semen quality, 
sperm number, sexual behavior and frequency of birth rate observed in wild and 




Gupta et al., 2000; Muehlenbein et al., 2002). Because of this potential 
confounding effect, we tested for seasonal differences in animals prior to 
continuing other analyses.  
No seasonality differences in semen measurements (ejaculate weight, 
volume, count, concentration, motility, viability, osmolarity, pH and ZP binding) 
were detected in our study using a paired Student’s t-test between spring and 
average fall collection values for each animal. Additionally, no correlation was 
detected between individual animal weight and the proportion of morphological 
sperm abnormalities (head, midpiece and tail). Analysis was performed using 
Statistical Analysis System (SAS Institute; Cary, NC) with P<0.05. 
 
Standard Sperm Functionality Measures 
Ejaculate weight, liquid volume of ejaculate, sperm count, sperm 
concentration, sperm motility, sperm viability, ejaculate osmolarity and ejaculate 
pH for freshly collected semen are presented in Figures 5.1 A-H and Table 5.2. 
No significant diet-induced changes were detected between groups in any of 
these parameters based on Student’s t-test comparisons. 
Examples of various morphological outcomes of sperm development can 
be seen in Figures 5.2 A-H. No significant diet-induced differences were detected 
between CON and CR groups with regards to the percentage of normal and 
abnormal sperm per ejaculate (Figure 5.3A). Similarly, no significant treatment 




abnormalities between groups (Figure 5.3B). Data are from fresh raw semen and 
are presented in Table 5.3. 
Two standard functional measures were taken of frozen-thawed sperm: 
motility and morphology. Results of frozen-thawed sperm motility outcome can 
be seen in Figure 5.4 and Table 5.4. Morphological characterization of the 
frozen-thawed samples are presented in Figures 5.5 A-B and Table 5.5. As with 
the freshly processed samples, no significant differences were observed between 
treatment groups in motility, the percentage of normal and abnormal sperm, or in 
the three categories of abnormalities.  
 
Seminal Plasma Constituents 
Attempts to quantify accessory sex gland contribution to the ejaculate 
were made using spectrophotometric enzymatic assays for fructose and citric 
acid. Unfortunately, it appears that the samples were too dilute due to the volume 
of wash buffer used during processing. Efforts will be made to concentrate the 
samples and quantify these markers at a later date. 
 
ZP Binding and Acrosome Reaction 
 Representative images of the zona pellucida binding and acrosome 
reaction assay are shown in Figure 5.6. Hoescht 33,258 staining of 
DNA/chromatin (blue) can clearly be seen in the upper portion of the figure while 
the lower portion demonstrates fluorescein isothiocyanate (FITC) double-




 The results of the ZP binding AR assay are given in Table 5.6 with the 
mean number of sperm bound per zonae and the percentage of acrosome 
reacted sperm. No significant differences were detected between groups for 
either of these endpoints. 
 
SCSA® 
A total of 14 samples from all eight animals were submitted to SCSA® 
Diagnostics (Brookings, SD) for analysis. No significant differences were 
detected between groups; results are given in Tables 5.7 and 5.8. Each ejaculate 
sample proved to be of high quality with the exception of CON #22382.  
Representative data sheets for the sperm chromatin structure assay 
(Figure 5.7) show a high quality sample (upper image) and a poor quality sample 
with a high DNA fragmentation index (DFI) score (lower image). A value above 
30% usually indicates that the animal would experience reduced success at 
siring offspring, whether from intercourse, intrauterine insemination, in vitro 
fertilization or intracytoplasmic sperm injection (Bungum et al., 2004; Larson-
Cook et al., 2003).  
 
Testosterone Concentrations 
 Daily circulating plasma testosterone levels for both treatment groups are 
displayed in Figure 5.8. Each group exhibited the same general pattern of T 
expression over the 24-hour period. There were no significant differences in 




T levels, however, were significantly lower (P<0.01) in the CON group compared 
to CR-treated animals. 
 
DISCUSSION 
Male rhesus macaques benefit from CR with an apparent slowing of age-
related changes in metabolic responses and improved overall health. Such 
findings seem to indicate a metabolic shift from growth and reproduction toward a 
strategy of life maintenance (Roth et al., 2004). The impact of moderate CR on 
male reproductive physiology is unclear, however, and appears to differ with 
degree and timing of treatment.  For example, CR prior to puberty can delay the 
maturational increase in circulating testosterone concentrations, indicative of 
reproductive activation, by approximately one year (Lane et al., 1997; Roth et al., 
2000). 
We previously examined the impact of moderate CR on testicular gene 
expression in young adult rhesus macaques and found limited effects. 
Epididymal function, however, has a major effect on the functional capacity of 
sperm. Mammalian spermatozoa leaving the testis are not capable of fertilizing 
oocytes. During passage through the epididymis they undergo a progressive 
series of morphological and physiological changes in a process known as 
epididymal maturation. Only after these changes will sperm acquire the ability to 
fertilize (Elder and Dale, 2000; Harrison and Lewis, 1986). Recent findings by 
Jervis and Robaire (2003) have demonstrated an effect of short-term, moderate 




testicular gene expression, it becomes necessary to utilize functional assays to 
determine sperm vigor since changes in the epididymis could potentially lead to 
post-production alterations. 
The aim of the present study was to investigate the potential impact of 
moderate CR on parameters of normal sperm physiology and function in young 
adult rhesus macaques. This was achieved through the use of semen collection 
and analysis utilizing a large number of quantifiable endpoints to provide a 
complete characterization of ejaculate quality and sperm health. These 
endpoints, though specific, were chosen in order to address three broader 
questions of male reproductive function: 1) Can sperm physically reach the site 
of fertilization? 2) Can sperm undergo physiological modifications necessary for 
fertilization? and 3) Can sperm initiate and sustain embryo development? 
 
Can sperm physically reach the site of fertilization? 
Assessment techniques which are robust, reliable and as easy as possible 
to perform are fundamental to modern basic semen analysis. Nine components 
of the classical spermiogram that were investigated in our study include ejaculate 
weight, liquid volume of ejaculate, sperm count, sperm concentration, sperm 
motility, sperm viability, ejaculate osmolarity, ejaculate pH and sperm 
morphology. Cumulatively, these measures give an indication of the probable 
success a male would have in mating and siring offspring. Our findings indicated 
no significant differences (P<0.05) between CON and CR groups in any of these 




the normal ranges for macaque semen (Gould and Mann, 1988; Lanzendorf et 
al., 1990). 
Ejaculate weight and volume indicate the ability to produce adequate 
means for sperm delivery to the female reproductive tract.  These two 
parameters are primarily determined by accessory sex gland secretions, with low 
volume typically indicative of retrograde semen flow into the bladder or accessory 
sex gland pathology. Count and concentration demonstrate the ability of the 
animal to produce adequate spermatozoa to survive transport through the female 
tract. These parameters were not statistically significant between treatment 
groups, although variability was much less in the CR-treated animals as 
measured by SEM. 
Motility is an evaluation of spontaneous sperm movement and was 
measured in both fresh semen and frozen-thawed samples. The ability of 
spermatozoa to propel themselves through the female reproductive tract 
following ejaculation is important if the sperm are to reach the uterine isthmus 
where fertilization typically occurs. Sperm motility in both treatment groups was 
generally good with no significant differences observed. It is important to 
remember, however, that although good sperm are necessarily motile, motile 
sperm are not necessarily fertile; thus, the need for a complete battery of tests in 
determining reproductive potential. From a purely observational standpoint, it 
seems that sperm from CR animals may have tolerated freezing slightly better as 
motility only dropped from 56% to 37% following post-thaw analysis compared to 




not statistically significant due to biological variation, and post-thaw motility was 
generally lower in both groups compared to values reported in the literature 
(Nichols and Bavister, 2006). 
Spermatozoa, like all other cells, must selectively regulate the movement 
of molecules across their surface to maintain equilibrium between themselves 
and their environment. When exposed to hypo-osmotic conditions sperm will 
allow water to enter the cytoplasm in an attempt to reach osmotic equilibrium. It 
can be assumed that the capacity of sperm to swell in the presence of a hypo-
osmotic solution is a sign that membrane integrity and normal functional activity 
are intact. Membrane viability is not only important for sperm metabolism but 
critically timed changes in membrane properties are required for successful 
sperm activation, acrosome reaction and binding to the oocyte. We chose to use 
the HOS assay to evaluate the functional integrity of the sperm membrane rather 
than the ‘live-dead’ EN stain which only measures whether the membrane is 
morphologically intact (Jeyendran et al., 1984). The assay is simple to run and 
demonstrates a high correlation between the percentage of sperm in an ejaculate 
that are capable of swelling and their ability to undergo activation and/or oocyte 
binding. The percentage of viable sperm was not significantly different between 
CON and CR animals in the present study. 
Seminal plasma is derived primarily (50-80%) from seminal vesicles with a 
smaller fraction (13-30%) contributed by the prostate (Harraway et al., 2000; 
Haugen and Grotmol, 1998). Ejaculate osmolarity and pH are both dependent on 




the animal. Stable osmolarity and the basic pH of semen allow spermatozoa to 
survive in the slightly acidic environment of the vagina until they can pass 
through the cervix into the uterus. Our data showed no significant differences 
between diet groups for either of these parameters. 
Morphology refers to the shape, size, and surface appearance of sperm. 
This can be determined with the one-step eosin-nigrosin staining technique 
which does not need negative phase contrast optics but instead can be run with 
ordinary bright-field microscopy. It includes few methodological steps to control, 
making it preferable in terms of standardization and quality control management. 
Evaluation of stained semen smears from our study, both fresh and frozen-
thawed samples, showed no statistically significant diet-induced differences 
between treatments. There were significant differences between fresh and 
frozen-thawed samples, but these differences are simply an artifact of the 
cryopreservation and/or thawing process and not attributable to diet. 
While the nine sperm parameters analyzed showed no statistically 
significant differences between experimental groups, it is worth noting that in 
every instance, with the exception of sperm viability, biological variation in the 
CR-treated animals was similar or less than that measured in their CON 
counterparts. In fact, upon analysis, CR variability was found to be significantly 
smaller for sperm count (P<0.04) and tended toward significance for three other 
ejaculate parameters: volume, weight and osmolarity (P<0.06-0.11). This may be 




strategy of life maintenance as these parameters appeared to be more tightly 
regulated in our CR-treated animals. 
Additionally, we attempted to quantify the seminal plasma constituents, 
fructose and citric acid. This is not a component of the traditional spermiogram, 
but since the seminal vesicles and prostate contribute approximately 90% of the 
seminal plasma volume it is of great interest to determine if these glands are 
functioning properly (Gonzales, 2001; Owen and Katz, 2005). Seminal vesicle 
secretion is important for sperm metabolism, semen coagulation, sperm motility, 
stability of chromatin and suppression of immune activity in the female 
reproductive tract (Gonzales, 2001; Lewis-Jones et al., 1996). Specifically 
fructose, the major carbohydrate in human semen, has been reported to be a 
source of energy for the motile sperm (Elzanaty et al., 2002; Lewis-Jones et al., 
1996). As a result, the measurement of seminal fructose has been used in most 
fertility labs worldwide and by the World Health Organization as a marker of 
seminal vesicle function (Gonzales, 2001; Harrison and Lewis, 1986). Prostate 
derived citrate is one of the most important anions present in human semen and 
is probably responsible for regulating ionized calcium levels in the seminal 
plasma. It may also be responsible for the high buffering capacity of semen 
which allows sperm to survive in the acidic vaginal environment until it can enter 
the neutral pH cervical mucus (Owen and Katz, 2005). Determination then of 
fructose and citric acid concentration becomes one of the major methods for 




Unfortunately, the spectrophotometric enzymatic assays we used were 
unable to measure these constituents accurately, possibly due to the dilution of 
plasma during our washing of each semen collection. Previous reports of semen 
collection in squirrel monkeys (Yeoman et al., 1998) used only 4 mL of buffer for 
washing each ejaculate compared to our 15 mL. They also heated the wash 
supernatant to 80oC for 15 minutes to stop any enzymatic reactions. We did not 
do this, so it is possible that our samples may have appreciably degraded in the 
time it took to perform the wash and get the supernatant into a -80oC freezer. 
Future efforts will be made, however, to concentrate the samples and quantify 
these markers. 
Taken together these data demonstrate that moderate CR had limited 
impact on semen quality in adult rhesus macaques based on the spermiogram 
parameters observed. Despite these similarities it is still possible that sperm 
competency could be affected at some point further along the reproductive 
pathway, possibly at the point of fertilization. 
 
Can sperm undergo physiological modifications necessary for fertilization? 
Fertilization is a complex process requiring the spermatozoa to undergo a 
cascade of events before it can fuse with the oocyte plasma membrane 
(Yanagimachi, 1994). The zona pellucida, a unique extracellular translucent 
matrix surrounding the mature oocyte, mediates critical steps in the fertilization 
process, including induction of sperm acrosome reaction in some species, sperm 
binding and establishment of block to polyspermy. Unlike other vertebrates, 




Instead, a final stage of maturation, termed capacitation, is required in which 
sperm acquire the ability to undergo the acrosome reaction (Mortimer, 1994; 
Yanagimachi, 1994). Capacitation regulates the induction of the acrosome 
reaction and is marked by hyperactivation in motility of the sperm. Using the ZP 
binding and AR assay we quantified the ability of collected sperm to become 
capacitated, bind to homologous zona pellucida and undergo the acrosome 
reaction. 
 Our results showed no statistically significant difference between 
experimental groups for the number of bound sperm per zonae and the percent 
of bound sperm which were acrosome reacted. While the variation in our 
samples was comparable to published reports, our mean values were 
considerably lower than those reported by VandeVoort et al. (1992; 1994). Using 
the same assay, they documented sperm binding at anywhere from 71 (+ 28) to 
96.2 (+ 17) sperm per ZP. They also reported an acrosome reacted percentage 
of 8.2 (+0.9) to 30 (+8) in rhesus macaques as compared to our 0.4-1%.  
There are a few possible reasons for these differences. First, while human 
sperm will spontaneously capacitate in vitro, rhesus macaque spermatozoa must 
be exposed to the activators caffeine and dbcAMP (VandeVoort et al., 1994). 
Once capacitated, ZP binding will occur when exposed to zona pellucida 
membranes, and this binding acts as a signal to induce the sperm acrosome 
reaction. Although activation was checked prior to coincubation with ZP, perhaps 
we achieved lower limits of sperm capacitation than was needed for binding. 




binding and will only acrosome react when exposed to a homologous sperm-ZP 
interaction (VandeVoort et al., 1992; VandeVoort et al., 1994). Unlike humans 
where acrosome reacted sperm can still bind, if rhesus macaque sperm 
acrosome react prior to interaction with the oocyte, their binding capacity is 
significantly reduced (VandeVoort et al., 1997). It is possible that sperm in each 
of our assays was already acrosome reacted and thus was unable to fuse to the 
ZP. Finally, assay differences may simply be a result of animal variation. 
Subjects in our study were inexperienced males chosen not for their breeding 
success but rather because they were a part of a CR study. 
 
Can sperm initiate and sustain embryo development? 
Sperm chromatin, consisting of DNA and heterogeneous nucleoproteins, 
is normally a highly organized and compact structure intended to protect genetic 
integrity during transport through the male and female reproductive tracts. 
Accumulating data suggest that alterations in genomic organization of the sperm 
nuclei are negatively correlated with the fertility potential of sperm and its ability 
to maintain embryo survival. The sperm chromatin structure assay (SCSA®) 
measures DNA integrity, an essential component for the accurate transmission of 
genetic information to the offspring, via DNA fragmentation levels and has proven 
highly effective in predicting fertility outcome both in vivo and in vitro (Larson-
Cook et al., 2003).  
Recent reports by Evenson et al. (2006) have indicated that natural 




suggested that sperm DNA integrity may even be a more objective measure of 
sperm function compared to standard semen analysis, which can be very 
subjective and prone to intra- and inter-observer variability (Agarwal and Said, 
2003). Meta-analyses of the Georgetown Male Factor Infertility Study show that 
SCSA® infertility test is significantly predictive for reduced pregnancy success 
using intercourse, intrauterine insemination, routine in vitro fertilization and, to a 
lesser extent, intracytoplasmic sperm injection (Evenson and Wixon, 2006). 
Findings in the present experiment found no significant differences between 
treatment groups and indicate that DNA integrity was very high in all eight of the 
study animals. The one exception was a CON animal for which there was only 
one available sample for assay. In this instance, the subject demonstrated a DFI 
of 32.5%. It would appear that this animal would be infertile based on the one 
ejaculate, but it is difficult to speculate without further samples. 
 
Finally, we know that Leydig cell-derived testosterone is the driving force 
behind masculinization, sperm production, and male secondary sex 
characteristics. There have been sporadic studies of testosterone measurement 
in rhesus macaques, and they are often contradictory. Some reports claim non-
significant declines in testicular mass, serum T levels and pulsatile T release in 
aged animals (Black and Lane, 2002; Roth et al., 2004) while others show no 
evidence of different T levels with age (Mattison et al., 2003; Mattison et al., 




levels vary widely amongst individuals, throughout the day and even from day-to-
day.  
Due to the extensive expertise of the ONPRC to catheterize our 
experimental subjects and sample remotely, we were able to obtain blood 
samples every 30 minutes across a 24-hour period. Such timely sampling is 
necessary if true T profiles are to be established, as sampling too infrequently will 
not allow detection of the circadian pattern of testicular T release. In our study 
treatment groups displayed a similar pattern of daily circulating plasma 
testosterone levels. Likewise, no statistically significant differences were detected 
between CON and CR animals for mean or maximum circulating T levels. Daily 
minimum levels, however, were significantly different (P<0.01) with CON subjects 
lower than their CR counterparts. The biological relevance of this is uncertain, 
but it may be another indication of physiological efficiency. By decreasing the 
daily swing between maximum and minimum levels and maintaining tighter 
control over T release, CR animals may be able to divert energy toward more 
critical functions of life maintenance. This may in turn account for the decreased 
variability observed in the majority of our spermiogram parameters. 
Our findings may also be an indication that CR can maintain T levels, 
which would be of great benefit since age-related testosterone decline can cause 
weakened muscle function, lower bone density and loss of cognitive function. 
Studies in Brown Norway rats have shown that CR initiated at 4 months of age 
and applied continuously for 30 months results in significantly higher 




suggesting that long-term CR can transiently suppress the reductions in 
steroidogenesis that are characteristic of aging (Chen et al., 2005). Should CR 
be shown to elicit the same biological response in a nonhuman primate model, it 
could potentially be implemented as a counterbalancing force in human aging. 
This could have far-reaching social consequences by improving quality of life 
issues including immune function, bone and muscle health, libido and cognition.  
 
SUMMARY 
In the present study we investigated the potential impact of moderate CR 
on parameters of normal sperm physiology and function in young adult rhesus 
macaques (Macaca mulatta). Semen samples were collected via penile 
electrostimulation three times over a 7-month period from 8 Young Adult (12 
years) rhesus macaques fed a control diet (CON; n=4) or calorie restricted at 
30% CON (CR; n=4) for the previous 8 years post-pubertally. Ejaculate weight, 
liquid volume of ejaculate, sperm count, sperm concentration, sperm motility, 
sperm viability, ejaculate osmolarity, ejaculate pH and sperm morphology for 
freshly collected semen were determined along with motility and morphology 
analysis of frozen-thawed samples. Our findings indicated no statistically 
significant differences (P<0.05) between the two groups in any of these ejaculate 
characteristics, although variability in CR-treated subjects tended to be lower. ZP 
binding and AR assay and SCSA® were conducted and also indicated no 
significant differences between CON and CR-treated animals. Additionally, 




with an additional animal in each group (CON and CR; n=5). Both groups 
exhibited the same general pattern of T expression over the 24-hour period with 
no significant differences in mean or maximum levels of circulating testosterone. 
Daily minimum T levels, however, were significantly lower (P<0.01) in the CON 
group compared to CR-treated animals. The biological relevance of this is 
uncertain, but it may indicate a metabolic shift toward a more efficient strategy of 
life maintenance. Thus, moderate CR was neither detrimental nor beneficial to 
semen quality in young adult rhesus macaques based on the physiological 
parameters observed. This study is among the first to address the effects of CR 
on male reproductive function in nonhuman primates. Whether CR impacts 
fertility in aging male macaques remains to be determined. These data represent 
a unique and valuable opportunity to contribute to the growing body of literature 
regarding the effects of caloric restriction and its impact on biological function. 
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Table 5.1 Summary of Semen Measurements 
Measure Rationale 
Ejaculate appearance Indicative of cell (sperm) numbers 
Ejaculate weight Indicative of accessory sex gland production and secretion 
Ejaculate color Abnormal color may indicate accessory sex gland or other clinical 
pathology 
Ejaculate volume Low volume may indicate retrograde semen flow into the bladder or accessory sex gland pathology 
Osmolarity/osmolality Indicative of ionic composition 
pH Indicative of ratio of alkaline seminal vesicle secretions and acidic prostatic secretions 
Count Indicative of overall spermatogenesis success 
Concentration Indicative of successful spermatogenesis and accessory sex gland production 
Motility Indicative of sperm ability to reach the ova 
Morphology Indicative of cell maturation status 
Activation (capacitation) Indicative of sperm ability to reach the ova and then penetrate the zona pellucida 
Agglutination May indicate possible surface antigen problems 
Zona pellucida (ZP) 
binding 
Sperm binding to the ZP outer surface is a prerequisite for oocyte 
vitelline membrane binding and penetration 
Acrosome reaction Prior to fertilization the outer acrosomal membrane fuses with the surrounding plasma membrane 
Hypo-osmotic swelling 
assay 
Indicative of intact sperm membrane. Membrane integrity can 
influence motility, activation, acrosome reaction and is required for 
successful fusion with the ova 
Seminal plasma 
composition Overall measure of accessory sex gland contribution 
Sperm chromatin 






Figures 5.1 A-H Semen Parameters in Young Adult CON and CR Rhesus 
Macaques Data for each male were averaged for three collections and then 
group treatment averages were determined for Young Adult rhesus macaques. 
Analyses were made between CON and CR by Student’s t-test (P<0.05) using 
SPSS (SPSS Inc.; Chicago, IL) or Excel (Microsoft; Redmond, WA). Each point, 
along with SEM, represents mean data from four animals. No significant 


































































































































































































































 CON CR  
ejaculate weight (g) 0.95 + 0.57 0.91 + 0.16 
ejaculate volume (mL) 0.34 + 0.20 0.27 + 0.07 
sperm count (x 106) 20.27 + 13.4 13.48 + 3.1 
sperm concentration (per mL; x 106) 47.66 + 9.21 42.81 + 4.38 
sperm motility (%) 64 + 13 56 + 11 
sperm viability (%) 79 + 3 82 + 6 
ejaculate osmolarity (mOsm) 430 + 43 359 + 15 
ejaculate pH 7.9 + 0.3 8.2 + 0.1 
  
 
Table 5.2 Semen Parameter Values in Young Adult CON and CR Rhesus 
Macaques Mean data (+ SEM) from the preceding figures are presented in 
numerical form. No significant differences (P<0.05) were observed between the 
two diet groups for the ejaculate characteristics. 
 
Variability, however, was found to be significantly smaller for CR-treated animals 
in sperm count (P<0.04) and tended toward significance for three other ejaculate 





Figures 5.2 A-H Sperm Morphology Examples from Young Adult Rhesus 
Macaques Representative images showing normal morphology (A and B) along 
with various abnormalities found in sperm for CON and CR treated animals (n=4 
each). Black arrows show the locations of abnormalities. 
• Head abnormality: round head (C) and acrosome damage (D) 
• Midpiece abnormality: thickened midpiece (E) and coiled midpiece (F) 



























































Figures 5.3 A-B Fresh Sperm Morphology in Young Adult CON and CR 
Rhesus Macaques Morphology classifications per ejaculate were normalized 
into percentages for all descriptive categories. Statistical comparisons were then 
made by Student’s t-test (P<0.05) using SPSS (SPSS Inc.; Chicago, IL) Each 
bar, along with SEM, represents mean, normalized data from four treatment 
animals. In Figure A no significant diet-induced differences were observed 
between Normal and Abnormal sperm morphology. Figure B shows no significant 




















































































Sperm Morphology (%) CON CR 
          Normal 21.3 + 1.6 17.0 + 3.6 
          Abnormal 78.7 + 1.6 83.0 + 3.6 
 
Morphological Sperm 
Abnormalities (% of Abnormal) CON CR 
          Head 24.3 + 3.5 14.8 + 5.1 
          Midpiece 37.3 + 2.4 45.7 + 2.6 
          Tail 38.4 + 5.9 39.5 + 7.0 
 
Table 5.3 Fresh Sperm Morphology Values in Young Adult CON and CR 
Rhesus Macaques Mean data (+ SEM) from the preceding figures are 
presented in numerical form. No significant differences (P<0.05) were observed 































Figure 5.4 Motility of Frozen-Thawed Sperm in Young Adult CON and CR 
Rhesus Macaques Data for each male was averaged for three collections and 
then group treatment averages were determined for Young Adult rhesus 
macaques. Analyses were made between CON and CR by Student’s t-test 
(P<0.05) using SPSS (SPSS Inc.; Chicago, IL) or Excel (Microsoft; Redmond, 
WA). Each point, along with SEM, represents mean data from four animals. No 





Table 5.4 Frozen-Thawed Sperm Motility Values in Young Adult CON and 
CR Rhesus Macaques Mean data (+ SEM) from the preceding figure is 
presented in numerical form. No significant difference (P<0.05) was observed 
between the two diet groups.  
 
 CON CR 







Figures 5.5 A-B Frozen-Thawed Sperm Morphology in Young Adult CON 
and CR Rhesus Macaques Morphology classifications of frozen-thawed 
samples were normalized into percentages for all descriptive categories. 
Statistical comparisons were then made by Student’s t-test (P<0.05) using SPSS 
(SPSS Inc.; Chicago, IL) or Excel (Microsoft; Redmond, WA). Each bar, along 
with SEM, represents mean, normalized data from four treatment animals. In 
Figure A no significant diet-induced differences were observed between Normal 
and Abnormal sperm morphology. Figure B shows no significant treatment 

















































































Sperm Morphology (%) CON CR 
          Normal 30.6 + 1.3 69.4 + 1.3 
          Abnormal 31.9 + 3.6 68.1 + 3.6 
 
Morphological Sperm 
Abnormalities (% of abnormal) CON CR 
          Head 20.0 + 3.9 18.7 + 5.5 
          Midpiece 27.0 + 2.0 24.3 + 2.5 
          Tail 53.0 + 3.2 57.0 + 3.0 
 
Table 5.5 Frozen-Thawed Sperm Morphology Values in Young Adult CON 
and CR Rhesus Macaques Mean data (+ SEM) from the preceding figures are 
presented in numerical form. No significant differences (P<0.05) were observed 








Figure 5.6 Example of Staining for ZP Binding and AR Assay The upper 
image demonstrates Hoescht 33,258 staining of DNA/chromatin. The lower 
image shows fluorescein isothiocyanate (FITC) double-antibody staining of the 
sperm acrosomal membrane. By using alternating fluorescent filters we are able 
to count the total number of sperm bound to each oocyte zonae and their 












Treatment No. of sperm/zonae
% acrosome 
reacted 
CON 14 + 11 0.4 + 0.4 
CR 4 + 3 1.0 + 0.8 
 
 
Table 5.6 ZP Binding and AR Assay Results for Young Adult CON and CR 
Rhesus Macaques Data for each male was averaged and then group treatment 
averages were determined. Analyses were made between CON and CR by 
Student’s t-test (P<0.05) using SPSS (SPSS Inc.; Chicago, IL) or Excel 
(Microsoft; Redmond, WA). Mean value (+ SEM) are from four animals. No 
significant differences were detected between groups for the number of sperm 







Table 5.7 Individual SCSA® Results for Young Adult CON and CR Rhesus 
Macaques Experimental findings of the sperm chromatin structure assay for 
Young Adult CON and CR rhesus macaques are shown. All of the animals 
appear to have excellent sperm with the exception of CON #22382. This animal 
would most likely be infertile based on the one sample obtained. 
 
Key: 
% Total: DNA Fragmentation Index (DFI; % Moderate + % High) 
     % Moderate: moderately damaged sperm 
     % High: highly damaged sperm 
%HDS: High DNA Stainability or measure of immature chromatin 
 
DNA Fragmentation Index (%DFI; % sperm cells containing damaged DNA) 
a.     < 15% DFI = excellent sperm DNA integrity 
b.     > 15 to < 30% DFI = good sperm DNA integrity 
c.     > 30% DFI = fair to poor sperm DNA integrity 
 
High DNA stainability (HDS; % cells with immature chromatin) 
a.     < 15% HDS = normal 






     
CONTROL CR
DNA Fragmentation Index DNA Fragmentation Index
Sample % Total % Moderate % High % HDS Sample % Total % Moderate % High % HDS
22388 0.4 0.3 0.1 0.7 22389 5.1 3.9 1.2 1.7
0.2 0.2 0.0 0.7 5.2 4.1 1.1 1.5
Mean 0.3 0.2 0.1 0.7 Mean 5.2 4.0 1.2 1.6
S.D. 0.1 0.1 0.0 0.0 S.D. 0.1 0.2 0.0 0.2
DNA Fragmentation Index DNA Fragmentation Index
Sample % Total % Moderate % High % HDS Sample % Total % Moderate % High % HDS
22382 32.4 8.4 24.0 1.4 22384 1.7 1.7 0.1 1.9
32.7 8.5 24.1 2.3 1.6 1.5 0.1 1.9
Mean 32.5 8.5 24.1 1.9 Mean 1.7 1.6 0.1 1.9
S.D. 0.2 0.1 0.1 0.6 S.D. 0.1 0.1 0.0 0.0
DNA Fragmentation Index DNA Fragmentation Index
Sample % Total % Moderate % High % HDS Sample % Total % Moderate % High % HDS
22376 0.7 0.5 0.1 0.8 22375 0.3 0.3 0.0 3.0
0.5 0.4 0.1 1.5 0.2 0.2 0.0 2.9
Mean 0.6 0.5 0.1 1.1 Mean 0.3 0.2 0.0 3.0
S.D. 0.1 0.1 0.0 0.5 S.D. 0.1 0.1 0.0 0.1
22376 0.6 0.5 0.1 1.4 22375 1.0 0.8 0.3 2.1
0.9 0.5 0.4 1.2 1.1 0.8 0.3 2.3
Mean 0.7 0.5 0.2 1.3 Mean 1.0 0.8 0.3 2.2
S.D. 0.2 0.0 0.2 0.1 S.D. 0.0 0.0 0.0 0.2
22376 Mean (all) 0.6 0.5 0.2 1.2 22375 Mean (all) 0.6 0.5 0.1 2.6
S.D. 0.2 0.1 0.1 0.3 S.D. 0.0 0.0 0.0 0.1
DNA Fragmentation Index DNA Fragmentation Index
Sample % Total % Moderate % High % HDS Sample % Total % Moderate % High % HDS
22387 0.3 0.2 0.1 0.9 22371 0.0 0.0 0.0 0.8
0.2 0.2 0.0 0.9 0.1 0.1 0.0 0.8
Mean 0.2 0.2 0.1 0.9 Mean 0.1 0.1 0.0 0.8
S.D. 0.0 0.0 0.0 0.0 S.D. 0.1 0.0 0.0 0.0
22387 0.1 0.1 0.0 0.9 22371 0.2 0.2 0.1 3.1
0.2 0.1 0.0 1.3 0.4 0.3 0.1 4.2
Mean 0.1 0.1 0.0 1.1 Mean 0.3 0.2 0.1 3.7
S.D. 0.1 0.0 0.0 0.3 S.D. 0.1 0.1 0.0 0.8
22387 1.2 1.2 0.0 3.2 22371 0.3 0.2 0.1 1.2
0.3 0.3 0.0 2.6 0.3 0.2 0.1 1.2
Mean 0.8 0.7 0.0 2.9 Mean 0.3 0.2 0.1 1.2
S.D. 0.6 0.6 0.0 0.4 S.D. 0.0 0.0 0.0 0.0
22387 Mean (all) 0.4 0.3 0.0 1.6 22371 Mean (all) 0.2 0.2 0.1 1.9







Table 5.8 Mean DNA Fragmentation Index for Young Adult CON and CR 
Rhesus Macaques Data for each male was averaged and then group treatment 
averages were determined. Analyses were made between CON and CR by 
Student’s t-test (P<0.05) using SPSS (SPSS Inc.; Chicago, IL) or Excel 
(Microsoft; Redmond, WA). Mean value (+ SEM) are from four animals. No 
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Figure 5.7 Representative Sperm Chromatin Structure Assay Output Example of 
output provided by SCSA® Diagnostics on two rhesus macaque sperm samples. The 
upper data sheet displays a high quality sample with a very low DNA Fragmentation 
Index (DFI). The lower data sheet shows a DFI above 30% meaning that sperm from this 
animal would have reduced pregnancy success whether from intercourse, intrauterine 















Figure 5.8 Daily Circulating Plasma Testosterone Levels for Young Adult 
CON and CR Rhesus Macaques Plot shows similar pattern of daily circulating 
testosterone in both treatment groups. Data from a single 24-hour period is 
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Figure 5.9 Mean, Maximum and Minimum Daily Plasma Testosterone Levels 
for Young Adult CON and CR Rhesus Macaques Data are expressed as 
group mean + SEM with n=5 for each treatment. Statistical comparisons between 
CON and CR groups were made by Student’s t-test with significant differences 
established at P<0.05. No significant differences were detected for mean or 
maximum circulating T levels, but minimum T levels were significantly lower 










Biological aging represents a complex, multifactorial cascade of events 
that occurs simultaneously at molecular, cellular and systemic levels, resulting in 
disruption of an organism’s homeostatic mechanisms and ability to respond to 
stress. Aging thus leads to a progressive loss of function, including reproductive 
capacity, accompanied by increasing incidence of disease and mortality. The 
objectives of this project were to: 1) analyze neuroendocrine changes to the HPG 
axis that occur with aging and 2) evaluate the effects of moderate CR on 
reproductive function in male rhesus macaques. 
 There are many theories that attempt to explain senescence, each which 
may adequately describe some or all of the observed processes alone or in 
combination with other theories. The Disposable Soma Theory proposes that 
organisms may have the innate ability to shift metabolic resources from growth 
and reproduction to improved somatic maintenance and repair, effectively 
slowing the aging process and prolonging disease resistance and health 
(Kirkwood and Austad, 2000; Miller et al., 2002). The Gene Regulation Theory 
proposes that senescence results from changes in gene expression. One 
example of this is the identification of an insulin-like signaling pathway or its 
homolog that can modify lifespan in yeast, nematodes, flies and mice (Kenyon, 
2001; Weinert and Timiras, 2003). The Free Radical Theory proposes that aging 




reactive oxygen species produced during normal cellular respiration (Koubova 
and Guarente, 2003; Weinert and Timiras, 2003). A growing body of evidence 
implicates mitochondrial derived ROS as a major cause of cellular decline and a 
direct relationship between individual age, species longevity and rate of ROS 
production has been documented (Gredilla and Barja, 2005; Kirkwood and 
Austad, 2000; Weinert and Timiras, 2003). The Neuroendocrine Theory proposes 
that aging is a result of neural and endocrine functional changes which are 
crucial for coordinating an organism’s response to its environment and 
maintaining an optimal functional state to balance reproduction and survival 
(Weinert and Timiras, 2003). 
Regardless of the causes, aging occurs in all biological systems. Over the 
last 75 years calorie restriction has been established as the only proven non-
genetic method of altering longevity and attenuating biological changes 
associated with aging (Koubova and Guarente, 2003; Lane et al., 1999b; McCay 
et al., 1935). To date, this nutritional paradigm has been found to be effective in 
protozoa, yeast, rotifers, fleas, nematodes, spiders, flies, mollusks, fish, mice, 
rats, dogs and possibly non-human primates such as squirrel monkeys and 
cynomolgus and rhesus macaques (Ingram et al., 1990; Lane et al., 1999b; Roth 
et al., 1999; Weindruch and Walford, 1988). Not only is CR effective for 
extending lifespan but it also demonstrates widespread, beneficial health effects 
on almost every physiological system within the organism. Researchers have 
shown that CR can reduce body mass and adiposity, lower body temperature 




increasing insulin sensitivity and high density lipoprotein levels, and reduce 
oxidative stress (Gredilla and Barja, 2005; Gresl et al., 2001; Heilbronn and 
Ravussin, 2003; Koubova and Guarente, 2003; Lane et al., 1997). Its long history 
notwithstanding, however, very little is known with regard to the exact 
mechanism(s) of CR action. 
 The potential health benefits of CR could be very valuable, especially in 
developed societies where life expectancy is increasing and demographics are 
shifting to an older population. Many reports from scientific and mainstream 
sources in the United States warn of an impending healthcare crisis and financial 
difficulties of dealing with an aging population and the medical challenges that 
inevitably follow. Additionally, the recent phenomenon of increased average body 
mass index (BMI) experienced by the Western world has resulted in an increased 
incidence of obesity and manifestations of poor health including type II diabetes, 
heart disease, stroke and high blood pressure. The consequences of increased 
BMI negatively impact reproductive potential as well, with men experiencing 
lower sperm concentrations and total sperm counts (Jensen et al., 2004), while 
also demonstrating an inverse relationship between BMI and total number of 
motile sperm cells and a positive relationship between BMI and sperm DNA 
fragmentation per subject (Kort et al., 2006). 
These kinds of statistics and data do not bode well for a population that 
has delayed child-bearing for a number of socioeconomic reasons. Since 1980, 
in the United States, there has been an upward trend in the average age of 




rate for fathers over age 35 years (Buwe et al., 2005; Eskenazi et al., 2003; Kidd 
et al., 2001). One consequence of reproductive decline is infertility with 
approximately 25-50% of conception difficulties attributable to male factors, 
making it the single most common cause of infertility in clinical cases (Agarwal 
and Said, 2003; Eskenazi et al., 2003; Kidd et al., 2001; Larson-Cook et al., 
2003). 
Reproductive aging in men typically follows a gradual course where 
decline may be due to functional deterioration at several sites including reduced 
testosterone production, decreased hypothalamic gonadotropin-releasing 
hormone and altered pituitary gland release of gonadotropins (Harman et al., 
2001; Moffat et al., 2002; Ottinger, 1998). In men testosterone is responsible for 
regulation of gonadotropin secretion by the hypothalamic-pituitary system and 
predominantly drives spermatozoa production. Although the impact of its decline 
on reproductive senescence is not completely understood, there is the potential 
for a cascade effect to the entire reproductive system with its fall. Testosterone 
loss can also result in weakened muscle function, decreased bone density and 
degradation of other physiological parameters related to overall aging (Harman et 
al., 2001; Moffat et al., 2002). Also of importance is the neurological impact of 
testosterone decline. Men with Alzheimer’s disease (AD) have significantly lower 
T levels than aged men without AD. Importantly, testosterone depletion appears 
to occur before clinical and pathological diagnosis of AD, suggesting that low T 




 Other parameters of reproductive function and fertility in elderly men have 
traditionally focused on semen analysis. For conventional spermiogram 
measures the weight of scientific evidence suggests that increased male age is 
associated with undesirable changes in reproductive potential such as decreased 
semen volume (Henkel et al., 2005; Kidd et al., 2001), increased DNA 
fragmentation (Evenson and Wixon, 2006), lower sperm motility (Eskenazi et al., 
2003; Zubkova and Robaire, 2006) and increased sperm abnormalities (Kidd et 
al., 2001; Zubkova and Robaire, 2006). In general, however, most measures of 
male reproductive health exhibit no evidence of an age ‘threshold’ but rather 
display gradual changes over time (Eskenazi et al., 2003). 
Since calorie restriction is capable of reducing body mass and adiposity 
and improving general health parameters, it would be of great benefit to know if 
CR could also maintain reproductive fitness and attenuate age-related changes. 
The National Institute on Aging’s study of CR in rhesus macaques (Ingram et al., 
1990) has shown positive health effects paralleling those observed in other 
species. Could moderate CR, which was implemented in these animals post-
pubertally, also improve male reproductive health parameters? Alternatively, 
could it have no impact or even an unfavorable effect on reproductive outcome or 
the neuroendocrine system? 
Throughout life and during specific mammalian life stages the HPG axis is 
responsible for a number of circadian activities including rhythmic release of 
GnRH, ACTH, luteinizing hormone and  growth hormone (Griffin and Ojeda, 




as testosterone, are regulated in a circadian fashion in mammals (Jilg et al., 
2005; Sehgal, 2004). Pituitary gland gene expression profiling and semi-
quantitative RT-PCR in our first experiment showed circadian clock mechanism 
components present in Juvenile, Young Adult and Old Adult macaques and 
demonstrated age differences in Per2 expression. This is an important finding 
since there are well documented alterations in circadian organization during 
aging, including changes in hormonal rhythms, core body temperature, 
sleep/wake cycles, activity and locomotor patterns, behavioral responses, and 
response to the phase-shifting effects of light (Asai et al., 2001; Hofman and 
Swaab, 2006; Oster et al., 2003).  Despite these overt signs, however, the 
physiological underpinnings for the circadian dysregulation remain unclear. Due 
to its unique position in the HPG axis, age-related changes in the pituitary gland 
and its clock components could be responsible for many of these physiological 
manifestations. 
Pituitary gland gene expression profiles of Young Adult CON and CR 
macaques in our study detected potential differential expression in <150 
probesets. Changes in TSHR and CGA expression, as measured by sqRT-PCR, 
were observed resulting in lower levels for both genes in CR-treated animals. 
Other genes associated with reproduction, metabolism and oxidative stress 
showed no treatment effects. The biological relevance of these observations is 
unknown, but it may be connected to two well-documented CR-induced 
metabolic adjustments, lower core-body temperature (Heilbronn et al., 2006; 




Walford, 1988) and suppression of the thyroid axis as measured by lower TSH 
and thyroid hormone levels (Gredilla and Barja, 2005; Heilbronn and Ravussin, 
2003; Koubova and Guarente, 2003; Mattison et al., 2001).  
These two phenomena may be linked, as a depression in body 
temperature often indicates a reduction in the rate of oxygen consumption. The 
hypometabolic state imposed by CR is reflected by the approximately 50% 
reduction in serum triiodothyronine hormone concentrations (Weindruch and 
Sohal, 1997). Because calorie restriction is a nutritional paradigm, impact on an 
animal’s metabolism is a likely mode of action. In fact, several hypotheses 
related to the mechanisms of CR’s biological effects are linked to reduced (or 
more efficient) processing of energy (Heilbronn and Ravussin, 2003; Mattison et 
al., 2003; Weinert and Timiras, 2003). The changes in TSHR and CGA mRNA 
expression in our CR animals indicate a modification of the metabolic pathway 
and could potentially correlate with these kinds of physiological responses. While 
the changes may have been subtle, this line of investigation is still very important 
since mRNA expression has the potential to cause or inhibit temporal 
dysregulation of gene expression, a principal factor in cellular malfunction and 
disease. 
Our third experiment profiled testicular gene expression in Young Adult 
CON and CR animals and found diet-related changes in <300 probesets, 
although mRNA expression was not altered based on sqRT-PCR and real-time 
RT-PCR for a large group of selected genes. Having found limited impact of CR 




expression in an aging series of rhesus macaque testicular tissue. Here we 
observed age-related and/or diet-induced changes in HSD17β3, INSL3, CSNK1E 
and CGA expression with CGA in Old Adult CR subjects returning to youthful 
levels. This matched results of our pituitary gland gene expression experiment 
where significantly different levels of CGA were observed between treatment 
groups. In both instances the CR-treated group exhibited lower levels of 
expression, and in the case of the Old Adult CR subjects, testicular CGA was 
restored to the level of Juvenile and Young Adult expression. Unlike the 
connection to TSHR in the pituitary gland, however, CGA in the testis may be 
playing a role as a paracine factor of gonadal function where differences in 
expression may indicate a more tightly regulated feedback mechanism. Most 
importantly there were no observable differences in expression levels between 
Old Adult animals and their age-matched CR-treated counterparts. These results 
suggest that CR can elicit general beneficial health effects without negative 
consequences on the gonadal portion of the HPG axis.  
Normal spermiogram measures, ZP binding, AR assay and SCSA® for 
Young Adult CON and CR macaques indicated no differences between groups. It 
is worth noting that in every instance, with the exception of sperm viability, 
biological variation in the CR-treated animals was similar or less than that 
measured in their CON counterparts. In fact, upon analysis, variation was found 
to be significantly different for sperm count (P<0.04) and trended toward 
significance for three other ejaculate parameters: volume, weight and osmolarity 




metabolic shift to a more efficient strategy of life maintenance as these 
parameters appeared to be more tightly regulated in our CR-treated animals. 
Both groups exhibited similar daily testosterone profiles with no difference in 
mean or maximum levels, however, daily minimum testosterone levels were 
lower in the CON group. The biological relevance of this is uncertain, but it may 
be another indication of physiological efficiency. By decreasing the daily swing 
between maximum and minimum levels and maintaining tighter control over T 
release, CR animals may be able to divert energy toward more critical functions 
of life maintenance. This may in turn account for the decreased variability 
observed in the majority of our spermiogram parameters. Taken together, our 
data demonstrate that moderate CR was not detrimental to semen quality in adult 
rhesus macaques based on the spermiogram parameters observed; thus, CR 
could potentially be executed without causing problems with testicular 
physiology. 
The more promising aspect of our study could be in regard to the 
observed CR-modified testosterone levels. Because declining testosterone may 
cause weakened muscle function, lower bone density and loss of cognitive 
function, it would be of great benefit if CR were shown to maintain T levels. 
Studies in Brown Norway rats have shown that CR initiated at 4 months of age 
and applied continuously for 30 months results in significantly higher 
concentrations of serum testosterone concentration compared to controls, 
suggesting that long-term CR can transiently suppress the reductions in 




be shown to elicit the same biological response in a nonhuman primate model, it 
could potentially be implemented as a counterbalancing force in human aging. 
This could have far-reaching social consequences by improving quality of life 
issues including immune function, bone and muscle health, libido and cognition.  
Animals in our study previously demonstrated CR-induced attenuations of 
age-related changes and improved health parameters (Mattison et al., 2003; 
Roth et al., 2002). Findings even suggest a metabolic shift from growth and 
reproduction toward a strategy of life maintenance (Roth et al., 2004). In all of our 
studies, we found negligible impact of CR on neuroendocrine or reproductive 
function in the male rhesus macaque. The observed changes in gene expression 
and T levels, however, may be regulating diverse physiological responses due to 
their key location in the HPG axis and their critical functional importance. As to 
how these variations are connected, the answer may come from the study of 
toxicology. 
Hormesis, in a toxicological context, implies that small doses of toxin may 
have long term benefits in conditioning an organism’s enhanced stress 
responses. Biologically, the Hormesis Hypothesis states that CR is not simply a 
passive effect of nutrient deprivation, but a highly conserved active defense 
response that appeared early in evolutionary history to increase an organism’s 
chance of surviving adversity (Sinclair, 2005). Without discerning the specific 
mechanisms behind it, the hypothesis asserts that low calorie intake is a mildly 




organism to survive environmental perturbations by altering metabolism and 
increasing defenses against aging. 
The appeal of the Hormesis Hypothesis is that it explains so many 
different observations about CR, ranging from the ability of CR cells/animals to 
withstand stress, to the finding that lower organisms have conserved stress 
response pathways that lengthen lifespan, to the link between CR and the 
endocrine system. It may even be that many of the current hypotheses of aging 
and CR stem from researchers attempting to describe different parts of the same 
phenomenon. In this regard the Hormesis Hypothesis may be able to unite 
disparate parts of other hypotheses that have until now not been connected. 
One example of a possible hormetic response in our studies may be the 
real-time PCR results for testicular StAR expression. An age-related decline in 
StAR mRNA and protein in the testis has been observed in rodents (Luo et al., 
2001). We observed a similar age-related decline in mRNA expression from 
Juvenile to Young Adult and Old Adult macaques. Our study also included Old 
Adult subjects that had been calorie restricted for the previous five years. These 
animals appeared to have StAR levels similar to the Juvenile group, but also 
exhibited a great deal of variability in expression. This variability confounded the 
results, thus providing no significant differences between any of the groups. Is it 
possible, however, that CR was triggering a hormetic response in the OACR 
group and as a result StAR was returning to more youthful levels? Was the true 
biological response to CR execution simply masked by the late age of CR onset 




cohort of macaques over time using the measures utilized in our experiments. 
This is difficult to do, however, due to expense and the large number of animals 
required for sampling at multiple timepoints. 
The downside of the Hormesis Hypothesis is that it does not determine the 
proximal causes of senescence but instead targets longevity regulators which in 
turn counter aging. It is similar to putting gas in a car to go somewhere, but 
having no idea or care that there is a combustion engine driving the process. 
Most people may not need to have a functional understanding of the machinery, 
but science doesn’t work that way; it needs to understand the driving forces 
behind phenomena. This is especially true with CR because even if 
advantageous health benefits can be achieved without negative consequences to 
the male HPG axis, it is unlikely that most people could adhere to the strict 
dietary regimen. Thus, an understanding of the biological mechanisms 
responsible for its effects is necessary if we are to develop alternative strategies 
of implementation. For that reason it would be an exciting possibility to undertake 
a collaborative relationship with the Pennington Biomedical Research Center in 
Louisiana and their ongoing human studies. In doing so we could monitor the 
possible effects of CR on male reproduction in a population adhering to a diet 
which is feasible for most people. 
 Based on our studies, pituitary gland and testicular gene expression and 
gonadal function appear resistant to CR-induced changes. Such stability may 
correlate with lifetime reproductive strategies and species-specific life histories 




a primary axis, such as the HPG, to be fluctuating too broadly under anything 
less than pathological conditions. With CR, however, there may be a few key 
components that are carefully modified in such a way as to affect multiple 
physiological responses simultaneously. Calorie restricted animals may, in effect, 
be walking a finer biological tightrope between somatic maintenance and 
reproduction than that experienced by free-feeding animals. In the case of males, 
where the energy investment in continuous reproductive capacity is minimal, it 
may be more efficient to fine-tune rather than cease sperm production completely 
due to the time and energy requirements necessary to restart the system. 
Ultimately I hope this work will have contributed in some small way to the 











   There is only one thing for it then - to learn. 
Learn why the world wags and what wags it. 
 




Appendix A: Protocol for RNA Extraction of Pituitary Gland  
and Testes Tissue 
 
1. Set up for the area where extraction is to be performed is extremely 
important. Use a biological safety cabinet that can be maintained as 
RNA/RNase free as possible. Use the ultraviolet light for 10 minutes prior 
to using the hood in order to destroy any RNase from mold or bacteria. 
2. It is extremely important to clean all equipment before extraction with 
RNase Zap® and to change/spray gloves regularly. Using filtered pipet tips 
will also help limit potential contamination. 
3. The homogenizer should be cleaned prior to use and between samples by 
running the blade in the following: 
a. DEPC water (diethylpyrocarbonate, one 50 mL volume) 
b. 70% EtOH (one 50 mL volume) 
c. chloroform (one 50 mL volume) 
d. Probe should be wiped and dried with tissue between each step 
4. Determine the tissue to be used and how it was harvested, stabilized, and 
stored. If necessary excise the sample from the complete tissue. How this 
is done will depend on how the tissue was stored (i.e. RNAlater or LNO2).  
LNO2 preserved tissue can be cut on an aluminum foil-wrapped block of 
dry ice while RNAlater tissue can be cut at room temperature (RT, 
although the dry ice method is preferred). 
5. Determine the starting amount of sample/tissue and record.   
6. Place the tissue in a 2 mL flat-bottom microcentrifuge tube and add the 
appropriate volume of Buffer RLT lyses solution. The buffer is supplied in 
the Qiagen RNeasy Mini Kit but must have β-mercaptoethanol added to it 
prior to use (10 μL 14.3M β-ME / mL Buffer RLT). Solution is stable for 
one month at RT. 
a. < 20 mg 350-600 μL RLT (600 μL if tissue was in RNAlater) 
b. 20-50 mg 600 μL RLT 
7. Homogenize tissue immediately for 20-40 seconds using a Rotor-stator 
homogenizer. Do not load all tissue samples and then homogenize. 
8. Spin lysate in tabletop microcentrifuge for 5 minutes at maximum speed 
(13,000RPM) with tabs out. 
9. After centrifugation pipet the supernatant to a new 2 mL flat-bottom 
microcentrifuge tube. Be careful to avoid transferring the pellet or any lipid 
layer that may be on the surface of the supernatant. 
10. Add 1 volume of molecular grade 70% ethanol (ex. add 600 μL EtOH if 
600 μL RLT was used). Mix by pipeting and continue immediately. 
11. Apply up to 700 μL of sample to the Qiagen column placed inside a 2 mL 
collection tube. Centrifuge for 30 seconds >8000G (>10,000RPM). If the 
original sample was in a volume >700 μL this step will have to be repeated 
using the same column (i.e. elute-centrifuge-elute-centrifuge-continue).   
12. Move filter to a new 2 mL collection tube and discard the flowthrough tube. 
13. Add 700 μL of Buffer RW1 to the RNeasy column.  Allow to sit for two 




14. Centrifuge for 30 seconds at >8000G to wash the column. 
15. Move filter to a new 2 mL collection tube and discard the flowthrough tube. 
16. Add 500 μL Buffer RPE to the RNeasy column. Allow to sit for 5 minutes 
at RT with lid closed. 
17. Centrifuge for 30 seconds at >8000G. 
18. Move filter to a new 2 mL collection tube and discard the flowthrough tube. 
19. Add another 500 μL Buffer RPE and centrifuge for 1 minute at >8000G. 
20. Move filter to a new 2 mL collection tube and discard the flowthrough tube. 
21. Centrifuge again for 2 minutes to eliminate the RPE buffer completely. 
22. Transfer column to a final 2 mL collection tube.  This tube will be used for 
storage so it should be labeled clearly. Leave the cap off the column and 
open for 5 minutes so as to completely dry the filter. 
23. To elute the RNA pipet 40 μL of RNase-free water directly onto the 
membrane.  Allow to sit for 2-3 minutes at RT. 
24. Centrifuge for 1 minute at >8000G. 
25. Place total RNA extract on ice as quickly as possible. 
26. RNA quality and concentration can be analyzed by microcapillary 
electrophoresis (bioanalyzer) prior to being used for microarray 
hybridization. A good quality RNA sample will have two ribosomal peaks 
on the bioanalyzer output at 18S (first peak) and 28S. The graph should 
have a low, constant baseline with sharp peaks; a degraded sample will 
show an abnormal profile. The next page shows an example of successful 
extraction results from our experiments as determined by model 2100 













Appendix B: Protocol for Use of Genesifter® Software 
 
1. Once you have received the data files from the microarray experiments, 
select the .CEL files to be analyzed and compress them for uploading 
2. Login to GeneSifter®: Import Data: Upload Tools 
3. Run Advanced Upload Methods 
a. Select: Method → GCRMA. RMA normalizes data across a group 
of arrays while MAS5 normalizes within individual chips. We chose 
RMA because we expected fewer mismatches with rhesus tissue 
on the GeneChip® Rhesus Macaque Genome Arrays (Affymetrix) 
b. Array → Rhesus macaque 
4. Select Data File: Find the zip compressed file on the hard drive 
a. Target Creation → how many Groups are in the study 
5. Name the Data set.  Be descriptive and add notes as needed. Name the 
study Groups and assign individual data files to a Group 
6. Data is now uploaded and in the GeneSifter® server 
7. Analysis is run 
8. Go to Analysis: Pairwise and click on the magnifying glass next to the 
Array of interest 
9. Select/Assign experiments to a Group 
10. Advanced Analysis Settings (RMA) – the following options need to be set 
by the user depending on their preferences 
a. Normalization: None (this has already been done with the 
Affymetrix software algorithms in Step 3) 
b. Statistics: t-test (in our case or ANOVA if more than two Groups) 
c. Quality (Signal): choose level of sensitivity to cutoff/exclude weaker 
signals. We left this as N/A initially since we filtered by hand later 
d. √ box for Exclude Control Probes: these were only needed by the 
Core during hybridization as a quality control check 
e. √ box for Show Genes that are Upregulated 
f. √ box for Show Genes that are Downregulated 
g. Threshold: Lower – None, Upper – None: this way fold-changes are 
ignored and only statistically significant P-values are used. This 
allowed us to set and sort a fold-change threshold later in Excel 
h. Correction:  
i. Bonferroni – may incur too many false negatives as it is the 
most conservative 
ii. Holm – moderately conservative 
iii. Westfall and Young – moderately conservative 
iv. Benjamini and Hochberg – least conservative, corrects error 
rate by estimating the false discovery rate (FDR). There is 
still the possibility of false discovery error 
i. Data is already log transformed 
11. Analyze - For our samples we ran pairwise comparisons (Student’s t-test) 
with Benjamini and Hochberg post-hoc correction. The result was 1018 





Signal Data from Microarrays
A1: Utilize Genesifter® to process global 
scaled data with MAS5 or unscaled
data with RMA (See Appendix B)
B1: Import global scaled data  
(normalized) into spreadsheet software. 
Filter for group differences with ANOVA 
or t-test
A2: X number of genes found to be 
significantly different based on selected 
parameters of ANOVA or t-test
B2: X number of genes. Filter further, 
keep only genes with a required fold-
change (ie. 1.5 ↑ or ↓) and mean signal 
intensity above a desired threshold (ie. 
100)A3: Import data into spreadsheet 
software and filter further. Keep only 
genes with a required fold-change (ie. 
1.5 ↑ or ↓) and mean signal intensity 
above a desired threshold (ie. 100)
B3: Y number of genes that are 
potentially changing; select your genes 
of interest.
A4: Y number of genes that are 
potentially changing; select your genes 
of interest.
B4: Find all probesets from original data 
that correspond to selected genes. 
Copy and group them into the 
spreadsheet along with the specific 
probesets that made it through the filter.
A5: Find all probesets from original data 
that correspond to selected genes. 
Copy and group them into the 
spreadsheet along with the specific 
probesets that made it through the filter.
Important: You should now have a data set similar to the table on the next page. It will 
include probeset(s) for genes potentially changing based on the filtering procedure 
along with their corresponding, non-significant probesets that the filter removed. Before 
making a final judgment as to which genes to pursue (ie. sqRT-PCR) consider two 
things: 1) do the probesets give conflicting results (ie. 2 probesets show increase and 2 
show decreased expression for IGF-1); and 2) how many probesets does the gene have 
and how many made it through the filter. Following this procedure should ensure that 




Appendix C: Flow diagram (previous page) of two possible methods for filtering microarray data. Option A utilizes 
Genesifter® software which provides faster analysis and embedded links for each gene to multiple databases. 
Option B is more labor intensive and requires effort later to search databases for genes. Both methods should work 
equally well but will not always give matching results. In addition to finding potentially significant genes you can add 
in other genes of interest by doing a keyword search of the raw microarray data.  
 
The table below is an example of the type of results achieved after filtering the microarray data with the two 
methods described above. 
 
Method A: the signal data is log2 transformed 
Gene Title Other ID / Probeset Gene ID mean 1 mean 2 SEM 1 SEM 2 Stats
ATP binding domain 4 MmugDNA.6466.1.S1_at ATPBD4 3.3299 4.3619 0.1401 0.2519 0.0232
RYK receptor-like tyrosine kinase MmugDNA.30524.1.S1_at RYK 3.5830 4.6055 0.1863 0.1976 0.0197
Growth hormone inducible transmembrane protein MmugDNA.32920.1.S1_at GHITM 8.2073 9.2208 0.1172 0.1842 0.0097
Zinc finger protein 492 MmugDNA.17791.1.S1_at ZNF492 5.3034 6.3061 0.2812 0.1673 0.0375
Nuclear receptor subfamily 4, group A, member 2 MmugDNA.20818.1.S1_s_at NR4A2 10.7475 9.7416 0.2854 0.2136 0.0477
Secreted frizzled-related protein 1 MmugDNA.34907.1.S1_at SFRP1 4.3145 3.2463 0.1004 0.0836 0.0012
MCF.2 cell line derived transforming sequence-like MmugDNA.33725.1.S1_at MCF2L 7.2038 6.1219 0.2920 0.2452 0.0470
Serine/threonine/tyrosine kinase 1 MmugDNA.2954.1.S1_at STYK1 5.2432 4.1279 0.2216 0.1714 0.0164
Lix1 homolog (mouse) MmugDNA.26440.1.S1_at LIX1 5.5621 4.4434 0.1858 0.2106 0.0163
Collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia) MmugDNA.24005.1.S1_at COL2A1 6.8697 5.6806 0.2909 0.2099 0.0295
ATPase, Na+/K+ transporting, beta 1 polypeptide MmugDNA.24357.1.S1_at ATP1B1 10.4057 9.2054 0.2621 0.1448 0.0160
Oculocutaneous albinism II (pink-eye dilution homolog, mouse) MmugDNA.21826.1.S1_at OCA2 6.8704 5.5854 0.2734 0.1333 0.0134  
 
Method B: retains the original signal data and mean 
Other ID / Probeset CON 1 Call CON 2 Call CON 3 Call Gene ID CR 1 Call CR 2 Call CR 3 Call CON mean CON SEM CR mean CR SEM
Fold 
Change
MmugDNA.13551.1.S1_at 68.2 P 85.7 P 71.7 M PLCB 39.8 A 54.2 A 40.2 A 75.20 5.35 44.73 4.73 0.59
MmugDNA.40784.1.S1_at 189 P 216.1 P 163.1 P 200.2 P 206.4 P 179.4 P 189.40 15.30 195.33 8.17 1.03
MmugDNA.16826.1.S1_s_at 3337.8 P 3308.7 P 2853.3 P CROP 3091.2 P 3184.5 P 3138.1 P 3166.60 156.88 3137.93 26.93 0.99
MmugDNA.33064.1.S1_x_at 215.1 P 257.9 P 273 P 90.4 P 394.9 P 188.7 P 248.67 17.34 224.67 89.72 0.90
MmugDNA.33064.1.S1_at 214.2 P 198.1 P 187.7 P 124.9 P 405 P 230.6 P 200.00 7.71 253.50 81.66 1.27
MmugDNA.24030.1.S1_at 364.7 P 345.5 P 345.5 P SOD2 420 P 353.8 P 345.6 P 351.90 6.40 373.13 23.55 1.06
MmugDNA.19007.1.S1_at 254.1 P 134.6 P 184.9 P CAT 191.7 P 221.1 P 239.4 P 191.20 34.64 217.40 13.89 1.14





Appendix D: Genesifter® filtering of our experimental groups (Young Adult CON, n=3; Young Adult CR, n=3). 
Screening was determined with t-test (P<0.05) and Benjamini-Hochberg correction followed by hand filtering for 1.5 
fold-change. The result was 145 probesets indicating potential differences in pituitary gland gene expression.  
 
Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Phospholipase C, beta 1 (phosphoinositide-specific) PLCB1 MmugDNA.13551.1.S1_at 4.0000 0.0277 3.3777 0.0471 0.0003
Fibronectin type III domain containing 3B FNDC3B MmugDNA.38842.1.S1_at 4.7213 0.0302 4.0216 0.0661 0.0007
POU domain, class 2, transcription factor 2 POU2F2 MmugDNA.2090.1.S1_at 4.2572 0.0619 3.5024 0.0484 0.0007
Secreted frizzled-related protein 1 SFRP1 MmugDNA.34907.1.S1_at 4.3145 0.1004 3.2463 0.0836 0.0012
Adenosine A2b receptor ADORA2B MmugDNA.35810.1.S1_at 3.2735 0.0098 3.8923 0.0852 0.0020
not provided - MmugDNA.42299.1.S1_at 4.0021 0.0249 4.8205 0.1126 0.0021
Fibroblast growth factor 10 FGF10 MmugDNA.19579.1.S1_at 4.3279 0.0302 5.1306 0.1131 0.0024
Guanine nucleotide binding protein (G protein), alpha 14 GNA14 MmugDNA.41403.1.S1_at 5.3485 0.0571 4.4196 0.1294 0.0028
Potassium voltage-gated channel, subfamily H (eag-related), member 2 KCNH2 MmugDNA.8632.1.S1_at 6.7130 0.0369 6.1132 0.0859 0.0030
1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 MmugDNA.39097.1.S1_at 9.5874 0.0423 8.9716 0.0919 0.0037
Snf2-related CBP activator protein SRCAP MmugDNA.23155.1.S1_at 4.2016 0.0823 3.5607 0.0669 0.0038
not provided - MmugDNA.16026.1.S1_at 8.6620 0.3274 4.6756 0.6049 0.0044
Lectin, galactoside-binding, soluble, 8 (galectin 8) LGALS8 MmugDNA.28010.1.S1_at 3.6676 0.0643 4.3105 0.0923 0.0046
Filamin A interacting protein 1 FILIP1 MmugDNA.17551.1.S1_at 4.2554 0.0962 4.9825 0.0855 0.0048
not provided - MmugDNA.27855.1.S1_at 4.8568 0.0112 5.6371 0.1421 0.0054
Chloride intracellular channel 4 CLIC4 MmugDNA.28843.1.S1_at 9.0570 0.0451 9.6855 0.1065 0.0056
Suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein) ST18 MmugDNA.30345.1.S1_at 5.8635 0.1323 5.1176 0.0510 0.0062
Zinc finger protein 506 ZNF506 MmugDNA.31196.1.S1_at 7.8758 0.0984 7.2061 0.0830 0.0065
RNA-binding protein FLJ20273 MmugDNA.20089.1.S1_at 5.9644 0.1003 6.6234 0.0805 0.0069
Nipped-B homolog (Drosophila) NIPBL MmugDNA.24065.1.S1_at 8.6000 0.0891 7.9614 0.0903 0.0073
PDZ and LIM domain 3 PDLIM3 MmugDNA.18347.1.S1_at 8.8537 0.0302 8.0691 0.1576 0.0081
gb:CO646781  DB_XREF=gi:50568275  DB_XREF=ILLUMIGEN_MCQ_39627  
CLONE=IBIUW:23193  TID=Mmu.9549.1  CNT=6  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.9549.1.S1_at 5.8398 0.1664 6.7684 0.0943 0.0083
Transcribed locus - MmugDNA.42157.1.S1_at 3.7717 0.2795 5.2529 0.1280 0.0085
Thyroid stimulating hormone receptor TSHR MmugDNA.32655.1.S1_at 3.28999 0.111393 2.631527 0.029322 0.0086
CDNA FLJ36663 fis, clone UTERU2002826 - MmugDNA.28098.1.S1_at 8.4939 0.1188 9.1459 0.0663 0.0087
Neuron navigator 1 NAV1 MmugDNA.32339.1.S1_at 6.6341 0.1022 5.8121 0.1379 0.0087
Protein geranylgeranyltransferase type I, beta subunit PGGT1B MmugDNA.10009.1.S1_at 5.5542 0.0135 6.1714 0.1286 0.0088
Solute carrier family 20 (phosphate transporter), member 1 SLC20A1 MmugDNA.16839.1.S1_at 9.5518 0.0901 8.8813 0.1104 0.0093
Chromosome 10 open reading frame 49 C10orf49 MmugDNA.27226.1.S1_at 8.3836 0.2234 7.0708 0.1672 0.0093
Immunoglobulin kappa constant IGKC MmugDNA.23504.1.S1_s_at 6.6961 0.1399 7.3692 0.0316 0.0094
Growth hormone inducible transmembrane protein GHITM MmugDNA.32920.1.S1_at 8.2073 0.1172 9.2208 0.1842 0.0097
Syntaxin 3 STX3 MmugDNA.3869.1.S1_at 4.7479 0.0546 5.8603 0.2376 0.0103
Hypothetical protein LOC645721 LOC645721 MmugDNA.23383.1.S1_at 6.7367 0.1057 7.5044 0.1322 0.0105
KIAA0513 KIAA0513 MmugDNA.16133.1.S1_at 4.8186 0.1223 5.5726 0.1132 0.0106
not provided - MmugDNA.40550.1.S1_at 3.6893 0.0091 4.2770 0.1349 0.0122
gi:59676429  DEF=SCN4B_3456.2 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA3456.2, sequence tagged site - MmuSTS.1023.1.S1_at 5.2869 0.3679 6.9707 0.1215 0.0122
Osteomodulin OMD MmugDNA.17909.1.S1_at 7.3038 0.2263 8.4702 0.1485 0.0126
Oculocutaneous albinism II (pink-eye dilution homolog, mouse) OCA2 MmugDNA.21826.1.S1_at 6.8704 0.2734 5.5854 0.1333 0.0134
Immediate early response 2 IER2 MmugDNA.26855.1.S1_at 11.1255 0.1334 10.3051 0.1499 0.0150
Tescalcin TESC MmugDNA.30872.1.S1_at 10.2908 0.1063 9.6995 0.1006 0.0156
AP2 associated kinase 1 AAK1 MmugDNA.26429.1.S1_at 5.9302 0.1546 6.6435 0.0873 0.0159
ATPase, Na+/K+ transporting, beta 1 polypeptide ATP1B1 MmugDNA.24357.1.S1_at 10.4057 0.2621 9.2054 0.1448 0.0160
Lix1 homolog (mouse) LIX1 MmugDNA.26440.1.S1_at 5.5621 0.1858 4.4434 0.2106 0.0163









Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Hypothetical protein FLJ12505 VASH2 MmugDNA.30454.1.S1_at 6.0800 0.1744 5.3214 0.0773 0.0165
DPH5 homolog (S. cerevisiae) DPH5 MmugDNA.14615.1.S1_s_at 4.6256 0.1914 5.3904 0.0218 0.0165
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) NHP2L1 MmugDNA.3458.1.S1_at 6.4103 0.4512 4.6511 0.0509 0.0179
Ankyrin repeat and SOCS box-containing 8 ASB8 MmugDNA.19994.1.S1_at 8.5876 0.1735 7.7784 0.1174 0.0181
Potassium channel, subfamily K, member 1 KCNK1 MmugDNA.12778.1.S1_at 7.2444 0.1290 7.8345 0.0822 0.0182
IQ motif containing GTPase activating protein 1 IQGAP1 MmugDNA.19813.1.S1_at 9.7648 0.1529 9.1677 0.0250 0.0183
gi:51853714  DEF=CTSL2_2905 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA2905, sequence tagged site.  GEN=CTSL2  
PROD=cathepsin L2 - MmuSTS.4178.1.S1_at 10.1170 0.1756 9.3704 0.0819 0.0183
Formin 2 FMN2 MmugDNA.20444.1.S1_at 6.2923 0.1181 6.9622 0.1289 0.0186
Transcribed locus - MmugDNA.29329.1.S1_at 8.2406 0.1084 7.3737 0.1992 0.0187
Chondroitin sulfate proteoglycan 5 (neuroglycan C) CSPG5 MmugDNA.14190.1.S1_at 7.1158 0.1326 6.5157 0.0853 0.0190
CDNA FLJ41934 fis, clone PERIC2005111 - MmugDNA.18540.1.S1_at 5.4854 0.0981 6.2115 0.1641 0.0191
Syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) SNTB1 MmugDNA.18390.1.S1_at 5.0557 0.0851 5.8128 0.1804 0.0192
RYK receptor-like tyrosine kinase RYK MmugDNA.30524.1.S1_at 3.5830 0.1863 4.6055 0.1976 0.0197
gb:CO580930  DB_XREF=gi:50412176  DB_XREF=ILLUMIGEN_MCQ_48010  
CLONE=IBIUW:17041  TID=Mmu.2883.1  CNT=2  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.2883.1.S1_at 7.8018 0.0642 8.3908 0.1445 0.0204
ATPase, Na+/K+ transporting, beta 1 polypeptide ATP1B1 MmugDNA.26322.1.S1_s_at 12.6125 0.1254 11.9742 0.1179 0.0207
Chromosome 2 open reading frame 34 C2orf34 MmugDNA.31052.1.S1_at 4.5103 0.1638 3.9038 0.0223 0.0214
Transmembrane protein 20 TMEM20 MmugDNA.31724.1.S1_at 4.4162 0.1931 5.1812 0.0796 0.0215
gi:47776948  DEF=PCDH20_1029 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA1029, sequence tagged site.  GEN=PCDH20  
PROD=protocadherin 20 - MmuSTS.2010.1.S1_at 3.8353 0.0154 4.9254 0.2976 0.0216
Chromosome 6 open reading frame 194 C6orf194 MmugDNA.16575.1.S1_at 4.4463 0.1039 5.1675 0.1678 0.0217
Carbohydrate (chondroitin 4) sulfotransferase 11 CHST11 MmugDNA.9039.1.S1_at 5.9585 0.1472 6.8940 0.2106 0.0220
Within bgcn homolog (Drosophila) WIBG MmugDNA.35808.1.S1_at 7.1137 0.1508 6.1556 0.2162 0.0221
gi:49533512  DEF=SFRP1_1897 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1897, sequence tagged site.  GEN=SFRP1  
PROD=secreted frizzled-related protein 1 - MmuSTS.4330.1.S1_at 8.3461 0.2762 6.9961 0.2483 0.0221
Transcribed locus - MmugDNA.15702.1.S1_at 6.2726 0.0586 6.9522 0.1783 0.0223
Small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta SGTB MmugDNA.17918.1.S1_at 3.3096 0.1460 3.9542 0.1021 0.0224
CDNA clone IMAGE:3934193 - MmugDNA.21342.1.S1_at 4.1907 0.1995 5.2372 0.2108 0.0226
Transmembrane 4 L six family member 18 TM4SF18 MmugDNA.6970.1.S1_at 6.0288 0.1647 5.4149 0.0459 0.0229
ATP binding domain 4 ATPBD4 MmugDNA.6466.1.S1_at 3.3299 0.1401 4.3619 0.2519 0.0232
Tripartite motif-containing 4 TRIM4 MmugDNA.4424.1.S1_at 5.5035 0.2025 4.6816 0.1090 0.0233
Myosin heavy chain Myr 8 RP11-54H7.1 MmugDNA.15890.1.S1_at 6.5733 0.1367 7.2763 0.1439 0.0240
ADP-ribosylation factor-like 11 ARL11 MmugDNA.28111.1.S1_at 7.8023 0.2037 8.6869 0.1459 0.0242
gi:47777234  DEF=VCAM1_385 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA385, sequence tagged site.  GEN=VCAM1  
PROD=vascular cell adhesion molecule 1 - MmuSTS.4697.1.S1_at 5.9631 0.4055 7.4657 0.1450 0.0251
Ataxin 1 ATXN1 MmugDNA.32588.1.S1_at 5.9401 0.2022 5.0616 0.1520 0.0255
Dipeptidyl-peptidase 6 DPP6 MmugDNA.37049.1.S1_at 11.0942 0.2255 10.1948 0.1277 0.0256
RALBP1 associated Eps domain containing 2 REPS2 MmugDNA.39023.1.S1_at 5.8124 0.0465 6.5195 0.1985 0.0256







Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Calpain 1, (mu/I) large subunit CAPN1 MmugDNA.8965.1.S1_at 4.9625 0.1892 4.3125 0.0157 0.0267
Poly(rC) binding protein 2 PCBP2 MmugDNA.4665.1.S1_at 7.0127 0.1483 6.4209 0.0909 0.0272
Indolethylamine N-methyltransferase INMT MmugDNA.27753.1.S1_at 4.6948 0.2624 6.2542 0.3777 0.0275
Transmembrane protein 116 TMEM116 MmugDNA.23118.1.S1_at 5.1113 0.2260 4.3352 0.0396 0.0277
not provided - MmugDNA.32599.1.S1_at 4.5153 0.2464 3.6473 0.0805 0.0286
Blood vessel epicardial substance BVES MmugDNA.8035.1.S1_at 4.3093 0.1635 5.0116 0.1322 0.0288
Trophoblast-derived noncoding RNA TncRNA MmugDNA.13964.1.S1_at 4.2395 0.1993 5.1667 0.1933 0.0289
Transcribed locus, moderately similar to NP_061913.2 elongation protein 4 
homolog; PAX6 neighbor gene; chromosome 11 open rea - MmugDNA.6193.1.S1_at 9.5222 0.1369 8.9273 0.1150 0.0292
Collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, 
congenital) COL2A1 MmugDNA.24005.1.S1_at 6.8697 0.2909 5.6806 0.2099 0.0295
gi:60301119  DEF=ASS_8219 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8219, sequence tagged site - MmuSTS.2126.1.S1_s_at 9.9162 0.1866 9.0997 0.1618 0.0298
gi:47777053  DEF=RGS1_1489 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1489, sequence tagged site.  GEN=RGS1  
PROD=regulator of G-protein signalling 1 - MmuSTS.3131.1.S1_at 4.8501 0.2503 6.0279 0.2559 0.0302
gi:47776742  DEF=IGF1_1346 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1346, sequence tagged site.  GEN=IGF1  PROD=insulin-
like growth factor 1 - MmuSTS.628.1.S1_at 5.7329 0.3015 4.7445 0.0147 0.0307
Hypothetical protein LOC162073 LOC162073 MmugDNA.32218.1.S1_at 7.7181 0.0949 7.1191 0.1571 0.0310
GRAM domain containing 1A GRAMD1A MmugDNA.33477.1.S1_at 3.3993 0.1945 4.1954 0.1517 0.0321
Protease, serine, 1 (trypsin 1) PRSS1 MmugDNA.10752.1.S1_at 4.6141 0.1789 5.3448 0.1415 0.0328
KIAA0495 KIAA0495 MmugDNA.18652.1.S1_at 6.2333 0.1905 7.0399 0.1655 0.0330
Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) AKR7A3 MmugDNA.13635.1.S1_s_at 5.3546 0.1777 4.5856 0.1652 0.0339
RAB2, member RAS oncogene family RAB2 MmugDNA.15882.1.S1_at 7.4699 0.1193 5.7666 0.5254 0.0341
not provided - MmugDNA.6966.1.S1_at 4.2398 0.1735 4.8971 0.1146 0.0342
Sidekick homolog 2 (chicken) SDK2 MmugDNA.38063.1.S1_at 8.4958 0.0764 7.7463 0.2253 0.0345
ADP-ribosylation factor-like 11 ARL11 MmugDNA.28111.1.S1_x_at 7.7983 0.1849 8.5799 0.1671 0.0350
Hypothetical protein LOC90784 LOC90784 MmugDNA.19148.1.S1_at 4.4512 0.0407 5.0870 0.2022 0.0368
Collagen, type XII, alpha 1 COL12A1 MmugDNA.27864.1.S1_at 5.8450 0.3217 7.0218 0.2056 0.0368
gi:53828476  DEF=TM7SF3 _5273 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA5273, sequence tagged site.  GEN=TM7SF3  
PROD=transmembrane 7 superfamily member 3 - MmuSTS.944.1.S1_at 8.4411 0.1776 7.5302 0.2363 0.0369
gi:59676223  DEF=GPC4 _7535 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA7535, sequence tagged site - MmuSTS.4265.1.S1_at 11.4041 0.1576 10.7802 0.1274 0.0370
Zinc finger protein 492 ZNF492 MmugDNA.17791.1.S1_at 5.3034 0.2812 6.3061 0.1673 0.0375
Alpha-methylacyl-CoA racemase AMACR MmugDNA.36476.1.S1_at 5.8645 0.2074 6.6364 0.1450 0.0380
not provided - MmugDNA.35833.1.S1_at 5.7849 0.1157 6.3890 0.1618 0.0385
gi:47776569  DEF=EDNRB_607 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA607, sequence tagged site.  GEN=EDNRB  
PROD=endothelin receptor type B - MmuSTS.4094.1.S1_at 7.7539 0.0200 8.5533 0.2624 0.0385g g
221745_at WD-repeat protein - MmugDNA.4928.1.S1_at 7.3792 0.1676 6.7388 0.1343 0.0407
Hypothetical protein LOC339457 LOC339457 MmugDNA.36513.1.S1_at 6.5849 0.2235 5.6815 0.2049 0.0408
NMD3 homolog (S. cerevisiae) NMD3 MmugDNA.36304.1.S1_at 6.1956 0.2332 7.5240 0.3810 0.0410
Acyl-CoA synthetase medium-chain family member 3 ACSM3 MmugDNA.7137.1.S1_s_at 3.8922 0.0986 3.1942 0.2135 0.0412
Hypothetical protein BC009732 LOC133308 MmugDNA.3901.1.S1_at 5.6485 0.1823 6.2631 0.0984 0.0413







Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Calcium channel, voltage-dependent, alpha 1G subunit CACNA1G MmugDNA.30662.1.S1_at 5.4910 0.2007 4.8688 0.0650 0.0420
MYC induced nuclear antigen MINA MmugDNA.26614.1.S1_at 7.9115 0.1953 8.5429 0.0878 0.0420
Annexin A4 ANXA4 MmugDNA.28580.1.S1_at 11.3659 0.2073 10.6760 0.1086 0.0421
gi:55960839  DEF=OMD _6110 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA6110, sequence tagged site.  GEN=OMD  
PROD=osteomodulin - MmuSTS.722.1.S1_at 7.3262 0.2861 8.3701 0.2117 0.0427
Ankyrin repeat domain 10 ANKRD10 MmugDNA.2810.1.S1_at 5.6822 0.2940 6.5818 0.0885 0.0428
CDNA clone IMAGE:5263455 - MmugDNA.10813.1.S1_at 6.6621 0.1462 5.8084 0.2522 0.0429
Syntaxin 3 STX3 MmugDNA.23304.1.S1_at 8.3230 0.2249 9.3101 0.2515 0.0430
gb:CO582780  DB_XREF=gi:50414838  DB_XREF=ILLUMIGEN_MCQ_43967  
CLONE=IBIUW:16462  TID=Mmu.8925.1  CNT=2  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.8925.1.S1_at 9.4828 0.1748 10.1069 0.1246 0.0438
Muscleblind-like (Drosophila) MBNL1 MmugDNA.23132.1.S1_s_at 7.6985 0.0581 8.3211 0.2061 0.0438
CDNA clone IMAGE:4814184 - MmugDNA.21664.1.S1_at 6.2720 0.5587 7.9498 0.1457 0.0439
gi:52626966  DEF=DMRT3 _4753 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA4753, sequence tagged site.  GEN=DMRT3  
PROD=doublesex and mab-3 related transcription factor 3 - MmuSTS.1310.1.S1_at 8.2976 0.4411 6.5404 0.4150 0.0441
CDNA clone IMAGE:4799094 - MmugDNA.8934.1.S1_at 6.8264 0.2437 6.0371 0.1218 0.0442
Reticulon 4 RTN4 MmugDNA.11786.1.S1_at 6.6544 0.4249 8.4994 0.4757 0.0445
gi:49533179  DEF=F3_45.3 Rhesus macaque genomic DNA Macaca mulatta STS 
genomic clone MMA45.3, sequence tagged site.  GEN=F3  PROD=coagulation 
factor III - MmuSTS.1925.1.S1_at 8.2253 0.2931 9.2072 0.1718 0.0446
CDNA clone IMAGE:4814184 - MmugDNA.17794.1.S1_at 5.1248 0.4666 6.6045 0.2125 0.0447
Tripartite motif-containing 33 TRIM33 MmugDNA.20660.1.S1_at 6.9196 0.0569 6.1954 0.2465 0.0458
matrix metallopeptidase 23A - MmugDNA.29748.1.S1_at 7.2641 0.2434 6.4869 0.1204 0.0458
gi:60301337  DEF=MYOC_8491 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8491, sequence tagged site - MmuSTS.3230.1.S1_at 4.3538 0.2149 6.2356 0.6229 0.0461
Carboxypeptidase M CPM MmugDNA.37694.1.S1_at 7.6415 0.0941 8.2837 0.2045 0.0463
gb:CB553954  DB_XREF=gi:31303149  DB_XREF=MMSP0046_B11  
TID=Mmu.14068.2  CNT=1  FEA=EST  TIER=ConsEnd  STK=1  
NOTE=sequence(s) clustered along genome - Mmu.14068.2.A1_at 3.7368 0.2114 4.3811 0.0796 0.0463
gb:CN645072  DB_XREF=gi:47158515  DB_XREF=ILLUMIGEN_MCQ_11205  
CLONE=IBIUW:9888  TID=Mmu.2050.1  CNT=5  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along gene - Mmu.2050.1.S1_s_at 10.0760 0.1487 11.0569 0.3104 0.0464
Transcribed locus - MmugDNA.17471.1.S1_at 7.6247 0.1224 6.6648 0.3143 0.0466
not provided - MmugDNA.104.1.S1_at 5.9002 0.1740 6.5154 0.1283 0.0466
MCF.2 cell line derived transforming sequence-like MCF2L MmugDNA.33725.1.S1_at 7.2038 0.2920 6.1219 0.2452 0.0470
Nuclear receptor subfamily 4, group A, member 2 NR4A2 MmugDNA.20818.1.S1_s_at 10.7475 0.2854 9.7416 0.2136 0.0477
gb:CB308356  DB_XREF=gi:28831066  DB_XREF=AGENCOURT_11818364  
CLONE=IMAGE:6882119  TID=Mmu.12441.1  CNT=11  FEA=EST  
TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along gene - Mmu.12441.1.S1_at 10.6749 0.2808 11.5230 0.1083 0.0479
not provided - MmugDNA.33118.1.S1_s_at 6.5648 0.1075 5.7987 0.2512 0.0486
not provided - MmugDNA.27103.1.S1_at 3.2195 0.1453 4.5172 0.4403 0.0489
gi:49533147  DEF=CXCL14 _2459 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA2459, sequence tagged site.  GEN=CXCL14  
PROD=chemokine (C-X-C motif) ligand 14 - MmuSTS.1894.1.S1_at 5.4121 0.3638 6.8856 0.3820 0.0491
2'-5'-oligoadenylate synthetase 3, 100kDa OAS3 MmugDNA.20819.1.S1_at 7.5521 0.2107 6.8187 0.1590 0.0499





Appendix E: Genesifter® filtering of our experimental groups (Young Adult CON, n=3; Young Adult CR, n=3). 
Screening was determined with t-test (P<0.05) and Benjamini-Hochberg correction followed by hand filtering for 1.5 
fold-change. The result was 260 probesets indicating potential differences in testicular gene expression.  
 
Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
gi:59676458  DEF=SLC7A1_7877 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA7877, sequence tagged site - MmuSTS.1093.1.S1_at 10.5008 0.0324 11.1026 0.0165 0.0001
Dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) DPP4 MmugDNA.5046.1.S1_at 7.7196 0.0390 6.9920 0.0379 0.0002
Transducin (beta)-like 1Y-linked TBL1Y MmugDNA.25035.1.S1_s_at 6.8790 0.0631 5.8355 0.0583 0.0003
newRS.gi:21071024    DEF=Orthologous to gi:21071024 Homo sapiens histone 1, 
H4c (HIST1H4C), mRNA.  GEN=HIST1H4C  PROD=H4 histone family, member G - MmunewRS.661.1.S1_at 13.0693 0.0573 11.0048 0.1744 0.0004
Heat shock 60kDa protein 1 (chaperonin) HSPD1 MmugDNA.36856.1.S1_at 10.6129 0.0396 9.8421 0.0685 0.0006
not provided - MmugDNA.16026.1.S1_at 6.9346 0.3259 3.8948 0.1351 0.0010
gi:53828476  DEF=TM7SF3 _5273 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA5273, sequence tagged site.  GEN=TM7SF3  
PROD=transmembrane 7 superfamily member 3 - MmuSTS.944.1.S1_at 6.6577 0.0676 5.9359 0.0519 0.0011
Establishment of cohesion 1 homolog 1 (S. cerevisiae) ESCO1 MmugDNA.42000.1.S1_at 8.7018 0.0851 7.5326 0.1205 0.0014
Staphylococcal nuclease domain containing 1 SND1 MmugDNA.1637.1.S1_at 3.5476 0.0878 4.3499 0.0548 0.0015
Exocyst complex component 6 EXOC6 MmugDNA.25604.1.S1_at 6.7695 0.0559 6.1550 0.0566 0.0015
UDP glycosyltransferase 3 family, polypeptide A1 UGT3A1 MmugDNA.16619.1.S1_at 3.3092 0.0712 5.1200 0.2237 0.0015
Syntaxin 6 STX6 MmugDNA.34574.1.S1_at 4.9534 0.0903 4.2759 0.0127 0.0017
Glycosyltransferase 8 domain containing 3 GLT8D3 MmugDNA.30383.1.S1_at 5.2723 0.1966 3.7824 0.0646 0.0020
gDNA.Hs.103915.0.S1  FEA=U133PSR  GEN=JMJD3   DEF=Orthologous to 
213146_at jumonji domain containing 3 - MmugDNA.6170.1.S1_at 8.4101 0.0861 9.2090 0.0713 0.0020
Sperm specific antigen 2 SSFA2 MmugDNA.26522.1.S1_at 7.6727 0.2266 5.8902 0.1146 0.0022
gi:60301372  DEF=PEG10_8006 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8006, sequence tagged site - MmuSTS.3365.1.S1_at 8.6675 0.0479 7.9190 0.0975 0.0023
Transcribed locus - MmugDNA.13576.1.S1_at 5.8685 0.1112 5.1016 0.0219 0.0025
Enolase superfamily member 1 ENOSF1 MmugDNA.32608.1.S1_at 7.5035 0.0985 8.3245 0.0768 0.0028
Bruno-like 4, RNA binding protein (Drosophila) BRUNOL4 MmugDNA.5472.1.S1_at 4.3843 0.0330 5.2330 0.1254 0.0028
gi:52626809  DEF=ADRA2A _4205 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA4205, sequence tagged site.  GEN=ADRA2A  
PROD=adrenergic, alpha-2A-, receptor - MmuSTS.417.1.S1_at 7.7602 0.0739 6.5727 0.1659 0.0028
gi:60301103  DEF=AMPH_8202 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8202, sequence tagged site - MmuSTS.2085.1.S1_at 5.1151 0.0846 4.4983 0.0524 0.0034
gb:CN646290  DB_XREF=gi:47159733  DB_XREF=ILLUMIGEN_MCQ_25961  
CLONE=IBIUW:8718  TID=Mmu.12457.1  CNT=4  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along gene - Mmu.12457.1.S1_s_at 11.6796 0.1142 10.8799 0.0669 0.0038
gi:51854151  DEF=SPP1_3239 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA3239, sequence tagged site.  GEN=SPP1  
PROD=secreted phosphoprotein 1 - MmuSTS.2862.1.S1_at 4.8351 0.0801 5.9989 0.1778 0.0040
gb:CN644246  DB_XREF=gi:47157689  DB_XREF=ILLUMIGEN_MCQ_9960  
CLONE=IBIUW:9053  TID=Mmu.5363.1  CNT=5  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.5363.1.S1_at 7.4558 0.0805 6.7895 0.0802 0.0042
Cell division cycle 2, G1 to S and G2 to M CDC2 MmugDNA.42865.1.S1_at 10.5137 0.1037 9.5826 0.1208 0.0043
gDNA.g8923837  FEA=U133PSR  GEN=KIAA1212    DEF=Orthologous to 
219387_at KIAA1212 - MmugDNA.33282.1.S1_at 9.8410 0.0542 9.0441 0.1258 0.0043
not provided - MmugDNA.10943.1.S1_at 5.9061 0.0957 5.2080 0.0727 0.0044
gi:62000413  DEF=TNFSF4_270 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA270, sequence tagged site - MmuSTS.2557.1.S1_at 6.0067 0.0808 5.4085 0.0640 0.0044








Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Heat shock 70kDa protein 4 HSPA4 MmugDNA.37971.1.S1_at 10.1530 0.1230 9.4399 0.0143 0.0045
Transcribed locus - MmugDNA.27647.1.S1_at 8.1009 0.3290 6.0113 0.1552 0.0046
not provided - MmugDNA.42703.1.S1_at 8.6371 0.0947 8.0351 0.0475 0.0047
gDNA.Hs.247828.1.A1  FEA=U133PSR    DEF=Orthologous to 222225_at Similar 
to bA476I15.3 (novel protein similar to septin) - MmugDNA.37161.1.S1_at 7.2867 0.0951 8.0101 0.0848 0.0047
Spectrin repeat containing, nuclear envelope 2 SYNE2 MmugDNA.12872.1.S1_at 5.1372 0.1236 4.2410 0.1008 0.0049
Transcribed locus - MmugDNA.11482.1.S1_at 5.7666 0.1528 6.8194 0.1149 0.0053
Plexin C1 PLXNC1 MmugDNA.8622.1.S1_at 8.5547 0.0731 7.5028 0.1794 0.0056
not provided - MmugDNA.14737.1.S1_at 6.5964 0.1236 5.8465 0.0619 0.0056
gi:60301269  DEF=HSPA4_7803 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA7803, sequence tagged site - MmuSTS.2729.1.S1_s_at 8.9122 0.1264 8.1920 0.0428 0.0057
gi:62000459  DEF=ZNF423_9303 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA9303, sequence tagged site - MmuSTS.2633.1.S1_at 7.1432 0.1233 8.1035 0.1344 0.0062
Cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant CSTF2T MmugDNA.23306.1.S1_at 7.7477 0.1024 8.4670 0.0931 0.0065
Transcribed locus - MmugDNA.12213.1.S1_at 7.6909 0.0512 8.3272 0.1118 0.0066
Chloride channel, nucleotide-sensitive, 1A CLNS1A MmugDNA.3618.1.S1_at 6.7181 0.1122 5.7922 0.1399 0.0067
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 ST3GAL6 MmugDNA.10160.1.S1_at 7.2071 0.0362 6.5296 0.1265 0.0067
SAM domain containing 1 RP5-875H10.1 MmugDNA.15856.1.S1_at 3.9788 0.0983 3.3526 0.0721 0.0068
Lymphocyte antigen 96 LY96 MmugDNA.11614.1.S1_at 6.2554 0.1831 7.4623 0.1503 0.0070
gi:49533548  DEF=SPTBN4_2491 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA2491, sequence tagged site.  GEN=SPTBN4  
PROD=spectrin, beta, non-erythrocytic 4 - MmuSTS.4490.1.S1_at 7.1692 0.0962 6.5768 0.0677 0.0073
BAT2 domain containing 1 BAT2D1 MmugDNA.11808.1.S1_at 9.9701 0.0881 9.3661 0.0813 0.0073
gDNA.Hs.192907.0.A1  FEA=U133PSR  GEN=TTN    DEF=Orthologous to 
241791_at titin - MmugDNA.20569.1.S1_at 7.1424 0.1124 6.2145 0.1461 0.0073
POU domain, class 6, transcription factor 1 POU6F1 MmugDNA.3065.1.S1_at 6.3275 0.1158 7.4267 0.1858 0.0074
Sulfide quinone reductase-like (yeast) SQRDL MmugDNA.36497.1.S1_at 8.4300 0.0940 9.0379 0.0774 0.0075
not provided - MmugDNA.24287.1.S1_at 9.7570 0.1863 10.6978 0.0406 0.0078
gi:55167870  DEF=VHL _5065 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA5065, sequence tagged site.  GEN=VHL  PROD=von 
Hippel-Lindau syndrome - MmuSTS.1838.1.S1_at 7.1866 0.1417 6.3004 0.1108 0.0079
not provided - MmugDNA.42299.1.S1_at 3.3925 0.1259 4.3587 0.1511 0.0080
Chromosome 20 open reading frame 108 C20orf108 MmugDNA.39842.1.S1_s_at 10.2930 0.0759 9.5570 0.1313 0.0083
Transmembrane protein 56 TMEM56 MmugDNA.37454.1.S1_at 6.0535 0.1447 5.3385 0.0291 0.0084
STS genomic clone MMA37, sequence tagged site.  GEN=ENO2  PROD=enolase 
2 - MmuSTS.4136.1.S1_at 6.1931 0.1449 7.0973 0.1208 0.0087
Prickle-like 1 (Drosophila) PRICKLE1 MmugDNA.23051.1.S1_at 6.6279 0.1305 5.8955 0.0798 0.0087
gDNA.Hs.7218.0.A1  FEA=U133PSR  GEN=ACAS2L    DEF=Orthologous to 
224882_at acetyl-Coenzyme A synthetase 2 (AMP forming)-like - MmugDNA.26367.1.S1_at 8.6648 0.1191 8.0076 0.0694 0.0089
Ferredoxin 1 FDX1 MmugDNA.29297.1.S1_at 10.4396 0.0995 11.0691 0.0878 0.0090
Protein kinase C, beta 1 PRKCB1 MmugDNA.30839.1.S1_at 6.1771 0.1209 5.3960 0.1130 0.0092
Heat shock 60kDa protein 1 (chaperonin) HSPD1 MmugDNA.36856.1.S1_s_at 10.6783 0.1238 9.9986 0.0736 0.0092
Zinc finger protein 161 ZNF161 MmugDNA.3735.1.S1_at 7.6860 0.0805 6.7856 0.1750 0.0095
Hypothetical protein LOC283075 LOC283075 MmugDNA.26953.1.S1_at 5.6705 0.0524 4.8837 0.1612 0.0097
gDNA.Hs.44024.0.A1  FEA=U133PSR    DEF=Orthologous to 238448_at 
Transcribed locus - MmugDNA.42707.1.S1_at 4.0113 0.1407 3.2119 0.1000 0.0098








Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
gi:60301269  DEF=HSPA4_7803 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA7803, sequence tagged site - MmuSTS.2729.1.S1_at 7.5492 0.1579 6.7368 0.0812 0.0102
Cullin 4B CUL4B MmugDNA.20224.1.S1_at 9.2914 0.1687 8.5063 0.0347 0.0104
Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 FAM19A5 MmugDNA.41812.1.S1_at 7.2179 0.1082 6.4622 0.1270 0.0106
Mucosa associated lymphoid tissue lymphoma translocation gene 1 MALT1 MmugDNA.522.1.S1_at 6.4061 0.2094 5.2875 0.1321 0.0107
Jumonji domain containing 1C JMJD1C MmugDNA.34169.1.S1_at 9.9346 0.0215 9.2575 0.1493 0.0109
Chromosome 1 open reading frame 148 C1orf148 MmugDNA.9726.1.S1_at 5.9856 0.0686 6.6578 0.1335 0.0110
Casein kinase 1, alpha 1 CSNK1A1 MmugDNA.39332.1.S1_at 4.9273 0.0982 4.3288 0.0918 0.0112
Family with sequence similarity 107, member B FAM107B MmugDNA.38951.1.S1_at 8.3467 0.1042 7.4412 0.1766 0.0116
Chromosome 10 open reading frame 118 C10orf118 MmugDNA.9437.1.S1_at 9.9865 0.1511 9.1508 0.1144 0.0116
gb:CN646290  DB_XREF=gi:47159733  DB_XREF=ILLUMIGEN_MCQ_25961  
CLONE=IBIUW:8718  TID=Mmu.12457.1  CNT=4  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.12457.1.S1_at 10.6076 0.1454 9.9400 0.0429 0.0117
Plexin A1 PLXNA1 MmugDNA.2754.1.S1_at 6.9930 0.1221 6.3544 0.0788 0.0117
ELK1, member of ETS oncogene family ELK1 MmugDNA.38775.1.S1_at 6.8850 0.1283 6.1899 0.0948 0.0121
gDNA.Hs.296695.0.S1  FEA=U133PSR  GEN=LOC154761    DEF=Orthologous to 
234088_at Hypothetical protein LOC154761 - MmugDNA.26631.1.S1_at 3.1632 0.0496 3.7598 0.1285 0.0123
SET and MYND domain containing 2 SMYD2 MmugDNA.16584.1.S1_at 6.2211 0.0639 5.2070 0.2264 0.0125
Chromosome 1 open reading frame 95 C1orf95 MmugDNA.34555.1.S1_at 3.8890 0.0796 4.4895 0.1150 0.0127
Ellis van Creveld syndrome EVC MmugDNA.9242.1.S1_at 6.4712 0.1436 7.1238 0.0509 0.0128
Peroxisomal LON protease like LONPL MmugDNA.30130.1.S1_at 9.7886 0.1396 10.4850 0.0842 0.0129
RAB2, member RAS oncogene family RAB2 MmugDNA.15882.1.S1_at 5.4311 0.1376 4.5867 0.1447 0.0134
Musashi homolog 2 (Drosophila) MSI2 MmugDNA.9375.1.S1_at 6.5067 0.1862 7.3411 0.0686 0.0136
Limb region 1 homolog (mouse) LMBR1 MmugDNA.29113.1.S1_at 6.8757 0.0943 6.2881 0.1035 0.0137
gDNA.Hs.247711.1.S1  FEA=U133PSR  GEN=FLJ20557    DEF=Orthologous to 
234902_s_at hypothetical protein FLJ20557 - MmugDNA.7226.1.S1_at 9.8919 0.1055 10.4955 0.0988 0.0140
not provided - MmugDNA.34944.1.S1_at 5.0858 0.1775 6.1944 0.1986 0.0141
ROD1 regulator of differentiation 1 (S. pombe) ROD1 MmugDNA.26968.1.S1_s_at 9.1956 0.1452 8.5319 0.0665 0.0142
Amino-terminal enhancer of split AES MmugDNA.43210.1.S1_at 9.6832 0.1463 9.0721 0.0219 0.0145
Family with sequence similarity 84, member A FAM84A MmugDNA.26517.1.S1_at 7.3498 0.1530 6.2011 0.2325 0.0145
CUB and Sushi multiple domains 1 CSMD1 MmugDNA.451.1.S1_at 4.5191 0.1911 5.9661 0.2964 0.0148
gi:55167728  DEF=PDP2 _5850 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA5850, sequence tagged site.  GEN=PDP2  
PROD=pyruvate dehydrogenase phosphatase isoenzyme 2 - MmuSTS.1131.1.S1_at 6.2131 0.2659 5.0315 0.1122 0.0149
gDNA.g12053092  FEA=U133PSR  GEN=FLJ35934    DEF=Orthologous to 
224172_at FLJ35934 protein - MmugDNA.6975.1.S1_at 5.4800 0.0604 6.6391 0.2786 0.0153
Receptor accessory protein 1 REEP1 MmugDNA.31866.1.S1_at 10.1940 0.1402 9.4957 0.1006 0.0155
Neuroblastoma-amplified protein NAG MmugDNA.34091.1.S1_s_at 5.2048 0.0848 4.5865 0.1273 0.0156
Zinc finger protein 160 ZNF160 MmugDNA.32096.1.S1_at 6.4504 0.1676 7.1756 0.0652 0.0157
D4, zinc and double PHD fingers, family 3 DPF3 MmugDNA.29362.1.S1_at 4.8769 0.0313 4.0744 0.1972 0.0159
Dynein, axonemal, heavy polypeptide 9 DNAH9 MmugDNA.25552.1.S1_at 8.6953 0.2080 9.7519 0.1619 0.0160
Hypothetical protein LOC641515 LOC641515 MmugDNA.29680.1.S1_at 7.4748 0.1650 8.3303 0.1376 0.0164
gi:47776372  DEF=ALDH1B1_1553 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA1553, sequence tagged site.  GEN=ALDH1B1  
PROD=aldehyde dehydrogenase 1 family, member B1 - MmuSTS.2796.1.S1_at 7.0657 0.0854 6.4241 0.1367 0.0164
gi:49533200  DEF=GAB3_1528 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1528, sequence tagged site.  GEN=GAB3  PROD=GRB2-








Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
PCTAIRE protein kinase 2 PCTK2 MmugDNA.870.1.S1_at 5.3887 0.1334 4.7421 0.0935 0.0165
NudE nuclear distribution gene E homolog like 1 (A. nidulans) NDEL1 MmugDNA.17067.1.S1_at 5.0310 0.1348 4.3395 0.1109 0.0167
Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) PTPN5 MmugDNA.3314.1.S1_at 6.4709 0.1819 5.6748 0.0870 0.0168
gi:62000083  DEF=ASGR1_8213 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8213, sequence tagged site - MmuSTS.107.1.S1_at 6.1331 0.1375 7.2140 0.2378 0.0170
gi:59676473  DEF=SNTA1 _6874 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA6874, sequence tagged site - MmuSTS.1146.1.S1_at 7.3237 0.1592 6.6903 0.0268 0.0172
gi:47776604  DEF=F11R_1772 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1772, sequence tagged site.  GEN=F11R  PROD=F11 
receptor - MmuSTS.4739.1.S1_at 7.3580 0.2044 6.4596 0.1039 0.0173
Cisplatin resistance-associated overexpressed protein CROP MmugDNA.33064.1.S1_x_at 6.7473 0.0591 6.1355 0.1463 0.0179
Establishment of cohesion 1 homolog 1 (S. cerevisiae) ESCO1 MmugDNA.16962.1.S1_at 8.3590 0.1634 7.5770 0.1183 0.0179
Cofactor required for Sp1 transcriptional activation, subunit 3, 130kDa CRSP3 MmugDNA.42284.1.S1_s_at 6.5749 0.0742 7.2011 0.1440 0.0181
Epithelial stromal interaction 1 (breast) EPSTI1 MmugDNA.15476.1.S1_at 5.4452 0.0956 4.7518 0.1520 0.0181
Calcitonin-related polypeptide, beta CALCB MmugDNA.4167.1.S1_at 4.0314 0.2125 4.9053 0.0805 0.0184
Adenylate cyclase 8 (brain) ADCY8 MmugDNA.17241.1.S1_at 4.1835 0.0267 4.8553 0.1727 0.0184
Transcribed locus - MmugDNA.38168.1.S1_at 6.8319 0.1693 6.0785 0.0994 0.0185
Multiple substrate lipid kinase MULK MmugDNA.3836.1.S1_at 7.6641 0.1006 7.0477 0.1254 0.0185
Solute carrier family 9 (sodium/hydrogen exchanger), member 9 SLC9A9 MmugDNA.5028.1.S1_at 4.4886 0.3068 5.8454 0.1762 0.0185
gb:CN644288  DB_XREF=gi:47157731  DB_XREF=ILLUMIGEN_MCQ_10067  
CLONE=IBIUW:9095  TID=Mmu.15849.1  CNT=2  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along gene - Mmu.15849.1.S1_a_at 7.8242 0.1596 7.0580 0.1202 0.0186
Olfactomedin 3 OLFM3 MmugDNA.36167.1.S1_at 4.3905 0.3578 3.0147 0.0282 0.0186
Oxysterol binding protein-like 6 OSBPL6 MmugDNA.37149.1.S1_s_at 5.8482 0.1293 5.2241 0.1012 0.0191
gb:CD767529  DB_XREF=gi:32426031  DB_XREF=AGENCOURT_14716309  
CLONE=IMAGE:6973283  TID=Mmu.12628.1  CNT=2  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along gene - Mmu.12628.1.S1_at 6.5116 0.1789 5.7429 0.0947 0.0191
gDNA.Hs.158154.0.A1  FEA=U133PSR  GEN=MGC2610    DEF=Orthologous to 
217505_at hypothetical protein MGC2610 - MmugDNA.25118.1.S1_at 5.9151 0.2485 4.9584 0.0608 0.0201
gb:CO583226  DB_XREF=gi:50415879  DB_XREF=ILLUMIGEN_MCQ_44565  
CLONE=IBIUW:17369  TID=Mmu.6559.1  CNT=3  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.6559.1.S1_s_at 8.3684 0.0811 7.7670 0.1396 0.0204
Solute carrier family 39 (zinc transporter), member 14 SLC39A14 MmugDNA.34818.1.S1_at 4.9687 0.1222 4.2645 0.1455 0.0207
gb:BM423033  DB_XREF=gi:18392527  DB_XREF=PLATE1_C06  
TID=Mmu.4039.1  CNT=2  FEA=EST  TIER=ConsEnd  STK=0  
NOTE=sequence(s) clustered along genome - Mmu.4039.1.S1_at 7.7714 0.2287 5.8782 0.4578 0.0208
Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) H6PD MmugDNA.28426.1.S1_at 6.1390 0.1371 5.3745 0.1562 0.0212
gi:55774112  DEF=ZNF6 _4707 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA4707, sequence tagged site.  GEN=ZNF6  PROD=zinc 
finger protein 6 (CMPX1) - MmuSTS.2203.1.S1_at 7.8938 0.2169 6.9363 0.1444 0.0213
CAMP-binding guanine nucleotide exchange factor IV (cAMP-GEFIV) mRNA, clone 
W15, partial sequence - MmugDNA.28928.1.S1_at 6.5383 0.0361 5.9160 0.1664 0.0217
Zinc finger protein 584 ZNF584 MmugDNA.26148.1.S1_at 8.1669 0.1497 8.8167 0.0960 0.0217
Tousled-like kinase 1 TLK1 MmugDNA.30536.1.S1_x_at 4.3725 0.1642 3.6994 0.0854 0.0220
Chromosome 5 open reading frame 5 C5orf5 MmugDNA.29493.1.S1_at 5.6106 0.1638 5.0088 0.0265 0.0222









Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
Euchromatic histone-lysine N-methyltransferase 1 EHMT1 MmugDNA.42551.1.S1_at 7.9316 0.1483 7.2713 0.1075 0.0227
Transcribed locus - MmugDNA.5319.1.S1_at 5.6535 0.0569 6.4317 0.2083 0.0227
gi:51854088  DEF=S100B_3127 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA3127, sequence tagged site.  GEN=S100B  PROD=S100 
calcium binding protein, beta - MmuSTS.2362.1.S1_at 5.1274 0.2787 7.5689 0.6184 0.0228
ATPase, Na+/K+ transporting, beta 1 polypeptide ATP1B1 MmugDNA.24357.1.S1_at 8.4481 0.2432 7.2352 0.2337 0.0228
Peroxisomal biogenesis factor 5-like PEX5L MmugDNA.5498.1.S1_at 8.3821 0.1203 7.6284 0.1722 0.0230
gb:BV208356.1  DB_XREF=gi:49533039  GEN=ABCG2  TID=Mmu.1351.1  CNT=5 
FEA=STS  TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along genome  
DEF=ABCG2_1993 Rhesus macaque genomic DNA Macaca mulatta STS genomic 
clone MMA1993, sequence tagged site.  PR - Mmu.1351.1.S1_at 6.2243 0.0974 5.5181 0.1713 0.0231
newRS.gi:46409363    DEF=Orthologous to gi:46409363 Homo sapiens FLJ44060 
protein (FLJ44060), mRNA.  GEN=FLJ44060  PROD=FLJ44060 protein - MmunewRS.1007.1.S1_at 9.8142 0.1613 9.1633 0.0846 0.0233
KRR1, small subunit (SSU) processome component, homolog (yeast) KRR1 MmugDNA.35.1.S1_at 7.9282 0.2960 6.8408 0.0839 0.0241
not provided - MmugDNA.29708.1.S1_at 4.8866 0.1591 5.6544 0.1496 0.0246
Transcribed locus - MmugDNA.12201.1.S1_at 8.1665 0.1627 8.8032 0.0814 0.0249
MCF.2 cell line derived transforming sequence MCF2 MmugDNA.1622.1.S1_at 7.3565 0.1724 6.4158 0.2069 0.0251
gi:47777150  DEF=SOX4_1527 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA1527, sequence tagged site.  GEN=SOX4  PROD=SRY 
(sex determining region Y)-box 4 - MmuSTS.3908.1.S1_at 10.1262 0.2094 9.2194 0.1536 0.0251
Cullin 5 CUL5 MmugDNA.25803.1.S1_at 7.3527 0.0602 6.6848 0.1818 0.0252
SUB1 homolog (S. cerevisiae) SUB1 MmugDNA.24125.1.S1_s_at 6.9946 0.1202 6.3908 0.1246 0.0252
Small trans-membrane and glycosylated protein LOC57228 MmugDNA.6744.1.S1_at 6.5225 0.1667 7.3464 0.1675 0.0252
Phosphatidylinositol 4-kinase type II PI4KII MmugDNA.18437.1.S1_at 5.3380 0.0498 4.5207 0.2293 0.0253
Phosphodiesterase 11A PDE11A MmugDNA.39988.1.S1_at 4.5772 0.1160 3.8399 0.1778 0.0255
Splicing factor, arginine/serine-rich 3 SFRS3 MmugDNA.15838.1.S1_at 7.6545 0.1581 6.9486 0.1289 0.0258
Esophageal cancer related gene 4 protein ECRG4 MmugDNA.4152.1.S1_at 10.7997 0.0892 11.8221 0.2818 0.0258
gb:CO580468  DB_XREF=gi:50411618  DB_XREF=ILLUMIGEN_MCQ_48638  
CLONE=IBIUW:16483  TID=Mmu.8587.1  CNT=4  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.8587.1.S1_at 6.8402 0.1645 6.2203 0.0713 0.0259
not provided - MmugDNA.23280.1.S1_at 7.0199 0.1713 6.3198 0.1092 0.0261
Similar to ECT2 protein (Epithelial cell transforming sequence 2 oncogene) RP3-509I19.5 MmugDNA.16841.1.S1_at 3.9156 0.2687 4.8509 0.0431 0.0264
gi:47776533  DEF=CYP1B1_568 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA568, sequence tagged site.  GEN=CYP1B1  
PROD=cytochrome P450, family 1, subfamily B, polypeptide 1 - MmuSTS.4020.1.S1_at 7.2963 0.1087 8.0887 0.2036 0.0264
Centrosomal protein 350kDa CEP350 MmugDNA.33476.1.S1_at 9.1591 0.1467 8.3638 0.1799 0.0267
Ubiquitin specific peptidase 34 USP34 MmugDNA.23342.1.S1_at 10.0012 0.1253 9.4156 0.1165 0.0267
Par-3 partitioning defective 3 homolog (C. elegans) PARD3 MmugDNA.4680.1.S1_s_at 7.0125 0.1546 6.3857 0.0990 0.0269
Oxysterol binding protein-like 6 OSBPL6 MmugDNA.6874.1.S1_at 7.5631 0.1991 6.6665 0.1731 0.0273
gi:47776614  DEF=FBXO21_1269 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA1269, sequence tagged site.  GEN=FBXO21  
PROD=F-box only protein 21 - MmuSTS.4759.1.S1_at 10.7364 0.1657 9.9634 0.1559 0.0273
gi:47777086  DEF=SEMA3C_394 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA394, sequence tagged site.  GEN=SEMA3C  
PROD=sema domain, immunoglobulin domain (Ig), short basic domain, sec, ted, - MmuSTS.3255.1.S1_at 7.6108 0.1702 7.0023 0.0558 0.0273









Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
NPC1 (Niemann-Pick disease, type C1, gene)-like 1 NPC1L1 MmugDNA.43041.1.S1_at 7.0910 0.2876 8.1632 0.1336 0.0278
Calpastatin CAST MmugDNA.13716.1.S1_s_at 10.2139 0.0976 9.5638 0.1667 0.0282
Oxysterol binding protein-like 8 OSBPL8 MmugDNA.31287.1.S1_at 6.6312 0.1499 5.6748 0.2419 0.0283
Amnionless homolog (mouse) AMN MmugDNA.40561.1.S1_at 4.8819 0.1900 5.6050 0.1032 0.0287
Ankyrin repeat and SOCS box-containing 13 ASB13 MmugDNA.43105.1.S1_at 3.9196 0.0570 4.6475 0.2104 0.0288
1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 MmugDNA.24842.1.S1_at 6.9155 0.1831 5.8291 0.2697 0.0290
not provided - MmugDNA.40445.1.S1_at 6.2120 0.1735 5.0962 0.2870 0.0292
CD200 molecule CD200 MmugDNA.3834.1.S1_at 5.9106 0.0617 6.6426 0.2115 0.0293
Ryanodine receptor 3 RYR3 MmugDNA.26610.1.S1_at 6.1387 0.1838 7.0617 0.2084 0.0293
AF4/FMR2 family, member 2 AFF2 MmugDNA.39958.1.S1_at 7.4549 0.1776 6.8099 0.0803 0.0296
Male sterility domain containing 1 MLSTD1 MmugDNA.5167.1.S1_at 3.3113 0.2361 4.6192 0.3193 0.0301
Hypothetical protein FLJ14503 RP11-393H10.2 MmugDNA.40188.1.S1_at 7.8088 0.2102 7.0808 0.0694 0.0303
Hypothetical protein LOC147646 LOC147646 MmugDNA.21637.1.S1_at 6.7120 0.1521 6.0935 0.1111 0.0304
gi:49533243  DEF=GPR48_2097 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA2097, sequence tagged site.  GEN=GPR48  PROD=G 
protein-coupled receptor 48 - MmuSTS.2467.1.S1_at 9.7143 0.1453 9.1038 0.1164 0.0305
Adaptor-related protein complex 3, beta 1 subunit AP3B1 MmugDNA.31519.1.S1_at 5.0789 0.1826 4.3062 0.1489 0.0305
Integrin, alpha 9 ITGA9 MmugDNA.23640.1.S1_at 3.5743 0.3401 4.9898 0.2696 0.0310
Hypothetical protein LOC283666 LOC283666 MmugDNA.35151.1.S1_at 5.4552 0.1064 4.7350 0.1936 0.0311
Full length insert cDNA clone ZE05E03 - MmugDNA.35572.1.S1_at 5.4967 0.1231 4.6539 0.2277 0.0312
Discs, large homolog 2, chapsyn-110 (Drosophila) DLG2 MmugDNA.19569.1.S1_at 8.7637 0.1660 9.4064 0.1094 0.0319
Latrophilin 3 LPHN3 MmugDNA.42945.1.S1_at 6.3277 0.2196 5.4846 0.1412 0.0320
gi:60301433  DEF=SH3GL2_8623 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA8623, sequence tagged site - MmuSTS.3981.1.S1_at 7.0450 0.2134 6.2084 0.1470 0.0320
mitogen activated protein kinase binding protein 1 - MmugDNA.40041.1.S1_at 5.6704 0.1154 5.0614 0.1501 0.0324
Inter-alpha (globulin) inhibitor H5 ITIH5 MmugDNA.27539.1.S1_at 7.8735 0.1647 7.1019 0.1748 0.0325
Kelch-like 23 (Drosophila) KLHL23 MmugDNA.37133.1.S1_at 8.1791 0.1364 7.3495 0.2194 0.0326
AFFX-HS-5-8SrRNA  TID=MmurRNA.1.1  CNT=1  FEA=rRNA  
DEF=gi|555853:6623-6779 Human 5.8S ribosomal RNA - MmurRNA.1.1.S1_at 8.2973 0.0911 10.8682 0.7965 0.0327
Hypothetical protein LOC285429 LOC285429 MmugDNA.31358.1.S1_s_at 9.5724 0.2104 8.8892 0.0352 0.0328
Cardiomyopathy associated 3 CMYA3 MmugDNA.32217.1.S1_at 8.5775 0.1996 6.2651 0.6969 0.0332
Phospholipase A2, group IB (pancreas) PLA2G1B MmugDNA.2316.1.S1_s_at 9.2994 0.2387 8.4885 0.0903 0.0336
Poly (ADP-ribose) polymerase family, member 15 PARP15 MmugDNA.22391.1.S1_at 7.0326 0.4052 9.9686 0.8337 0.0339
gi:51853642  DEF=BST1_2659 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA2659, sequence tagged site.  GEN=BST1  PROD=bone 
marrow stromal cell antigen 1 - MmuSTS.3501.1.S1_at 6.9889 0.3283 8.1578 0.1693 0.0340
Complement factor H-related 1 CFHR1 MmugDNA.30885.1.S1_at 5.7228 0.2227 6.5195 0.1187 0.0343
NGFI-A binding protein 1 (EGR1 binding protein 1) NAB1 MmugDNA.37875.1.S1_at 6.6894 0.1488 6.0586 0.1348 0.0348
SH3 domain protein D19 SH3D19 MmugDNA.30001.1.S1_at 5.7559 0.1439 5.0655 0.1673 0.0352
Dipeptidyl-peptidase 7 DPP7 MmugDNA.28618.1.S1_at 7.3914 0.1817 6.7120 0.1189 0.0352
Dickkopf homolog 3 (Xenopus laevis) DKK3 MmugDNA.42302.1.S1_at 10.2406 0.1728 9.4762 0.1729 0.0353
gi:62000495  DEF=GCN5L2_3982 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA3982, sequence tagged site - MmuSTS.2728.1.S1_at 7.6650 0.1756 7.0604 0.0818 0.0355
not provided - MmugDNA.4020.1.S1_at 5.2273 0.0793 4.3190 0.2802 0.0355









Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
CTP synthase II CTPS2 MmugDNA.43.1.S1_at 6.7734 0.1987 6.0962 0.0944 0.0370
gDNA.Hs.247712.0.S1  FEA=U133PSR  GEN=LOC284307    DEF=Orthologous to 
232774_x_at Hypothetical protein LOC284307 - MmugDNA.18660.1.S1_at 7.8014 0.1788 8.6348 0.2033 0.0370
gDNA.Hs2.406180.1.S1  FEA=U133PSR  GEN=KIAA2018    DEF=Orthologous to 
1559601_at similar to K06A9.1b.p - MmugDNA.9948.1.S1_at 5.4410 0.1190 6.0381 0.1544 0.0375
gi:47776812  DEF=KCNK13_1417 Rhesus macaque genomic DNA Macaca 
mulatta STS genomic clone MMA1417, sequence tagged site.  GEN=KCNK13  
PROD=potassium channel, subfamily K, member 13 - MmuSTS.1405.1.S1_at 6.6483 0.1254 6.0109 0.1670 0.0379
SRY (sex determining region Y)-box 5 SOX5 MmugDNA.25319.1.S1_at 7.5083 0.0843 8.1046 0.1764 0.0381
Dynein, axonemal, heavy polypeptide 9 DNAH9 MmugDNA.4110.1.S1_at 6.5010 0.2004 7.1663 0.0910 0.0390
Fibrinogen-like 1 FGL1 MmugDNA.26990.1.S1_at 6.2877 0.0248 7.3872 0.3649 0.0397
Glycosyltransferase-like domain containing 1 GTDC1 MmugDNA.37449.1.S1_s_at 5.0769 0.3033 4.1588 0.0367 0.0397
RAN binding protein 2 RANBP2 MmugDNA.31162.1.S1_at 8.4340 0.1563 7.8471 0.1172 0.0398
Erythrocyte membrane protein band 4.1 like 5 EPB41L5 MmugDNA.6620.1.S1_at 3.9813 0.2498 4.8147 0.1222 0.0401
gi:62000188  DEF=FPGT_8857 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA8857, sequence tagged site - MmuSTS.948.1.S1_at 6.7846 0.1356 6.1880 0.1462 0.0403
1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 MmugDNA.39097.1.S1_at 9.2073 0.1725 8.5831 0.1190 0.0408
Collagen, type I, alpha 1 COL1A1 MmugDNA.26445.1.S1_at 7.8845 0.1683 9.0522 0.3543 0.0409
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, TAF9B MmugDNA.20363.1.S1_at 6.3241 0.0789 5.7144 0.1897 0.0412
not provided - MmugDNA.13529.1.S1_at 6.5464 0.1785 7.5959 0.3056 0.0413
Phosphoglucomutase 2 PGM2 MmugDNA.21887.1.S1_at 5.9704 0.1712 5.3474 0.1225 0.0416
gb:AF227555.1  DB_XREF=gi:8132802  TID=Mmu.10994.1  CNT=1  FEA=mRNA  
TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along genome  
DEF=Macaca mulatta interleukin-6 signal transducer receptor (IL-6) mRNA, partial - Mmu.10994.1.S1_at 7.2277 0.1929 6.4760 0.1661 0.0418
gDNA.Hs.307059.0.S1  FEA=U133PSR    DEF=Orthologous to 234748_x_at 
KRMP1 mRNA for mitotic kinesin-related protein, partial cds, alternative exon - MmugDNA.8037.1.S1_at 7.3903 0.1380 8.1461 0.2159 0.0420
Transcribed locus - MmugDNA.23580.1.S1_at 11.5090 0.1967 10.9060 0.0558 0.0420
Hypothetical protein LOC162993 LOC162993 MmugDNA.20052.1.S1_at 10.1147 0.2435 10.9494 0.1461 0.0424
Exocyst complex component 7 EXOC7 MmugDNA.37506.1.S1_at 6.1641 0.2049 5.4692 0.1183 0.0425
Chromosome 9 open reading frame 105 C9orf105 MmugDNA.22984.1.S1_at 5.6417 0.2063 4.9362 0.1239 0.0427
KIAA1109 KIAA1109 MmugDNA.30700.1.S1_at 7.6424 0.1675 7.0336 0.1233 0.0429
Nipsnap homolog 3B (C. elegans) NIPSNAP3B MmugDNA.9183.1.S1_at 4.7201 0.2458 3.8620 0.1630 0.0437
Collagen, type I, alpha 1 COL1A1 MmugDNA.34995.1.S1_s_at 10.0242 0.1009 11.0927 0.3535 0.0438
TRAF2 and NCK interacting kinase TNIK MmugDNA.28110.1.S1_at 7.2035 0.1315 6.6138 0.1549 0.0440
gDNA.Hs.72115.0.A1  FEA=U133PSR  GEN=C6orf105    DEF=Orthologous to 
229070_at chromosome 6 open reading frame 105 - MmugDNA.28889.1.S1_at 7.0522 0.1242 7.6716 0.1736 0.0440
Roundabout, axon guidance receptor, homolog 1 (Drosophila) ROBO1 MmugDNA.22252.1.S1_at 7.2392 0.1413 7.9087 0.1833 0.0444
gDNA.Hs.28391.0.A1  FEA=U133PSR  GEN=LPHN3    DEF=Orthologous to 
242186_x_at latrophilin 3 - MmugDNA.4650.1.S1_at 5.9853 0.0192 5.3396 0.2229 0.0447
Phosphotriesterase related PTER MmugDNA.38414.1.S1_at 5.4088 0.2256 6.0679 0.0363 0.0448
Deleted in lymphocytic leukemia 8 DLEU8 MmugDNA.25512.1.S1_at 4.5146 0.2223 5.2799 0.1452 0.0449
gb:AF235162.1  DB_XREF=gi:9408532  TID=Mmu.12516.1  CNT=1  FEA=mRNA  
TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along genome  
DEF=Macaca mulatta Flt-1 mRNA, partial cds. - Mmu.12516.1.S1_at 5.9339 0.1010 6.5218 0.1779 0.0453
Chromosome 21 open reading frame 57 C21orf57 MmugDNA.1454.1.S1_at 8.9070 0.3355 10.0495 0.2134 0.0453
LSM11, U7 small nuclear RNA associated LSM11 MmugDNA.7409.1.S1_at 7.4848 0.0644 8.5287 0.3582 0.0455













Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM t -test
chromosome 10 open reading frame 25 - MmugDNA.26101.1.S1_at 6.4484 0.1779 7.1141 0.1501 0.0459
Transcribed locus, strongly similar to NP_061844.1 G protein-coupled receptor 27; 
super conserved receptor expressed in brain - MmugDNA.28513.1.S1_at 9.1433 0.2187 8.2940 0.2008 0.0459
gi:56089251  DEF=SPG6 _5293 Rhesus macaque genomic DNA in pCR-XL-TOPO 
Macaca mulatta STS genomic clone MMA5293, sequence tagged site.  
GEN=SPG6  PROD=spastic paraplegia 6 (autosomal dominant) - MmuSTS.255.1.S1_at 7.8828 0.0897 6.8970 0.3329 0.0460
Kallikrein 10 KLK10 MmugDNA.23514.1.S1_at 4.6574 0.1688 4.0477 0.1306 0.0461
G elongation factor, mitochondrial 1 GFM1 MmugDNA.14779.1.S1_at 4.5263 0.2249 3.8640 0.0583 0.0464
Leucine rich repeat containing 58 LRRC58 MmugDNA.946.1.S1_at 5.5232 0.2720 4.7373 0.0532 0.0470
Ankyrin repeat and SOCS box-containing 8 ASB8 MmugDNA.19994.1.S1_at 7.6021 0.2271 6.7681 0.1870 0.0471
Solute carrier family 5 (low affinity glucose cotransporter), member 4 SLC5A4 MmugDNA.17537.1.S1_at 7.0746 0.2239 7.9148 0.1951 0.0474
Within bgcn homolog (Drosophila) WIBG MmugDNA.35808.1.S1_at 7.3735 0.2805 6.4234 0.1848 0.0474
S100 calcium binding protein A13 S100A13 MmugDNA.37998.1.S1_s_at 6.6918 0.0944 7.4735 0.2597 0.0474
Solute carrier family 44, member 1 SLC44A1 MmugDNA.39116.1.S1_at 5.5614 0.1652 4.9679 0.1305 0.0478
Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 SLC7A1 MmugDNA.6417.1.S1_at 5.5375 0.2163 6.1928 0.0855 0.0479
not provided - MmugDNA.11903.1.S1_at 6.8654 0.1373 6.0274 0.2649 0.0484
Ankyrin repeat and SOCS box-containing 5 ASB5 MmugDNA.38981.1.S1_at 8.3716 0.2172 9.1670 0.1820 0.0485
gi:60301528  DEF=WIF1_7996 Rhesus macaque genomic DNA Macaca mulatta 
STS genomic clone MMA7996, sequence tagged site - MmuSTS.4753.1.S1_at 5.4693 0.1497 6.3067 0.2583 0.0486
Protein phosphatase 1, regulatory (inhibitor) subunit 1A PPP1R1A MmugDNA.14104.1.S1_at 5.8026 0.2228 5.0828 0.1275 0.0486
TRAF2 and NCK interacting kinase TNIK MmugDNA.3074.1.S1_at 4.7422 0.0838 4.1238 0.2042 0.0487
Luteinizing hormone/choriogonadotropin receptor LHCGR MmugDNA.21104.1.S1_at 7.5216 0.2428 8.3359 0.1602 0.0488
Ankyrin repeat and IBR domain containing 1 ANKIB1 MmugDNA.26186.1.S1_at 5.3457 0.1029 4.7170 0.2000 0.0490
CNKSR family member 3 CNKSR3 MmugDNA.14645.1.S1_s_at 4.4822 0.1831 3.8883 0.1078 0.0490
Cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, CCBL1 MmugDNA.31015.1.S1_at 8.6614 0.2176 7.9950 0.0976 0.0491
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) DCUN1D4 MmugDNA.36638.1.S1_at 5.5776 0.1367 4.9894 0.1601 0.0491
gb:CB230611  DB_XREF=gi:28282189  DB_XREF=AGENCOURT_11467541  
CLONE=IMAGE:6883556  TID=Mmu.12981.1  CNT=13  FEA=EST  
TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along genome - Mmu.12981.1.S1_at 9.1237 0.2359 8.0945 0.2831 0.0491
gb:CN647784  DB_XREF=gi:47161227  DB_XREF=ILLUMIGEN_MCQ_29068  
CLONE=IBIUW:7248  TID=Mmu.12423.1  CNT=3  FEA=EST  TIER=ConsEnd  
STK=0  NOTE=sequence(s) clustered along genome - Mmu.12423.1.S1_at 4.8968 0.1833 4.1725 0.1842 0.0494
gb:CB230611  DB_XREF=gi:28282189  DB_XREF=AGENCOURT_11467541  
CLONE=IMAGE:6883556  TID=Mmu.12981.1  CNT=13  FEA=EST  
TIER=ConsEnd  STK=0  NOTE=sequence(s) clustered along genome - Mmu.12981.1.S1_s_at 9.7647 0.1485 8.5300 0.4185 0.0498






Appendix F: Compiled list of genes considered for investigation after screening microarray data for our 
experimental groups (Young Adult CON, n=3; Young Adult CR, n=3). The table includes pituitary gland and testis 
genes that showed a significant and non-significant change in gene expression based on our filtering parameters. 
 
Pituitary genes (Filtered with Genesifter: t-test (P<0.05) and 1.5 fold-change: 145 probesets) Signal means have been log2 transformed
Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM Ratio/Direction t -test
1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 MmugDNA.39097.1.S1_at 9.59 0.04 8.97 0.09 1.53 / Down 0.0037
Phospholipase C, beta 1 (phosphoinositide-specific) PLCB1 MmugDNA.13551.1.S1_at 4.00 0.03 3.38 0.05 1.54 / Down 0.0003
Thyroid stimulating hormone receptor TSHR MmugDNA.32655.1.S1_at 3.29 0.11 2.63 0.03 1.58 / Down 0.0046
Pituitary genes (not significantly different but potentially worth investigating)
Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM Ratio Direction
Glycoprotein hormones, alpha polypeptide CGA MmugDNA.4648.1.S1_at 9.88 0.44 6.68 1.82 9.15 Down
Glycoprotein hormone alpha 2 GPHA2 MmugDNA.19830.1.S1_at 3.01 0.01 2.98 0.03 1.02 Down
Glycoprotein hormone beta 5 GPHB5 MmugDNA.39443.1.S1_at 3.52 0.01 3.54 0.02 1.01 Up
Uncoupling protein 2 (mitochondrial, proton carrier) UCP2 MmugDNA.16174.1.S1_at 9.33 0.17 9.43 0.02 1.06 Up
Thyroid stimulating hormone, beta TSHB MmuSTS.968.1.S1_at 14.05 0.13 14.39 0.03 1.26 Up
Macaca mulatta chorionic gonadotropin beta subunit mRNA CGB Mmu.13013.1.S1_at 10.51 0.19 10.43 0.04 1.06 Down
Prolactin releasing hormone Prolactin MmuSTS.2319.1.S1_at 15.43 0.05 15.43 0.04 1.00 Up
Proopiomelanocortin POMC MmugDNA.3018.1.S1_at 15.41 0.05 15.52 0.04 1.08 Up
Monkey growth hormone mRNA GH Mmu.15973.2.S1_x_at 6.56 0.04 6.41 0.08 1.12 Down
Follicle stimulating hormone, beta polypeptide FSHB MmugDNA.37655.1.S1_at 9.68 0.35 9.39 0.43 1.22 Down
Luteinizing hormone, beta subunit and Adrenocorticotropin hormone LHB and ACTH Do not exist on microarray
Testicular genes (Filtered with Genesifter: t-test (P<0.05) and 1.5 fold-change: 260 probesets) Signal means have been log2 transformed
Gene Title Gene ID Other ID / Probeset CON mean CR mean CON SEM CR SEM Ratio/Direction t -test
Cisplatin resistance-associated overexpressed protein CROP MmugDNA.33064.1.S1_x_at 6.75 6.14 0.06 0.15 1.53 / Down 0.0179
1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 MmugDNA.39097.1.S1_at 9.21 8.58 0.17 0.12 1.54 / Down 0.0408
Luteinizing hormone/choriogonadotropin receptor LHCGR MmugDNA.21104.1.S1_at 7.52 8.34 0.24 0.16 1.76 / Up 0.0488
Sperm specific antigen 2 SSFA2 MmugDNA.26522.1.S1_at 7.67 5.89 0.23 0.11 3.44 / Down 0.0022
Testicular genes (not significantly different but potentially worth investigating)
Gene Title Gene ID Other ID / Probeset CON mean CON SEM CR mean CR SEM Ratio Direction
Glycoprotein hormones, alpha polypeptide CGA MmugDNA.29263.1.S1_at 9.30 0.07 9.46 0.14 1.12 Up
Glycoprotein hormone alpha 2 GPHA2 MmugDNA.19830.1.S1_at 3.18 0.03 3.23 0.06 1.03 Up
Glycoprotein hormone beta 5 GPHB5 MmugDNA.39443.1.S1_at 5.14 0.13 5.00 0.09 1.10 Down
Steroidogenic acute regulatory protein StAR MmuSTS.4519.1.S1_at 7.89 0.40 7.97 0.74 1.06 Up
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) PTGS2 MmugDNA.4494.1.S1_at 2.00 0.03 2.01 0.05 1.00 Up
Superoxide dismutase 2, mitochondrial SOD2 MmugDNA.24030.1.S1_at 12.99 0.17 13.01 0.04 1.01 Up
Catalase CAT MmugDNA.19007.1.S1_at 7.15 0.07 7.74 0.31 1.50 Up
Glutathione peroxidase 5 (epididymal androgen-related protein) GPX5 MmugDNA.34442.1.S1_at 5.16 0.02 5.36 0.16 1.15 Up
Insulin-like 3 (Leydig cell) INSL3 MmugDNA.29281.1.S1_s_at 11.78 0.36 12.58 0.66 1.74 Up
Hydroxysteroid (17-beta) dehydrogenase 3 HSD17B3 MmugDNA.20457.1.S1_at 10.75 0.44 10.52 0.59 1.18 Down
Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta, somerase 2 HSD3B2 MmuSTS.601.1.S1_at 2.74 0.01 2.67 0.05 1.05 Down
Cytochrome P450, family 17, subfamily A, polypeptide 1 CYP17A1 MmuSTS.4193.1.S1_at 7.46 0.47 8.23 0.81 1.71 Up
Cytochrome P450, family 11, subfamily A, polypeptide 1 CYP11A1 MmuSTS.4192.1.S1_at 5.95 0.43 6.09 0.68 1.10 Up
Thyroid stimulating hormone, beta TSHB MmuSTS.968.1.S1_at 5.16 0.35 5.09 0.13 1.05 Down
Macaca mulatta chorionic gonadotropin beta subunit mRNA CGB Mmu.13013.1.S1_at 7.88 0.06 7.85 0.14 1.02 Down
Prolactin releasing hormone Prolactin MmuSTS.2319.1.S1_at 8.96 0.55 8.94 0.58 1.01 Down
Proopiomelanocortin POMC MmugDNA.3018.1.S1_at 10.53 0.17 10.72 0.10 1.14 Up
Monkey growth hormone mRNA GH Mmu.15973.2.S1_x_at 6.14 0.32 6.02 0.24 1.08 Down
Follicle stimulating hormone, beta polypeptide FSHB MmugDNA.37655.1.S1_at 3.15 0.06 3.18 0.10 1.02 Up





Appendix G: Protocol for Use of PrimerExpress® Software 
 
The following is the general protocol for designing PCR primers using the 
PrimerExpress® software. There are other software options available or 
alternatively you can design primers by hand using calculations based on melting 
temperatures. Although this is the system used for designing our primers it is 
intended only as a general example and adjustments can be made as needed. 
 
1. Choose the gene(s) of interest based on microarray results 
2. Go to NCBI (www.ncbi.nlm.hih.gov) 
3. Select: All Databases from menu options then: Nucleotide: sequence 
database 
4. Under Search: Nuceotide▼: for _____________ enter in a search term.  
The best is the Gene Identifier from the microarray output. Other terms 
such as Gene Title, Gene ID or a common name are also useful 
5. Choose the best result option, preferably one that has the complete 
mRNA sequence in your species of choice. Try to avoid clones and partial 
mRNA, different species and STS fragments which could be either an 
intron or exon and won’t be good for primer design. A list of all the genes 
in the NCBI database that we used for designing our primers is included at 
the end of this protocol. 
6. Some important components of the Results Page: 
a. Locus – should be same as Gene Identifier 
b. Definition – tells common name and if complete or partial mRNA, 
clone, cDNA, etc. 
c. Source Organism – from where the sequence was derived 
d. References – links to relevant PubMed articles 
e. Features: Source – organ or tissue source and possibly who/where 
sequence discovered/posted into the database 
f. CDS – coding sequence from ‘start’ to ‘stop’ codon; protein/amino 
acid sequence 
g. Gene – location and length 
h. Origin – actual base pair (bp) sequence 
7. There are many other options for each search result and NCBI is 
continually adding new tools to the database. It’s now possible to 
automatically receive the reverse complemented strand, search for STS 
only, export the results to text files, and many more options. 
8. There are roughly three possible search result outcomes. 
a. Complete mRNA sequence from your species of interest is shown. 
This is the best case scenario. 
b. Partial mRNA or clone from your species of interest 
c. Complete or partial mRNA or clone from another species (ortholog) 
is given. With the last two options you will need to BLAST the 
ortholog sequence to possibly find a better sequence in another 
species or listing. 




10. Click on BLAST and under Nucleotide select Option: nucleotide-nucleotide 
BLAST (blastn). Also on this page is the option to compare two sequences 
in order to compare homology [Under Special select Option: Align two 
sequences (bl2seq)]. 
11. Copy the gene sequence (Origin) from your previous results and paste 
into the Search box on the newly opened BLASTn window 
12. Now hit the BLAST! button followed by FORMAT! button 
13. Scroll down to: Sequences producing significant alignments. 
14. Want to look for: high score, low E value, species of interest and mRNA 
15. By clicking on score you can see a comparison of the GeneChip® 
sequence you BLASTed with the new sequence you want to use. It shows 
Identities (how many base pairs match) and Gaps (mismatches). 
16. Click on new gene that you will now use for PrimerExpress®. If there is no 
ideal match then BLAST the two sequences to see how much homology 
there is between the two. For example, human LHβ and mouse LHβ are 
almost identical meaning that the gene is relatively conserved across 
species. From this you could infer that it would be possible to use the 
human sequence of LHβ in order to design primers intended for use in 
rhesus macaque tissue. 
17. Copy the final sequence to be used for primer design into a word 
processing file of some kind. 
18. Open the PrimerExpress® software. 
19. Click on File: New: RT-PCR Document (sqRT-PCR) or Taqman® Probe 
and Primer Design (qRT-PCR). 
20. Open the word processing file with the sequence and Copy and Paste it 
into Sequence window. 
21. Go to Params tab and enter the following guidelines, adjust as necessary:  
for sqRT-PCR: 
a. Tm Requirements: Min 55-57oC  Max 65-68oC  Opt 60oC  Max Diff 2 
(Tm is melting temperature while Ta is annealing temperature) 
b. GC Content: Min 40-45  Max 55-60  Clamp 0-2 
c. Length: Min 19  Max 24  Opt 22 
d. 5’ Tail: ignore this option 
e. Amplicon: Min 70  Max 90 (Tm)  Min 300  Max 500 (Length) 
for qRT-PCR primer and probe parameters: 
a. Min GC: 40%  Max GC: 80% 
b. Min length: 18  Max length: 25  (Targeting 20) 
c. Amplicon Min: 100 bp  Amplicon Max: 150 bp 
d. We allowed ourselves a penalty between 9-11 and wanted to have 
more C than G bases. If there were more G than C in the probe we 
used the complementary strand instead. For example, if the 
software returned a probe 5’ ATCGGCGTCTGG 3’ then the 
complementary 3’ TAGCCGCAGACC 5’ would become  
5’ CCAGACGCCGAT 3’ for the preferred probe to use. 
e. Probe had to be < 30 bp with the shortest possibility preferred 




g. Tm between primers and probe had to be > 10oC (9oC is tolerable) 
h. Kept penalty low 
22. Click on Primers tab. Then on top menu select Options: Find Primers Now 
23. What you will get is a list of potential primers. You want to select the 
primers that have the best combination of the following: low penalty, few 
base pair repeats, appropriate lengths for primers and amplicon, similar 
Tm for both primers, good % of G/C content and limited A/T content. 
 
Designing primers by hand 
1. Target the 3’ end of the mRNA sequence 
2. 20-23 base pairs in length 
3. Ta: 65-72oC (which is the mean of the Tm for both primers) 
4. 60% G/C content 
5. Finish with GC, CG, CC or GG with A/T in the middle (ie. CAG, GTC) 
6. 300-500 bp for amplicon length 
7. Forward and Reverse primers should have approximately equal Tm 
8. No more than four C or G in a row 
Use the calculation: Tm = 4(G+C) + 2(A+T)  
 
When producing cDNA from mRNA you can either work with oligo dNTP 
hexamers or random dNTP hexamers. Oligos will attach only at the 3’ PolyAAA 
tail end of the mRNA sequence whereas random hexamers will attach anywhere 
along the sequence. If you choose to produce cDNA with random dNTP 
hexamers then the primer can be anywhere in the sequence because you 
typically get longer translated genes. If you choose to produce cDNA with oligo 
dNTP hexamers then you should limit the primer design sequence to the 3’ 
PolyAAA tail end of your mRNA. The translated genes will be more similar to 
each other but length may vary as transcriptase falls off. These non-specific 
amplified products are of different lengths and is why higher/specific 
temperatures help eliminate ‘ghost’ bands. We designed all our probes and 
primers to the 3’ end of the mRNA sequence so that they would function with 
oligo or random dNTP hexamer derived cDNA. 
 
Here is the complete list of genes we used for designing our sqRT-PCR and 
qRT-PCR primers and probes used in Chapters 3 and 4. They can be found in 
the National Center for Biotechnology Information (NCBI) Entrez Nucleotide 
database, a collection of sequences from several sources. The only exception 
was StAR primers and probe for qRT-PCR which were graciously supplied by Dr. 
Jon Hennebold at the Oregon National Primate Research Center. 
 
1. LOCUS: XM_001090917; 628 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta similar to Glycoprotein 
hormones alpha chain precursor (Anterior pituitary glycoprotein hormones 
common alpha subunit) (Follitropin alpha chain) (Follicle-stimulating 
hormone alpha chain) (FSH-alpha) (Lutropin alpha chain) (Luteinizing 




2. LOCUS: XM_001104839; 4420 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta thyroid stimulating hormone 
receptor, transcript variant 2 (TSHR), mRNA 
3. LOCUS: XM_001104367; 6316 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta 1-acylglycerol-3-phosphate 
O-acyltransferase 3 (AGPAT3), mRNA 
4. LOCUS: XM_001115559; 2094 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta uncoupling protein 2 (UCP2), 
mRNA 
5. LOCUS: XM_001101290; 4965 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta similar to sperm specific 
antigen 2, mRNA. 
6. LOCUS: XM_001093672; 2103 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta casein kinase 1 epsilon 
(CSNK1E), mRNA 
7. LOCUS: XM_001107538; 5111 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta prostaglandin-endoperoxide 
synthase 2 (PTGS2, COX2), mRNA. 
8. LOCUS: XM_001114090; 3041 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta luteinizing hormone/ 
choriogonadotropin receptor (LHCGR), mRNA 
9. LOCUS: XM_001090472; 2343 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta similar to steroidogenic acute 
regulator isoform 1, transcript variant 3, mRNA (sqRT-PCR only) 
10. LOCUS: XM_001105829; 1131 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta estradiol 17 beta-
dehydrogenase 3, transcript variant 2 (HSD17B3), mRNA. 
11. LOCUS: DR769273; 549 bp mRNA linear 
DEFINITION ILLUMIGEN_MCQ_62609 Katze_MMTE Macaca mulatta 
cDNA clone IBIUW:34171 5' similar to Bases 6 to 449 highly similar to 
human INSL3 (Hs.37062), mRNA sequence 
12. LOCUS: XM_001113717; 1815 bp mRNA linear 
DEFINITION PREDICTED: Macaca mulatta hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and steroid delta-isomerase 2, transcript variant 1 
(HSD3B2), mRNA. 
 
Two other primer sets were designed for earlier work with macaque adrenals by 
Dr. Urbanski’s staff.  They used the following human sequences: 
 
1. LOCUS: NM_000102; 1755 bp mRNA linear 
DEFINITION Homo sapiens cytochrome P450, family 17, subfamily A, 
polypeptide 1 (CYP17A1), mRNA  
2. LOCUS: NM_000781; 1821 bp mRNA linear 
DEFINITION Homo sapiens cytochrome P450, family 11, subfamily A, 





Appendix H: Protocol for RT-PCR and Gel Imaging 
 
Reverse Transcription (RT) 
1. Prepare one batch of RT-MasterMix in a tube. Always prepare mix for 
n+0.5 (or n+1) where n = number of samples. For each sample you will 
need (in this order): 
4.0 μl of 10X RT Buffer 
2.4 μl of 25 mM MgCl2 
2.0 μl of 5 mM dNTPs 
2.0 μl of RNAsin (RNase inhibitor; 10 units / µL) 
1.0 μl of Reverse Transcriptase 
3.6 μl of DEPC H20 
Total of 15 µL final volume 
2. Separately, prepare RNA samples for denaturing and oligo d(T)15 
annealing. For each RNA sample you will need: 
1 μl of oligo d(T)15 (could also use random hexamers if desired) 
X μl of sample containing 1 μg of RNA (no more than 4 μl) 
Y μl of H20 (volume needed to complete 5 μl) 
Total of 5 μl final volume 
3. Heat RNA samples in thermocycler to denature the RNA: 5 min @ 70°C  
4. Quickly cool the sample tubes down on ice:  5 min @ 4°C 
5. Add the enzyme-containing RT-MasterMix to the treated RNA samples. 
6. Load the 20 µL RNA/MasterMix tubes and run an RT program on the 
thermocycler:  5 min @ 25°C  →  60 min @ 37°C  →  15 min @ 70°C 
7. Place cDNA on ice immediately and store at -20oC if not using right away. 
 
Primer Preparation 
Primers arrive in a lyophilized form and must be rehydrated: 
1. Take the primers out of the -20oC freezer and place at RT for 10 minutes 
2. Spin them down to make sure all the powder is at the bottom of the vial 
3. From the spec sheet supplied with each primer find the number of nmoles 
of product. Multiply the value by 10 and add this amount of water or TE 
buffer (µL) in order to obtain a 100 µM stock. Vortex. 
4. Store stock at -20oC; remove aliquots as needed to make 25 µM working 
dilutions (1:4 dilution) 
 
Polymerase Chain Reaction Protocol (PCR) 
1. Prepare one batch of PCR-MasterMix per set of primers in a tube. Always 
prepare mix for n+0.5 (or n+1) where n = number of samples. 
2. For each sample you will need (in this order): 
2.5 µL of 10X PCR buffer (containing 15mM MgCl2) 
0.5 µL of dNTPs (10mM concentration, or random hexamers) 
0.5 µL of 5’ forward primer (25-50µM) 
0.5 µL of 3’ reverse primer (25-50µM) 
0.15 µL of HotStarTaq® DNA Polymerase 




Total of 24 µL final volume 
3. Add 1 µL of cDNA sample to 24 µL of PCR-MasterMix. Spin down sample 
if needed before loading in thermocycler. 
4. Load the 25 µL cDNA/MasterMix tubes and run a PCR amplification 
program on the thermocycler: 
a) 15 min at 95°C – activation of HotStarTaq® DNA Polymerase 
b) 1 min at 94°C – denaturation of cDNA 
c) 1 min at specific annealing temperature for the primer pair 
d) 1 min at 72°C – amplification/extension 
e) Repeat for # of cycles specific to each primer pair 
5. Place amplified cDNA on ice immediately and store @ -20oC if not running 
a detection gel right away. 
 
DNA Detection Protocol using Agarose Gel 
1) Prepare 1 L of stock 10X TBE Buffer (Tris-Borate-EDTA) 
a. 1 g NaOH (to speed the reaction) 
b. 108 g Tris base (Trizma, C4H11NO3, F.W. 121.1) 
c. 55 g boric acid (H3BO3, F.W. 61.8) 
d. 7.4 g EDTA-disodium salt (F.W. 372.2) OR 9.3 g EDTA-
monosodium salt (F.W. X) 
e. Add dH20 to 1 Liter 
f. pH is 8.3 and requires no adjustment 
2) Prepare 2 L of stock 1X TBE Buffer  (200 mL 10X stock + 1800 mL dH2O) 
3) Prepare agarose gel at the appropriate % (2% for our studies) 
4) 100 mL 1X TBE Buffer + 2 g agarose 
5) Heat in microwave, swirling occasionally, until agarose is dissolved. 
6) Cool under tap water and add 1 µL of ethidium bromide [50 µg / mL] to 
achieve a final concentration of 0.5 µg / mL. 
7) Pour into electrophoresis mold and insert combs.  
8) Once the gel has set remove combs and place gel in the electrophoresis 
chamber. Cover with 1X buffer. 
9) Mix 1µL of DNA loading buffer with 7µL of sample. 
10) Load samples into gel wells and load 1.5 µL MassRuler DNA Ladder Low 
Range (Feremantas) in first column. 
11) Run electrophoresis at 90 volts (lower for higher resolution). 
12) Visualize the gel using QuantityOne software and GelDoc.  Save images 




Appendix I: Troubleshooting Microarray Data, Primer Design, 
RT-PCR and Gel Imaging 
 
During the course of events leading from microarray data to successful 
quantification of gene expression there are a number of potential pitfalls. I had to 
overcome many of them during my research so I thought it useful to document 
some of the solutions I found to these problems. In addition, there are a number 
of background details I discovered along the way which others may find valuable 
to their own research. The comments, though relevant to them, don’t really 
belong in any of the earlier chapters so I’ve compiled them here. 
 
Finally, I encourage anyone performing microarray experiments for the first time 
to extensively mine the company website of the array platform they are using. It 
will have a wealth of information which will only help you as you work through 
proper experimental design and analysis. 
 
Affymetrix Microarrays 
The raw signal data point in a global scaled (normalized) dataset represents the 
amount of RNA bound to the microarray chip. It is one arbitrary value for the 
signal intensity of that one particular probeset for a gene. The probeset consists 
of 11-16 matching probe pairs as well as 11-16 mismatched probe pairs; each 
probe is 25 base pairs long. This setup allows the chip/algorigthm to check for 
errors/mismatches/false positives and to globally scale the data to its own chip or 
across a series of chips. All matching probe pair sequences are designed to 
target the 3’ untranslated region (UTR) of mRNA. Information on all probesets 
and their probe pair sequences can be found at the Affymetrix website 
(www.affymetrix.com) where, in the case of the Rhesus Macaque Genome Array, 
they list ~600,000 probe (~300,000 probe pair) sequences. These are only the 
matches, however, so there are actually 1.2 x 106 probe (600,000 probe pair) 
sequences. Each probeset for a given gene has its probe pairs scattered across 
the microarray chip in a grid. The instrument system knows where the sequences 
are based on their position and consolidates the signals to give one 
average/scaled intensity value (arbitrary units). Each gene can have anywhere 
from 1-8+ probesets on the chip. That is why, for example, that StAR has 1 
probeset while LHCGR has 3 and AGPAT has 7. There are 52,000+ probesets 
on the rhesus macaque chip representing 47,000+ transcripts/genes. The image 
below is taken from the Affymetrix manual: Data Analysis and Fundamentals. It 
shows a probeset which includes 10 probe pairs. For simplicity the probe pairs 
are shown grouped together, but on the actual GeneChip® they would be 













So where do these gene sequences come from? At the time of our experiments, 
the sequences on the Affymetrix GeneChip® Rhesus Macaque Genome Array 
came from the University of Nebraska and the Baylor School of Medicine. These 
two facilities are working to determine the entire rhesus macaque genome, 
including introns and exons. They shared their data with Affymetrix for use in 
their array system. Affymetrix then attached a GeneID to each probeset so that it 
can be found in the NCBI Entrez Nucleotide database (National Center for 
Biotechnology Information; www.ncbi.nlm.nih.gov). When you search for these 
probesets, however, the link will take you to a human ortholog for the gene. 
Why? It seems that Nebraska/Baylor have not yet entered the sequences into the 
NCBI GeneBank. Instead they are posting their data at the Ensembl project 
(www.ensembl.org) with some additional sequences available at 
(http://rhesusgenechip.unomaha.edu). Baylor also has its own website but it’s not 
as user-friendly as Ensembl and in theory should be identical. Since the 
sequences are not in NCBI, Affymetrix did the next best thing and connected to 
all the human orthologs. This is not a problem as long as you are aware of it and 
take the extra step to find the rhesus macaque mRNA sequence. What we did 
was to BLAST the human ortholog sequence for our genes of interest at the 
NCBI website so as to get the best fitting, alternative sequences. In every case, 
except INSL3 and LHβ, we were able to find a predicted rhesus macaque 
sequence. (We eventually found a cloned mRNA sequence for INSL3 which we 
used in our primer design). The predicted sequences are from the Southwest 
National Primate Research Center in San Antonio, TX. They have been using 
Baylor’s genomic sequences (including introns and exons) and computational 
comparing them to other species in order to make a best fit prediction as to the 




researcher may mistakenly think the rhesus macaque array is simply using 




Although elegant in its simplicity, the fundamental technique of reverse-
transcription polymerase chain reaction (sqRT-PCR) is fraught with challenges. 
Even though the methodology is identical for each gene investigated, it is the 
subtle nuances that can determine success or failure.  
 
First, for each pair of primers we determined the optimal annealing temperature 
and linear range of amplification. This involved preparing a pooled sample of 
cDNA to run with the primers. Then, using a lower temperature and higher 
number of cycles, we ran the PCR to see if any single band amplicons were 
detected. From the initial run we were able to make a judgment as to the need for 
temperature and cycle adjustments. We always investigated β-actin first because 
it is a highly expressed housekeeping gene, showed even expression on the 
microarray data and would demonstrate that the cDNA was of good quality. 
Usually if adjustments had to be made for the PCR it meant raising the annealing 
temperature of the run. 
 
Once we had a rough idea of the ideal temperature setting we kept the 
temperature constant and pulled samples at various cycles of the reaction. By 
doing this and running the products on a gel we were able to determine the linear 
range of amplification for each gene. We were now ready to run individual 
samples at the appropriate temperature and cycle count for each pair of primers. 
Even though we were fairly fortunate and ran these trials very carefully, it still 
took multiple reactions to get each gene to work properly. 
 
One of the biggest problems we had with a number of primers was the presence 
of a double band on the electrophoresis gel. There are a few possibilities as to 
the cause of multiple bands on a gel. It could be that the cDNA is not good. In our 
case this did not seem to be the problem because the results of our β-actin PCR 
were very clean. It could also be a reagent problem, but again this seemed 
unlikely as other researchers in the lab were having success with the same 
materials. It could be that the gene was being expressed differentially in 
individual animals (i.e. splice variants). This too seemed unlikely, but we 
reconfirmed our primer design to make sure we were picking up our desired 
genes. It seemed the most likely explanation was a temperature issue. The 
secondary bands we were seeing were most likely caused by poorly annealing 
primers that were replicating smaller amplicons randomly. Ultimately, the way to 
determine what was going on was to increase annealing temperatures during the 
PCR run. In doing so we hoped to eliminate any nonspecific primer binding and 





Below are gel images from two of our experiments. Image A shows TSHβ during 
linear range amplification trials. As you can see there are two distinct bands. 
Unfortunately, even with increased annealing temperatures, this was one of the 
primer pairs that we were unable to completely correct. Although it may have 
been possible to get them working by further adjustments or redesigning new 
primers, the decision was made to discontinue our investigation of this gene 
(discussed in Chapter 2). 
 
Images B and C show experimental results of StAR detection. Our initial trials, 
seen in Image B, resulted in nonspecific binding and double bands. In this 
instance we were able to achieve results by raising the annealing temperature 
and adjusting the number of cycles. We confirmed proper PCR amplification by 













Appendix J: Protocol for Microwave Antigen Retrieval (MAR)  
and Immunohistochemistry (IHC)1 
 
Day 1 
1) Procedure has been optimized for free floating tissue sections. 
2) Place sectioned tissue into a six-well plate and rinse sections 2 X 10 
minutes in 0.02M KPBS at room temperature (RT) on an orbital shaker.  
Rather than transferring tissue keep sections in one plate as long as 
possible by suctioning out solutions. Alternatively, use individual mesh 
screen cups for each well so all tissues can be transferred together. This 
is the best method for microwave antigen retrieval (MAR) because it 
allows for a quick and efficient transfer during heating. 
3) Microwave antigen retrieval: 
a. Prepare 60 mL of 2X Antigen Retrieval Citra (BioGenex; San 
Ramon, CA) from stock and bring to RT. 
b. Irradiate* the beaker of retrieval solution at full power (level 10) for 
~60 seconds until the buffer boils**. Once it boils, quickly pour the 
solution into a six-well plate. Transfer the tissue from the wash 
plate to the retrieval solution. Heat the tissue at power level 4 for 20 
seconds so as to maintain the buffer at ~80oC. When finished 
remove plate and place on countertop so as to cool slowly to RT. 
c. After antigen retrieval a check of tissue integrity can be performed.  
Mount the treated sections onto slides and allow to air dry. Stain 
tissue with a contrasting stain (such as eosin-Y), dehydrate, and 
coverslip. Look at tissue under the microscope to determine if it has 
been damaged (i.e. holes, cellular degradation, etc). 
4) After cooling, transfer the tissue back to the six-well plate and wash 2 X 10 
minutes in 0.02M KPBS at RT on an orbital shaker. 
5) Optional step: Elimination of endogenous peroxidases. 
a. Transfer tissue into 0.3-2% hydrogen peroxide in absolute 
methanol for 20-60 minutes at room temperature (adjust % and 
time based on the nature of the tissue being stained). Incubation 
time will be reduced as you increase % of H2O2. When doing ICC 
for GnRH do not use methanol. Instead treat for 30 minutes in 1% 
hydrogen peroxidase made in 0.02M KPBS. 
b. Wash sections 2 X 10 minutes in KPBS at RT on an orbital shaker. 
c. In the case of the pituitary gland the nature of the tissue makes it 
too fragile to withstand incubation in hydrogen peroxide. 
6) Block non-specific binding sites by incubating sections in KPBS-B for 90 
minutes at RT using orbital shaker. 
7) Wash sections 2 X 10 minutes in 0.02M KPBS at RT on an orbital shaker. 
                                                 
1From Dr. Henryk Urbanski’s lab. Modification of original protocol from Dr. Susan Smith’s lab at ONPRC. The key to good 
antigen retrieval and IHC depends on three things: is the tissue mounted or free floating, what type of tissue is it, and what 
antibody is being used. This protocol should serve as a guideline and can be modified to fit the situation depending on 




8) Incubate sections in 1o antibody (Ab) diluted in KPBS-B (1:500) for 60 
minutes at RT followed by 24-48 hours at 4oC on orbital shaker.   
 
Day 2 
1. After incubation with the 1o Ab, wash tissue 4 X 10 minutes in 0.02M 
KPBS at RT on an orbital shaker. 
2. Dilute biotinylated 2o Ab 1:250 in KPBS-A. 
3. Incubate sections with biotinylated Ab for 60 minutes at RT on an orbital 
shaker. 
4. Wash tissue 4 X 10 minutes in 0.02M KPBS at RT on an orbital shaker. 
5. Incubate sections in Avidin: Biotinylated enzyme Complex (VECTASTAIN 
ABC System; Vector Laboratories; Burlingame, CA) made in KPBS-A for 
60 minutes at RT. Prepare the solution at least 1 hour prior to incubation. 
6. After ABC incubation wash sections 4 X 10 minutes in 0.02M KPBS at RT 
on an orbital shaker. 
7. Follow this with 2 X 10 minute rinses in 150 mM sodium acetate. 
8. While rinsing prepare the diaminobenzidine solution (DAB; Sigma; St. 
Louis, MO) under a fume hood. 
9. Just before using add 15 μL 30% H2O2 to the filtered 30 mL DAB. The 
DAB is now activated and must be used under a hood. DAB is extremely 
carcinogenic and mutagenic so use carefully.  
10. Aliquot appropriate volume of DAB into each well and observe.  The 
reaction will usually go very quickly.   
11. As sections turn brown transfer them back into sodium acetate and 
observe.  If more staining is needed return to DAB, otherwise move tissue 
to 0.02M KPBS to arrest the DAB reaction.   
12. When all sections are out of the DAB, wash 3 X 10 minutes in 0.02M 
KPBS at RT on an orbital shaker. 
 Treat all DAB exposed equipment with excess bleach.  Dumping 
and/or spraying bleach directly onto equipment will deactivate the 
DAB.  It can then be soaked in bleach water and left to stand for at 
least an hour.  Pour fluid down drain and wash equipment. 
13. Mount sections onto glass slides and allow to air dry for 1-2 hours. Label 
slides with HistoPrep pen in advance so information doesn’t come off 
during dehydrating and mounting. 
14. Dehydrate slides in ethanol series (70%, 90%, 100%) for 10 minutes per 
concentration. Skip the 70% wash if slides were allowed to dry overnight. 
15. Continue dehydrating slides through two stages of xylene for 10 minutes 
each. 
16. Coverslip each slide as it is removed from the final xylene wash. Slides 
can be left in the wash until ready to coverslip. 
17. Allow slides to air dry minimum of two hours. 
 
*Settings for the microwave in Dr. Urbanski’s lab: 
Specifications - 800 watt output, 1.25 KW power consumption, high frequency 




**To standardize timer and power level settings for different microwaves: 
1. Prepare beaker of retrieval solution as normal. 
2. Irradiate at maximal power level and register the time necessary to boil. 
3. Once buffer boils quickly distribute it evenly among a six well plate.  Turn 
power level to 2/3/4/5 and irradiate for 30-60 seconds (depending on 
tissue and antibody to be used).  Monitor to make sure buffer does not boil 
and check temperature after each trial.  If temperature tends to decrease 
repeat procedure with the next increasing power level. 
4. Proceed only when power, irradiation times, and liquid volume have been 
established for a given temperature. 
5. To obtain repetitive results remember to maintain the same total volume of 




0.12M KPBS Stock Solution 
1.47 g KH2PO4 
8.59 g K2HPO4 
27.0 g NaCl 
Add DEPC water to 400 mL. Adjust pH to 7.4 and complete volume to 500 mL.  
Autoclave. Adjust recipe for larger volumes. 
 
0.02M KPBS 
Dilute from 0.12M KPBS stock solution 
 
KPBS-A 
497.5 mL 0.02M KPBS  
  + 2.5 mL Triton X-100 (final concentration of 0.5%) 
Has a very long shelf life when stored at 4oC 
 
KPBS-B 
487.5 mL 0.02M KPBS  
2.5 mL Triton X-100 (final concentration of 0.5%) 
  + 10 mL heat inactivated (56oC for 30 minutes) 2% normal donkey serum  
Has a very long shelf life when stored at 4oC 
 
ABC (VECTASTAIN ABC System; Vector Laboratories; Burlingame, CA) 
 10 mL KPBS 
 20 µL Solution A 
  + 20 µL Solution B 
Make at least one hour prior to use 
 
1% H2O2 
 29 mL 0.02M KPBS 





150 mM sodium acetate 
136.1 g sodium acetate in 1 L water (1 M) 
75 mL of 1 M sodium acetate to total volume of 500 mL of water 
 
DAB (Sigma; St. Louis, MO) 
30 mL of 150 mM sodium acetate 
  +   One 10 mg DAB tablet 
Dissolve completely by stirring (protect from light while doing this) 
Add 15 µL of 30% H2O2 to activate solution 
 
1o Ab → rabbit anti-REV-ERBα (Lifespan Biosciences; Seattle, WA) 
2o Ab → donkey anti-rabbit IgG 
 
 
Tissue fixation prevents diffusion of soluble components and cellular 
decomposition, but is itself a major artifact when contemplating 
immunocytochemistry (IHC). Of main concern is masking of potential tissue 
antigens. When aldehyde-based fixatives are used (in our case 
paraformaldehyde), methylene bridges are formed between reactive sites on 
different portions of the same molecule or adjacent proteins. Fixation does not, 
however, alter the secondary protein structure. Consequently, the antigen is 
presumed to be masked in the fixed tissue rather than destroyed by the 
paraformaldehyde fixative making it possible to utilize microwave oven-boiled 
slides/tissue for IHC.  
 
The two most important factors influencing MAR effectiveness are the heating 
conditions (time and temperature) and pH value of the MAR solution. Although 
the exact chemical reaction is not clear, the mechanism of MAR-IHC appears to 
involve a renaturation of the structure of fixed proteins through a series of 
conformational changes, including the possible hydrolysis of formalin-induced 
cross-linkages (Shi et al., 2001). It appears that 0.01M citrate or bicarbonate 
buffer (pH 6.0) and 6M urea are superior as bath solutions during boiling 




Appendix K: Protocol for Fresh Sperm Processing2 
 
Caution: Primate semen potentially carries Herpes B virus. Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples. Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
Note: TALP-Hepes w/ BSA should be equilibrated to 37oC, pH 7.4.  TALP w/ 
BSA should be equilibrated to 37oC, 5% CO2, pH 7.4. Check pH prior to use. 
Sperm and TALP w/ BSA should be kept in loosely capped 15 mL conical 
centrifuge tube in the 37oC, 5% CO2, incubator as much as possible. 
 
1. Samples are collected into pre-weighed, sterile, plastic collection tubes. 
Animal ID#, date, animal technicians, sedative, stimulations, time of 
collection (T=0), and other comments are noted on the collection sheet. 
2. Sample (and tube) is weighed and placed in biosafety hood at room 
temperature in order to allow semen to exude from the contracting 
coagulum. Exudate will eventually be reabsorbed by coagulum if allowed 
to sit too long. Note appearance of whole sample on data sheet. 
3. Exactly 30 minutes (T=30) post-collection the liquid fraction of sample is 
transferred to a sterile 15 mL conical centrifuge tube using a P200 or 
P1000 pipetman. (One piece plastic pipets and serological pipets are toxic 
to sperm.  Never use these). Avoid transferring any coagulum. Volume is 
recorded to the nearest 0.01 mL. Remember to dispose of all equipment in 
the appropriate biohazard container or treat with bleach. 
4. While transferring make two 5 μL eosin-nigrosin (EN) morphology/viability 
slides for later analysis. Also note color of liquid fraction on data sheet. 
a. If volume is sufficient, the following measures should be taken, in 
descending order of importance: 
i. 5 μL into 100 μL HOS solution 
ii. pH using 5 μL and pH paper 
iii. osmolarity using 5 μL and osmometer 
5. Add 5 mL warm TALP-Hepes w/ BSA to the sample and gently mix using 
a pipetman. Avoid vigorous trituration as it can damage the sperm. Then 
add the remaining 10 mL of media.It is VERY IMPORTANT that the 
sample is thoroughly mixed for all washes in order to remove anti-
capacitation factors and debris. DO NOT wash coagulum. 
6. Sample is centrifuged at 130-150G for 10 minutes at room temperature 
(RT). Make sure the centrifuge is balanced with 15 mL water. Record color 
and weight of coagulum (and tube). 
7. After centrifugation the supernatant is immediately removed using a 
P1000 and/or P200 pipetman and clean tip. SAVE THIS FIRST WASH 
FOR ANALYSIS. Place wash in another clean 15 mL conical centrifuge 
tube.  Label with animal number and date and place in –80oC freezer for 
later analysis. 
                                                 




8. Add 5 mL warm TALP-Hepes w/ BSA to tube and gently resuspend sperm 
pellet with pipetman. Add another 10 mL of media. Centrifuge again at 
130-150G for 10 minutes. 
9. Repeat steps 7 and 8 for a total of three washes. Do not save the 
supernatant, instead dispose of it in a container with 10% bleach solution. 
After 20 minutes this can be dumped down the drain. 
10. After final centrifugation the pellet is carefully resuspended in 1 mL warm 
TALP w/ BSA using a P1000 pipetman. 
11. Count and concentration can be determined immediately and recorded on 
data sheet. While doing this the washed sperm should be placed loosely 
capped in the 37oC, 5% CO2 incubator. 
12. Check results of HOS test. This added time will allow the sperm to 
continue warming in the incubator after so much time washing at RT. 
13. Check motility and status. While checking motility also make note of 
agglutination and non-sperm cellular components (NSCC). 
14. Determine the volume of washed sample containing ~10 x 106 sperm. 
Aliquot this amount into a 15 mL conical centrifuge tube and bring to 1 mL 
in warm TALP w/ BSA. Place loosely capped in incubator at 37oC, 5% 
CO2 and record on data sheet. This dilution is needed for the Sperm-Zona 
Binding and Acrosomal Staining assay. (Depending on original 
concentration it may not be possible to have ~10 x 106 sperm/mL.) 
15. Depending on remaining washed sample volume, ~200 μL aliquots should 
be made for ROS, SCSA®, and membrane assays. Label screw-top 
cryovials with animal number, volume, and date and place in –80oC 
freezer for later analysis. Record volumes on data sheet. 
16. The remainder of the sample should be frozen in TEST-yolk extender with 
cryoprotectant.  If needed, reduce the volume aliquoted for assays in step 
16 in order to have an adequate concentration for freezing. Record 
volume on data sheet. 
Count and Concentration 
1. 190 μL milliQ H2O and 10 μL of sperm dilution from step 10 are combined 
into a 0.6 mL microcentrifuge tube.   
2. 10 μL of the mix is added to each side of a Neubauer or other 
hemocytometer with affixed cover slip. Let hemocytometer sit for 5 
minutes to make counting easier, but do not let fluid dry out. Sperm are 
counted using a phase contrast microscope. Make appropriate calculation 
corrections for the hemocytometer (if necessary) and average the results.  
Concentration is recorded in million sperm/mL (x 106 sperm/mL). 
3. If counts differ by >10% between sides then recount using fresh sample 





Motility and Status 
1. 190 μL warm TALP w/ BSA is aliquoted into a 0.6 mL microcentrifuge 
tube.  10 μL of sperm suspension from step 10 is added (1:20 dilution) and 
mixed gently but thoroughly. 
2. A 20 μL pipetman is used to place 10 μL of dilution onto a warm 
microscope slide.  A coverslip is carefully added. 
3. Motility is determined by counting 100 sperm using a phase contrast 
microscope (with stage warmer or warm room if possible). 
4. Status is determined by giving the sample an average score based on the 
following scale: 
  0 = all dead 
1 = slight side-to-side, no forward progress 
  2 = rapid side-to-side, no forward progress 
  3 = rapid side-to-side, forward progress in spurts 
  4 = slow, steady forward progress 




TALP (w/ BSA) 
157 mM NaCl     9.2 g / 1000 mL 
166 mM KCl    12.4 g / 1000 mL    (2.48 g / 200 mL) 
120 mM CaCl2 + 2H2O  17.6 g / 1000 mL    (3.52 g / 200 mL) 
120 mM MgCl2 + 6H2O  24.4 g / 1000 mL    (4.88 g / 200 mL) 
167 mM NaHCO3   14.0 g / 1000 mL    (2.80 g / 200 mL) 
295 mM glucose   53.1 g / 1000 mL    (26.55 g / 500 mL) 
 
1. Pour 500 mL NaCl stock solution into 1500 mL beaker. 
2. Add 10 mg (0.01 g ) phenol red. 
3. Make sodium lactate solution from 60% syrup [1:35 v/v (ex. 2 mL + 70 mL 
milliQ water)].  Add 67 mL to beaker. 
4. Add 1 mL gentamicin (50 mg/mL solution). 
5. Add the following stock solutions: 
a. KCl     19 mL 
b. CaCl2 + 2H2O   17 mL 
c. MgCl2 + 6H2O  4.1 mL 
d. NaHCO3  150 mL 
6. Dissolve 280 mg NaH2PO4 + H2O in 100 mL glucose stock.  Add 17 mL of 
this solution to beaker.  Add slowly in a dropwise fashion. 
7. Add 0.006 g (6 mg) sodium pyruvate. 
8. Add NaCl stock to bring final volume to 970 mL. 
9. Check osmolarity (between 285-295 mOsm).  Adjust with NaCl stock 
solution as needed. 





Prior to use: 
1. Place 100 mL TALP stock in beaker. 
2. Add 0.3 g (0.3%) BSA.  Let dissolve, do not stir. 
3. Sterile filter and store TALP w/ BSA in 37oC, 5% CO2, incubator for no 
more than one day. 
TALP-Hepes (w/ BSA) 
Combine the following ingredients into 1000 mL milliQ water 
NaCl    6.660 g 
KCl    0.239 g 
CaCl2 + 2H2O  0.294 g 
MgCl2 + 6H2O  0.102 g 
Na2HPO4   0.048 g 
glucose   0.900 g 
sodium lactate  1.87 mL 
phenol red   0.010 g 
NaHCO3   0.168 g 
gentamicin sulftate  0.050 g 
Hepes    2.603 g 
sodium pyruvate  0.060 g 
 
pH to 7.3-7.5 with osmolarity 275-290. Discard media if below 275 mOsm or 
above 300 mOsm.  If in the target range, use following formula to adjust: 
 
[initial reading – desired (280)] / initial reading = final volume 
 
Sterile filter and store at 4oC for one month. 
 
Prior to use: 
1. Place 100 mL TALP-Hepes stock in beaker. 
2. Add 0.3 g (300 mg / 0.3%) BSA.  Let dissolve, do not stir. 
3. Sterile filter and store TALP-Hepes w/ BSA in 37oC, 5% CO2, incubator for 
no more than one day. 
 
Expirations 
With Hepes = one month in refrigerator   
Without Hepes = one week in refrigerator 












Appendix L: Protocol for Sperm Hypo-osmotic  
Swelling Assay (HOS) 
 
Caution: Primate semen potentially carries Herpes B virus.  Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples.  Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
1. Incubate microcentrifuge tube containing 100 μL of HOS stock solution at 
37oC, 5% CO2, for 10 minutes. 
2. Add 5 μL of well-mixed, liquefied, raw semen to HOS solution and mix. 
3. Incubate semen/HOS solution mixture for at least 30 minutes, but not 
more than 3 hours, at 37oC, 5% CO2. 
4. After incubation place drop of well-mixed semen/HOS sample on a 
microscope slide and coverslip. 
5. Observe under phase contrast for sperm swelling. 
6. Count at least 100 (preferably 200) sperm per sample. 
7. Classify sperm as swollen or non-swollen and report as % swollen. 
 
Sperm swelling criteria 
1. Non-swollen – normal appearance 
2. Swollen – abnormal appearance 
a. Tip – tip of the tail is swollen, but the rest of the tail is normal 
b. Hairpin swelling – tail swells at midpiece and mainpiece junction 
i. with tip swelling 
ii. without tip swelling 
c. Shortened and thickened tail – tail swells, constricting surface and 
causing shortening 
d. Partly/completely enveloped sperm tail – tail balloons from swelling 
Results 
Normal –  >60%  Equivocal –  50-60%  Abnormal –  <50% 
 
Media/Buffers/Solutions 
Stock solutions for HOS solution 
1.5 mM fructose (MW 180.16)            2.70 g / 100 mL milliQ water 
1.5 mM sodium citrate + 2H2O (MW 294.1)          1.47 g / 100 mL milliQ water 
HOS stock 
1. Mix both solutions (fructose + sodium citrate) for final volume of 200 mL. 
2. Pipet 100 μL aliquots into disposable microcentrifuge tubes. 





Appendix M: Protocol for Sperm Morphology Staining 
 
Caution: Primate semen potentially carries Herpes B virus.  Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples.  Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
1. Label a frosted slide with animal number, date, and researchers initials. 
2. Prewarm slides and stain to 37oC. 
3. Pipet 5 μL raw semen sample and 5 μL eosin-nigrosin stain onto 2 slides. 
4. Mix together with wooden end of swab. 
5. Using a second slide, pull the droplet along the first slide to form a 
smooth, even smear. 
6. Dry the slide rapidly by placing on a slide warmer. 
7. Read immediately using phase contrast microscope as crystals and 
ferning start to appear if slide sits too long. 
8. Alternatively, slides can usually be read later if they are coverslipped with 
Permount mounting media to eliminate cracking.  
 
Criteria for scoring 
1. Live 
a. normal live sperm – unstained and morphologically normal 
b. abnormal live sperm – unstained but morphologically abnormal 
2. Dead 
a. normal dead sperm – stained but morphologically normal 
b. abnormal dead sperm – stained and morphologically abnormal 
 





 Appendix N: Protocol for Harvesting and Freezing Primate 
Oocytes for ZP Binding and Acrosomal Staining3 
 
Caution: All procedures should be done wearing a facemask to protect from 
potential Herpes B exposure from aerosols. 
 
1. Drain off the excess DPBS and transfer the ovaries to the 60 mm petri 
dish. Add enough fresh DPBS to keep the ovaries dampened. Remove 
excess tissue if needed. 
2. Holding the ovary with the forceps, bisect each ovary with the razor blade. 
3. Using the 1 cc syringe with 25 ga needle, puncture and tear all visible 
follicles on both ovaries. Turn ovaries over and repeat on the other side.  
Continue to shred the ovaries with the needles until no additional oocytes 




1. Stimulated ovaries are aspirated laparoscopically into 15 mL conical 
centrifuge tubes containing heparin and TALP-Hepes w/ BSA. 
2. Aspirates are taken to the ART Core for processing. 
3. Two days post-collection extra oocytes, of varying stages, are given to our 
lab in a four-well plate containing HECM-9 maturation medium. 
4. Remove the oocytes from the 60 mm petri dish or four-well plate using a 
micropipet and stripper tip. Place the oocytes into a 35 mm petri dish 
containing 2 mL fresh DPBS.  
5. Add 2 mL of 4M DMSO (becomes 4 mL of 2M DMSO). Add the DMSO 
slowly, swirling the dish constantly. If needed the 35 mm dish can be 
placed in the refrigerator for up to 24 hours although this is not optimal. 
6. Using a micropipet with a capillary tube adapter, load intact oocytes into 
the capillary tube. Load 5-10 oocytes into each tube 
7. Draw the column of fluid containing the oocytes up into the capillary tube 
so that there is an air gap of at least 5 mm at each end. Seal the end of 
the capillary tube with CritoSeal and remove from the micropipet. Seal the 
remaining end and place in a 15 mL conical centrifuge tube labeled with 
the animal ID, date, and your initials. 
8. Note on the centrifuge tube the total number of straws. Store the tube in 




4M DMSO in Dulbecco’s Phosphate Buffered Saline (DPBS) 
2.8 mL DMSO +  7.2 mL sterile filtered DPBS without calcium chloride 
Store at room temperature for 1 month 
 
                                                 




Appendix O: Protocol for Sperm Activation (Capacitation) 
for Zona Pellucida Binding and Acrosomal Staining4 
 
Caution: Primate semen potentially carries Herpes B virus.  Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples.  Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
1. Weigh5 194 mg caffeine into labeled sterile 15 mL conical centrifuge tube. 
Add 10 mL milliQ water and vortex to dissolve. 
2. Weigh4 49 mg dbcAMP into labeled 15 mL conical centrifuge tube.   
3. Add 1 mL caffeine solution to  dbcAMP and vortex to dissolve. 
4. Dilute the sperm to ~10 x 106 sperm/mL in warm TALP w/ BSA. This may 
already be done if the sperm was freshly processed. If different 
concentration make sure to note on data sheet. 
5. Pipet 1 mL diluted sperm into sterile 15 mL conical centrifuge tube. 
6. Add 10 μL of dbcAMP/caffeine solution to the 1 mL aliquot of diluted 
sperm. Incubate at 37oC, 5% CO2 with lid loosely capped for 15-30 min. 
7. Pipet 20 μL of activated sperm suspension onto a slide and quickly 
coverslip. Observe for activation and motility. If properly activated the 
sperm heads should have a distinct side-to-side movement. 
8. Make note of capacitation results on data sheet. 
 
 
                                                 
4 Modified from Cathi VandeVoort’s lab at CNPRC 
5 There are multiple ways to make these solutions depending on how many mL are needed.  The important thing is to 




Appendix P: Protocol for Sperm-Zona Pellucida Binding  
and Acrosomal Staining6 
Binding 
1. Setup five 35 mm petri dishes with 3-5 mL DPBS near the dissecting 
microscope. These will be used to wash the DMSO from the oocytes. It 
may be useful to draw small circular targets on the underside of the plates 
to help keep track of the oocytes. 
2. Place a 75 μL drop of TALP w/ BSA in the middle of a 35 mm petri dish, fill  
dish with mineral oil, label ‘zona’ and place in 37oC, 5% CO2 incubator. 
3. Prepare a dish for each male to be used by drawing a 10μL ‘disk’ of TALP 
w/ BSA on the bottom of a labeled 35 mm petri dish. Add ~3mL of mineral 
oil and place in the 37oC, 5% CO2 incubator.   
4. Label the frosted end of a 10-well Teflon-masked slide with the male ID #, 
date, and your initials and place on the left rear of the dissecting 
microscope stage. 
5. Oocytes are kept frozen at –80oC in capillary tubes (5-10 oocytes/tube).  
Remove the needed number of tubes from the freezer and allow to thaw at 
RT. Carefully score and break off the ends of the tube just below the 
CritoSeal and use the capillary tube adapter and micropipet to expel the 
tube’s contents into the first 35 mm petri dish of DPBS. Repeat if needed, 
placing all the oocytes into the same dish. It may be necessary to rinse the 
tube with the well solution in order to free all the oocytes. 
6. Using a micropipet and stripper tip, transfer oocytes through the remaining 
dishes to wash off the freezing medium. Check that all cumulus cells have 
been removed from the oocytes and remove any that might be remaining. 
7. Transfer the rinsed oocytes to the 75 μL drop of TALP w/ BSA in the 35 
mm petri dish labeled ‘zona’. Return it to the 37oC, 5% CO2 incubator until 
needed. Dispose of the washing plates. 
8. Prepare the activated sperm according to protocol at a dilution of ~10 x 
106 sperm/mL. 
9. During activation place the Boerner 9-well glass plate near the dissecting 
microscope. Fill each well with ~500 μL DPBS.  These will be used to 
rinse the oocytes after binding. Place a 35 mm petri dish at the upper left 
of the microscope on a Kimwipe-covered ice pack and pipet 2-3 mL of ice-
cold ethanol into the dish. Immediately before sperm activation is 
complete place the ‘zona’ dish on the rear right of the microscope. 
10. After activation pipet 90 μL of sperm through the oil of the appropriate petri 
dish, adding to the 10 μL disk to create a 100 μL dome.  (Try to avoid 
making a bubble that can trap oocytes later). 
11. Using a micropipet and stripper tip, transfer the desired number of oocytes 
from the ‘zona’ dish into the activated sperm drop. Incubate for EXACTLY 
the predetermined time (i.e. 30 seconds) and then transfer into the DPBS 
in the Boerner plate. 
                                                 




12. Transfer the oocytes through four more wells to wash off any unbound 
sperm before moving the oocytes to the petri dish of iced ethanol. 
Remember to use one of the extra DPBS wells to flush the pipet tip 
between transfers. 
13. The oocytes and bound sperm are now fixed and can be mounted to a 10-
well Teflon-masked slide. Transfer them to the appropriately labeled well. 
14. Allow the slide to dry VERY WELL then place in a slide box at –20oC or    
–80oC (non-frostfree) until staining. They should not be left more than a 
few weeks before staining. If the slide is to be stained immediately pipet 
~30 μL of 4% paraformaldehyde onto each used well and allow to 
incubate for 10 minutes. 
Staining 
1. If the slide(s) has been frozen, warm to room temperature and then pipet 
30 μL of 4% paraformaldehyde onto each used well. Make sure slide is 
completely warm or oocytes may come loose during processing. Incubate 
for 10 minutes. Move the slide to a 100 mm petri dish containing a small 
water-soaked pad to maintain humidity. Rinse each well with 30 μL DPBS 
for 5 minutes. While observing the slide on the dissecting microscope 
remove the DPBS with a micropipet and stripper tip, being careful to 
remove as much as possible without disturbing the oocytes. This 
technique should be used for all subsequent washes/removals to avoid 
freeing the oocytes from the slide and ultimately losing or destroying them. 
Repeat two more times. 
2. Pipet 30 μL of BSA blocking solution onto each well used and incubate at 
RT for 15 minutes. Prepare the 1:30 RAS dilution (10 μL RAS + 290 μL 
blocking solution) during this incubation. 
3. Pipet 30 μl of RAS onto each well used. Cover the petri dish and place in 
incubator at 37oC for 60 minutes. 
4. Remove the RAS solution with micropipet and stripper tip. Add 30 μl of 
BSA blocking solution to each well used in order to wash off the excess 
RAS. Incubate at room temperature for 5 minutes and then remove 
blocking solution. Repeat two more times. During the last RAS wash 
prepare the FGAR dilution (1 μL FGAR + 49 μL blocking solution). 
5. ALL REMAINING STEPS ARE DONE WITH THE ROOM DARK. A red 
filter can be placed over the microscope light source in order to protect the 
stain from photobleaching. 
6. After removing the last wash from the slide, pipet 30 μL of the FGAR 
dilution onto each well used. Cover and place in the incubator at 37oC for 
60 minutes. 
7. Remove the FGAR solution with micropipet and stripper tip. Wash off the 
excess FGAR by pipetting 30 μl of BSA blocking solution to each well 
used. Incubate at RT for 5 minutes and then remove blocking solution. 
Repeat two more times. During the third wash dilute the Hoescht 33,258 in 
DPBS (10 μL Hoescht stock + 190 μL DPBS).   




to each well used. Place in the 37oC incubator, covered, for 20 minutes. 
9. Remove the H258 with micropipet and stripper tip. Wash off the excess 
H258 by pipetting 30 μL of DPBS to each well used. Incubate at RT for 5 
minutes under an inverted slide box. Remove the DPBS. Repeat once. 
10. After the final wash allow the slide to dry at RT under a slide box to block 
out light. Once dry place a 5 μL drop of Permount mounting medium on 
each well used and cover with a coverslip. Carefully remove excess 
bubbles with a pipet tip pressed against the coverslip. 
11. Observe on the fluorescence microscope. If needed, slides can be stored 
in a slide box at 4oC until viewed. They should not be left more than a few 
weeks before reading. 
Criteria for Scoring 
1. Using the filter for Hoescht 33,258, first count the total number of sperm 
bound to the oocyte zona. Start at the top of the oocyte and work down to 
the bottom of the slide. Hoescht is a DNA/chromatin stain that is able to 
penetrate the sperm and oocyte due to the ethanol fixation step. 
2. Next begin taking a count of the total number of sperm for which an 
acrosomal status can be determined. It will be less than the total bound 
because the double Ab staining cannot penetrate to the sperm trapped 
between the oocyte and slide. This is done by switching to the FITC filter 
and moving away from the slide. 
3. When the first clearly stained FITC sperm is observed alternate between 
the Hoescht and FITC filters. If a sperm’s acrosome is intact it will appear 
as a ¾ head. If a sperm is seen under H258 and disappears with FITC 
then it is acrosomally reacted. 
Media/Buffers/Solutions 
 
4% paraformaldehyde in Dulbecco’s Phosphate Buffered Saline (DPBS) 
10.8 mL of 37% paraformaldahyde + 89.2 mL sterile filtered DPBS without 
calcium chloride 
Aliquot into 1.6 mL tubes (leaving very little air) and store at –20oC indefinitely 
Thaw with hot water when ready to use (making sure crystals go into solution) 
 
blocking solution 
10mg/mL (1%) BSA in DPBS.  Freeze 1 mL aliquots and store at –20oC  
 
• rabbit antiserum (RAS) [freshly diluted to 1:30 in blocking solution] 
• FITC-goat anti-rabbit IgG (FGAR) [freshly diluted 1:50 in blocking solution] 
• bisbenzimide fluorochrome (Hoescht 33,258) [freshly diluted 1:20 in DPBS 
from frozen 10μg/mL stock7] 
                                                 
7 bisbenzimide fluorochrome stock:  1mg bisbenzimide dissolved in 1mL distilled water.  Store 1mg/ml concentrate at –
20oC in an amber vial or wrapped in foil.  Dilute 10μl concentrate with 0.99ml DPBS to make a 10μg/ml stock.  Store at 




Appendix Q: Protocol for Sperm Cryopreservation8 
 
Caution: Primate semen potentially carries Herpes B virus.  Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples.  Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
1. Begin with a washed and prepared sample in TALP w/ BSA. 
2. If not already, place the specimen in a 15 mL conical centrifuge tube and 
centrifuge at 130-150G for 10 minutes. 
3. While centrifuging add 60 μL glycerol (cryoprotectant) to 940 μL TEST-
yolk extender and vortex. Refrigerate the 6% glycerol solution until needed 
4. After centrifuging remove supernatant and discard in 10% bleach solution.  
Resuspend pellet in the second vial of TEST-yolk extender to 1 mL. 
5. Place the tube in a beaker filled with cool water. Slowly add 330 μL of 
glycerol solution dropwise to extended sperm, mixing after every few 
drops. 
6. Place the beaker containing the specimen into the refrigerator for 10 min. 
7. Add another 330 μL of glycerol solution to the sample, gently mix in the 
same way, and return to refrigerator for 10 minutes. 
8. Add the last third of the glycerol, mixing gently, and return to refrigerator 
for 60 minutes. 
9. Prelabel enough Nalgene screw-top cryovials to hold all the pellets to be 
made (vials can hold about fifteen 50 μL pellets).  Place vials and caps in 
a shallow bucket containing liquid nitrogen until needed. 
10. Set up small block of dry ice on lid of styrofoam container. Create small 
depressions in the dry ice with the connected end of a pair of forceps or 
other tool. Clean the item before using it to make the depressions. 
11. When 60 minute cooling is complete, mix sperm gently with pipet and 
begin aliquoting 50 μL drops directly onto the dry ice. Pellets should freeze 
in ~1 minute. 
12. Within 1-3 minutes remove pellets from dry ice by dumping them into 
shallow bucket of LN2 (the pellets should look like cooked egg yolks).  Be 
careful as the pellets slide off very easily.  If the LN2 is too deep it will be 
hard to see the pellets and load them properly. 
13.  Use forceps to hold cryovials under the liquid nitrogen while loading 
pellets with another pair of forceps. Seal the vials tightly with liquid 
nitrogen still in them. 
14. Return capped cryovials to liquid nitrogen bucket until all pellets are 
loaded.  Quickly load vials into canes and store in designated LN2 tank. 
15. Record animal ID#, date, motility, concentration, number of pellets per 
vial, and number of vials on data sheet. 
 
                                                 






  g/100 mL 
TES  4.326   penicillin G/streptomycin sulfate 1.000 mL 
Trizma base 1.027    fresh egg yolk        60 mL 
(D+)glucose 1.000   skim milk         40 mL 
Day 1 
1. Bring the first three ingredients to 100 mL with milliQ water. 
2. Adjust pH to 7.4 with 1.0M NaOH or 1.0M HCl. 
3. If needed, sterile filter the buffer and store in refrigerator overnight.  
Otherwise continue with next step. 
4. Combine 60 mL egg yolk with 40 mL skim milk and mix well. 
5. Combine the buffer solution with 25 mL of the egg-milk mixture. 
6. Inactivate the solution (125 mL) at 56oC for 30-60 minutes while stirring.  
This can be done by submersing an Erlenmeyer flask into a larger beaker 
of water.  Place the beaker on a hot plate.  Monitor water temperature, 
adding ice whenever it becomes too hot. 
7. Cool to less than 20oC in the refrigerator. 
8. Add 1 mL pen/strep. 
9. Store in refrigerator overnight.  This is supposedly to allow some 
sedimentation to occur, but it seems to be very minimal.  Centrifugation 
later will take care of most of the protein sediment.  If needed this step can 
be skipped and continue with step 10 immediately. 
Day 2 
10. The next day do not resuspend the solution, but instead remove 
supernatant and transfer to an appropriate centrifuge tube(s). 
11. Centrifuge for 4 hours at 100,000G.  Use the Beckman Ultracentrifuge 
(L7-65, rotor SW-28) with the Molecular Core in the Cooley Building.  Spin 
at 27,000 RPM to get close to 100,000G.  Should be able to spin three 
~35 mL tubes of cryoprotectant (and one water blank) at one time.   
12. Remove and save supernatant.  Centrifuge supernatant for 2 more hours 
at 100,000G. 
13. Remove supernatant and measure pH (7.4) and osmolarity (?).  Adjust if 
necessary. 
14. Filter through 0.45 μM syringe filters (in ART Core).  A fresh filter is 
required for every ~10 mL of extender or whenever it becomes too difficult 
to filter properly. 
15. Freeze in 1 mL aliquots at –80oC in cryovials for one month. 
 
To use TEST-yolk extender 





Appendix R: Protocol for Frozen/Thawed Sperm Processing9 
 
Caution: Primate semen potentially carries Herpes B virus.  Lab coat, gloves, 
mask, and goggles (or face shield) must be worn when handling primate semen 
samples.  Also remember to dispose of all biomaterial and/or equipment in the 
appropriate biohazard containers or treat with bleach. 
 
1. Sperm pellets are kept in cryovials in liquid nitrogen tank. Pellets should 
be at a concentration of ~0.5-1 x 106 sperm/pellet, but this should be 
verified by looking at the freezing record that corresponds to the sample. 
Place appropriate number of pellets in a sterile 15 mL conical centrifuge 
tube (without any media). We want ~1-2 x 106 total sperm for analysis. 
2. Place the capped centrifuge tube in a 37oC water bath for 40 seconds 
(warming rate of 350oC/minute). 
3. After thawing note pellet volume to nearest 0.05 mL with pipet. Add 15 mL 
warm TALP-Hepes w/ BSA to the tube and resuspend the pellet(s) by 
gently triturating using the pipetman. Take care to avoid vigorous mixing 
as it can damage the sperm. 
4. Centrifuge the sperm suspension at 130-150G for 8 minutes. Make sure 
the centrifuge is balanced with 15 mL water. 
5. After centrifuging remove supernatant and discard in 10% bleach solution. 
Add warm TALP w/ BSA to pellet to achieve a concentration of ~1-2 x 106 
sperm/mL (100µL) and gently resuspend. Count and concentration can be 
determined and morphology slides can be made at this point if desired. 
6. The washed sperm should be placed in the 37oC, 5% CO2, incubator 
(loosely capped) for 30 minutes before checking motility and status again.  
 
Count and Concentration 
1. 190 μL milliQ H2O and 10 μL of sperm suspension are combined into a 0.6 
mL microcentrifuge tube (1:20 dilution) and mixed gently but thoroughly.   
2. 10 μL of the mix is added to each side of a Neubauer or other 
hemocytometer with affixed cover slip.  Let hemocytometer sit for 5 
minutes to make counting easier, but do not let fluid dry out.  Sperm are 
counted using a phase contrast microscope.  Make appropriate calculation 
corrections for the hemocytometer (if necessary) and average the results.  
Concentration is recorded in million sperm/mL (x 106 sperm/mL). 
3. If counts differ by >10% between sides then recount using fresh sample 
until <10%.  Average results. 
 
 
                                                 




Motility and Status 
1. A 20 μL pipetman is used to place 10 μL of washed sperm suspension 
onto a warm microscope slide.  A coverslip is carefully added. 
2. Motility is determined by counting 100 sperm using a phase contrast 
microscope (with stage warmer or warm room if possible). 
3. Status is determined by giving the sample an average score based on the 
following scale: 
  0 = all dead 
1 = slight side-to-side, no forward progess 
  2 = rapid side-to-side, no forward progress 
  3 = rapid side-to-side, forward progress in spurts 
  4 = slow, steady forward progress 
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